Published;Title;Content;Entities;Categories;AYLIEN sentiment
2020-08-21  18:45;Prashant Khemka’s White Oak to acquire India’s smallest mutual fund;"White Oak Capital Management, a boutique investment management and advisory firm set up by former Goldman Sachs executive Prashant Khemka, will acquire the mutual fund arm of troubled private-sector lender Yes Bank.

The bank said in a stock-exchange filing Friday it has signed a pact to sell wholly owned subsidiaries YES Asset Management (India) Ltd and YES Trustee Ltd to White Oak-controlled GPL Finance and Investments Ltd.

Yes Bank said the deal value will be determined at the time of closing the transaction. The deal is likely to be complete in eight to 12 months’ time.

Yes AMC had a net worth of Rs 49.7 crore and revenue of Rs 33 lakh for the financial year ended March 2020.

Yes Mutual Fund is the smallest of India’s 44 mutual funds by assets under management. It had average assets under management of only Rs 56.98 crore for the April-June quarter, according to the Association of Mutual Funds in India.

This is a third of the average AUM of the second-smallest fund house, Shriram Mutual Fund, and a fraction of the average AUM of Rs 3.5-3.6 trillion that market leaders SBI Mutual Fund and HDFC Mutual Fund command.

Yes Bank has been struggling for the past several months as bad loans soared and it failed to raise fresh capital. In March, the bank was rescued by a group of state-run and private-sector lenders under a plan monitored by the Reserve Bank of India and approved by the government. As per the plan, State Bank of India took a 49% stake in the cash-starved lender while ICICI Bank, Axis Bank, Kotak Mahindra Bank, Bandhan Bank and mortgage lender HDFC Ltd also pitched in.

As for Khemka, he set up White Oak Capital in 2017, two months after quitting Goldman Sachs as managing director and chief investment officer of global emerging markets equities.

During his stint at Goldman, Khemka set up an India-focused equity fund in 2006 and oversaw emerging markets assets worth $5.3 billion.

The investment firm’s first India-dedicated debut fund had raised about Rs 1,200 crore (over $150 million) from high-net-worth individuals in 2018.

In April last year, VCCircle reported that White Oak’s second fund is exploring funding opportunities before initial share sales. The closed-ended fund has an investment window of four to five years and would back listed companies.

White Oak also advises London-listed Ashoka India Equity Investment Trust, which mainly invests in securities listed in India and listed securities of companies with a significant presence in India. The fund previously backed HDFC Asset Management Company.";"{'body': [{'indices': [[0, 4],
                       [376, 380],
                       [1637, 1641],
                       [2121, 2125],
                       [2311, 2315]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Race_and_ethnicity_in_the_United_States_Census'},
           'score': 0.9991717338562012,
           'text': 'White',
           'types': ['Disease', 'Items']},
          {'indices': [[2410, 2419], [2448, 2457]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Security_(finance)'},
           'score': 0.9977342486381531,
           'text': 'securities',
           'types': ['Asset', 'Agent']},
          {'indices': [[597, 605]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Net_worth'},
           'score': 0.9903386235237122,
           'text': 'net worth',
           'types': ['Organisation', 'Assets']},
          {'indices': [[1852, 1857]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.6309710741043091,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[156, 166]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 1.0,
           'text': 'mutual fund',
           'types': ['PersonFunction']},
          {'indices': [[738, 749]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 0.9896218180656433,
           'text': 'mutual funds',
           'types': ['PersonFunction']},
          {'indices': [[41, 61]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Investment_management'},
           'score': 0.9622542858123779,
           'text': 'investment management',
           'types': ['Company', 'PersonFunction', 'Management']},
          {'indices': [[1764, 1779], [1884, 1899]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Emerging_markets'},
           'score': 0.9840604066848755,
           'text': 'emerging markets',
           'types': ['Country', 'MusicalArtist']},
          {'indices': [[1520, 1528]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_Bank'},
           'score': 1.0,
           'text': 'Axis Bank',
           'types': ['Organisation', 'Company', 'Bank', 'Agent']},
          {'indices': [[1531, 1549]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Kotak_Mahindra_Bank'},
           'score': 1.0,
           'text': 'Kotak Mahindra Bank',
           'types': ['Organisation', 'Banking', 'Company', 'Bank', 'Agent']},
          {'indices': [[342, 346],
                       [727, 731],
                       [917, 921],
                       [1383, 1387],
                       [1452, 1456],
                       [1838, 1842],
                       [1957, 1961],
                       [2355, 2359],
                       [2431, 2435],
                       [2503, 2507]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9989116787910461,
           'text': 'India',
           'types': ['Location',
                     'MusicalArtist',
                     'PopulatedPlace',
                     'Country',
                     'Place']},
          {'indices': [[221, 224], [1269, 1272]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bank'},
           'score': 0.9992879629135132,
           'text': 'bank',
           'types': ['PersonFunction', 'University', 'Institution']},
          {'indices': [[645, 648]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Organisation', 'Unit']},
          {'indices': [[98, 110], [1690, 1702]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Goldman_Sachs'},
           'score': 0.9999650716781616,
           'text': 'Goldman Sachs',
           'types': ['Organisation', 'Company', 'Bank', 'Agent']},
          {'indices': [[618, 622], [835, 839], [2010, 2014]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[1729, 1752]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Chief_investment_officer'},
           'score': 1.0,
           'text': 'chief investment officer',
           'types': ['Title', 'PersonFunction']},
          {'indices': [[519, 526]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/The_Deal_(2003_film)'},
           'score': 0.9714586734771729,
           'text': 'The deal',
           'types': ['Film', 'Product', 'TelevisionShow', 'Work']},
          {'indices': [[1469, 1473]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Stake_(Latter_Day_Saints)'},
           'score': 0.6530019044876099,
           'text': 'stake',
           'types': ['Organisation', 'Unit']},
          {'indices': [[1508, 1517]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/ICICI_Bank'},
           'score': 1.0,
           'text': 'ICICI Bank',
           'types': ['Organisation', 'Banking', 'Company', 'Bank', 'Agent']},
          {'indices': [[2348, 2353]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ashoka'},
           'score': 0.9988911747932434,
           'text': 'Ashoka',
           'types': ['Emperor', 'Person', 'Royalty', 'Agent']},
          {'indices': [[587, 589]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
           'score': 0.6511716842651367,
           'text': 'AMC',
           'types': ['Broadcaster',
                     'Cable',
                     'Organisation',
                     'TelevisionStation',
                     'Agent']},
          {'indices': [[610, 611],
                       [639, 640],
                       [826, 827],
                       [1053, 1054],
                       [2001, 2002]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place', 'Person']},
          {'indices': [[826, 833]],
           'links': None,
           'score': None,
           'text': 'Rs 56.98',
           'types': ['Place']},
          {'indices': [[2334, 2339]],
           'links': None,
           'score': None,
           'text': 'London',
           'types': ['Place']},
          {'indices': [[568, 573], [1190, 1195], [1668, 1673]],
           'links': None,
           'score': None,
           'text': 'months',
           'types': ['Person']},
          {'indices': [[0, 8],
                       [376, 384],
                       [1637, 1645],
                       [2121, 2129],
                       [2311, 2319]],
           'links': None,
           'score': None,
           'text': 'White Oak',
           'types': ['Person', 'Organisation']},
          {'indices': [[0, 27]],
           'links': None,
           'score': None,
           'text': 'White Oak Capital Management',
           'types': ['Organisation']},
          {'indices': [[131, 136], [1619, 1624], [1821, 1826]],
           'links': None,
           'score': None,
           'text': 'Khemka',
           'types': ['Organisation']},
          {'indices': [[210, 213],
                       [435, 438],
                       [1144, 1147],
                       [1375, 1378],
                       [1444, 1447],
                       [1514, 1517],
                       [1525, 1528],
                       [1546, 1549],
                       [1560, 1563]],
           'links': None,
           'score': None,
           'text': 'Bank',
           'types': ['Organisation']},
          {'indices': [[320, 339]],
           'links': None,
           'score': None,
           'text': 'YES Asset Management',
           'types': ['Organisation']},
          {'indices': [[342, 351]],
           'links': None,
           'score': None,
           'text': 'India) Ltd',
           'types': ['Organisation']},
          {'indices': [[357, 371]],
           'links': None,
           'score': None,
           'text': 'YES Trustee Ltd',
           'types': ['Organisation']},
          {'indices': [[692, 706]],
           'links': None,
           'score': None,
           'text': 'Yes Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[886, 912]],
           'links': None,
           'score': None,
           'text': 'Association of Mutual Funds',
           'types': ['Organisation']},
          {'indices': [[956, 958], [1046, 1048]],
           'links': None,
           'score': None,
           'text': 'AUM',
           'types': ['Organisation']},
          {'indices': [[995, 1013]],
           'links': None,
           'score': None,
           'text': 'Shriram Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1093, 1107]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1113, 1128]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[206, 213], [431, 438], [1140, 1147]],
           'links': None,
           'score': None,
           'text': 'Yes Bank',
           'types': ['Organisation']},
          {'indices': [[1367, 1387]],
           'links': None,
           'score': None,
           'text': 'Reserve Bank of India',
           'types': ['Organisation']},
          {'indices': [[1438, 1456]],
           'links': None,
           'score': None,
           'text': 'State Bank of India',
           'types': ['Organisation']},
          {'indices': [[1552, 1563]],
           'links': None,
           'score': None,
           'text': 'Bandhan Bank',
           'types': ['Organisation']},
          {'indices': [[1585, 1592]],
           'links': None,
           'score': None,
           'text': 'HDFC Ltd',
           'types': ['Organisation']},
          {'indices': [[0, 16], [1637, 1653]],
           'links': None,
           'score': None,
           'text': 'White Oak Capital',
           'types': ['Organisation']},
          {'indices': [[98, 104], [1690, 1696], [1812, 1818]],
           'links': None,
           'score': None,
           'text': 'Goldman',
           'types': ['Organisation']},
          {'indices': [[2098, 2105]],
           'links': None,
           'score': None,
           'text': 'VCCircle',
           'types': ['Organisation']},
          {'indices': [[2348, 2383]],
           'links': None,
           'score': None,
           'text': 'Ashoka India Equity Investment Trust',
           'types': ['Organisation']},
          {'indices': [[2537, 2565]],
           'links': None,
           'score': None,
           'text': 'HDFC Asset Management Company',
           'types': ['Organisation']}],
 'title': [{'indices': [[18, 22]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Race_and_ethnicity_in_the_United_States_Census'},
            'score': 0.9988188147544861,
            'text': 'White',
            'types': ['Disease', 'Items']},
           {'indices': [[56, 66]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
            'score': 1.0,
            'text': 'mutual fund',
            'types': ['PersonFunction']},
           {'indices': [[39, 43]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
            'score': 0.9999122619628906,
            'text': 'India',
            'types': ['Location',
                      'MusicalArtist',
                      'PopulatedPlace',
                      'Country',
                      'Place']},
           {'indices': [[9, 14]],
            'links': None,
            'score': None,
            'text': 'Khemka',
            'types': ['Person']},
           {'indices': [[18, 26]],
            'links': None,
            'score': None,
            'text': 'White Oak',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.5699999928474426,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.28999999165534973,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': '04006002',
 'label': 'banking',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04006002',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04006000'},
 'score': 0.23000000417232513,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'neutral', 'score': 0.551239},
 'title': {'polarity': 'neutral', 'score': 0.696357}}"
2020-08-18  03:21;Glenmark Pharmaceuticals Ltd (GLKQY) CEO Glenn Saldanha on Q1 2021 Results-Earnings Call Transcript;"Ladies and gentlemen, good day, and welcome to the Q1 FY '21 Earning Conference Call of Glenmark Pharmaceuticals Limited. [Operator Instructions] Please note that this conference is being recorded.

I would now like to hand the conference over to Mr. Jason D’souza. Thank you, and over to you, sir.

Thank you, Janice. Apologies for the delay in the earnings call. We had a problem with the audio bridge. We'll begin Glenmark's Q1 Earnings Call.

Before we start the review of the operations for the quarter ended June 30, 2020: For the first quarter FY '21, Glenmark's consolidated revenue was at INR 23,447 million, recording an increase of 0.94%.

Business update on account of the COVID situation. The COVID-19 pandemic had a significant impact in India, as the entire country was under lockdown in April and most part of May. While the pharmaceutical plants being essential services were allowed to operate, it was challenging to run our production facilities in the month of March and April. By the middle of May, things started to settle down. Glenmark's manufacturing units managed to stabilize. Production and logistics were also in place to ensure uninterrupted supplies. Across all our markets, the operating environment, demand improved in June compared to April, May as the lockdown was lifted in many countries. From June till date, India has seen a significant surge in COVID-19 cases. This is leading to increasing number of COVID-19 cases at our manufacturing facilities. At Glenmark, we have a strong commitment and robust processes to ensure employee safety in these challenging times. We have instituted stringent SOPs to protect employees and their families. At the same time, we remain committed to our patients across the world and have put in place contingency plans to prevent medicine shortages for our patients.

Over to the business. GPL India: Sales from the formulation business in India for the first quarter FY '21 was INR 7,798 million, recording growth of 3.68%. The Indian business continued to outperform the industry growth as per IQVIA Q1 FY '21, recording growth of 5.5% as compared to the IPM de-growth of 1.8%. In terms of market share, Glenmark's India business strengthened its position in its core therapy areas such as cardiac, diabetes and respiratory.

In a landmark development for COVID-19 patients in India, after successfully conducting Phase III clinical trials, Glenmark became the first company to develop and launch an antiviral drug, Favipiravir, brand name FabiFlu, for the treatment of mild to moderate COVID-19 patients in June 2020. Glenmark received manufacturing and marketing approval from India's drug regulator as part of the accelerated approval process considering the emergency situation of the COVID-19 outbreak in India. The approval's restricted use entails responsible medication use where every patient must have signed informed consent before treatment initiation. Till date, Glenmark is the only company to have conducted a Phase III clinical trials on Indian patients with Favipiravir. Glenmark is also conducting another combination study along with Umifenovir, and those results also will be there shortly. Glenmark also recently introduced a 400 mg version of oral antiviral Favipiravir, FabiFlu, for the treatment of mild to moderate COVID-19 in India. The higher strength will improve patient compliance and experience by effectively reducing the number of tablets that patients require per day. During the quarter, Glenmark introduced a 3-in-1 inhaler therapy, AIRZ-FF, for COPD in India promising reduced risk of severe attacks and improvement in lung function.

Glenmark's novel, patent-protected, globally researched SGLT2 remogliflozin etabonate continues to do well in India. Glenmark is the first company in the world to launch remogliflozin, and the response from KOLs has been extremely encouraging.

Glenmark's consumer care business. The FMCG industry faced headwinds in the first quarter of the financial year, with a 17% decline in sales. And the GCC business also reflected a similar trend. The business delivered an overall top line value of INR 310.8 million in the first quarter with a decline of 15%, excluding VWash sales.

The U.S. business. Glenmark Pharmaceuticals U.S. revenue was INR 7,426 million, USD 98.51 million, for the quarter ended, recording growth of 1.61%. In the first quarter of the financial year, Glenmark was granted final approval and launched chlorzoxazone tablets 375 mg and 750 mg. In addition, Glenmark launched further 2 tablets. 1 additional tablet -- 1 additional approval was obtained for fingolimod capsules 0.5 mg. The company filed 3 ANDA applications with the U.S. FDA and plans to file additional 3 applications in the forthcoming quarter.

As part of its investigation into various generic pharmaceutical companies regarding antitrust violations, the United States Department of Justice filed an indictment in the United States District Court for the Eastern District of Pennsylvania which charges the company with one count of conspiracy to restrain trade. The indictment asserts that Glenmark engaged in a conspiracy to suppress and eliminate competition by agreeing to increase and maintain prices of pravastatin and other generic drugs sold in the United States. These charges run contrary to the very essence of Glenmark to drive down drug prices and improve patient access to medications. We strongly disagree with the false allegations being advanced by the justice department and do not believe the evidence supports the case. We will continue to vigorously defend against these charges, and we are confident that the overwhelming evidence will make that clear.

Glenmark's marketing portfolio through June 30, 2020, consists of 164 generic products authorized for distribution in the U.S.

Africa, Asia and CIS region. For the first quarter, revenue from Africa, Asia and CIS region was INR 2,120 million, recording a de-growth of minus 18.05%. In the first quarter of the financial year, secondary sales for the Russian subsidiary showed 23.2% de-growth in value. The Russia business continued to be subdued in the first quarter, and currency devaluation further impacted the business.

In the first quarter of the financial year, most of the Asian markets observed lockdown due to COVID-19, which has -- which impacted patient flows to the clinic or hospital OPD. Due to this, the Asia region continued to be under pressure, registering secondary de-growth, sales de-growth, of minus 9% for the first quarter of the financial year. The Philippines subsidiary, which is the largest, was impacted severely in terms of sales. The Africa region was also impacted due to the pandemic.

Glenmark's Europe operations for the first quarter recorded growth of 12.77%. The Western European business recorded good growth in the first quarter on account of the growth in the U.S. -- U.K. subsidiary and the Nordic region. The U.K. subsidiary managed to gain some good business opportunities presented due to competition being unable to service the market. The Nordic region performed well with the launch of Salmex across most Nordic markets. The U.K. and German subsidiary launched 3 products during the quarter.

Latin America. Glenmark's revenue from Latin America was at INR 658 million, recording de-growth of minus 18.89%. The Brazilian subsidiary recorded good growth in constant currency on account of the 3 in-licensed products. However, due to the lockdown, the Mexico subsidiary de-grew by 33%, which impacted the performance in the region. Further, the performance in the region was impacted due to all currencies weakening in the quarter.

Ryaltris nasal spray is the company's respiratory pipeline asset and is currently under review in the U.S. FDA as a treatment for seasonal allergic rhinitis in the U.S. During the first quarter, Glenmark's partner Seqirus enabled the commercial launch of Ryaltris in Australia. Glenmark plans to initiate commercial launch in South Africa and Namibia in the second quarter of the financial year. Glenmark is also supporting its partner in South Korea, Yuhan Corporation, to launch Ryaltris in early 2021. So far, Glenmark has received approval for Ryaltris in Australia, South Korea, Cambodia, Ukraine, Uzbekistan, Namibia and South Africa. Glenmark's partner in China, Grand pharmaceuticals, plans to submit an IND in the third quarter of this financial year. A pre-IND meeting application was submitted to the CDE in the first quarter of the year.

GBR 310. The company is in discussions with potential partners and is targeting to conclude a deal before initiating Phase III studies. GRC 39815: This compound is currently in preclinical development, and the company plans to initiate a Phase I study shortly.

Glenmark Life Sciences Limited, GLS. For the first quarter, external sales from Glenmark Life Sciences was at INR 2,348 million, recording growth of 1.83%. The growth for the first quarter remained almost flat due to the initial impact on supplies due to COVID-19. The Indian market experienced strong growth at 19%, while the other regions had muted growth.

Ichnos Sciences. For the first quarter ended June 30, Glenmark invested INR 1,734 million, as compared to INR 1,900 million invested in the corresponding quarter of the previous year. For further updates on the pipeline and the organization, please log on to www.ichnossciences.com. The pipeline for the first quarter of the financial year is published on the site.

Just some notes before we open the Q&A.

R&D expenditure for the quarter was 254 crores, at 10.84% of sales. ForEx gain and other income was to the extent of 40 crores in the first quarter.

Gross debt was at 4,851 crores as on June 30, 2020, as compared to 4,868 crores as on March 31, 2020. Net cash was at 1,249 crores as on June 30, 2020. Net debt was at 3,602 crores as on June 30, 2020, as compared to 3,758 crores as on March 31, 2020. In constant currency, net debt was down by 180 crores, as compared to March 31, 2020.

Inventory was at 2,185 crores as on June 30, 2020, as compared to 2,136 crores as on March 31. Receivables was at 2,455 crores, as compared to 2,409 crores on March 31. Payables was at 2,055 crores as on June 30, as compared to 2,126 crores as on March 31.

Total asset addition for the quarter was at 130 crores for the first quarter of this financial year.

Before we open the floor for Q&A, I would like to introduce the members of Glenmark management. We have Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals V. S. Mani, Executive Director and CFO, Glenmark Pharmaceuticals and Robert Crockart, Chief Commercial Officer, Glenmark Pharmaceuticals Limited.

With that, we would like to open the floor for Q&A. Over to you, moderator.

[Operator Instructions] We take the first question from the line of Neha Manpuria from JPMorgan.

My first question is on the U.S. business. After the -- could you give a little more color on the quarter-on-quarter decline? And what are the trends you are seeing in July and August in terms of recovery.

Neha, this is Robert here. So first of all, I think it's fair to say that we had some challenges in quarter 1 in the U.S. and it's due to several reasons, right? We've had some challenges around the price erosion in the derma section and also on the competition on mupirocin. We do actually have seen that this has now stabilized and we expect from this quarter, quarter 2, onwards to get quarter-on-quarter growth.

And this growth will be driven by -- are new launches contributing? Because we've not seen a very sharp pickup in our new launches or any limited competition launches come through.

So I think, Neha, we are expecting some launches in this quarter. So hopefully, that should come through and you should see some growth coming out of the new launches.

Okay, understood. How many launches are we targeting for this year, Glenn?

Typically, 8 to 10 is what we think we will achieve this year in terms of new launches.

And you mentioned derma price erosion. What is the level of price erosion that we saw, if you could give some color on that? We are still continuing to see -- I mean it's been close to a year of very sharp price erosion even if I were to exclude mupirocin. Do you think we are close to the bottom? Or could this continue for some more time, particularly for derma?

Neha, we've seen at pretty much as high as 15%, right? And so however, we have seen this -- we believe that this has now stabilized, and we won't see it as aggressive moving forward.

And the 15%, I'm assuming, obviously is year-on-year.

Okay, okay, understood. And my second question is on the reduction in other expenses. If I were to strip out our R&D, obviously there is a very large reduction largely because of lower spending, I'm assuming, in a branded market. How should we look at our cost optimization efforts, keeping aside the sort of onetime savings that we have seen in the first quarter?

So Neha, this is Mani here. So I think, I mean, if we look at it broadly, the SG&A expenses have come down quite substantially, but then again, over the last couple of years, we've been working a lot on the other expenses. So I think, a substantial amount of this reduction, we should see it continuing into the coming quarters in the current year. So I think, in a way, we've been working on this for some time in terms of our indirect costs and our SG&A and et cetera, and now it's all the more focused and more driven towards being pretty lean and mean in terms of those expenses, okay? So it's pretty much across the board, okay, if we look at it.

When you say substantial portion of this should continue -- or could you quantify that? I mean 20%, 50%. What proportion, in your view...

Rather, Neha, the other way to put that is, see, we could look at our EBITDA as being close to 19% to 20%. So that's the better way to put it. So we see that, at least a -- good previous years or last quarter, we used to be at about 16%, 17%. So we have seen a good expansion of 2% to 3% coming out of all this, okay? So that's how I look at it.

Okay, okay. So you think on a sustainable basis we can still do 19%, 20% EBITDA in terms of…

We feel very much -- I mean we feel very strongly about that, yes.

[Operator Instructions] The next question is from the line of Nitin Agarwal from IDFC Securities.

Glenn, on the U.S. business, we've got now a pipeline, as you mentioned, of 44 ANDAs pending approval. Now this is a reasonably thin pipeline, if you're looking at about 10 new approvals sort of coming through every year and especially in the context of how -- where most of our peer set is sort of positioned right now. So where do you guys sort of view U.S. generics fit in the overall scheme of things for Glenmark when you take a 3- to 5-year view of business?

I think, Nitin, it continues to be an attractive business. It's not that we are taking our foot off the pedal or anything of that type. So we still see U.S. generics as an important piece of Glenmark going forward. I think, the pipeline, specifically we've just become much more focused on products which are differentiated and which make a difference, right? I think it's more important to get the right products approved than file a host of products every year. So our view is a little different on how we look at the U.S. business and how we want to play in the U.S. going forward.

And in terms of growth on this business, we've been stuck in this $100 million plus-or-minus range for a while now on a quarterly basis. Where does this thing really end up? I mean, do we see a meaningful accretion on it? Or it's going to be, I mean, softer products which are getting eroded, getting replaced on a consistent basis, but you more or less stay around these levels. Is that a fair way to look at it?

I think, Q1, we have seen the bottom, Nitin. So from Q2 onwards, as Robert mentioned, you should see Q-over-Q growth in the U.S. business. And then I think, on a sustained basis, a lot will depend on the new product approvals that we'll get to drive growth longer term. Yes, go ahead.

Okay -- sorry. On the other part of the tree which are earlier discussed around cost reductions. So how should we look at R&D now? This is, I mean, a first quarter where -- I don't know -- again. So 2 things. One is [Indiscernible] R&D cost reductions. Were it partly influenced by the COVID sort of disruptions in terms of clinical trials and all not really going through? Or -- and so -- and how should we look at R&D, both innovation and generics, for the year and going forward?

So Nitin, just to address it. Even in the last call, we had said that we'll continue to, I mean, focus on R&D, but we'll be very careful about the way we spend. So we've talked about 11-odd percent, so we'll be somewhere there. We will not try and let it go up too much, okay? So -- and obviously, the proportion, what we normally do, 6%, 7% of basically the innovation and 4%, 5% of generics, that will continue. So I mean you might see a little bit here and there, but broadly we'll be there. And in terms of amount of spend, obviously, as the quarters go and the turnover goes up, there'll be little extra spend, but we'll try and keep this pretty much well within these levels, okay? We won't let it go beyond this.

So Mani, when you say at these levels, you mean 11% of revenues, or in absolute terms around that

Yes, about 11% of the revenue. It's not absolute terms. I mean this first quarter is a little lower, but otherwise, in absolute terms we'll try and keep it around 11%, yes.

[Operator Instructions] Next question is from the line of Prakash Agarwal from Axis Capital.

Just on Ichnos. You mentioned that -- the expectation of fundraising by second half of the year, yes. So on these assets, we've been looking to raise some capital in the past as well. What is giving us confidence that we'll be able to close by end of this year? Are we already in talks? Or what is the progress here, please?

Look, Prakash, this is a capital raise and it's the first time we are attempting it, okay? So we have not tried to do anything in the past, but just to -- so we've now appointed a banker, right, who is -- who will help us with the capital raise in the U.S. And that's -- so we are hoping to close it in the second half of this financial year.

Yes. When I meant in the past molecule level, we've been looking to out-license, right? So...

That still continues, Prakash, and we still continue to have various partnering discussions with a number of companies, but that's besides the capital raise. So there are 2 elements to Ichnos. One is the partnerships, and the second is raising equity capital, right? We are working on both angles.

Okay. So this -- so the earlier one was at molecule level. This is at entity level, raising of

Yes, money in the U.S. markets is what you mean [Indiscernible].

Okay. And what is the size we are looking at?

So we can't comment on that, Prakash.

Okay. And secondly, if I look at your other income and the statement you made on [Indiscernible] income. So I understand that's only the gain part of it which you have that -- reported on the other income side. So looking at net debt, the -- because of maybe rupee-dollar, it is flat, but on dollar terms, how were that moved? Could you give us some color, please?

Well, in terms of dollar terms, we've told now that on a constant currency or otherwise it will be about 180 crores. So with the dollar thing, it is still 150. So I mean even if there was about a 30 crore move in the debt because of the rupee having depreciated in this quarter. Last quarter, it was something like [74 74]. This quarter, it ended at [75 22]. So there was a movement move on that.

So 150 crores is then CC terms debt reduction.

Yes, 150 crores [Indiscernible]. And if you were to take it, strip out the currency impact, it will be almost 180.

Right. I understand. And lastly, on the margin front, I think something was covered on the cost side, how -- going forward, what is the cost, how will cost increase, but if you could just give us some color on how the margin trajectory should be. We are now stable at 16% base business? And how should we look at it going forward given the statement you made that U.S. could start growing, a? And I think your domestic business is growing well. So what is the outlook on margins?

So that's the reason why it gives us confidence. There are 2, 3 things. One, we look at the markets improving. Secondly, also our realization is improving. Secondly, also on the costs side, if you recollect, even over the years, we've got some good handle on that side. So we took 30%. Now it came down to 28%. Of course, this quarter is much lower, but on an overall basis we look at an EBITDA margin of close to 19%, 20%. That's where we are very confident and we strongly about that.

[Operator Instructions] The next question is from the line of Shyam Srinivasan from Goldman Sachs.

First one is on the India business. I think, 4Q, we had the benefit of stocking up. We have seen slight soft-ish trends in the June quarter. I just want to understand, on the path forward on the India business, how is, say, July, August kind of trending for you.

So in quarter 1, we did -- the growth was in fact due [Indiscernible], but two, we expect to outperform the market. And also again [Indiscernible].

Robert, your line is a little distorted. So I'll take that question. So Shyam, second quarter, obviously with the launch of FabiFlu, we are seeing a good run in the India business, right? And we think that will help Q2 onwards.

Yes. So Glenn, just on this favi, we have seen a lot of competitors also put in their offering to the market and prices which have kind of sharply come. I know you've launched also a better compliance version, but just can you walk us through how large could this opportunity be? What's -- anything that you could share on favi would be helpful just to understand the addressable opportunity.

Would you let me maybe give it a shot...

So I think -- go ahead, Robert. Try. Let's start again, yes. Go ahead.

All right. If it doesn't work, just stop me, okay?

So again, I think we are truly excited about FabiFlu, right? And it's doing really well and it's been a great story for Glenmark. And it's -- at this stage, from a top line perspective, we are not 100% exactly sure it takes us, but for sure, we are very, very optimistic in terms of the year ahead.

Okay. And my second question is on Ryaltris. I believe we have responded to the CRL, right? The MD&A says that is currently under review. Is that understanding right? This is for the year.

No, we've -- no. You said -- we have responded to the CRL is what you're saying.

Yes, that's the question, Jason, yes.

So Shyam, we have collected all the information. We have not yet -- we are awaiting to hear from the FDA. We are all ready with it, but we are still awaiting to hear from the FDA.

Okay. And is there any time lines that you would attribute to the Ryaltris in the U.S.?

I mean it's a next calendar year event, Shyam, mostly second half of next year, calendar year.

Got it. And my last question is on the life sciences business. Given the kind of trends we have seen to some of the rest of the business, 2 fronts, right? One is what's the outlook for this business. Is it that we are doing a lot of insourcing for Glenmark Pharmaceuticals only? Or how are you seeing third-party sales? And two, is there a possibility of the capital raise that was kind of probably put on the back burner? Will that come back to -- on the life sciences side?

Sorry. Can you just -- so yes. I mean, as far as Glenmark Life Sciences, I think there is no current plan to go out and raise any capital, right? That's been on the back burner and will continue to stay in the back burner. The second part of your question, I think we -- I couldn't pick up. Can you just repeat that?

Yes, yes. So Glenn, just in terms of the API trends for the industries have been quite strong, yes. So I just want to see what you're seeing on third-party sales. Maybe many of them we are using for our own consumption, Glenmark pharma consumption.

I just wanted to understand how you're seeing your therapy areas on the API side. How are they kind of

Yes. I think the -- on the API side, see, Q1 was a soft quarter because -- on external sales primarily because of a lot of our capacity has got utilized in manufacturing of favi, right, for the launch, but I think Q2 should -- we should be back in terms of seeing good growth coming out of the API side of the business.

[Operator Instructions] Next question is from the line of Saion Mukherjee from Nomura.

So basically, can you -- I just missed the inventory number, if you can share that. And secondly, it seems that receivables have gone up. Or working capital seems to have gone up despite there is a meaningful slowdown this quarter. Can you just explain that? Are there any stresses in receivables, et cetera?

No. I don't see any stress or anything. It's just quarter-to-quarter kind of thing. So I don't see it as such a big issue. And also, inventory, across the industry everybody have seen some rises, okay? So it's not like -- in fact, ours is a little lower. So I wouldn't put it beyond that. There's no stressing. And normally, our receivables have always been pretty clean, and we've never had many issues.

And what is the inventory number, sir?

Okay. And secondly, can you give some detail on this VWash sale to Unilever in the quarter? I'm slightly confused in terms of the consumer number that you've shared at INR 31 crores, right, in this quarter. That seems to be a lot down year-on-year, like around 40% down, and correct me if that number is right. So I thought like VWash will happen only towards the end of quarter. So am I missing something here?

I think the transition, Saion, and -- during the transition, right because -- and because of the lockdown, right? There were sales which were slowed down in the quarter, right, because it was a transition to HUL, right? But I think, going forward, sales will come back, right, on the GCC business.

Okay. So this INR 31 crore number that we have from this quarter, do you think this will sustain? Or like adjusted now next quarter, [Indiscernible] not be there at all. Or it will be more or less right. Like how should we think about it?

I mean the portfolio without VWash is about a 140 crore, 150 crore portfolio this year, right? So you should expect growth from next quarter.

And can you share the amount of money we got from the sale of this -- VWash in this quarter?

No. Actually, Saion, as per the agreement, we are not supposed to disclose the amount. So that's the reason why.

Okay, but have you received all of it this quarter? Or how is it? Or is this staggered...

Some of the portion, we'll receive later, okay? So it happens. And also we're also receiving monies in terms of supply of goods, in terms of percentage of sales. So those are also there. And some portion of the upfront is still there. These are all there.

Okay, but you would say most of -- it has been received, or most of it will come later. I mean in terms of

So a decent amount has been already received, yes.

Okay. And is there any other transaction which was there which helped cash flow this quarter, other than

No. Other than that, it's purely the business that's actually helping, and the way we manage our cost side and overall. That's helped us.

[Operator Instructions] The next question is from the line of Alankar Garude from Macquarie.

Glenn, the first question is on ROW and Lat Am. Both these geographies were pretty impacted in the first quarter not just on a year-on-year basis but particularly on a sequential basis. There was a very sharp fall, but yes, maybe a sequential comparison might not make sense. So -- but going ahead, can you comment on what is the base kind of run rate for these geographies, these segments excluding the currency impacts?

Robert, sorry. We can't hear you. I don't know whether...

There is some distortion in your line, Robert.

Alankar, can you hear him?

Okay, so I think it was [Indiscernible].

Okay. So Alankar -- Robert, I'll just take it because I think your line is a little distorted. I don't know why. But I think, Alankar, just to answer your question on Lat Am and ROW: See, in Q1, there were 2 major impacts, okay, that we saw in Lat Am and ROW. One is the whole COVID situation, right. Was -- because of the lockdowns, it was pretty severe in terms of sales drops in these geographies. Second is currency, right? So it was 2 hits that we took. From Q2 onwards, we see both these geographies coming back. So you will see growth coming back from Q2 onwards, right, Y-o-Y growth, right, and sequential growth in both Latin America as well as in Europe.

Understood. That's helpful, Glenn. And second question is on -- so last quarter, we had mentioned that we will be signing at least one out-licensing deal in the U.S. in this fiscal. So are we on track, as far as that is concerned?

We still maintain that we're trying our best to close at least 1 out-licensing this year.

[Operator Instructions] The next question is from the line of Harith Mohammed from Spark Capital.

So when you talk about the parent company's investment in Ichnos this quarter, so INR 175 crores for this quarter. Trying to understand the cash flows a little better. Is this investment corresponding to the R&D spend right now? Or is there a component of SG&A that is being funded?

No. There's no SG&A or anything. It's purely the R&D effort. That's it.

Okay. And then on Glenmark Life Sciences, the external sales growth of 2% this quarter. Quite a few API players have commented on later demand [Indiscernible] from China. Did we see some of that queries on account of that? And do you think this China Plus One strategy will be a driver for the API business?

So I think -- can you just repeat the question again, please?

So a lot of API players have commented that their customers are trying to diversify their sourcing away from China to some extent. Are we seeing some of that? And do you think this can be a driver for Glenmark Life Sciences?

Sure, absolutely. I think, going forward -- I mean, even otherwise, also people and those who are backward integrated have always looked at it, and now there is a good opportunity. So I think all of us look at it that way, okay?

And any update on the warning letter at Baddi? Have we received any communication from the FDA on [the inspection]

We are still working on a resolution, yes.

[Operator Instructions] The next question is from the line of Jigar Shah from Maybank.

Congratulations for a good set of numbers. My question pertains to the Ichnos life sciences -- sorry, Ichnos and research activity. The position generally Glenmark has taken over the years is, fairly, if I may say, contrarian in terms of lot of NCE expenditure. Now given this COVID situation, suddenly everybody has realized that basic research will be very important. So do you think that really helps our plan to better capitalize this activity?

Well, look, see, Ichnos is a cutting-edge biotech company, right, which is doing cutting-edge research in the U.S., Switzerland and various geographies. It has a huge technology advantage with the bispecifics, trispecific antibody platforms, right, which is world class, right? So our investment into Ichnos over the years, we think, is a very valuable investment. And I think, with the capital raise, it will unlock a lot of value and actually ascribe a value for Ichnos, right, and our -- and whatever investments we've made in that entity. So Glenmark will still, in the near term at least, be a majority shareholder. So I think it will help the company actually get exposure to a great innovative platform and an innovative franchise, which clearly not too many Indian companies have, right? So it's an exciting portfolio for us.

[Operator Instructions] The next question is from the line of Chirag Dagli from HDFC Mutual Fund.

This EBITDA margin guidance, is this like a long-term aspiration, or is this something that we'll see immediately in FY '21?

So we see it in FY '21. And obviously that's always an aspiration for every company, to improve. And we were there at that level. And we will -- and again, we have shown over the last couple of quarters that we are able to improve our efficiencies and as the sales growth also comes into play and we are more efficient in the way we use our resources. I think it's something that is doable.

Understood. Sir, there is a very sharp dip in stock-in-trade purchases, and there is a commensurate increase in owned raw material consumed. It's a fairly sharp number. What used to be 10%, 11% of sales is down to 2%. Can you just sort of clarify what's happening there?

So we see it detailed. I mean, from quarter to quarter, you can't really plan it that way. So sometimes, you buy inventory a little in advance. So obviously, when the COVID thing started, people would have gone ahead and bought a few things. So I mean you can't -- I mean year is the best way to look at it rather than quarter to quarter, yes.

So this will unwind in the rest of the 3 quarters is what you are saying...

Yes, it will unwind. And obviously, I mean, the aspiration is always to make materials yourself, but always all companies have a policy of make or buy, okay? And we go by that.

Understood. And did you in the call indicate Ryaltris is a 2H calendar year '21 approval expectation, Glenn?

Yes. So I think that's our goal, right, to try and get it approved in second half of next year.

In the U.S. So Chirag, just to clarify: Look, Ryaltris is -- will contribute in FY '22 quite substantially because of all the approvals that we've got already, right? So be it Australia, South Africa and various geographies. We also expect Europe to be filed, right? So end of this year or FY '21, we will start seeing European approvals coming through. So FY '22 should be a good year for Ryaltris overall. But the U.S. approval, we anticipate, will get pushed out to second half of calendar '22. Calendar -- sorry.

When we -- understood. So when we look at all these other markets, Europe included, ex U.S., can this pot be as large as the U.S. on a sustainable basis, say, a couple of years out?

I would think this is a substantial opportunity for us, right? I mean I can't give you the specific numbers, but this will be a significant contributor to the company over the next 4, 5 years...

But when you think of the asset itself, a large -- a majority part of the monetization should happen in the U.S.

No, no. I -- not necessarily, Chirag. This is a -- I mean it's an allergic rhinitis product, right? So you can imagine there are many geographies like Russia and CIS, Latin America, Europe, for instance, right, where realizations are very good.

Understood -- and in the -- in our current Q1 base, if you can just sort of help us understand how big is mupirocin now. And how big is the dermatology portfolio in this space of $95 million?

Dermatology will be around 30% of sales now, about 30%, 35%, all put together.

35% of sales. And this includes mupirocin.

This is only a ballpark number, yes, and includes mupirocin.

Okay. And versus, say, 4 quarters back, Glenn, what would this have been?

My guess is around 45 -- at the peak, we were around 45%, trending around 45%, 50%.

[Operator Instructions] The next question is from the line of Vishal Manchanda from Nirmal Bang.

Basically, on Europe and Latin America, could you share what percentage of your sales will be from in-licensed products?

So if you take Europe, roughly about 40% or 45% will be all in-licensed products, yes.

Latin America also -- it will not be that much. It will be...

It will be around 25% max.

Okay. And like we continue to spend on intangibles every year. Basically that is -- as I understand, is in-licensing of products, so basically I want to understand what will have been the cumulative investment into intangibles related to in-licensing of products opportunities.

So a substantial amount of our -- whatever intangibles we have, have gone into basically in-licensing of products. I mean on a yearly basis normally we'll do about 200-odd crores, and that's where we are. And that's how we have grown our business going there.

We have some exciting products like Salmex, tiotropium, DPI. So lots of exciting products getting launched this year and helping this year and next year, right, coming out of the in-license portfolio in Europe, plus other markets also.

Okay. And just one more, on the Monroe facility. Is all the cost into the structure now? Or there is yet -- there are still operational costs being capitalized.

Basically now the oral solids have gone online, so that's basically a write-down, so -- and the rest of them, the injectable will happen some time in the coming quarters, and only the nebulizer will be left out. That's it, but a large amount will get -- start getting operationalized in the current period.

Okay. And will you still be able to do the guided numbers on EBITDA margin around 18%, 19%?

Okay. And then what was the CapEx during the quarter?

[Operator Instructions] The next question is from the line of Damayanti Kerai from HSBC.

Just coming back on Monroe. So you just mentioned you should be launching a large part of products this year, so we should expect costs breakeven to happen this fiscal year itself. Is that the correct assumption?

See, Damayanti, the way to look at it is we'll operationalize it completely. And we'll also look at how the products take off, et cetera. So I think normally, in the first year of any plant being launched, especially U.S., et cetera, you'll need to get a sense and a handle on that. We believe we have some decent products lined up. So as the year goes by, we'll be better positioned to -- really to give a fix how quickly we'll break even completely, but we are very excited about this opportunity, yes.

Okay. In terms of launches, we should be making substantial progress. That should we taken. And then as the sales pick up, we should look at the costs coming to start hold.

Okay. And just a clarification on the U.S. generic pricing erosion. So are we seeing, I'll say, severe pricing pressure across the portfolio? Or it's more on the derma side. And then we have kind of stabilized pricing for OSD [Indiscernible].

I think the rest of the portfolio is stabilized, okay, right? It's only the derm where we saw significant erosion. And I think that's -- that also was in Q1. From Q2 onwards, we think you should have stable price erosion going forward.

Okay. And I understand first quarter derm sales obviously were impacted due to COVID's lockdown and all. So in the U.S. now we should be seeing a pickup happening, right? And...

Okay. So by second half, we should be broadly back on the normal course of operations.

Okay. And a final comment on the debt reduction part, 180 crore in constant currency this quarter. So how should we look for the full year? And if you can talk about your targets in longer term.

So Damayanti, the way we look at it, we see a reduction quarter-on-quarter. So I mean we'll see -- and as the business also improves, we should see it. I mean, difficult to put numbers, but I think we definitely see a very positive way of looking at this overall.

Okay. So mostly debt reduction coming from the cash from our operations. Or there may be little contribution from some asset sale or from other opportunities.

Yes, going forward, definitely there -- it will be more from the business side and the cash that the business generates. That should help us to.

[Operator Instructions] The next question is from the line of Nitin Agarwal from IDFC Securities.

Just on CapEx, Mani, where -- how should we see CapEx for the year now and next year? Any broad guidance on that?

Yes. As we have guided, see, we are hoping to keep it at about -- all in all, I mean, the highest will be around 700 crores or so or a little more -- or thereabouts. I mean it will be much lower than the year that we went through. So we'll be somewhere there.

Yes, yes, including all eventually. I think I've guided in the last call about 700 crores to 800 crores. We will try and keep it on the lower end, yes, and see...

And this is where it should stay in the coming years or in the next couple of years, also around these levels.

I would assume so, yes, Nitin, because we also want to be quite tight on the way we do things.

Okay. That's helpful. And secondly, Glenn, on the -- on FabiFlu, any perspectives on global supply opportunity on this product?

So right now, it's small, Nitin. We are looking at export opportunities, but it's relatively small.

And lastly, on EU. How should we look at -- so this has been a fairly steady performer over the last few quarters now. However, we have -- and so where are we on the whole inhaler scale-up there? And where -- how should we see this business out, say, this year or next year?

Europe. Robert, do you want to try again?

Sorry. I didn't -- yes, I can, but can I just get the question again, please?

Yes. So I was asking around the European outlook for -- the business outlook for the European business this year and next year. And how is the whole inhaler scale-up playing out for us?

Okay, okay. Thank you. Thanks for the question. So yes, I think, if you look at its coming quarter, quarter 2, we do expect the softer, potentially weaker quarter due to one of our products, atovaquone-proguanil, which has been impacted through the travel restrictions that we have across Europe. However, we are still optimistic that we will continue to grow in high single digits, potentially low double digits for the year ahead.

[Operator Instructions] The next question is from the line of Saion Mukherjee from Nomura.

So Glenn, I think on just continuing on the European business, particularly on inhalers. On Salmex, can you just take us through like what's the size and what kind of market share you have in some of these Nordic countries? And I understood it was a substitutable product. And what's happening for launches in the rest of the Europe given the litigation we had with Glaxo earlier in markets like Germany and others, if you can just update. And like how should we see Salmex like growing from the current levels?

I'll take that. Then maybe, Glenn, you can build on it. But we have now settled with GSK, and Salmex is doing well. And you -- we will continue to be pretty aggressive on the products. We have relaunched now in multiple markets, Czech, Slovakia, Germany. We are looking at launching in the Netherlands. And then also we will continue in the Nordics and the U.K. So all in all, we will continue to be aggressive. And we have high expectations, but since a lot of this is still in early stages of reentering and -- it's difficult to give you the extent of what this would be.

Okay, but currently the market share will be in single digit, I guess. Will that be a right assessment?

Yes, it will be low [Indiscernible].

[Indiscernible], yes. It depends on where -- yes.

Okay. And also, on tiotropium DPI, what is the time line? And how should we see? And what's the size, if we can -- indicators for Europe.

It's a big product, Saion -- okay, go ahead, Robert. Go ahead.

So on -- sorry. [Indiscernible]. No, no, no. It's fine. No, I was also just going to say, yes, it will be a big product for us. And we're expecting in -- that the impact will be primarily in the next financial year. I mean, Glenn, you can build on that, yes.

So launch may be earlier, Saion, but the real impact will be next year instead.

And are there any patent issues there? Or -- and what is the competitive landscape?

So it's hard to comment on patent issues, Saion. Competitor landscape, obviously we are -- we probably will be first generic again, like Salmex, right, with the DPI version.

We take the last question from the line of Chirag Dagli from HDFC Mutual Fund.

So is there a time line that you want to share with us on the Ichnos capital raise?

So Chirag, we started the process. We've appointed a banker and we've just initiated talking to investors, right? And -- but we've clearly said that we're giving ourselves till the second half of this year, this financial year, to close it.

Okay. And what was the operating cash flow for the first quarter?

So in terms of operating cash flow, we've seen an EBITDA, right, INR 478 crores. And obviously, we had basically the interest costs of about 80 crores, cash tax of about 120 crores and some increase in basically the working capital and the CapEx of 180 crores.

So broadly, it kind of trends towards the 180 crores of the improvement in the debt is what is there.

Okay. Is there a tax rate guidance, both P&L and cash flow, that you want to share for full year?

Broadly, it may be about 28%, 29%, yes.

And the cash tax will also remain similar.

Broadly, yes, give and take a percentage [Indiscernible].

Thank you. Well, ladies and gentlemen, that was the last question for today. I would now like to hand the conference over to Mr. Jason D’souza for closing comments.

Thank you, moderator. We'll just read the disclaimer. The information, statement and analysis made during this call describing company's objectives, projections and estimates are forward-looking statements and projects -- and progressive within the meanings of applicable security laws and regulation. The analysis contained herein is based on numerous assumptions. Actual results may vary from those expressed or implied, depending upon economic conditions, government policies and other incidental factors. No representation of warranty either expressed or implied is provided in relation to this presentation. This presentation should not be regarded as -- by recipients as a substitute for the exercise of their own judgment.

With this, we end Glenmark's Q1 Earnings Call. Thank you, everyone.

Thank you. On behalf of Glenmark Pharmaceuticals Limited, that concludes this conference. Thank you all for joining. You may now disconnect your lines.";"{'body': [{'indices': [[6289, 6293]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Race_and_ethnicity_in_the_United_States_Census'},
           'score': 0.995905339717865,
           'text': 'Asian',
           'types': ['Items', 'Disease']},
          {'indices': [[3630, 3633]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lung'},
           'score': 0.9582899212837219,
           'text': 'lung',
           'types': ['AnatomicalStructure', 'Organs']},
          {'indices': [[4826, 4849]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pharmaceutical_industry'},
           'score': 0.9932195544242859,
           'text': 'pharmaceutical companies',
           'types': ['PersonFunction']},
          {'indices': [[8716, 8738]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pre-clinical_development'},
           'score': 1.0,
           'text': 'preclinical development',
           'types': ['Stage', 'Person']},
          {'indices': [[3438, 3444], [4480, 4486], [4548, 4554]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Tablet_computer'},
           'score': 0.8586677312850952,
           'text': 'tablets',
           'types': ['InformationAppliance', 'Product', 'Computer']},
          {'indices': [[2068, 2072]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/IQVIA'},
           'score': 1.0,
           'text': 'IQVIA',
           'types': ['Person']},
          {'indices': [[19327, 19331], [19671, 19675]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Rupee'},
           'score': 0.9156383275985718,
           'text': 'rupee',
           'types': ['Name', 'Currency']},
          {'indices': [[5852, 5854], [5917, 5919], [34984, 34986]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Commonwealth_of_Independent_States'},
           'score': 0.8859961628913879,
           'text': 'CIS',
           'types': ['Place',
                     'Country',
                     'Organisation',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[4041, 4043], [26255, 26257]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/GNU_Compiler_Collection'},
           'score': 0.5354604721069336,
           'text': 'GCC',
           'types': ['Software', 'Product', 'Work', 'System', 'Organisation']},
          {'indices': [[7955, 7963], [8248, 8256], [33987, 33995]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Australia'},
           'score': 0.9925089478492737,
           'text': 'Australia',
           'types': ['Place',
                     'Country',
                     'MusicalArtist',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[6579, 6593]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Philippines'},
           'score': 0.9997385144233704,
           'text': 'The Philippines',
           'types': ['Place',
                     'Country',
                     'MusicalArtist',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[6058, 6064]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Russian_language'},
           'score': 0.6248539090156555,
           'text': 'Russian',
           'types': ['Language']},
          {'indices': [[7747, 7751],
                       [10322, 10326],
                       [34734, 34738],
                       [39713, 39717]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asset'},
           'score': 0.9972164034843445,
           'text': 'asset',
           'types': ['Resource', 'Work', 'Product']},
          {'indices': [[5835, 5840],
                       [5900, 5905],
                       [6674, 6679],
                       [8020, 8025],
                       [8321, 8326],
                       [34004, 34009]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Africa'},
           'score': 0.999207615852356,
           'text': 'Africa',
           'types': ['Place',
                     'Country',
                     'Continent',
                     'Agent',
                     'World',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[18765, 18778]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 1.0,
           'text': 'equity capital',
           'types': ['Difference', 'Disease']},
          {'indices': [[10631, 10633]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Chief_financial_officer'},
           'score': 0.9998142123222351,
           'text': 'CFO',
           'types': ['Person', 'Officer', 'Organisation']},
          {'indices': [[1119, 1127]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Logistics'},
           'score': 0.9792230725288391,
           'text': 'logistics',
           'types': ['MusicGenre']},
          {'indices': [[4887, 4899], [4950, 4962], [5288, 5300]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/United_States'},
           'score': 0.9998898506164551,
           'text': 'United States',
           'types': ['Place',
                     'Country',
                     'Person',
                     'Republic',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[2398, 2412], [3009, 3023], [16508, 16522]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Clinical_trial'},
           'score': 0.9982288479804993,
           'text': 'clinical trials',
           'types': ['Experiments', 'Organisation']},
          {'indices': [[17741, 17744]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_powers'},
           'score': 0.9976868033409119,
           'text': 'Axis',
           'types': ['Place',
                     'Country',
                     'EthnicGroup',
                     'Nations',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[4932, 4941], [5098, 5107]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Indictment'},
           'score': 0.9996611475944519,
           'text': 'indictment',
           'types': ['Accusation']},
          {'indices': [[598, 600],
                       [1951, 1953],
                       [4138, 4140],
                       [4285, 4287],
                       [5932, 5934],
                       [7310, 7312],
                       [8911, 8913],
                       [9233, 9235],
                       [9267, 9269],
                       [25726, 25728],
                       [26284, 26286],
                       [29479, 29481],
                       [44713, 44715]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Indian_rupee'},
           'score': 0.9295132756233215,
           'text': 'INR',
           'types': ['Currency', 'Organisation']},
          {'indices': [[6739, 6744],
                       [28966, 28971],
                       [34051, 34056],
                       [34396, 34401],
                       [35004, 35009],
                       [35719, 35724],
                       [35842, 35847],
                       [36749, 36754],
                       [41253, 41258],
                       [41851, 41856],
                       [42414, 42419],
                       [43500, 43505]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Europe'},
           'score': 0.9988473057746887,
           'text': 'Europe',
           'types': ['Place',
                     'Country',
                     'Continent',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[8272, 8279]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Cambodia'},
           'score': 0.9995951056480408,
           'text': 'Cambodia',
           'types': ['Place',
                     'Country',
                     'MusicalArtist',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[7250, 7262],
                       [7289, 7301],
                       [28938, 28950],
                       [34989, 35001],
                       [35730, 35742],
                       [35915, 35927]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Latin_America'},
           'score': 0.9999148845672607,
           'text': 'Latin America',
           'types': ['Place',
                     'Country',
                     'Continent',
                     'Band',
                     'Group',
                     'Location',
                     'PopulatedPlace',
                     'Person',
                     'Organisation']},
          {'indices': [[11648, 11653], [39012, 39017]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pickup_(music_technology)'},
           'score': 0.7301151156425476,
           'text': 'pickup',
           'types': ['Transducer']},
          {'indices': [[12926, 12937]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mathematical_optimization'},
           'score': 0.988415002822876,
           'text': 'optimization',
           'types': ['Selection', 'CultivatedVariety', 'MusicGenre']},
          {'indices': [[6942, 6954], [7095, 7107]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nordic_countries'},
           'score': 0.9999983906745911,
           'text': 'Nordic region',
           'types': ['Place',
                     'Country',
                     'Settlement',
                     'Location',
                     'PopulatedPlace',
                     'Region']},
          {'indices': [[3556, 3559]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Chronic_obstructive_pulmonary_disease'},
           'score': 1.0,
           'text': 'COPD',
           'types': ['Disease', 'Organisation']},
          {'indices': [[5509, 5518]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Departments_of_France'},
           'score': 0.9991573095321655,
           'text': 'department',
           'types': ['Levels', 'SportsLeague']},
          {'indices': [[14791, 14798],
                       [15054, 15061],
                       [16625, 16632],
                       [17052, 17059]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Generic_programming'},
           'score': 0.6141930222511292,
           'text': 'generics',
           'types': ['Style', 'MusicGenre']},
          {'indices': [[4861, 4869]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Competition_law'},
           'score': 0.973173201084137,
           'text': 'antitrust',
           'types': ['Agent', 'Law']},
          {'indices': [[752, 756],
                       [1347, 1351],
                       [1866, 1870],
                       [1912, 1916],
                       [2189, 2193],
                       [2351, 2355],
                       [2653, 2657],
                       [2784, 2788],
                       [3326, 3330],
                       [3564, 3568],
                       [3756, 3760],
                       [21085, 21089],
                       [21260, 21264],
                       [21643, 21647]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9988387227058411,
           'text': 'India',
           'types': ['Place',
                     'Country',
                     'MusicalArtist',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[8400, 8402], [8455, 8457]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.5693953037261963,
           'text': 'IND',
           'types': ['Place',
                     'Country',
                     'MusicalArtist',
                     'Location',
                     'PopulatedPlace',
                     'Organisation']},
          {'indices': [[5007, 5018]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pennsylvania'},
           'score': 0.9997380375862122,
           'text': 'Pennsylvania',
           'types': ['Place',
                     'AdministrativeRegion',
                     'Settlement',
                     'Location',
                     'Region',
                     'PopulatedPlace',
                     'State']},
          {'indices': [[3930, 3933]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fast-moving_consumer_goods'},
           'score': 0.9851652979850769,
           'text': 'FMCG',
           'types': ['Products', 'Company', 'Organisation']},
          {'indices': [[6180, 6199]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Devaluation'},
           'score': 1.0,
           'text': 'currency devaluation',
           'types': ['Organisation', 'Reduction']},
          {'indices': [[5843, 5846], [5908, 5911], [6428, 6431]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asia'},
           'score': 0.9985368251800537,
           'text': 'Asia',
           'types': ['Place',
                     'Country',
                     'Continent',
                     'Earth',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[24080, 24082],
                       [24361, 24363],
                       [24420, 24422],
                       [24687, 24689],
                       [29854, 29856],
                       [30048, 30050],
                       [30138, 30140]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Application_programming_interface'},
           'score': 0.9984539747238159,
           'text': 'API',
           'types': ['Set', 'MusicGenre']},
          {'indices': [[4619, 4628]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fingolimod'},
           'score': 1.0,
           'text': 'fingolimod',
           'types': ['ChemicalSubstance', 'Drug', 'Product']},
          {'indices': [[8291, 8300]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Uzbekistan'},
           'score': 0.9963815212249756,
           'text': 'Uzbekistan',
           'types': ['Place', 'Country', 'Location', 'PopulatedPlace']},
          {'indices': [[6114, 6119], [34973, 34978]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Russia'},
           'score': 0.9921480417251587,
           'text': 'Russia',
           'types': ['Place', 'Country', 'Location', 'PopulatedPlace']},
          {'indices': [[16224, 16227]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Tree'},
           'score': 0.9637824892997742,
           'text': 'tree',
           'types': ['Plant']},
          {'indices': [[2164, 2175], [42255, 42266], [43200, 43211]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Market_share'},
           'score': 0.9991878867149353,
           'text': 'market share',
           'types': ['Percentage']},
          {'indices': [[7818, 7843]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Rhinitis'},
           'score': 1.0,
           'text': 'seasonal allergic rhinitis',
           'types': ['Irritation', 'Disease']},
          {'indices': [[8031, 8037], [8303, 8309]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Namibia'},
           'score': 0.9983662962913513,
           'text': 'Namibia',
           'types': ['Place',
                     'Country',
                     'MusicalArtist',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[8282, 8288]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ukraine'},
           'score': 0.9992170333862305,
           'text': 'Ukraine',
           'types': ['Place',
                     'Country',
                     'MusicalArtist',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[4304, 4306]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/United_States_dollar'},
           'score': 0.9964800477027893,
           'text': 'USD',
           'types': ['Currency', 'Organisation']},
          {'indices': [[10908, 10915]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/JPMorgan_Chase'},
           'score': 0.9921063184738159,
           'text': 'JPMorgan',
           'types': ['Banking', 'Agent', 'Company', 'Bank', 'Organisation']},
          {'indices': [[8127, 8137], [8259, 8269]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/South_Korea'},
           'score': 0.9983213543891907,
           'text': 'South Korea',
           'types': ['Place',
                     'Country',
                     'Location',
                     'PopulatedPlace',
                     'State']},
          {'indices': [[21049, 21061]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Goldman_Sachs'},
           'score': 0.9999722838401794,
           'text': 'Goldman Sachs',
           'types': ['Agent', 'Company', 'Bank', 'Organisation']},
          {'indices': [[2133, 2141],
                       [5963, 5971],
                       [6090, 6098],
                       [6494, 6502],
                       [6511, 6519],
                       [7337, 7345]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Degrowth'},
           'score': 1.0,
           'text': 'de-growth',
           'types': ['Movement', 'Organisation']},
          {'indices': [[13459, 13472]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Indirect_costs'},
           'score': 1.0,
           'text': 'indirect costs',
           'types': ['Costs']},
          {'indices': [[7507, 7512]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mexico'},
           'score': 0.9986176490783691,
           'text': 'Mexico',
           'types': ['Place',
                     'Person',
                     'Country',
                     'Republic',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[11331, 11337],
                       [12090, 12096],
                       [12126, 12132],
                       [12272, 12278],
                       [38444, 38450],
                       [38735, 38741],
                       [38842, 38848]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Erosion'},
           'score': 0.9979152679443359,
           'text': 'erosion',
           'types': ['MilitaryConflict', 'Action']},
          {'indices': [[3702, 3706]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/SGLT2'},
           'score': 1.0,
           'text': 'SGLT2',
           'types': ['Protein']},
          {'indices': [[19633, 19637],
                       [26291, 26295],
                       [26561, 26565],
                       [26572, 26576],
                       [39191, 39195]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[9569, 9571],
                       [12778, 12780],
                       [16306, 16308],
                       [16416, 16418],
                       [16600, 16602],
                       [16774, 16776],
                       [29605, 29607],
                       [29730, 29732]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Research_and_development'},
           'score': 1.0,
           'text': 'R&D',
           'types': ['Term', 'MusicGenre']},
          {'indices': [[8351, 8355],
                       [29918, 29922],
                       [29999, 30003],
                       [30235, 30239]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/China'},
           'score': 0.9982512593269348,
           'text': 'China',
           'types': ['Place',
                     'Country',
                     'Location',
                     'PopulatedPlace',
                     'State']},
          {'indices': [[7738, 7745],
                       [9372, 9379],
                       [9448, 9455],
                       [14476, 14483],
                       [14564, 14571],
                       [15125, 15132]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pipeline_transport'},
           'score': 0.9869398474693298,
           'text': 'pipeline',
           'types': ['Transportation', 'Company']},
          {'indices': [[2273, 2280]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Diabetes_mellitus'},
           'score': 0.9971608519554138,
           'text': 'diabetes',
           'types': ['Band', 'Group', 'Disease']},
          {'indices': [[791, 798],
                       [1287, 1294],
                       [6312, 6319],
                       [7493, 7500],
                       [26068, 26075],
                       [38953, 38960]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lockdown'},
           'score': 0.9560496211051941,
           'text': 'lockdown',
           'types': ['Book', 'Product', 'Definitions']},
          {'indices': [[13893, 13898],
                       [14243, 14248],
                       [20865, 20870],
                       [32219, 32224],
                       [37314, 37319],
                       [44698, 44703]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Earnings_before_interest,_taxes,_depreciation,_and_amortization'},
           'score': 1.0,
           'text': 'EBITDA',
           'types': ['Software', 'Product', 'Measure', 'Organisation']},
          {'indices': [[1802, 1809]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Medicine'},
           'score': 0.9948555827140808,
           'text': 'medicine',
           'types': ['Science',
                     'MusicGenre',
                     'Work',
                     'Product',
                     'MedicalSpecialty']},
          {'indices': [[6397, 6404]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Hospital'},
           'score': 0.9999281764030457,
           'text': 'hospital',
           'types': ['Institution', 'University', 'PersonFunction']},
          {'indices': [[3526, 3532], [41149, 41155], [41524, 41530]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Inhaler'},
           'score': 0.893792986869812,
           'text': 'inhaler',
           'types': ['Device', 'Product']},
          {'indices': [[715, 722], [6717, 6724]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pandemic'},
           'score': 0.9952402114868164,
           'text': 'pandemic',
           'types': ['Epidemic', 'Arachnid']},
          {'indices': [[15688, 15696]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Accretion_(astrophysics)'},
           'score': 0.7461386919021606,
           'text': 'accretion',
           'types': ['Disease', 'Accumulation']},
          {'indices': [[4818, 4839]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Generic_drug'},
           'score': 1.0,
           'text': 'generic pharmaceutical',
           'types': ['Drug', 'Product']},
          {'indices': [[5262, 5274]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Generic_drug'},
           'score': 1.0,
           'text': 'generic drugs',
           'types': ['Drug', 'Product']},
          {'indices': [[14791, 14798],
                       [15054, 15061],
                       [16625, 16632],
                       [17052, 17059]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Generic_drug'},
           'score': 0.5453217029571533,
           'text': 'generics',
           'types': ['Drug', 'Product']},
          {'indices': [[10602, 10605],
                       [13048, 13051],
                       [17392, 17395],
                       [40014, 40017]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mani_Peninsula'},
           'score': 0.6152173280715942,
           'text': 'Mani',
           'types': ['Settlement', 'Region', 'Country', 'Person']},
          {'indices': [],
           'links': {'dbpedia': 'http://dbpedia.org/resource/United_Kingdom'},
           'score': 0.9997626543045044,
           'text': 'U.K.',
           'types': ['Place',
                     'Country',
                     'Location',
                     'PopulatedPlace',
                     'State']},
          {'indices': [[6180, 6187],
                       [7422, 7429],
                       [9983, 9990],
                       [19500, 19507],
                       [19955, 19962],
                       [28113, 28120],
                       [28720, 28727],
                       [39209, 39216]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Currency'},
           'score': 0.9982068538665771,
           'text': 'currency',
           'types': ['PersonFunction']},
          {'indices': [[397, 402]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bridge'},
           'score': 0.9419889450073242,
           'text': 'bridge',
           'types': ['Building', 'Structure']},
          {'indices': [[685, 689],
                       [706, 710],
                       [1385, 1389],
                       [1441, 1445],
                       [2330, 2334],
                       [2561, 2565],
                       [2763, 2767],
                       [3314, 3318],
                       [6328, 6332],
                       [9056, 9060],
                       [16470, 16474],
                       [28586, 28590],
                       [31107, 31111],
                       [33171, 33175],
                       [38945, 38949]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Coronavirus_disease_2019'},
           'score': 1.0,
           'text': 'COVID',
           'types': ['Place']},
          {'indices': [[706, 713],
                       [1385, 1392],
                       [1441, 1448],
                       [2330, 2337],
                       [2561, 2568],
                       [2763, 2770],
                       [3314, 3321],
                       [6328, 6335],
                       [9056, 9063]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Coronavirus_disease_2019'},
           'score': 1.0,
           'text': 'COVID-19',
           'types': ['Person', 'Organisation']},
          {'indices': [[8014, 8025], [8315, 8326], [33998, 34009]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/South_Africa'},
           'score': 0.9921451807022095,
           'text': 'South Africa',
           'types': ['Place',
                     'Country',
                     'Location',
                     'PopulatedPlace',
                     'State']},
          {'indices': [[618, 626],
                       [1970, 1978],
                       [2085, 2093],
                       [4346, 4354],
                       [5951, 5959],
                       [7327, 7335],
                       [8930, 8938]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Sound_recording_and_reproduction'},
           'score': 0.8756647706031799,
           'text': 'recording',
           'types': ['Book', 'Product', 'Inscription', 'PersonFunction']},
          {'indices': [[4699, 4701],
                       [7795, 7797],
                       [22979, 22981],
                       [23053, 23055],
                       [30673, 30675]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Food_and_Drug_Administration'},
           'score': 1.0,
           'text': 'FDA',
           'types': ['Agency', 'Agent', 'GovernmentAgency', 'Organisation']},
          {'indices': [[2474, 2487]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Antiviral_drug'},
           'score': 1.0,
           'text': 'antiviral drug',
           'types': ['Medication', 'Drug', 'Product']},
          {'indices': [[2474, 2482], [3244, 3252]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Antiviral_drug'},
           'score': 0.9981995224952698,
           'text': 'antiviral',
           'types': ['Medication', 'Drug', 'Product']},
          {'indices': [[2893, 2908]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Informed_consent'},
           'score': 0.9997164607048035,
           'text': 'informed consent',
           'types': ['Election', 'Process']},
          {'indices': [[88, 95],
                       [417, 424],
                       [559, 566],
                       [1051, 1058],
                       [1492, 1499],
                       [2178, 2185],
                       [2415, 2422],
                       [2593, 2600],
                       [2950, 2957],
                       [3062, 3069],
                       [3185, 3192],
                       [3497, 3504],
                       [3646, 3653],
                       [3763, 3770],
                       [3891, 3898],
                       [4243, 4250],
                       [4417, 4424],
                       [4520, 4527],
                       [5122, 5129],
                       [5353, 5360],
                       [5707, 5714],
                       [6728, 6735],
                       [7265, 7272],
                       [7883, 7890],
                       [7966, 7973],
                       [8084, 8091],
                       [8201, 8208],
                       [8329, 8336],
                       [8801, 8808],
                       [8881, 8888],
                       [9215, 9222],
                       [10493, 10500],
                       [10570, 10577],
                       [10636, 10643],
                       [10709, 10716],
                       [14840, 14847],
                       [15088, 15095],
                       [22387, 22394],
                       [23492, 23499],
                       [23770, 23777],
                       [24259, 24266],
                       [29772, 29779],
                       [30327, 30334],
                       [30985, 30992],
                       [31826, 31833],
                       [46171, 46178],
                       [46246, 46253]],
           'links': None,
           'score': None,
           'text': 'Glenmark',
           'types': ['Place', 'Person', 'Organisation']},
          {'indices': [[3127, 3136]],
           'links': None,
           'score': None,
           'text': 'Umifenovir',
           'types': ['Place']},
          {'indices': [[4210, 4214],
                       [25611, 25615],
                       [25887, 25891],
                       [26540, 26544],
                       [26724, 26728]],
           'links': None,
           'score': None,
           'text': 'VWash',
           'types': ['Place']},
          {'indices': [[4228, 4230],
                       [4268, 4270],
                       [4694, 4696],
                       [5829, 5831],
                       [6910, 6912],
                       [7790, 7792],
                       [7852, 7854],
                       [10947, 10949],
                       [11243, 11245],
                       [14445, 14447],
                       [14786, 14788],
                       [15049, 15051],
                       [15417, 15419],
                       [15462, 15464],
                       [16022, 16024],
                       [18334, 18336],
                       [18934, 18936],
                       [20360, 20362],
                       [23141, 23143],
                       [29136, 29138],
                       [31390, 31392],
                       [33818, 33820],
                       [34227, 34229],
                       [34416, 34418],
                       [34454, 34456],
                       [34816, 34818],
                       [37922, 37924],
                       [38423, 38425],
                       [38981, 38983]],
           'links': None,
           'score': None,
           'text': 'U.S',
           'types': ['Place']},
          {'indices': [[4950, 4977]],
           'links': None,
           'score': None,
           'text': 'United States District Court',
           'types': ['Place']},
          {'indices': [[4987, 5002]],
           'links': None,
           'score': None,
           'text': 'Eastern District',
           'types': ['Place']},
          {'indices': [[5829, 5840]],
           'links': None,
           'score': None,
           'text': 'U.S.\n\nAfrica',
           'types': ['Place']},
          {'indices': [[6583, 6593]],
           'links': None,
           'score': None,
           'text': 'Philippines',
           'types': ['Place']},
          {'indices': [[6918, 6920],
                       [6961, 6963],
                       [7182, 7184],
                       [42958, 42960]],
           'links': None,
           'score': None,
           'text': 'U.K',
           'types': ['Place']},
          {'indices': [[7688, 7695],
                       [7943, 7950],
                       [8169, 8176],
                       [8236, 8243],
                       [22602, 22609],
                       [23125, 23132],
                       [33649, 33656],
                       [33857, 33864],
                       [34201, 34208]],
           'links': None,
           'score': None,
           'text': 'Ryaltris',
           'types': ['Place', 'Person']},
          {'indices': [[8358, 8362]],
           'links': None,
           'score': None,
           'text': 'Grand',
           'types': ['Place']},
          {'indices': [[13109, 13112],
                       [13482, 13485],
                       [29653, 29656],
                       [29696, 29699]],
           'links': None,
           'score': None,
           'text': 'SG&A',
           'types': ['Place', 'Organisation']},
          {'indices': [[27677, 27683],
                       [28239, 28245],
                       [28318, 28324],
                       [28435, 28441]],
           'links': None,
           'score': None,
           'text': 'Alankar',
           'types': ['Place', 'Person']},
          {'indices': [[51, 52],
                       [428, 429],
                       [2074, 2075],
                       [15907, 15908],
                       [24435, 24436],
                       [28500, 28501],
                       [35111, 35112],
                       [38783, 38784],
                       [46182, 46183]],
           'links': None,
           'score': None,
           'text': 'Q1',
           'types': ['Place', 'Product']},
          {'indices': [[30622, 30626]],
           'links': None,
           'score': None,
           'text': 'Baddi',
           'types': ['Place']},
          {'indices': [[31396, 31406]],
           'links': None,
           'score': None,
           'text': 'Switzerland',
           'types': ['Place']},
          {'indices': [[9161, 9166],
                       [17764, 17769],
                       [18706, 18711],
                       [29455, 29460],
                       [30901, 30906],
                       [30932, 30937],
                       [31297, 31302],
                       [31581, 31586],
                       [31745, 31750],
                       [44316, 44321]],
           'links': None,
           'score': None,
           'text': 'Ichnos',
           'types': ['Place', 'Person']},
          {'indices': [[32177, 32182],
                       [33826, 33831],
                       [34852, 34857],
                       [44217, 44222],
                       [44342, 44347]],
           'links': None,
           'score': None,
           'text': 'Chirag',
           'types': ['Place']},
          {'indices': [[36815, 36820], [37511, 37516]],
           'links': None,
           'score': None,
           'text': 'Monroe',
           'types': ['Place']},
          {'indices': [[42484, 42490], [42847, 42853]],
           'links': None,
           'score': None,
           'text': 'Germany',
           'types': ['Place']},
          {'indices': [[42837, 42844]],
           'links': None,
           'score': None,
           'text': 'Slovakia',
           'types': ['Place']},
          {'indices': [[42891, 42901]],
           'links': None,
           'score': None,
           'text': 'Netherlands',
           'types': ['Place']},
          {'indices': [[251, 263], [45385, 45397]],
           'links': None,
           'score': None,
           'text': 'Jason D’souza',
           'types': ['Person']},
          {'indices': [[311, 316]],
           'links': None,
           'score': None,
           'text': 'Janice',
           'types': ['Person']},
          {'indices': [[7902, 7908]],
           'links': None,
           'score': None,
           'text': 'Seqirus',
           'types': ['Person']},
          {'indices': [[9719, 9723]],
           'links': None,
           'score': None,
           'text': 'Gross',
           'types': ['Person']},
          {'indices': [[10058, 10066]],
           'links': None,
           'score': None,
           'text': 'Inventory',
           'types': ['Person']},
          {'indices': [[10227, 10234]],
           'links': None,
           'score': None,
           'text': 'Payables',
           'types': ['Person']},
          {'indices': [[10522, 10535]],
           'links': None,
           'score': None,
           'text': 'Glenn Saldanha',
           'types': ['Person']},
          {'indices': [[10596, 10605]],
           'links': None,
           'score': None,
           'text': 'V. S. Mani',
           'types': ['Person']},
          {'indices': [[10666, 10680]],
           'links': None,
           'score': None,
           'text': 'Robert Crockart',
           'types': ['Person']},
          {'indices': [[10889, 10901]],
           'links': None,
           'score': None,
           'text': 'Neha Manpuria',
           'types': ['Person']},
          {'indices': [[10889, 10892],
                       [11126, 11129],
                       [11738, 11741],
                       [12426, 12429],
                       [13034, 13037],
                       [13831, 13834]],
           'links': None,
           'score': None,
           'text': 'Neha',
           'types': ['Person']},
          {'indices': [[10666, 10671],
                       [11140, 11145],
                       [15966, 15971],
                       [21478, 21483],
                       [22167, 22172],
                       [28132, 28137],
                       [28230, 28235],
                       [28329, 28334],
                       [41261, 41266],
                       [43554, 43559]],
           'links': None,
           'score': None,
           'text': 'Robert',
           'types': ['Person']},
          {'indices': [[10522, 10526],
                       [11963, 11967],
                       [14431, 14435],
                       [21715, 21719],
                       [24052, 24056],
                       [27709, 27713],
                       [29003, 29007],
                       [33706, 33710],
                       [35487, 35491],
                       [40783, 40787],
                       [42091, 42095],
                       [42629, 42633],
                       [43797, 43801]],
           'links': None,
           'score': None,
           'text': 'Glenn',
           'types': ['Person']},
          {'indices': [[11971, 11979]],
           'links': None,
           'score': None,
           'text': 'Typically',
           'types': ['Person']},
          {'indices': [[13031, 13037]],
           'links': None,
           'score': None,
           'text': 'So Neha',
           'types': ['Person']},
          {'indices': [[13823, 13828]],
           'links': None,
           'score': None,
           'text': 'Rather',
           'types': ['Person']},
          {'indices': [[11895, 11898],
                       [12665, 12668],
                       [14170, 14173],
                       [16184, 16187],
                       [18820, 18823],
                       [18982, 18985],
                       [19068, 19071],
                       [22567, 22570],
                       [23059, 23062],
                       [25558, 25561],
                       [26270, 26273],
                       [26862, 26865],
                       [27210, 27213],
                       [27370, 27373],
                       [28267, 28270],
                       [28309, 28312],
                       [29754, 29757],
                       [35447, 35450],
                       [36006, 36009],
                       [36783, 36786],
                       [37253, 37256],
                       [37346, 37349],
                       [38211, 38214],
                       [38385, 38388],
                       [38866, 38869],
                       [39045, 39048],
                       [39133, 39136],
                       [39594, 39597],
                       [40747, 40750],
                       [41562, 41565],
                       [43176, 43179],
                       [43370, 43373],
                       [44581, 44584],
                       [45013, 45016]],
           'links': None,
           'score': None,
           'text': 'Okay',
           'types': ['Person']},
          {'indices': [[14394, 14406], [39962, 39974]],
           'links': None,
           'score': None,
           'text': 'Nitin Agarwal',
           'types': ['Person']},
          {'indices': [[14394, 14398],
                       [14906, 14910],
                       [15936, 15940],
                       [16671, 16675],
                       [39962, 39966],
                       [40675, 40679],
                       [40902, 40906]],
           'links': None,
           'score': None,
           'text': 'Nitin',
           'types': ['Person']},
          {'indices': [[16668, 16675]],
           'links': None,
           'score': None,
           'text': 'So Nitin',
           'types': ['Person']},
          {'indices': [[17389, 17395]],
           'links': None,
           'score': None,
           'text': 'So Mani',
           'types': ['Person']},
          {'indices': [[17720, 17734]],
           'links': None,
           'score': None,
           'text': 'Prakash Agarwal',
           'types': ['Person']},
          {'indices': [[18082, 18085], [33851, 33854]],
           'links': None,
           'score': None,
           'text': 'Look',
           'types': ['Person']},
          {'indices': [[21027, 21042]],
           'links': None,
           'score': None,
           'text': 'Shyam Srinivasan',
           'types': ['Person']},
          {'indices': [[21027, 21031],
                       [21550, 21554],
                       [22881, 22885],
                       [23188, 23192]],
           'links': None,
           'score': None,
           'text': 'Shyam',
           'types': ['Person']},
          {'indices': [[251, 255], [22865, 22869], [45385, 45389]],
           'links': None,
           'score': None,
           'text': 'Jason',
           'types': ['Person']},
          {'indices': [[23244, 23246]],
           'links': None,
           'score': None,
           'text': 'Got',
           'types': ['Person']},
          {'indices': [[23721, 23725], [41296, 41300]],
           'links': None,
           'score': None,
           'text': 'Sorry',
           'types': ['Person']},
          {'indices': [[27677, 27690]],
           'links': None,
           'score': None,
           'text': 'Alankar Garude',
           'types': ['Person']},
          {'indices': [[27697, 27705]],
           'links': None,
           'score': None,
           'text': 'Macquarie',
           'types': ['Person']},
          {'indices': [[27741, 27743], [28487, 28489], [28564, 28566]],
           'links': None,
           'score': None,
           'text': 'ROW',
           'types': ['Person']},
          {'indices': [[27749, 27754], [28476, 28481], [28553, 28558]],
           'links': None,
           'score': None,
           'text': 'Lat Am',
           'types': ['Person']},
          {'indices': [[28318, 28334]],
           'links': None,
           'score': None,
           'text': 'Alankar -- Robert',
           'types': ['Person']},
          {'indices': [[28476, 28485], [28553, 28562]],
           'links': None,
           'score': None,
           'text': 'Lat Am and',
           'types': ['Person']},
          {'indices': [[29360, 29374]],
           'links': None,
           'score': None,
           'text': 'Harith Mohammed',
           'types': ['Person']},
          {'indices': [[30352, 30355]],
           'links': None,
           'score': None,
           'text': 'Sure',
           'types': ['Person']},
          {'indices': [[30804, 30813]],
           'links': None,
           'score': None,
           'text': 'Jigar Shah',
           'types': ['Person']},
          {'indices': [[28975, 28984],
                       [32732, 32741],
                       [33604, 33613],
                       [35068, 35077]],
           'links': None,
           'score': None,
           'text': 'Understood',
           'types': ['Person', 'Organisation']},
          {'indices': [[35261, 35271]],
           'links': None,
           'score': None,
           'text': 'Dermatology',
           'types': ['Person']},
          {'indices': [[35669, 35684]],
           'links': None,
           'score': None,
           'text': 'Vishal Manchanda',
           'types': ['Person']},
          {'indices': [[35691, 35701]],
           'links': None,
           'score': None,
           'text': 'Nirmal Bang',
           'types': ['Person']},
          {'indices': [[35705, 35713], [36069, 36077], [36945, 36953]],
           'links': None,
           'score': None,
           'text': 'Basically',
           'types': ['Person']},
          {'indices': [[37463, 37471], [37710, 37718], [39332, 39340]],
           'links': None,
           'score': None,
           'text': 'Damayanti',
           'types': ['Person']},
          {'indices': [[39329, 39340]],
           'links': None,
           'score': None,
           'text': 'So Damayanti',
           'types': ['Person']},
          {'indices': [[21712, 21719], [24049, 24056], [42088, 42095]],
           'links': None,
           'score': None,
           'text': 'So Glenn',
           'types': ['Person']},
          {'indices': [[45112, 45118], [45197, 45203]],
           'links': None,
           'score': None,
           'text': 'Broadly',
           'types': ['Person']},
          {'indices': [[2490, 2500], [3049, 3059], [3254, 3264]],
           'links': None,
           'score': None,
           'text': 'Favipiravir',
           'types': ['Product']},
          {'indices': [[9563, 9565], [10447, 10449], [10791, 10793]],
           'links': None,
           'score': None,
           'text': 'Q&A',
           'types': ['Product', 'Organisation']},
          {'indices': [[651, 658]],
           'links': None,
           'score': None,
           'text': 'Business',
           'types': ['Organisation']},
          {'indices': [[2129, 2134]],
           'links': None,
           'score': None,
           'text': 'IPM de',
           'types': ['Organisation']},
          {'indices': [[2514, 2520],
                       [3267, 3273],
                       [21602, 21608],
                       [22312, 22318],
                       [40803, 40809]],
           'links': None,
           'score': None,
           'text': 'FabiFlu',
           'types': ['Organisation']},
          {'indices': [[3543, 3546]],
           'links': None,
           'score': None,
           'text': 'AIRZ',
           'types': ['Organisation']},
          {'indices': [[88, 111],
                       [4243, 4266],
                       [10570, 10593],
                       [10636, 10659],
                       [10709, 10732],
                       [23492, 23515],
                       [46246, 46269]],
           'links': None,
           'score': None,
           'text': 'Glenmark Pharmaceuticals',
           'types': ['Organisation']},
          {'indices': [[4694, 4701], [7790, 7797]],
           'links': None,
           'score': None,
           'text': 'U.S. FDA',
           'types': ['Organisation']},
          {'indices': [[4887, 4921]],
           'links': None,
           'score': None,
           'text': 'United States Department of Justice',
           'types': ['Organisation']},
          {'indices': [[6406, 6408]],
           'links': None,
           'score': None,
           'text': 'OPD',
           'types': ['Organisation']},
          {'indices': [[7143, 7148],
                       [36582, 36587],
                       [42180, 42185],
                       [42555, 42560],
                       [42695, 42700],
                       [44136, 44141]],
           'links': None,
           'score': None,
           'text': 'Salmex',
           'types': ['Organisation']},
          {'indices': [[8140, 8156]],
           'links': None,
           'score': None,
           'text': 'Yuhan Corporation',
           'types': ['Organisation']},
          {'indices': [[8500, 8502]],
           'links': None,
           'score': None,
           'text': 'CDE',
           'types': ['Organisation']},
          {'indices': [[8801, 8830]],
           'links': None,
           'score': None,
           'text': 'Glenmark Life Sciences Limited',
           'types': ['Organisation']},
          {'indices': [[8833, 8835]],
           'links': None,
           'score': None,
           'text': 'GLS',
           'types': ['Organisation']},
          {'indices': [[8801, 8822],
                       [8881, 8902],
                       [23770, 23791],
                       [29772, 29793],
                       [30327, 30348]],
           'links': None,
           'score': None,
           'text': 'Glenmark Life Sciences',
           'types': ['Organisation']},
          {'indices': [[8911, 8927]],
           'links': None,
           'score': None,
           'text': 'INR 2,348 million',
           'types': ['Organisation']},
          {'indices': [[9161, 9175]],
           'links': None,
           'score': None,
           'text': 'Ichnos Sciences',
           'types': ['Organisation']},
          {'indices': [[9267, 9283]],
           'links': None,
           'score': None,
           'text': 'INR 1,900 million',
           'types': ['Organisation']},
          {'indices': [[88, 119], [10709, 10740], [46246, 46277]],
           'links': None,
           'score': None,
           'text': 'Glenmark Pharmaceuticals Limited',
           'types': ['Organisation']},
          {'indices': [[123, 143],
                       [10822, 10842],
                       [14333, 14353],
                       [17663, 17683],
                       [20966, 20986],
                       [24715, 24735],
                       [27616, 27636],
                       [29299, 29319],
                       [30743, 30763],
                       [32116, 32136],
                       [35608, 35628],
                       [37402, 37422],
                       [39901, 39921],
                       [41997, 42017]],
           'links': None,
           'score': None,
           'text': 'Operator Instructions',
           'types': ['Organisation']},
          {'indices': [[14413, 14427], [39981, 39995]],
           'links': None,
           'score': None,
           'text': 'IDFC Securities',
           'types': ['Organisation']},
          {'indices': [[17741, 17752]],
           'links': None,
           'score': None,
           'text': 'Axis Capital',
           'types': ['Organisation']},
          {'indices': [[19854, 19855]],
           'links': None,
           'score': None,
           'text': 'CC',
           'types': ['Organisation']},
          {'indices': [[22663, 22666]],
           'links': None,
           'score': None,
           'text': 'MD&A',
           'types': ['Organisation']},
          {'indices': [[21547, 21554], [22878, 22885]],
           'links': None,
           'score': None,
           'text': 'So Shyam',
           'types': ['Organisation']},
          {'indices': [[24772, 24786], [42058, 42072]],
           'links': None,
           'score': None,
           'text': 'Saion Mukherjee',
           'types': ['Organisation']},
          {'indices': [[24793, 24798], [42079, 42084]],
           'links': None,
           'score': None,
           'text': 'Nomura',
           'types': ['Organisation']},
          {'indices': [[25625, 25632]],
           'links': None,
           'score': None,
           'text': 'Unilever',
           'types': ['Organisation']},
          {'indices': [[25726, 25731], [26284, 26289]],
           'links': None,
           'score': None,
           'text': 'INR 31',
           'types': ['Organisation']},
          {'indices': [[26179, 26181]],
           'links': None,
           'score': None,
           'text': 'HUL',
           'types': ['Organisation']},
          {'indices': [[29381, 29393]],
           'links': None,
           'score': None,
           'text': 'Spark Capital',
           'types': ['Organisation']},
          {'indices': [[31075, 31077]],
           'links': None,
           'score': None,
           'text': 'NCE',
           'types': ['Organisation']},
          {'indices': [[32177, 32188], [44217, 44228]],
           'links': None,
           'score': None,
           'text': 'Chirag Dagli',
           'types': ['Organisation']},
          {'indices': [[32195, 32210], [44235, 44250]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[37374, 37378],
                       [40007, 40011],
                       [40047, 40051],
                       [44888, 44892]],
           'links': None,
           'score': None,
           'text': 'CapEx',
           'types': ['Organisation']},
          {'indices': [[37463, 37477]],
           'links': None,
           'score': None,
           'text': 'Damayanti Kerai',
           'types': ['Organisation']},
          {'indices': [[37484, 37487]],
           'links': None,
           'score': None,
           'text': 'HSBC',
           'types': ['Organisation']},
          {'indices': [[40047, 40082]],
           'links': None,
           'score': None,
           'text': 'CapEx for the year now and next year',
           'types': ['Organisation']},
          {'indices': [[40992, 40993]],
           'links': None,
           'score': None,
           'text': 'EU',
           'types': ['Organisation']},
          {'indices': [[42454, 42458]],
           'links': None,
           'score': None,
           'text': 'Glaxo',
           'types': ['Organisation']},
          {'indices': [[42686, 42688]],
           'links': None,
           'score': None,
           'text': 'GSK',
           'types': ['Organisation']},
          {'indices': [[42942, 42948]],
           'links': None,
           'score': None,
           'text': 'Nordics',
           'types': ['Organisation']},
          {'indices': [[36602, 36604], [43400, 43402], [44160, 44162]],
           'links': None,
           'score': None,
           'text': 'DPI',
           'types': ['Organisation']},
          {'indices': [[33823, 33831], [44339, 44347]],
           'links': None,
           'score': None,
           'text': 'So Chirag',
           'types': ['Organisation']},
          {'indices': [[44888, 44906]],
           'links': None,
           'score': None,
           'text': 'CapEx of 180 crores',
           'types': ['Organisation']},
          {'indices': [[45054, 45056]],
           'links': None,
           'score': None,
           'text': 'P&L',
           'types': ['Organisation']}],
 'title': [{'indices': [[37, 39]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Chief_executive_officer'},
            'score': 1.0,
            'text': 'CEO',
            'types': ['PersonFunction']},
           {'indices': [[41, 54]],
            'links': None,
            'score': None,
            'text': 'Glenn Saldanha',
            'types': ['Person']},
           {'indices': [[0, 27]],
            'links': None,
            'score': None,
            'text': 'Glenmark Pharmaceuticals Ltd',
            'types': ['Organisation']},
           {'indices': [[30, 34]],
            'links': None,
            'score': None,
            'text': 'GLKQY',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB3',
 'label': 'Business',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB3',
           'parent': None},
 'score': 0.28999999165534973,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB3-11',
 'label': 'Marketing',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB3-11',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB3'},
 'score': 0.25,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.05000000074505806,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.9331},
 'title': {'polarity': 'neutral', 'score': 0.669194}}"
2020-08-14  13:09;HDFC Mutual Fund Invests in Yes Bank, Wipro, Jindal Steel, Tech Mahindra and Sun Pharma during July | TopNews;"HDFC Mutual fund purchased 16.3 crore shares of troubled private sector lender Yes Bank in July. It is interesting to note that as the position of Yes Bank has stabilized, LIC and HDFC Mutual Fund have acted quickly to buy Yes Bank stock at attractive valuations. Yes Bank declined to Rs 12 from Rs 28 during July as the bank raised Rs 15,000 crore from FPO. The major decline was due to Yes Bank selling shares at Rs 12 during FPO.

Other stocks purchased by Prashant Jain of HDFC Mutual Fund for different mutual fund schemes include Tech Mahindra, Wipro, Jindal Steel and Sun Pharmaucetical. Major investment was made in Wipro by purchasing 1.15 crore shares, followed by 25 lakh shares of Tech Mahindra.

Prashant Jain is known for his long term bets that have played really well for investors in HDFC Mutual Fund. The short term performance could be low but in long term, the funds managed by Jain have delivered really well. HDFC Top 100 Fund is a large cap scheme and HDFC Equity Fund is a multi cap scheme managing assets worth ₹16,202 crore and ₹19,150 crore respectively.

As per a report published by Dolat Capital, HDFC Mutual Fund sold Vodafone Idea (1.1 crore shares), public sector bank Punjab National Bank (1.1 crore shares), Reliance Industries (75 lakh shares), Bharti Infratel (69 lakh shares) and Bharat Petroleum Corporation (43 lakh shares).";"{'body': [{'indices': [[1183, 1195]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Public_sector'},
           'score': 0.9843858480453491,
           'text': 'public sector',
           'types': ['Part']},
          {'indices': [[1281, 1295]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bharti_Enterprises'},
           'score': 1.0,
           'text': 'Bharti Infratel',
           'types': ['Company', 'Conglomerate', 'Organisation', 'Agent']},
          {'indices': [[954, 962]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Market_capitalization'},
           'score': 1.0,
           'text': 'large cap',
           'types': ['Company', 'Value']},
          {'indices': [[469, 472], [718, 721], [898, 901]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Jainism'},
           'score': 0.9997695684432983,
           'text': 'Jain',
           'types': ['Religion', 'EthnicGroup', 'Country', 'Person']},
          {'indices': [[1202, 1221]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Punjab_National_Bank'},
           'score': 1.0,
           'text': 'Punjab National Bank',
           'types': ['Company', 'Bank', 'Organisation', 'Banking', 'Agent']},
          {'indices': [[1149, 1156]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Vodafone'},
           'score': 0.9800033569335938,
           'text': 'Vodafone',
           'types': ['Company', 'Organisation', 'Agent']},
          {'indices': [[558, 569]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Jindal_Steel_and_Power'},
           'score': 1.0,
           'text': 'Jindal Steel',
           'types': ['Company',
                     'ArchitecturalStructure',
                     'Steel',
                     'Organisation',
                     'Agent']},
          {'indices': [[1243, 1261]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Reliance_Industries'},
           'score': 1.0,
           'text': 'Reliance Industries',
           'types': ['Company', 'Conglomerate', 'Organisation', 'Agent']},
          {'indices': [[5, 15]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 1.0,
           'text': 'Mutual fund',
           'types': ['PersonFunction']},
          {'indices': [[508, 518]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 1.0,
           'text': 'mutual fund',
           'types': ['PersonFunction']},
          {'indices': [[960, 962], [1003, 1005]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Cap_(sport)'},
           'score': 0.6325376033782959,
           'text': 'cap',
           'types': ['Term']},
          {'indices': [[321, 324], [1197, 1200]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bank'},
           'score': 0.9990901947021484,
           'text': 'bank',
           'types': ['Institution', 'University', 'PersonFunction']},
          {'indices': [[536, 548], [693, 705]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Tech_Mahindra'},
           'score': 1.0,
           'text': 'Tech Mahindra',
           'types': ['Company', 'Provider', 'Organisation', 'Agent']},
          {'indices': [[678, 681], [1267, 1270], [1301, 1304], [1351, 1354]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Organisation', 'Unit']},
          {'indices': [[32, 36],
                       [343, 347],
                       [649, 653],
                       [1044, 1048],
                       [1062, 1066],
                       [1168, 1172],
                       [1228, 1232]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[1318, 1333]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bharat_Petroleum'},
           'score': 1.0,
           'text': 'Bharat Petroleum',
           'types': ['Company', 'Organisation', 'Oil', 'Agent']},
          {'indices': [[551, 555], [624, 628]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Wipro'},
           'score': 1.0,
           'text': 'Wipro',
           'types': ['Strategy',
                     'Company',
                     'Organisation',
                     'VideoGame',
                     'Product',
                     'Agent',
                     'Place']},
          {'indices': [[285, 286], [296, 297], [333, 334], [415, 416]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place', 'Organisation']},
          {'indices': [[460, 472], [709, 721]],
           'links': None,
           'score': None,
           'text': 'Prashant Jain',
           'types': ['Person']},
          {'indices': [[1158, 1161]],
           'links': None,
           'score': None,
           'text': 'Idea',
           'types': ['Person']},
          {'indices': [[0, 10],
                       [180, 190],
                       [477, 487],
                       [801, 811],
                       [1127, 1137]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual',
           'types': ['Organisation']},
          {'indices': [[83, 86],
                       [151, 154],
                       [227, 230],
                       [268, 271],
                       [392, 395],
                       [1218, 1221]],
           'links': None,
           'score': None,
           'text': 'Bank',
           'types': ['Organisation']},
          {'indices': [[172, 174]],
           'links': None,
           'score': None,
           'text': 'LIC',
           'types': ['Organisation']},
          {'indices': [[180, 195], [477, 492], [801, 816], [1127, 1142]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[354, 356], [428, 430]],
           'links': None,
           'score': None,
           'text': 'FPO',
           'types': ['Organisation']},
          {'indices': [[460, 492]],
           'links': None,
           'score': None,
           'text': 'Prashant Jain of HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[575, 592]],
           'links': None,
           'score': None,
           'text': 'Sun Pharmaucetical',
           'types': ['Organisation']},
          {'indices': [[931, 947]],
           'links': None,
           'score': None,
           'text': 'HDFC Top 100 Fund',
           'types': ['Organisation']},
          {'indices': [[975, 990]],
           'links': None,
           'score': None,
           'text': 'HDFC Equity Fund',
           'types': ['Organisation']},
          {'indices': [[1112, 1124]],
           'links': None,
           'score': None,
           'text': 'Dolat Capital',
           'types': ['Organisation']},
          {'indices': [[1318, 1345]],
           'links': None,
           'score': None,
           'text': 'Bharat Petroleum Corporation',
           'types': ['Organisation']}],
 'title': [{'indices': [[45, 56]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Jindal_Steel_and_Power'},
            'score': 1.0,
            'text': 'Jindal Steel',
            'types': ['Company',
                      'ArchitecturalStructure',
                      'Agent',
                      'Steel',
                      'Organisation']},
           {'indices': [[59, 71]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Tech_Mahindra'},
            'score': 1.0,
            'text': 'Tech Mahindra',
            'types': ['Company', 'Agent', 'Provider', 'Organisation']},
           {'indices': [[38, 42]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Wipro'},
            'score': 1.0,
            'text': 'Wipro',
            'types': ['VideoGame',
                      'Product',
                      'Company',
                      'Agent',
                      'Strategy',
                      'Organisation']},
           {'indices': [[77, 86]],
            'links': None,
            'score': None,
            'text': 'Sun Pharma',
            'types': ['Place']},
           {'indices': [[0, 23]],
            'links': None,
            'score': None,
            'text': 'HDFC Mutual Fund Invests',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.44999998807907104,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.25,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': '04006002',
 'label': 'banking',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04006002',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04006000'},
 'score': 0.44999998807907104,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.578213},
 'title': {'polarity': 'neutral', 'score': 0.940907}}"
2020-08-11  20:25;Inox Benefit Trust offloads entire stake in Inox Leisure, Westbridge Crossover Fund sells 2% stake in La Opala;"Inox Benefit Trust has offloaded its entire 4.23 percent equity stake in multiplex chain Inox Leisure on August 11 via open market transactions.

Pavan Kumar Jain, Vivek Kumar Jain and Deepak Asher the trustees of Inox Benefit Trust sold 43.50 lakh shares in the company at Rs 233 per share, bulk deals data available on the BSE showed. The stake sale was worth Rs 101.35 crore.

Skale Master Fund, Abu Dhabi Investment Authority and HDFC Mutual Fund acquired 8,55,092,  11.25 lakh and 23.7 lakh equity shares, respectively, in Inox Leisure at the same price.

Inox Leisure share price rallied 2.39 percent to close at Rs 235.60 on August 11.

Among other deals, Westbridge Crossover Fund offloaded 22,99,696 shares in tableware company La Opala RG (representing 2.07 percent of its paid-up equity capital) at Rs 185 per share on the NSE. It held 2.44 percent or 27,12,858 shares in La Opala as of June 30.

Eastspring Investments India Infrastructure Equity Open sold 31,87,919 shares in Consolidated Construction Consortium at Rs 0.32 per share.

Elara India Opportunities Fund offloaded 1 lakh shares in IT company GSS Infotech at Rs 23.86 per share, while BNK Capital Markets sold 2 lakh Rights Entitlement shares in Spencer's Retail at Rs 21.66 per share.";"{'body': [{'indices': [[73, 81]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Multiplex_(television)'},
           'score': 0.40719446539878845,
           'text': 'multiplex',
           'types': ['Term']},
          {'indices': [[158, 161], [176, 179]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Jainism'},
           'score': 0.9998968839645386,
           'text': 'Jain',
           'types': ['EthnicGroup', 'Religion', 'Country']},
          {'indices': [[57, 62], [496, 501], [791, 796]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.6069008111953735,
           'text': 'equity',
           'types': ['Disease', 'Difference']},
          {'indices': [[791, 804]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 1.0,
           'text': 'equity capital',
           'types': ['Disease', 'Difference']},
          {'indices': [[719, 727]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Tableware'},
           'score': 0.9959373474121094,
           'text': 'tableware',
           'types': ['Food', 'Product', 'Dishes']},
          {'indices': [[1049, 1053]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ellalan'},
           'score': 0.9999998807907104,
           'text': 'Elara',
           'types': ['Person',
                     'Film',
                     'Product',
                     'Royalty',
                     'Agent',
                     'Tamil',
                     'Organisation']},
          {'indices': [[931, 935], [1055, 1059]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9989084601402283,
           'text': 'India',
           'types': ['Country',
                     'Place',
                     'Location',
                     'MusicalArtist',
                     'PopulatedPlace']},
          {'indices': [[496, 508]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Common_stock'},
           'score': 1.0,
           'text': 'equity shares',
           'types': ['Form']},
          {'indices': [[244, 247],
                       [477, 480],
                       [491, 494],
                       [1092, 1095],
                       [1187, 1190]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Organisation', 'Unit']},
          {'indices': [[325, 327]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bombay_Stock_Exchange'},
           'score': 0.4958832859992981,
           'text': 'BSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[372, 376]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[399, 428]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Abu_Dhabi_Investment_Authority'},
           'score': 1.0,
           'text': 'Abu Dhabi Investment Authority',
           'types': ['Fund', 'Organisation', 'Agent', 'Company']},
          {'indices': [[64, 68], [341, 345]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Stake_(Latter_Day_Saints)'},
           'score': 0.6453912258148193,
           'text': 'stake',
           'types': ['Organisation', 'Unit']},
          {'indices': [[164, 168]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Vivek_(actor)'},
           'score': 1.0,
           'text': 'Vivek',
           'types': ['Person', 'Actor', 'Agent']},
          {'indices': [[834, 836]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.8105140328407288,
           'text': 'NSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[274, 279]],
           'links': None,
           'score': None,
           'text': 'Rs 233',
           'types': ['Place']},
          {'indices': [[619, 627]],
           'links': None,
           'score': None,
           'text': 'Rs 235.60',
           'types': ['Place']},
          {'indices': [[1134, 1141]],
           'links': None,
           'score': None,
           'text': 'Rs 23.86',
           'types': ['Place']},
          {'indices': [[89, 100], [528, 539], [561, 572]],
           'links': None,
           'score': None,
           'text': 'Inox Leisure',
           'types': ['Person']},
          {'indices': [[164, 179]],
           'links': None,
           'score': None,
           'text': 'Vivek Kumar Jain',
           'types': ['Person']},
          {'indices': [[185, 196]],
           'links': None,
           'score': None,
           'text': 'Deepak Asher',
           'types': ['Person']},
          {'indices': [[1221, 1227]],
           'links': None,
           'score': None,
           'text': 'Spencer',
           'types': ['Person']},
          {'indices': [[737, 747]],
           'links': None,
           'score': None,
           'text': 'La Opala RG',
           'types': ['Product']},
          {'indices': [[0, 17], [214, 231]],
           'links': None,
           'score': None,
           'text': 'Inox Benefit Trust',
           'types': ['Organisation']},
          {'indices': [[146, 161]],
           'links': None,
           'score': None,
           'text': 'Pavan Kumar Jain',
           'types': ['Organisation']},
          {'indices': [[380, 396]],
           'links': None,
           'score': None,
           'text': 'Skale Master Fund',
           'types': ['Organisation']},
          {'indices': [[434, 449]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[663, 687]],
           'links': None,
           'score': None,
           'text': 'Westbridge Crossover Fund',
           'types': ['Organisation']},
          {'indices': [[737, 744], [883, 890]],
           'links': None,
           'score': None,
           'text': 'La Opala',
           'types': ['Organisation']},
          {'indices': [[908, 962]],
           'links': None,
           'score': None,
           'text': 'Eastspring Investments India Infrastructure Equity Open',
           'types': ['Organisation']},
          {'indices': [[989, 1024]],
           'links': None,
           'score': None,
           'text': 'Consolidated Construction Consortium',
           'types': ['Organisation']},
          {'indices': [[1055, 1078]],
           'links': None,
           'score': None,
           'text': 'India Opportunities Fund',
           'types': ['Organisation']},
          {'indices': [[1118, 1129]],
           'links': None,
           'score': None,
           'text': 'GSS Infotech',
           'types': ['Organisation']},
          {'indices': [[1160, 1178]],
           'links': None,
           'score': None,
           'text': 'BNK Capital Markets',
           'types': ['Organisation']},
          {'indices': [[1192, 1209]],
           'links': None,
           'score': None,
           'text': 'Rights Entitlement',
           'types': ['Organisation']},
          {'indices': [[1231, 1248]],
           'links': None,
           'score': None,
           'text': 'Retail at Rs 21.66',
           'types': ['Organisation']}],
 'title': [{'indices': [[0, 17]],
            'links': None,
            'score': None,
            'text': 'Inox Benefit Trust',
            'types': ['Organisation']},
           {'indices': [[44, 55]],
            'links': None,
            'score': None,
            'text': 'Inox Leisure',
            'types': ['Organisation']},
           {'indices': [[58, 82]],
            'links': None,
            'score': None,
            'text': 'Westbridge Crossover Fund',
            'types': ['Organisation']},
           {'indices': [[102, 109]],
            'links': None,
            'score': None,
            'text': 'La Opala',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.28999999165534973,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.15000000596046448,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016018',
 'label': 'earnings',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016018',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.09000000357627869,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.657693},
 'title': {'polarity': 'neutral', 'score': 0.621602}}"
2020-08-08  12:26;Mangaluru: Online certificate course on Stock Market organized by St Agnes College (Autonomous);"Mangaluru, Aug 8: The department of Commerce, St Agnes College (Autonomous), here, had organized an online certificate course on Trends in Stock Market from July 13 to July 31 for 30 hours. The course was open to all the UG and PG students of the college and for students of various other colleges.

The course was introduced to teach the participants about investing in stock markets and to analyze the various factors influencing the stock prices. 120 students were the beneficiaries.

The resource persons were:

Anitha, assistant professor, department of Commerce, St Agnes College (Autonomous) explained the various terms used in the stock market.

Elston Neil Menezes worked with HCL Capital Market, Simplus Financial Consultancy, Franklin Templeton Mutual Funds and HDFC Mutual Funds. He is an entrepreneur for the last four years as a Personal Investment Services professional. He has work experience of more than 12 years in this industry. He explained to the students about the working of the stock market, how to analyze a company before investing and gave a brief description of Mutual Funds.

Roshni Yashwanth, assistant professor, Department of Commerce, Government First Grade College, Haleyangadi currently pursues PhD at Mangalore University. She has teaching experience for more than 19 years and she has also co-authored a book in financial management. Her session was interesting as she spoke about diversified investment and the need for maintaining the right portfolio.

Mahammad Thauseef P, assistant professor, St Aloysius College (Autonomous) who has a teaching experience of four years. He conducted sessions for three days explaining the various instruments available in the stock market, their functions and the risk factors. He also suggested some apps and explained their features and motivated the students to invest in stocks after analyzing them thoroughly.

The course included an assignment where the students had to observe the stock market and a company of their choice daily. The certificate course was coordinated by Sr Clera Rodrigues, assistant professor, Department of Commerce, St Agnes College.

The certificate course was appreciated by all the students who were satisfied with all the sessions. The students received e-certificates after submitting their assignments.";"{'body': [{'indices': [[1231, 1233]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Doctor_of_Philosophy'},
           'score': 0.9974345564842224,
           'text': 'PhD',
           'types': ['University', 'OfficeHolder', 'Doctorate']},
          {'indices': [[801, 812]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Entrepreneurship'},
           'score': 0.9994351863861084,
           'text': 'entrepreneur',
           'types': ['Process', 'PersonFunction', 'Election']},
          {'indices': [[1238, 1257]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mangalore_University'},
           'score': 1.0,
           'text': 'Mangalore University',
           'types': ['University',
                     'EducationalInstitution',
                     'Agent',
                     'Organisation']},
          {'indices': [[1535, 1553]],
           'links': {'dbpedia': ""http://dbpedia.org/resource/St_Aloysius'_College_(Sydney)""},
           'score': 0.5779147744178772,
           'text': 'St Aloysius College',
           'types': ['EducationalInstitution',
                     'Agent',
                     'Organisation',
                     'School']},
          {'indices': [[22, 31], [545, 554]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Departments_of_France'},
           'score': 0.9985204935073853,
           'text': 'department',
           'types': ['Levels', 'SportsLeague']},
          {'indices': [[639, 650], [1003, 1014], [1702, 1713], [1964, 1975]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Stock_market'},
           'score': 0.9969627261161804,
           'text': 'stock market',
           'types': ['AnatomicalStructure', 'Aggregation']},
          {'indices': [[46, 53], [569, 576], [2121, 2128]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/St_Agnes,_Cornwall'},
           'score': 0.7403814792633057,
           'text': 'St Agnes',
           'types': ['Settlement',
                     'Place',
                     'Parish',
                     'Location',
                     'PopulatedPlace']},
          {'indices': [[2065, 2073]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Rodrigues'},
           'score': 0.9989113211631775,
           'text': 'Rodrigues',
           'types': ['Settlement', 'Place', 'Location', 'PopulatedPlace']},
          {'indices': [[0, 8]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mangalore'},
           'score': 1.0,
           'text': 'Mangaluru',
           'types': ['Settlement',
                     'Place',
                     'Location',
                     'City',
                     'PopulatedPlace']},
          {'indices': [[737, 754]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Franklin_Templeton_Investments'},
           'score': 1.0,
           'text': 'Franklin Templeton',
           'types': ['Bank', 'Company', 'Agent', 'Organisation']},
          {'indices': [[221, 222]],
           'links': None,
           'score': None,
           'text': 'UG',
           'types': ['Place']},
          {'indices': [[1201, 1211]],
           'links': None,
           'score': None,
           'text': 'Haleyangadi',
           'types': ['Place']},
          {'indices': [[516, 521]],
           'links': None,
           'score': None,
           'text': 'Anitha',
           'types': ['Person']},
          {'indices': [[654, 672]],
           'links': None,
           'score': None,
           'text': 'Elston Neil Menezes',
           'types': ['Person']},
          {'indices': [[1106, 1121]],
           'links': None,
           'score': None,
           'text': 'Roshni Yashwanth',
           'types': ['Person']},
          {'indices': [[1493, 1509]],
           'links': None,
           'score': None,
           'text': 'Mahammad Thauseef',
           'types': ['Person']},
          {'indices': [[36, 43], [559, 566], [1159, 1166], [2111, 2118]],
           'links': None,
           'score': None,
           'text': 'Commerce',
           'types': ['Organisation']},
          {'indices': [[46, 61], [569, 584], [2121, 2136]],
           'links': None,
           'score': None,
           'text': 'St Agnes College',
           'types': ['Organisation']},
          {'indices': [[129, 150]],
           'links': None,
           'score': None,
           'text': 'Trends in Stock Market',
           'types': ['Organisation']},
          {'indices': [[686, 703]],
           'links': None,
           'score': None,
           'text': 'HCL Capital Market',
           'types': ['Organisation']},
          {'indices': [[737, 767]],
           'links': None,
           'score': None,
           'text': 'Franklin Templeton Mutual Funds',
           'types': ['Organisation']},
          {'indices': [[773, 789]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Funds',
           'types': ['Organisation']},
          {'indices': [[1145, 1198]],
           'links': None,
           'score': None,
           'text': 'Department of Commerce, Government First Grade College',
           'types': ['Organisation']},
          {'indices': [[1535, 1565]],
           'links': None,
           'score': None,
           'text': 'St Aloysius College (Autonomous',
           'types': ['Organisation']},
          {'indices': [[1145, 1166], [2097, 2118]],
           'links': None,
           'score': None,
           'text': 'Department of Commerce',
           'types': ['Organisation']}],
 'title': [{'indices': [[0, 8]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Mangalore'},
            'score': 1.0,
            'text': 'Mangaluru',
            'types': ['Location',
                      'PopulatedPlace',
                      'Place',
                      'Settlement',
                      'City']},
           {'indices': [[66, 73]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/St_Agnes,_Cornwall'},
            'score': 0.8986403942108154,
            'text': 'St Agnes',
            'types': ['Location',
                      'PopulatedPlace',
                      'Place',
                      'Settlement',
                      'Parish']},
           {'indices': [[66, 81]],
            'links': None,
            'score': None,
            'text': 'St Agnes College',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.28999999165534973,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-9',
 'label': 'Options',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-9',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.11999999731779099,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': '05002000',
 'label': 'further education',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/05002000',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/05000000'},
 'score': 0.10000000149011612,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.991162},
 'title': {'polarity': 'neutral', 'score': 0.984539}}"
2020-08-04  22:25;HDFC MF offloads Rs 17 crore worth stake in Aarti Surfactants, promoters turn buyers;"HDFC Mutual Fund through its funds offloaded Rs 17.02 crore worth of shares in Aarti Surfactants, the demerged entity of specialty chemical manufacturer Aarti Industries, on August 4 via open market transactions.

The asset management company (AMC) sold a total of 6.92 lakh shares in Aarti Surfactants. Of this, it sold 4.55 lakh shares at Rs 245.90 per share and the rest at Rs 245.4 per share, bulk deals data available on the exchanges showed.

Aarti Industries has demerged its home and personal care division and named it as Aarti Surfactants, which listed on exchanges with effect from July 14.

The stock opened at Rs 505 on the BSE on July 14 and since then it had consistently been falling up to Rs 234.20 till August 3, before showing an uptrend on August 4 when it closed 5 percent higher at Rs 245.90.

On the other side, its promoter entity Aarti Industries was up 3 percent on August 4. It closed at Rs 1,043.25 per share on the BSE.

Smallcap World Fund and DSP Mutual Fund sold 59,380 and 77,984 shares in Aarti Surfactants at Rs 234.44 and Rs 245.90 per share, respectively.

On the contrary, promoters Chandrakant Vallabhji Gogri and Jaya Chandrakant Gogri acquired one lakh and two lakh shares in Aarti Surfactants, respectively. Among others, Dhiren Kishore Shah (1.01 lakh shares), Alpha Leon Enterprises (1 lakh shares), Haresh Kunvarji Chheda HUF (40,000 shares) and Mulraj Chandulal Gala (57,020 shares) were also buyers in the company.

Among other deals, Ambit Finvest Private sold 40,36,149 shares in Future Enterprises at Rs 17.16 per share.";"{'body': [{'indices': [[85, 95],
                       [291, 301],
                       [537, 547],
                       [1029, 1039],
                       [1223, 1233]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Surfactant'},
           'score': 1.0,
           'text': 'Surfactants',
           'types': ['Compounds', 'ChemicalCompound']},
          {'indices': [[506, 513]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Division_(military)'},
           'score': 0.9945641756057739,
           'text': 'division',
           'types': ['MilitaryUnit', 'Unit', 'Organisation']},
          {'indices': [[974, 976]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Digital_signal_processor'},
           'score': 0.6261751055717468,
           'text': 'DSP',
           'types': ['Microprocessor']},
          {'indices': [[1367, 1369]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Hungarian_forint'},
           'score': 0.9913516044616699,
           'text': 'HUF',
           'types': ['Currency']},
          {'indices': [[218, 233]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asset_management'},
           'score': 0.9689750075340271,
           'text': 'asset management',
           'types': ['MusicGenre']},
          {'indices': [[270, 273],
                       [326, 329],
                       [1189, 1192],
                       [1202, 1205],
                       [1290, 1293],
                       [1330, 1333]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Unit', 'Organisation']},
          {'indices': [[637, 639], [944, 946]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bombay_Stock_Exchange'},
           'score': 0.5792520642280579,
           'text': 'BSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[1391, 1396]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mularaja'},
           'score': 0.9056103825569153,
           'text': 'Mulraj',
           'types': ['OfficeHolder', 'Person', 'Royalty', 'Agent']},
          {'indices': [[54, 58]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[79, 83],
                       [153, 157],
                       [285, 289],
                       [449, 453],
                       [531, 535],
                       [855, 859],
                       [1023, 1027],
                       [1217, 1221]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Aarti'},
           'score': 1.0,
           'text': 'Aarti',
           'types': ['EthnicGroup', 'Ritual']},
          {'indices': [[492, 504]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Personal_care'},
           'score': 0.9839394688606262,
           'text': 'personal care',
           'types': ['Industry', 'Company']},
          {'indices': [[121, 138]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fine_chemical'},
           'score': 1.0,
           'text': 'specialty chemical',
           'types': ['Substances', 'ChemicalCompound']},
          {'indices': [[1482, 1486]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ambit_(magazine)'},
           'score': 1.0,
           'text': 'Ambit',
           'types': ['Magazine',
                     'Product',
                     'WrittenWork',
                     'PeriodicalLiterature',
                     'Work']},
          {'indices': [[244, 246]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
           'score': 0.6431301832199097,
           'text': 'AMC',
           'types': ['Broadcaster',
                     'Cable',
                     'Organisation',
                     'Agent',
                     'TelevisionStation']},
          {'indices': [[706, 714]],
           'links': None,
           'score': None,
           'text': 'Rs 234.20',
           'types': ['Place']},
          {'indices': [[341, 349], [804, 812], [1058, 1066]],
           'links': None,
           'score': None,
           'text': 'Rs 245.90',
           'types': ['Place']},
          {'indices': [[45, 46],
                       [341, 342],
                       [377, 378],
                       [623, 624],
                       [706, 707],
                       [804, 805],
                       [915, 916],
                       [1044, 1045],
                       [1058, 1059],
                       [1551, 1552]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place', 'Organisation']},
          {'indices': [[1344, 1349]],
           'links': None,
           'score': None,
           'text': 'Haresh',
           'types': ['Place']},
          {'indices': [[79, 95],
                       [285, 301],
                       [531, 547],
                       [1023, 1039],
                       [1217, 1233]],
           'links': None,
           'score': None,
           'text': 'Aarti Surfactants',
           'types': ['Person', 'Organisation']},
          {'indices': [[1121, 1147]],
           'links': None,
           'score': None,
           'text': 'Chandrakant Vallabhji Gogri',
           'types': ['Person']},
          {'indices': [[1153, 1174]],
           'links': None,
           'score': None,
           'text': 'Jaya Chandrakant Gogri',
           'types': ['Person']},
          {'indices': [[1264, 1282]],
           'links': None,
           'score': None,
           'text': 'Dhiren Kishore Shah',
           'types': ['Person']},
          {'indices': [[0, 15]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[153, 168], [449, 464], [855, 870]],
           'links': None,
           'score': None,
           'text': 'Aarti Industries',
           'types': ['Organisation']},
          {'indices': [[950, 968]],
           'links': None,
           'score': None,
           'text': 'Smallcap World Fund',
           'types': ['Organisation']},
          {'indices': [[974, 988]],
           'links': None,
           'score': None,
           'text': 'DSP Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1304, 1325]],
           'links': None,
           'score': None,
           'text': 'Alpha Leon Enterprises',
           'types': ['Organisation']},
          {'indices': [[1529, 1546]],
           'links': None,
           'score': None,
           'text': 'Future Enterprises',
           'types': ['Organisation']}],
 'title': [{'indices': [[35, 39]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
            'score': 1.0,
            'text': 'stake',
            'types': ['Disease', 'Difference']},
           {'indices': [[5, 6]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Midfielder'},
            'score': 1.0,
            'text': 'MF',
            'types': ['Position', 'Person', 'Product']},
           {'indices': [[17, 18]],
            'links': None,
            'score': None,
            'text': 'Rs',
            'types': ['Place']},
           {'indices': [[0, 3]],
            'links': None,
            'score': None,
            'text': 'HDFC',
            'types': ['Organisation']},
           {'indices': [[44, 60]],
            'links': None,
            'score': None,
            'text': 'Aarti Surfactants',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.3700000047683716,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.17000000178813934,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016018',
 'label': 'earnings',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016018',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.05000000074505806,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'negative', 'score': 0.953826},
 'title': {'polarity': 'neutral', 'score': 0.667539}}"
2020-07-30  22:34;SEBI slaps Rs 2 crore fine on 4 entities in HDFC AMC front-running case;"Markets regulator Sebi on Thursday imposed a penalty totalling Rs 2 crore on four entities in HDFC Asset Management Company (AMC) front-running case. Front-running refers to an unethical practice by someone trading in shares on the basis of advance information given by a broker, analyst or other executive at a market intermediary before the trades are conducted by that entity.

The regulator levied a fine of Rs 50 lakh each on Nilesh Kapadia and Dharmesh Shah, Rs 40 lakh on Ashok Nayak and Rs 60 lakh on IKAB Securities and Investments Ltd.

During the investigation period of October 2006 to June 2007, Kapadia, who was equity dealer with HDFC AMC between June 2000 to 2010, tipped Dharmesh Shah regarding impending HDFC AMC trades, Sebi noted.

Dharmesh Shah in turn facilitated 109 instances of front-running the trades of HDFC AMC.

These front-running trades were executed in trading accounts of Nayak and Bankim Shah, one of the dealer of IKAB Securities and Investments, among others.

Dharmesh Shah and Nayak were clients of IKAB Securities and Investments.

Kapadia and Dharmesh Shah ""perpetrated a scheme of front running trades of HDFC AMC"" with the help of Bankim Shah and IKAB Securities and Investments, Sebi said.

The conduct of four entities in relation to 109 instances of front-run trades of HDFC MF/AMC indicate that the ""trades were front-run based on confidential information obtained and acted upon illegally to make wrongful gains at the expense of market participants who did not have this sensitive information,"" Sebi said in its 75-page order.

It further said that the four entities actually ""distorted the market for the said shares, by causing premeditated non-genuine trades to take place with profits for the traders (at the cost of HDFC Mutual Fund and its investors as well as ordinary general investors) which were nearly guaranteed on account of confidential information selectively available to them.""

By indulging in such activities, the entities violated the provisions of PFUTP (Prohibition of Fraudulent and Unfair Trade Practices) norms and accordingly, the regulator levied fine on them.

In November 2019, the regulator had levied a fine of Rs 25 lakh on Kapadia for misusing his position in the capacity of HDFC AMC dealer.";"{'body': [{'indices': [[626, 631]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.6192681193351746,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[1321, 1322]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Midfielder'},
           'score': 0.9881221055984497,
           'text': 'MF',
           'types': ['Position', 'Person', 'Product']},
          {'indices': [[418, 421], [471, 474], [501, 504], [2197, 2200]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Organisation', 'Unit']},
          {'indices': [[68, 72]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[2025, 2035]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Prohibition'},
           'score': 0.5310028791427612,
           'text': 'Prohibition',
           'types': ['Band', 'PoliticalParty', 'Act']},
          {'indices': [[125, 127],
                       [650, 652],
                       [727, 729],
                       [836, 838],
                       [1152, 1154],
                       [1324, 1326],
                       [2263, 2265]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
           'score': 0.7361403703689575,
           'text': 'AMC',
           'types': ['TelevisionStation',
                     'Organisation',
                     'Cable',
                     'Broadcaster',
                     'Agent',
                     'Product']},
          {'indices': [[63, 64],
                       [412, 413],
                       [465, 466],
                       [495, 496],
                       [2191, 2192]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place']},
          {'indices': [[485, 489], [906, 910], [1016, 1020]],
           'links': None,
           'score': None,
           'text': 'Nayak',
           'types': ['Place']},
          {'indices': [[18, 21], [739, 742], [1223, 1226], [1544, 1547]],
           'links': None,
           'score': None,
           'text': 'Sebi',
           'types': ['Person']},
          {'indices': [[450, 462],
                       [688, 700],
                       [752, 764],
                       [998, 1010],
                       [1084, 1096]],
           'links': None,
           'score': None,
           'text': 'Dharmesh Shah',
           'types': ['Person', 'Organisation']},
          {'indices': [[479, 489]],
           'links': None,
           'score': None,
           'text': 'Ashok Nayak',
           'types': ['Person']},
          {'indices': [[916, 926], [1174, 1184]],
           'links': None,
           'score': None,
           'text': 'Bankim Shah',
           'types': ['Person']},
          {'indices': [[438, 444], [609, 615], [1072, 1078], [2205, 2211]],
           'links': None,
           'score': None,
           'text': 'Kapadia',
           'types': ['Person', 'Organisation']},
          {'indices': [[63, 66]],
           'links': None,
           'score': None,
           'text': 'Rs 2',
           'types': ['Organisation']},
          {'indices': [[94, 122]],
           'links': None,
           'score': None,
           'text': 'HDFC Asset Management Company',
           'types': ['Organisation']},
          {'indices': [[150, 154]],
           'links': None,
           'score': None,
           'text': 'Front',
           'types': ['Organisation']},
          {'indices': [[431, 444]],
           'links': None,
           'score': None,
           'text': 'Nilesh Kapadia',
           'types': ['Organisation']},
          {'indices': [[509, 543]],
           'links': None,
           'score': None,
           'text': 'IKAB Securities and Investments Ltd',
           'types': ['Organisation']},
          {'indices': [[94, 97],
                       [645, 648],
                       [722, 725],
                       [831, 834],
                       [1147, 1150],
                       [1316, 1319],
                       [1770, 1773],
                       [2258, 2261]],
           'links': None,
           'score': None,
           'text': 'HDFC',
           'types': ['Organisation']},
          {'indices': [[509, 539], [950, 980], [1038, 1068], [1190, 1220]],
           'links': None,
           'score': None,
           'text': 'IKAB Securities and Investments',
           'types': ['Organisation']},
          {'indices': [[1770, 1785]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2018, 2076]],
           'links': None,
           'score': None,
           'text': 'PFUTP (Prohibition of Fraudulent and Unfair Trade '
                   'Practices',
           'types': ['Organisation']}],
 'title': [{'indices': [[11, 14]],
            'links': None,
            'score': None,
            'text': 'Rs 2',
            'types': ['Place']},
           {'indices': [[49, 51]],
            'links': None,
            'score': None,
            'text': 'AMC',
            'types': ['Product']},
           {'indices': [[44, 47]],
            'links': None,
            'score': None,
            'text': 'HDFC',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.12999999523162842,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.11999999731779099,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04006002',
 'label': 'banking',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04006002',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04006000'},
 'score': 0.07000000029802322,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'negative', 'score': 0.894901},
 'title': {'polarity': 'neutral', 'score': 0.539061}}"
2020-07-30  22:32;Sebi slaps Rs 2 cr fine on 4 entities in HDFC AMC front-running case;"regulator on Thursday imposed a penalty totalling Rs 2 crore on four entities in HDFC Asset Management Company (AMC) case.

refers to an unethical practice by someone trading in shares on the basis of advance information given by a broker, analyst or other executive at a market intermediary before the trades are conducted by that entity.

The regulator levied a fine of Rs 50 lakh each on Nilesh Kapadia and Dharmesh Shah, Rs 40 lakh on Ashok Nayak and Rs 60 lakh on IKAB Securities and Investments Ltd.

During the investigation period of October 2006 to June 2007, Kapadia, who was equity dealer with between June 2000 to 2010, tipped Dharmesh Shah regarding impending trades, noted.

Dharmesh Shah in turn facilitated 109 instances of the trades of

These front-running trades were executed in trading accounts of Nayak and Bankim Shah, one of the dealer of IKAB Securities and Investments,among others.

Dharmesh Shah and Nayak were clients of IKAB Securities and Investments.

Kapadia and Dharmesh Shah ""perpetrated a scheme of front running trades of HDFC AMC"" with the help of Bankim Shah andIKAB Securities and Investments, said.

The conduct of four entities in relation to 109 instances of front-run trades of HDFC MF/AMC indicate that the ""trades were front-run based on confidential information obtained and acted upon illegally to make wrongful gains at the expense of market participants who did not have this sensitive information,"" Sebi said in its 75-page order.

It further said that the four entities actually ""distorted the market for the said shares, by causing premeditated non-genuine trades to take place with profits for the traders (at the cost of HDFC Mutual Fund and its investors as well as ordinary general investors) which were nearly guaranteed on account of confidential information selectively available to them.""

 

 By indulging in such activities, the entities violated the provisions of PFUTP (Prohibition of Fraudulent and Unfair Trade Practices) norms and accordingly, the regulator levied fine on them.

In November 2019,the regulator had levied a fine of Rs 25 lakh on Kapadia for misusing his position in the capacity of HDFC AMC dealer.";"{'body': [{'indices': [[586, 591]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.6192681193351746,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[1227, 1228]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Midfielder'},
           'score': 0.9881221055984497,
           'text': 'MF',
           'types': ['Person', 'Position', 'Product']},
          {'indices': [[378, 381], [431, 434], [461, 464], [2106, 2109]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Unit', 'Organisation']},
          {'indices': [[55, 59]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[1935, 1945]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Prohibition'},
           'score': 0.5310028791427612,
           'text': 'Prohibition',
           'types': ['Band', 'PoliticalParty', 'Act']},
          {'indices': [[112, 114], [1064, 1066], [1230, 1232], [2172, 2174]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
           'score': 0.7361403703689575,
           'text': 'AMC',
           'types': ['Broadcaster',
                     'Agent',
                     'Cable',
                     'TelevisionStation',
                     'Organisation',
                     'Product']},
          {'indices': [[50, 53]],
           'links': None,
           'score': None,
           'text': 'Rs 2',
           'types': ['Place']},
          {'indices': [[50, 51],
                       [372, 373],
                       [425, 426],
                       [455, 456],
                       [2100, 2101]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place']},
          {'indices': [[445, 449], [819, 823], [928, 932]],
           'links': None,
           'score': None,
           'text': 'Nayak',
           'types': ['Place']},
          {'indices': [[410, 422],
                       [639, 651],
                       [689, 701],
                       [910, 922],
                       [996, 1008]],
           'links': None,
           'score': None,
           'text': 'Dharmesh Shah',
           'types': ['Person', 'Organisation']},
          {'indices': [[439, 449]],
           'links': None,
           'score': None,
           'text': 'Ashok Nayak',
           'types': ['Person']},
          {'indices': [[829, 839], [1086, 1096]],
           'links': None,
           'score': None,
           'text': 'Bankim Shah',
           'types': ['Person']},
          {'indices': [[398, 404], [569, 575], [984, 990], [2114, 2120]],
           'links': None,
           'score': None,
           'text': 'Kapadia',
           'types': ['Person', 'Organisation']},
          {'indices': [[81, 109]],
           'links': None,
           'score': None,
           'text': 'HDFC Asset Management Company',
           'types': ['Organisation']},
          {'indices': [[391, 404]],
           'links': None,
           'score': None,
           'text': 'Nilesh Kapadia',
           'types': ['Organisation']},
          {'indices': [[469, 503]],
           'links': None,
           'score': None,
           'text': 'IKAB Securities and Investments Ltd',
           'types': ['Organisation']},
          {'indices': [[469, 499], [863, 893], [950, 980]],
           'links': None,
           'score': None,
           'text': 'IKAB Securities and Investments',
           'types': ['Organisation']},
          {'indices': [[81, 84],
                       [1059, 1062],
                       [1222, 1225],
                       [1676, 1679],
                       [2167, 2170]],
           'links': None,
           'score': None,
           'text': 'HDFC',
           'types': ['Organisation']},
          {'indices': [[1086, 1131]],
           'links': None,
           'score': None,
           'text': 'Bankim Shah andIKAB Securities and Investments',
           'types': ['Organisation']},
          {'indices': [[1676, 1691]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1928, 1986]],
           'links': None,
           'score': None,
           'text': 'PFUTP (Prohibition of Fraudulent and Unfair Trade '
                   'Practices',
           'types': ['Organisation']}],
 'title': [{'indices': [[46, 48]],
            'links': None,
            'score': None,
            'text': 'AMC',
            'types': ['Product']},
           {'indices': [[41, 44]],
            'links': None,
            'score': None,
            'text': 'HDFC',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.15000000596046448,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.10999999940395355,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04006002',
 'label': 'banking',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04006002',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04006000'},
 'score': 0.07999999821186066,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'negative', 'score': 0.840188},
 'title': {'polarity': 'neutral', 'score': 0.533513}}"
2020-07-23  15:19;HDFC AMC Q1 PAT rises 4% to Rs 302 cr;"HDFC Asset Management Company reported 3.6% rise in net profit to Rs 302.36 crore in Q1 June 2020 from Rs 291.79 crore in the same period last year.

Revenue from operations stood at Rs 411.49 crore in Q1 June 2020, falling 18.4% from Rs 504.39 crore in Q1 June 2019. Profit before tax fell 11.5% to Rs 380.37 crore in Q1 June 2020 over Q1 June 2019. Total tax expense for quarter ending 30 June 2020 stood at Rs 78.01 crore, falling 44% from the corresponding period last year. The result was announced during market hours today, 23 July 2020.

The operating profit for the quarter was Rs 300.60 crore as against Rs 381.50 crore in the corresponding quarter of the previous year, a decrease of 21% YoY.

The quarterly average assets under management (QAAUM) stood at Rs 356,200 crore as of 30 June 2020 compared to Rs 362,400 crore as on 30 June 2019, registering a fall of 2%. It has 14.5% market share in QAAUM of the mutual fund industry.

QAAUM in actively managed equity oriented funds i.e. equity oriented QAAUM excluding index funds stood at Rs 129,300 crore as on 30 June 2020 with a market share of 14.5%. The AMC is the largest actively managed equity-oriented mutual fund manager in the country. The ratio of equity oriented AUM and non-equity oriented AUM is 39:61 compared to the industry ratio of 38:62.

As of 30 June 2020, 51.7% of the company's total monthly average AUM is contributed by individual investors compared to 50.5% for the industry.

Shares of HDFC AMC were up 0.11% at Rs 2507.50.

HDFC Asset Management Company (AMC) is investment manager to HDFC Mutual Fund. The company has a diversified asset class mix across equity and fixed income/others. It also has a countrywide network of branches along with a diversified distribution network comprising banks, independent financial advisors and national distributors.";"{'body': [{'indices': [[52, 61]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Net_profit'},
           'score': 0.9503227472305298,
           'text': 'net profit',
           'types': ['Software', 'Product', 'Measure']},
          {'indices': [[1184, 1190], [1564, 1570]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Manager_(association_football)'},
           'score': 0.4236067831516266,
           'text': 'manager',
           'types': ['SoccerClub']},
          {'indices': [[970, 975],
                       [997, 1002],
                       [1156, 1161],
                       [1221, 1226],
                       [1249, 1254],
                       [1646, 1651]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.6494560837745667,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[921, 931], [1172, 1182]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 1.0,
           'text': 'mutual fund',
           'types': ['PersonFunction']},
          {'indices': [[1623, 1633]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asset_classes'},
           'score': 0.9103086590766907,
           'text': 'asset class',
           'types': ['Group', 'Band']},
          {'indices': [[1800, 1817]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Financial_adviser'},
           'score': 1.0,
           'text': 'financial advisors',
           'types': ['PersonFunction']},
          {'indices': [[892, 903], [1093, 1104]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Market_share'},
           'score': 0.9992178678512573,
           'text': 'market share',
           'types': ['Percentage']},
          {'indices': [[1553, 1570]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asset_management'},
           'score': 0.5762402415275574,
           'text': 'investment manager',
           'types': ['MusicGenre']},
          {'indices': [[76, 80],
                       [113, 117],
                       [193, 197],
                       [245, 249],
                       [310, 314],
                       [419, 423],
                       [597, 601],
                       [624, 628],
                       [779, 783],
                       [827, 831],
                       [1061, 1065]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[550, 565]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Earnings_before_interest_and_taxes'},
           'score': 1.0,
           'text': 'operating profit',
           'types': ['Software', 'Product', 'Measure']},
          {'indices': [[1120, 1122], [1480, 1482], [1545, 1547]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
           'score': 0.7183505296707153,
           'text': 'AMC',
           'types': ['TelevisionStation',
                     'Broadcaster',
                     'Organisation',
                     'Agent',
                     'Cable',
                     'Product']},
          {'indices': [[103, 111]],
           'links': None,
           'score': None,
           'text': 'Rs 291.79',
           'types': ['Place']},
          {'indices': [[183, 191]],
           'links': None,
           'score': None,
           'text': 'Rs 411.49',
           'types': ['Place']},
          {'indices': [[66, 67],
                       [103, 104],
                       [183, 184],
                       [235, 236],
                       [300, 301],
                       [410, 411],
                       [587, 588],
                       [614, 615],
                       [768, 769],
                       [816, 817],
                       [1050, 1051],
                       [1501, 1502]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place', 'Organisation']},
          {'indices': [[300, 308]],
           'links': None,
           'score': None,
           'text': 'Rs 380.37',
           'types': ['Place']},
          {'indices': [[587, 595]],
           'links': None,
           'score': None,
           'text': 'Rs 300.60',
           'types': ['Place']},
          {'indices': [[150, 156]],
           'links': None,
           'score': None,
           'text': 'Revenue',
           'types': ['Person']},
          {'indices': [[752, 756], [908, 912], [944, 948], [1013, 1017]],
           'links': None,
           'score': None,
           'text': 'QAAUM',
           'types': ['Person', 'Organisation']},
          {'indices': [[1465, 1470]],
           'links': None,
           'score': None,
           'text': 'Shares',
           'types': ['Person']},
          {'indices': [[85, 86],
                       [202, 203],
                       [254, 255],
                       [319, 320],
                       [337, 338]],
           'links': None,
           'score': None,
           'text': 'Q1',
           'types': ['Product']},
          {'indices': [[0, 28], [1514, 1542]],
           'links': None,
           'score': None,
           'text': 'HDFC Asset Management Company',
           'types': ['Organisation']},
          {'indices': [[1237, 1239], [1265, 1267], [1385, 1387]],
           'links': None,
           'score': None,
           'text': 'AUM',
           'types': ['Organisation']},
          {'indices': [[1272, 1276]],
           'links': None,
           'score': None,
           'text': '39:61',
           'types': ['Organisation']},
          {'indices': [[0, 3], [1475, 1478], [1514, 1517], [1575, 1578]],
           'links': None,
           'score': None,
           'text': 'HDFC',
           'types': ['Organisation']},
          {'indices': [[1575, 1590]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']}],
 'title': [{'indices': [[5, 14]],
            'links': None,
            'score': None,
            'text': 'AMC Q1 PAT',
            'types': ['Product']},
           {'indices': [[0, 3]],
            'links': None,
            'score': None,
            'text': 'HDFC',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.33000001311302185,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.25,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04019000',
 'label': 'finance (general)',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04019000',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04000000'},
 'score': 0.07999999821186066,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'negative', 'score': 0.924264},
 'title': {'polarity': 'neutral', 'score': 0.780308}}"
2020-07-18  11:52;95% of Yes Bank FPO subscribed on last day;Mumbai: The Rs 15,000-crore follow on public offer (FPO) by Yes Bank scraped through on the last day of the issue on Friday with 95 per cent subscription. According to Sebi norms, companies need a minimum subscription of 90 per cent of the issued amount on the date of closure else they have to refund the entire subscription amount received. SBI Capital Markets would have had to underwrite Rs 3,000 crore worth of shares in the FPO, at a price equal to the lowest end of the price band in case of under-subscription. The issue attracted bids for 11.88 billion shares, or 95 per cent of the issue size of 12.51 billion shares offered, showed subscription data on NSE. While the qualified institutional buyers (QIB) portion was subscribed 1.4 times, the segments meant for high net-worth investors and retail buyers were subscribed just 63 per cent and 43 per cent, respectively. HDFC Standard Life, Norges Fund, Iffco Tokio, BNP Arbitrage Fund, HDFC Mutual Fund, DE Shaw, PNB Treasury, Jane Street, AURIGIN Funds and Millennium Management Global are some of the large institutional investors that have subscribed to the FPO, according to bankers. The issue, which had a price band of 12-13 per equity share of face value of 2 each, got 6.84 lakh applications. Shares of Yes Bank rose 2.86 per cent to 19.80 on Friday. On Tuesday, the bank raised nearly Rs 4,100 crore through anchor allotments ahead of its FPO opening. It allotted 3.42 billion equity shares to a total of 14 anchor investors. More than half of the anchor book was subscribed by Bay Tree India Holdings. At the upper end of the price band, Yes Bank demands an adjusted price-to-book value of 0.85 times. Although the valuations were much cheaper compared to current market price or compared with peers, many brokers had recommended avoiding the issue citing the stress and poor financial performance that is expected in the foreseeable future.;"{'body': [{'indices': [[974, 976]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Punjab_National_Bank'},
           'score': 0.7682985067367554,
           'text': 'PNB',
           'types': ['Agent', 'Organisation', 'Bank', 'Banking', 'Company']},
          {'indices': [[1070, 1092]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Institutional_investor'},
           'score': 1.0,
           'text': 'institutional investors',
           'types': ['Term']},
          {'indices': [[1196, 1201], [1447, 1452]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.6032126545906067,
           'text': 'equity',
           'types': ['Disease', 'Difference']},
          {'indices': [[1557, 1561]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9988576769828796,
           'text': 'India',
           'types': ['Place',
                     'MusicalArtist',
                     'Country',
                     'PopulatedPlace',
                     'Location']},
          {'indices': [[0, 5]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mumbai'},
           'score': 0.9957156181335449,
           'text': 'Mumbai',
           'types': ['City',
                     'Settlement',
                     'Place',
                     'PopulatedPlace',
                     'Location']},
          {'indices': [[1447, 1459]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Common_stock'},
           'score': 1.0,
           'text': 'equity shares',
           'types': ['Form']},
          {'indices': [[1336, 1339]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bank'},
           'score': 0.9990826845169067,
           'text': 'bank',
           'types': ['Institution', 'PersonFunction', 'University']},
          {'indices': [[920, 924]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Tokyo'},
           'score': 0.9296197891235352,
           'text': 'Tokio',
           'types': ['City',
                     'Prefectures',
                     'Settlement',
                     'Place',
                     'PopulatedPlace',
                     'Location']},
          {'indices': [[1243, 1246]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Organisation', 'Unit']},
          {'indices': [[988, 998]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/List_of_north–south_roads_in_Toronto'},
           'score': 0.971269965171814,
           'text': 'Jane Street',
           'types': ['List']},
          {'indices': [[22, 26], [402, 406], [1364, 1368]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[931, 939]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Arbitrage'},
           'score': 0.9897500276565552,
           'text': 'Arbitrage',
           'types': ['Company', 'Practice']},
          {'indices': [[965, 966]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Germany'},
           'score': 0.49763333797454834,
           'text': 'DE',
           'types': ['Place',
                     'Country',
                     'PopulatedPlace',
                     'Republic',
                     'Person',
                     'Location']},
          {'indices': [[1831, 1836]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Stress_(mechanics)'},
           'score': 0.46429184079170227,
           'text': 'stress',
           'types': ['Quantity']},
          {'indices': [[665, 667]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.7534066438674927,
           'text': 'NSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[12, 13], [393, 394], [1355, 1356]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place', 'Organisation']},
          {'indices': [[914, 924]],
           'links': None,
           'score': None,
           'text': 'Iffco Tokio',
           'types': ['Person']},
          {'indices': [[1019, 1046]],
           'links': None,
           'score': None,
           'text': 'Millennium Management Global',
           'types': ['Person']},
          {'indices': [[52, 54], [431, 433], [1122, 1124], [1409, 1411]],
           'links': None,
           'score': None,
           'text': 'FPO',
           'types': ['Organisation']},
          {'indices': [[64, 67], [1276, 1279], [1613, 1616]],
           'links': None,
           'score': None,
           'text': 'Bank',
           'types': ['Organisation']},
          {'indices': [[344, 362]],
           'links': None,
           'score': None,
           'text': 'SBI Capital Markets',
           'types': ['Organisation']},
          {'indices': [[712, 714]],
           'links': None,
           'score': None,
           'text': 'QIB',
           'types': ['Organisation']},
          {'indices': [[881, 884], [947, 950]],
           'links': None,
           'score': None,
           'text': 'HDFC',
           'types': ['Organisation']},
          {'indices': [[886, 911]],
           'links': None,
           'score': None,
           'text': 'Standard Life, Norges Fund',
           'types': ['Organisation']},
          {'indices': [[927, 944]],
           'links': None,
           'score': None,
           'text': 'BNP Arbitrage Fund',
           'types': ['Organisation']},
          {'indices': [[947, 962]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[965, 971]],
           'links': None,
           'score': None,
           'text': 'DE Shaw',
           'types': ['Organisation']},
          {'indices': [[974, 985]],
           'links': None,
           'score': None,
           'text': 'PNB Treasury',
           'types': ['Organisation']},
          {'indices': [[1001, 1013]],
           'links': None,
           'score': None,
           'text': 'AURIGIN Funds',
           'types': ['Organisation']},
          {'indices': [[1548, 1570]],
           'links': None,
           'score': None,
           'text': 'Bay Tree India Holdings',
           'types': ['Organisation']}],
 'title': [{'indices': [[11, 18]],
            'links': None,
            'score': None,
            'text': 'Bank FPO',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.4099999964237213,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.15000000596046448,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04006002',
 'label': 'banking',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04006002',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04006000'},
 'score': 0.09000000357627869,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'negative', 'score': 0.73814},
 'title': {'polarity': 'neutral', 'score': 0.542303}}"
2020-07-15  15:52;Rossari Biotech a big hit, subscribed 32 times on Day 3;NEW DELHI: The Rs 496-crore IPO by Rossari Biotech on Wednesday attracted 31.5 times bids on Day 3 of the bidding process. By 1.45 pm, the issue by the specialty chemicals company had attracted bids for 25,74,63,010 shares, which was 32 times the issue size of 81,73,530 shares. At the higher end of the Rs 423-425 price band, the specialty chemicals manufacturer is seeking a valuation that is 19.9 times FY20’s EV/Ebitda and 33.1 times earnings per share on a FY20 basis. The asking valuation multiple is higher than 27 times of what the peers are commanding. Analysts largely have 'subscribe' ratings on the issue. The company is expected to see strong growth in coming years following the full commencement of the Dahej facility . Even on the sectoral front, robust growth in user industries in India will support growth while emerging opportunities in exports led by clamp down in China and outsourcing opportunities from Western countries are expected to benefit companies, said Astha Jain of HEM Securities. On Friday, the company raised Rs 148.87 crore from anchor investors, which included top three fund houses: SBI Mutual Fund, HDFC Mutual Fund and ICICI Prudential Mutual Fund. “Rossari may command a premium over most of its chemical peers as it is net-debt free and has better asset turnover, working capital days return on equity,” said Angel Broking. This brokerage has a ‘subscribe’ rating on the issue. The company deals in three segments. The home care segment accounted for 46.81 per cent of FY20 revenues (against just 18.63 per cent in FY18), textile specialty 43.71 per cent (from 71.54 per cent in FY18) and animal healthcare 9.48 per cent (9.83 per cent in FY18). However, a few brokerages raised concerns over near-term demand from the textile industry and noted that Rossari’s Silvassa facility is critical to its business and any disturbance may have an adverse impact on its business. Other brokerages, however, are not overly worried about it and noted that demand from home and personal care segments has been on the rise. Despite the lockdown and the pandemic, the company did not suffer any major losses in revenue in the last four months. The company has added over 20 private label customers during the lockdown. The soaps & detergent and pulp & paper products segments have gained a lot of traction during this period, said Ventura Securities. The company has delivered robust growth. The new capacity expansion at Dahej should strengthen its portfolio in the high-growth HPPC segment to serve its wide customer base. Customized product offering, fungible capacities and rapid finished product conversion rate remain the key differentiators for the company, said Emkay Global. HPPC refers to the company's home and personal care segment.;"{'body': [{'indices': [[596, 602]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nielsen_ratings'},
           'score': 0.924111008644104,
           'text': 'ratings',
           'types': ['Systems', 'Place']},
          {'indices': [[991, 994]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Jainism'},
           'score': 0.9997722506523132,
           'text': 'Jain',
           'types': ['Country', 'Religion', 'EthnicGroup']},
          {'indices': [[1639, 1648]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Health_care'},
           'score': 0.9984838962554932,
           'text': 'healthcare',
           'types': ['Company', 'Maintenance']},
          {'indices': [[2260, 2268]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Detergent'},
           'score': 0.99648118019104,
           'text': 'detergent',
           'types': ['Surfactant', 'ChemicalCompound']},
          {'indices': [[28, 30]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Offering', 'Work', 'Product']},
          {'indices': [[152, 170], [331, 349]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 0.9926894307136536,
           'text': 'specialty chemicals',
           'types': ['Company', 'Products']},
          {'indices': [[1338, 1343]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.610020101070404,
           'text': 'equity',
           'types': ['Disease', 'Difference']},
          {'indices': [[2203, 2215]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Private_label'},
           'score': 1.0,
           'text': 'private label',
           'types': ['Company']},
          {'indices': [[1804, 1811]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Silvassa'},
           'score': 1.0,
           'text': 'Silvassa',
           'types': ['PopulatedPlace',
                     'Capital',
                     'Settlement',
                     'Place',
                     'City',
                     'Location']},
          {'indices': [[799, 803]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9988700151443481,
           'text': 'India',
           'types': ['PopulatedPlace',
                     'Country',
                     'MusicalArtist',
                     'Place',
                     'Location']},
          {'indices': [[2583, 2590]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fungibility'},
           'score': 1.0,
           'text': 'fungible',
           'types': ['Building', 'Property']},
          {'indices': [[1762, 1777]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile_industry'},
           'score': 0.7705661058425903,
           'text': 'textile industry',
           'types': ['PersonFunction']},
          {'indices': [[22, 26], [1055, 1059]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[718, 722], [2451, 2455]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Gujarat'},
           'score': 1.0,
           'text': 'Dahej',
           'types': ['PopulatedPlace',
                     'State',
                     'Place',
                     'Location',
                     'Settlement',
                     'Person']},
          {'indices': [[2009, 2021], [2751, 2763]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Personal_care'},
           'score': 0.9811744093894958,
           'text': 'personal care',
           'types': ['Company', 'Industry']},
          {'indices': [[886, 890]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/China'},
           'score': 0.9981107711791992,
           'text': 'China',
           'types': ['PopulatedPlace',
                     'Country',
                     'State',
                     'Place',
                     'Location']},
          {'indices': [[896, 906]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Outsourcing'},
           'score': 0.9997892379760742,
           'text': 'outsourcing',
           'types': ['PersonFunction']},
          {'indices': [[2066, 2073], [2238, 2245]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lockdown'},
           'score': 0.9403197169303894,
           'text': 'lockdown',
           'types': ['Book', 'Product', 'Definitions']},
          {'indices': [[413, 421]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Earnings_before_interest,_taxes,_depreciation,_and_amortization'},
           'score': 1.0,
           'text': 'EV/Ebitda',
           'types': ['Software', 'Product', 'Measure', 'Organisation']},
          {'indices': [[2083, 2090]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pandemic'},
           'score': 0.9954453706741333,
           'text': 'pandemic',
           'types': ['Epidemic', 'Arachnid']},
          {'indices': [[1565, 1571], [1762, 1768]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile'},
           'score': 0.9941277503967285,
           'text': 'textile',
           'types': ['Material', 'ChemicalCompound', 'MusicGenre']},
          {'indices': [[2360, 2366]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ventura,_California'},
           'score': 0.8215925693511963,
           'text': 'Ventura',
           'types': ['PopulatedPlace',
                     'Settlement',
                     'Place',
                     'Seat',
                     'City',
                     'Location']},
          {'indices': [[1352, 1356]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Angel_(Buffy_the_Vampire_Slayer)'},
           'score': 0.598692774772644,
           'text': 'Angel',
           'types': ['FictionalCharacter', 'Character']},
          {'indices': [[0, 8]],
           'links': None,
           'score': None,
           'text': 'NEW DELHI',
           'types': ['Place']},
          {'indices': [[1045, 1053]],
           'links': None,
           'score': None,
           'text': 'Rs 148.87',
           'types': ['Place']},
          {'indices': [[35, 49]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech',
           'types': ['Person']},
          {'indices': [[985, 994]],
           'links': None,
           'score': None,
           'text': 'Astha Jain',
           'types': ['Person']},
          {'indices': [[1352, 1364]],
           'links': None,
           'score': None,
           'text': 'Angel Broking',
           'types': ['Person']},
          {'indices': [[2508, 2511], [2713, 2716]],
           'links': None,
           'score': None,
           'text': 'HPPC',
           'types': ['Person', 'Organisation']},
          {'indices': [[2699, 2710]],
           'links': None,
           'score': None,
           'text': 'Emkay Global',
           'types': ['Person']},
          {'indices': [[406, 409], [462, 465], [1512, 1515]],
           'links': None,
           'score': None,
           'text': 'FY20',
           'types': ['Organisation']},
          {'indices': [[1122, 1136]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1139, 1154]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1160, 1187]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[35, 41], [1191, 1197], [1794, 1800]],
           'links': None,
           'score': None,
           'text': 'Rossari',
           'types': ['Organisation']},
          {'indices': [[2360, 2377]],
           'links': None,
           'score': None,
           'text': 'Ventura Securities',
           'types': ['Organisation']}],
 'title': [{'indices': [[0, 14]],
            'links': None,
            'score': None,
            'text': 'Rossari Biotech',
            'types': ['Person']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.36000001430511475,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-11',
 'label': 'Stocks',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-11',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.1599999964237213,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.05000000074505806,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'neutral', 'score': 0.370099},
 'title': {'polarity': 'neutral', 'score': 0.535648}}"
2020-07-14  15:53;Rossari Biotech IPO sails through on Day 2 of bidding process subscribed 1.10 times;NEW DELHI: The Rs 496 crore IPO by Rossari Biotech got fully subscribed on the Day 2 of bidding process. By 1 pm, the issue by specialty chemicals company had attracted bids for 89,61,015 shares, which was 1.10 times the issue size of 81,73,530 shares. The quota for qualified institutional bidders (QIBs) was subscribed 98 per cent while those of non-institutional investors and retail individual investors (RII) was subscribed 23 per cent and 1.42 times, respectively. At the higher end of the Rs 423-425 price band, the specialty chemicals manufacturer is seeking a valuation of 19.9 times FY20’s EV/Ebitda and 33.1 times earnings per share on a FY20 basis. The asking valuation multiple is higher than 27 times the peers are commanding, analysts largely have 'subscribe' ratings on the issue. The company is expected to see strong growth in coming years following the full commencement of the Dahej facility . Even on the sectoral front, robust growth in user industries in India will support growth while emerging opportunities in exports led by clamp down in China and outsourcing opportunities from Western countries are expected to benefit companies, said Astha Jain of HEM Securities. On Friday, the company raised Rs 148.87 crore from anchor investors, who included top three fund houses – SBI Mutual Fund, HDFC Mutual Fund and ICICI Prudential Mutual Fund. “Rossari may command a premium over most of its chemical peers, as it is net debt free and has better asset turnover, working capital days return on equity,” said Angel Broking. This brokerage has a ‘subscribe’ rating on the issue. The company deals in three segments. The home care segment accounted for 46.81 per cent of FY20 revenues (against just 18.63 per cent in FY18), textile specialty 43.71 per cent (from 71.54 per cent in FY18) and animal healthcare 9.48 per cent (9.83 per cent in FY18). A few brokerages raised concerns over near-term demand from the textile industry and noted that Rossari’s Silvassa facility is critical to its business and any disturbance may have an adverse impact on its business. Other brokerages, however, are not overly worried about it and noted that demand from home and personal care segments has been on the rise. Despite the lockdown and the pandemic, the company did not suffer any major losses in revenue in the last four months. The company has added over 20 private label customers during the lockdown. The soaps & detergent and pulp & paper products segments have gained a lot of traction during this period, said Ventura Securities. The company has delivered robust growth. The new capacity expansion at Dahej should strengthen its portfolio in the high-growth HPPC segment to serve its wide customer base. Customized product offering, fungible capacities and rapid finished product conversion rate remain the key differentiators for the company, said EMkay Global. HPPC refers to the company's home and personal care segment.;"{'body': [{'indices': [[775, 781]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nielsen_ratings'},
           'score': 0.9239675998687744,
           'text': 'ratings',
           'types': ['Systems', 'Place']},
          {'indices': [[1170, 1173]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Jainism'},
           'score': 0.9997722506523132,
           'text': 'Jain',
           'types': ['Country', 'EthnicGroup', 'Religion']},
          {'indices': [[1818, 1827]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Health_care'},
           'score': 0.9984838962554932,
           'text': 'healthcare',
           'types': ['Maintenance', 'Company']},
          {'indices': [[2430, 2438]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Detergent'},
           'score': 0.99648118019104,
           'text': 'detergent',
           'types': ['ChemicalCompound', 'Surfactant']},
          {'indices': [[28, 30]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Work', 'Product', 'Offering']},
          {'indices': [[127, 145], [523, 541]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 0.9926894307136536,
           'text': 'specialty chemicals',
           'types': ['Products', 'Company']},
          {'indices': [[1517, 1522]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.610854983329773,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[2373, 2385]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Private_label'},
           'score': 1.0,
           'text': 'private label',
           'types': ['Company']},
          {'indices': [[1974, 1981]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Silvassa'},
           'score': 1.0,
           'text': 'Silvassa',
           'types': ['Capital',
                     'Settlement',
                     'Location',
                     'Place',
                     'PopulatedPlace',
                     'City']},
          {'indices': [[978, 982]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9988682866096497,
           'text': 'India',
           'types': ['Country',
                     'Location',
                     'Place',
                     'PopulatedPlace',
                     'MusicalArtist']},
          {'indices': [[2753, 2760]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fungibility'},
           'score': 1.0,
           'text': 'fungible',
           'types': ['Building', 'Property']},
          {'indices': [[1932, 1947]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile_industry'},
           'score': 0.7705661058425903,
           'text': 'textile industry',
           'types': ['PersonFunction']},
          {'indices': [[22, 26], [1234, 1238]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[897, 901], [2621, 2625]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Gujarat'},
           'score': 1.0,
           'text': 'Dahej',
           'types': ['Settlement',
                     'Location',
                     'State',
                     'Place',
                     'PopulatedPlace',
                     'Person']},
          {'indices': [[2179, 2191], [2921, 2933]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Personal_care'},
           'score': 0.9806358814239502,
           'text': 'personal care',
           'types': ['Industry', 'Company']},
          {'indices': [[1065, 1069]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/China'},
           'score': 0.9981045722961426,
           'text': 'China',
           'types': ['Country',
                     'Location',
                     'State',
                     'Place',
                     'PopulatedPlace']},
          {'indices': [[1075, 1085]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Outsourcing'},
           'score': 0.9997892379760742,
           'text': 'outsourcing',
           'types': ['PersonFunction']},
          {'indices': [[2236, 2243], [2408, 2415]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lockdown'},
           'score': 0.9403197169303894,
           'text': 'lockdown',
           'types': ['Definitions', 'Book', 'Product']},
          {'indices': [[600, 608]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Earnings_before_interest,_taxes,_depreciation,_and_amortization'},
           'score': 1.0,
           'text': 'EV/Ebitda',
           'types': ['Measure', 'Software', 'Product', 'Organisation']},
          {'indices': [[2253, 2260]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pandemic'},
           'score': 0.9954453706741333,
           'text': 'pandemic',
           'types': ['Arachnid', 'Epidemic']},
          {'indices': [[1744, 1750], [1932, 1938]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile'},
           'score': 0.9941277503967285,
           'text': 'textile',
           'types': ['MusicGenre', 'ChemicalCompound', 'Material']},
          {'indices': [[2530, 2536]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ventura,_California'},
           'score': 0.8215925693511963,
           'text': 'Ventura',
           'types': ['Settlement',
                     'Location',
                     'Place',
                     'Seat',
                     'PopulatedPlace',
                     'City']},
          {'indices': [[1531, 1535]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Angel_(Buffy_the_Vampire_Slayer)'},
           'score': 0.598692774772644,
           'text': 'Angel',
           'types': ['FictionalCharacter', 'Character']},
          {'indices': [[0, 8]],
           'links': None,
           'score': None,
           'text': 'NEW DELHI',
           'types': ['Place']},
          {'indices': [[1224, 1232]],
           'links': None,
           'score': None,
           'text': 'Rs 148.87',
           'types': ['Place']},
          {'indices': [[35, 49]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech',
           'types': ['Person']},
          {'indices': [[1164, 1173]],
           'links': None,
           'score': None,
           'text': 'Astha Jain',
           'types': ['Person']},
          {'indices': [[1531, 1543]],
           'links': None,
           'score': None,
           'text': 'Angel Broking',
           'types': ['Person']},
          {'indices': [[2678, 2681], [2883, 2886]],
           'links': None,
           'score': None,
           'text': 'HPPC',
           'types': ['Person', 'Organisation']},
          {'indices': [[2869, 2880]],
           'links': None,
           'score': None,
           'text': 'EMkay Global',
           'types': ['Person']},
          {'indices': [[409, 411]],
           'links': None,
           'score': None,
           'text': 'RII',
           'types': ['Organisation']},
          {'indices': [[593, 596], [649, 652], [1691, 1694]],
           'links': None,
           'score': None,
           'text': 'FY20',
           'types': ['Organisation']},
          {'indices': [[1300, 1314]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1317, 1332]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1338, 1365]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[35, 41], [1369, 1375], [1964, 1970]],
           'links': None,
           'score': None,
           'text': 'Rossari',
           'types': ['Organisation']},
          {'indices': [[2530, 2547]],
           'links': None,
           'score': None,
           'text': 'Ventura Securities',
           'types': ['Organisation']}],
 'title': [{'indices': [[16, 18]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
            'score': 1.0,
            'text': 'IPO',
            'types': ['Work', 'Product', 'Offering']},
           {'indices': [[0, 14]],
            'links': None,
            'score': None,
            'text': 'Rossari Biotech',
            'types': ['Person']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.3700000047683716,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.15000000596046448,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.05000000074505806,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'negative', 'score': 0.421586},
 'title': {'polarity': 'negative', 'score': 0.481954}}"
2020-07-13  19:55;Rossari Biotech IPO subscribed 60% on Day 1- Business News;Rossari Biotech initial public offering (IPO) was subscribed nearly 60 per cent on the first day of bidding on Monday. The issue received bids for 49,30,030 equity shares as against offer size of 81,73,530 equity shares (excluding the anchor book portion). While the retail investor portion was subscribed 92 per cent, non-institutional portion was subscribed 11 per cent, the latest subscription data on the exchanges showed. The institutional investors' quota was subscribed 41 per cent. The IPO is open for public subscription from July 13-15. The public offering holds significance since it's the first one to hit markets after a gap of four months. SBI Cards & Payment Services was the last company to float IPO in March. On Friday, Rossari Biotech said that it has raised Rs 149 crore from anchor investors. The IPO comprises fresh issuance of shares worth Rs 50 crore and sale of 1,05,00,000 equity shares by company's promoters through offer-for-sale (OFS) route. At the upper end of the price band, the IPO size is about Rs 496 crore. Net proceeds from the issue will be utilised for funding working capital requirements, repaying certain debt availed by the company and for general corporate purposes. Axis Capital and ICICI Securities are the merchant bankers for the share-sale. The anchor investors include Abu Dhabi Investment Authority, HDFC Mutual Fund, Axis Mutual Fund, ICICI Prudential Mutual Fund, SBI Mutual Fund, Sundaram Mutual Fund, HDFC Life Insurance Company and Goldman Sachs India. Also read: HDFC Bank probes allegations of 'improper lending practices' at vehicle financing unit Also read: Petrol, diesel price today: Check out latest fuel rates in Delhi, Mumbai, other big cities;"{'body': [{'indices': [[1678, 1682]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Delhi'},
           'score': 0.9973721504211426,
           'text': 'Delhi',
           'types': ['Place',
                     'Location',
                     'Settlement',
                     'Territory',
                     'PopulatedPlace',
                     'City']},
          {'indices': [[16, 38]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'initial public offering',
           'types': ['Work', 'Product', 'Offering']},
          {'indices': [[41, 43],
                       [494, 496],
                       [713, 715],
                       [818, 820],
                       [1012, 1014]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Work', 'Product', 'Offering', 'Organisation']},
          {'indices': [[431, 453]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Institutional_investor'},
           'score': 1.0,
           'text': 'institutional investors',
           'types': ['Term']},
          {'indices': [[1212, 1215], [1370, 1373]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_powers'},
           'score': 0.9975234866142273,
           'text': 'Axis',
           'types': ['Place',
                     'Location',
                     'Country',
                     'EthnicGroup',
                     'Nations',
                     'PopulatedPlace']},
          {'indices': [[1521, 1529]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/HDFC_Bank'},
           'score': 0.9960517287254333,
           'text': 'HDFC Bank',
           'types': ['Bank', 'Banking', 'Company', 'Organisation', 'Agent']},
          {'indices': [[1503, 1507]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9989538192749023,
           'text': 'India',
           'types': ['Place',
                     'Country',
                     'Location',
                     'MusicalArtist',
                     'PopulatedPlace']},
          {'indices': [[1685, 1690]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mumbai'},
           'score': 0.9956215620040894,
           'text': 'Mumbai',
           'types': ['Place',
                     'Location',
                     'Settlement',
                     'PopulatedPlace',
                     'City']},
          {'indices': [[157, 169], [206, 218], [899, 911]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Common_stock'},
           'score': 1.0,
           'text': 'equity shares',
           'types': ['Form']},
          {'indices': [[1489, 1501]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Goldman_Sachs'},
           'score': 0.9999684691429138,
           'text': 'Goldman Sachs',
           'types': ['Bank', 'Company', 'Organisation', 'Agent']},
          {'indices': [[1627, 1632]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Diesel_engine'},
           'score': 0.6513924598693848,
           'text': 'diesel',
           'types': ['Engine', 'Product', 'Company', 'Software']},
          {'indices': [[785, 789], [869, 873], [1037, 1041]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[1320, 1349]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Abu_Dhabi_Investment_Authority'},
           'score': 1.0,
           'text': 'Abu Dhabi Investment Authority',
           'types': ['Fund', 'Company', 'Organisation', 'Agent']},
          {'indices': [[1229, 1233], [1388, 1392]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/ICICI_Bank'},
           'score': 1.0,
           'text': 'ICICI',
           'types': ['Bank', 'Banking', 'Company', 'Organisation', 'Agent']},
          {'indices': [[0, 14], [738, 752]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech',
           'types': ['Person', 'Organisation']},
          {'indices': [[654, 681]],
           'links': None,
           'score': None,
           'text': 'SBI Cards & Payment Services',
           'types': ['Organisation']},
          {'indices': [[778, 779], [863, 864], [1030, 1031]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Organisation']},
          {'indices': [[863, 867]],
           'links': None,
           'score': None,
           'text': 'Rs 50',
           'types': ['Organisation']},
          {'indices': [[960, 962]],
           'links': None,
           'score': None,
           'text': 'OFS',
           'types': ['Organisation']},
          {'indices': [[1212, 1223]],
           'links': None,
           'score': None,
           'text': 'Axis Capital',
           'types': ['Organisation']},
          {'indices': [[1229, 1244]],
           'links': None,
           'score': None,
           'text': 'ICICI Securities',
           'types': ['Organisation']},
          {'indices': [[1352, 1367]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1370, 1385]],
           'links': None,
           'score': None,
           'text': 'Axis Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1388, 1415]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1418, 1432]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1435, 1454]],
           'links': None,
           'score': None,
           'text': 'Sundaram Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1457, 1483]],
           'links': None,
           'score': None,
           'text': 'HDFC Life Insurance Company',
           'types': ['Organisation']},
          {'indices': [[1489, 1507]],
           'links': None,
           'score': None,
           'text': 'Goldman Sachs India',
           'types': ['Organisation']}],
 'title': [{'indices': [[16, 18]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
            'score': 1.0,
            'text': 'IPO',
            'types': ['Work', 'Product', 'Offering']},
           {'indices': [[0, 14]],
            'links': None,
            'score': None,
            'text': 'Rossari Biotech',
            'types': ['Person']},
           {'indices': [[45, 57]],
            'links': None,
            'score': None,
            'text': 'Business News',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.4300000071525574,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.18000000715255737,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04008023',
 'label': 'financial markets',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04008023',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04008000'},
 'score': 0.03999999910593033,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.968924},
 'title': {'polarity': 'neutral', 'score': 0.69431}}"
2020-07-13  15:53;Rossari Biotech IPO subscribed 24% on Day 1 so far;NEW DELHI: The Rs 496 crore IPO by Rossari Biotech on Monday attracted bids for a quarter of shares on the block, within four hours of the Day 1 bidding process. By 1.45 pm, the issue by specialty chemicals company had received bids for 19,25,595 shares, which was 24 per cent of the issue size of 81,73,530 shares. At the higher end of the Rs 423-425 price band, the specialty chemicals manufacturer is seeking a valuation of 19.9 times FY20’s EV/Ebitda and 33.1 times earnings per share on a FY20 basis. The asking valuation multiple is higher than 27 times the peers are commanding, analysts largely have 'subscribe' ratings on the issue. The company has delivered robust growth. The new capacity expansion at Dahej should strengthen its portfolio in the high-growth HPPC segment to serve its wide customer base. Customized product offering, fungible capacities and rapid finished product conversion rate remain the key differentiators for the company, said EMkay Global. HPPC refers to the company's home and personal care segment. On Friday, the company raised Rs 148.87 crore from anchor investors, who included top three fund houses – SBI Mutual Fund, HDFC Mutual Fund and ICICI Prudential Mutual Fund. “Rossari may command a premium over most of its chemical peers, as it is net debt free and has better asset turnover, working capital days return on equity,” said Angel Broking. This brokerage has a ‘subscribe’ rating on the issue. The company deals in three segments. The home care segment accounted for 46.81 per cent of FY20 revenues (against just 18.63 per cent in FY18), textile specialty 43.71 per cent (from 71.54 per cent in FY18) and animal healthcare 9.48 per cent (9.83 per cent in FY18). A few brokerages raised concerns over near-term demand from the textile industry and noted that Rossari’s Silvassa facility is critical to its business and any disturbance may have an adverse impact on its business. Other brokerages, however, are not overly worried about it and noted that demand from home and personal care segments has been on the rise. Despite the lockdown and the pandemic, the company did not suffer any major losses in revenue in last four months. The company has added over 20 private label customers during the lockdown. The soaps & detergent and pulp & paper products segments have gained a lot of traction during this period, said Ventura Securities.;"{'body': [{'indices': [[620, 626]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nielsen_ratings'},
           'score': 0.9336988925933838,
           'text': 'ratings',
           'types': ['Place', 'Systems']},
          {'indices': [[1660, 1669]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Health_care'},
           'score': 0.9985225796699524,
           'text': 'healthcare',
           'types': ['Maintenance', 'Company']},
          {'indices': [[2268, 2276]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Detergent'},
           'score': 0.9966806173324585,
           'text': 'detergent',
           'types': ['Surfactant', 'ChemicalCompound']},
          {'indices': [[28, 30]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Offering', 'Work', 'Product']},
          {'indices': [[187, 205], [368, 386]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 0.9926496744155884,
           'text': 'specialty chemicals',
           'types': ['Products', 'Company']},
          {'indices': [[1359, 1364]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.621536374092102,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[2211, 2223]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Private_label'},
           'score': 1.0,
           'text': 'private label',
           'types': ['Company']},
          {'indices': [[1816, 1823]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Silvassa'},
           'score': 1.0,
           'text': 'Silvassa',
           'types': ['Capital',
                     'PopulatedPlace',
                     'Place',
                     'Location',
                     'City',
                     'Settlement']},
          {'indices': [[845, 852]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fungibility'},
           'score': 1.0,
           'text': 'fungible',
           'types': ['Building', 'Property']},
          {'indices': [[1774, 1789]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile_industry'},
           'score': 0.7693495750427246,
           'text': 'textile industry',
           'types': ['PersonFunction']},
          {'indices': [[22, 26], [1076, 1080]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[713, 717]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Gujarat'},
           'score': 1.0,
           'text': 'Dahej',
           'types': ['State',
                     'PopulatedPlace',
                     'Place',
                     'Location',
                     'Settlement',
                     'Person']},
          {'indices': [[1013, 1025], [2021, 2033]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Personal_care'},
           'score': 0.982681393623352,
           'text': 'personal care',
           'types': ['Industry', 'Company']},
          {'indices': [[2078, 2085], [2246, 2253]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lockdown'},
           'score': 0.9466590881347656,
           'text': 'lockdown',
           'types': ['Book', 'Product', 'Definitions']},
          {'indices': [[445, 453]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Earnings_before_interest,_taxes,_depreciation,_and_amortization'},
           'score': 1.0,
           'text': 'EV/Ebitda',
           'types': ['Software', 'Product', 'Measure', 'Organisation']},
          {'indices': [[2095, 2102]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pandemic'},
           'score': 0.9954213500022888,
           'text': 'pandemic',
           'types': ['Epidemic', 'Arachnid']},
          {'indices': [[1586, 1592], [1774, 1780]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile'},
           'score': 0.9941917657852173,
           'text': 'textile',
           'types': ['MusicGenre', 'Material', 'ChemicalCompound']},
          {'indices': [[2368, 2374]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ventura,_California'},
           'score': 0.8200569152832031,
           'text': 'Ventura',
           'types': ['PopulatedPlace',
                     'Place',
                     'Location',
                     'City',
                     'Seat',
                     'Settlement']},
          {'indices': [[1373, 1377]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Angel_(Buffy_the_Vampire_Slayer)'},
           'score': 0.6007168292999268,
           'text': 'Angel',
           'types': ['Character', 'FictionalCharacter']},
          {'indices': [[0, 8]],
           'links': None,
           'score': None,
           'text': 'NEW DELHI',
           'types': ['Place']},
          {'indices': [[1066, 1074]],
           'links': None,
           'score': None,
           'text': 'Rs 148.87',
           'types': ['Place']},
          {'indices': [[35, 49]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech',
           'types': ['Person']},
          {'indices': [[770, 773], [975, 978]],
           'links': None,
           'score': None,
           'text': 'HPPC',
           'types': ['Person', 'Organisation']},
          {'indices': [[961, 972]],
           'links': None,
           'score': None,
           'text': 'EMkay Global',
           'types': ['Person']},
          {'indices': [[1373, 1385]],
           'links': None,
           'score': None,
           'text': 'Angel Broking',
           'types': ['Person']},
          {'indices': [[438, 441], [494, 497], [1533, 1536]],
           'links': None,
           'score': None,
           'text': 'FY20',
           'types': ['Organisation']},
          {'indices': [[1142, 1156]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1159, 1174]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1180, 1207]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[35, 41], [1211, 1217], [1806, 1812]],
           'links': None,
           'score': None,
           'text': 'Rossari',
           'types': ['Organisation']},
          {'indices': [[2368, 2385]],
           'links': None,
           'score': None,
           'text': 'Ventura Securities',
           'types': ['Organisation']}],
 'title': [{'indices': [[16, 18]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
            'score': 1.0,
            'text': 'IPO',
            'types': ['Offering', 'Work', 'Product']},
           {'indices': [[0, 14]],
            'links': None,
            'score': None,
            'text': 'Rossari Biotech',
            'types': ['Person']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.4099999964237213,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.15000000596046448,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.07000000029802322,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'negative', 'score': 0.858324},
 'title': {'polarity': 'neutral', 'score': 0.498134}}"
2020-07-13  14:07;Rossari Biotech IPO subscribed 21% so far on Day 1;Rossari Biotech initial public offering (IPO) has been subscribed 21 per cent so far on the first day of bidding on Monday. The Mumbai-headquartered speciality chemical manufacturer received bids for 17,35,905 equity shares as against offer size of 81,73,530 equity shares (excluding the anchor book portion), the latest subscription data on the exchanges showed. While the retail investor portion was subscribed 41 per cent, non-institutional portion was subscribed 3 per cent. The qualified institutional buyers' (QIB) quota was subscribed less than 1 per cent. The IPO is open for public subscription from July 13-15. The public offering holds significance since it's the first one to hit markets after a gap of four months. SBI Cards & Payment Services was the last company to float IPO in March. On Friday, Rossari Biotech said that it has raised Rs 149 crore from anchor investors. The IPO comprises fresh issuance of shares worth Rs 50 crore and sale of 1,05,00,000 equity shares by company's promoters through offer-for-sale (OFS) route. At the upper end of the price band, the IPO size is about Rs 496 crore. Net proceeds from the issue will be utilised for funding working capital requirements, repaying certain debt availed by the company and for general corporate purposes. Axis Capital and ICICI Securities are the merchant bankers for the share-sale. The equity shares will be listed on the NSE and BSE. Post the IPO, the promoter shareholding will fall to 73 per cent from 95 per cent earlier. The anchor investors include Abu Dhabi Investment Authority, HDFC Mutual Fund, Axis Mutual Fund, ICICI Prudential Mutual Fund, SBI Mutual Fund, Sundaram Mutual Fund, HDFC Life Insurance Company and Goldman Sachs India. Also read: HDFC Bank probes allegations of 'improper lending practices' at vehicle financing unit Also read: Petrol, diesel price today: Check out latest fuel rates in Delhi, Mumbai, other big cities;"{'body': [{'indices': [[1896, 1900]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Delhi'},
           'score': 0.9973549842834473,
           'text': 'Delhi',
           'types': ['Settlement',
                     'Place',
                     'City',
                     'PopulatedPlace',
                     'Location',
                     'Territory']},
          {'indices': [[16, 38]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'initial public offering',
           'types': ['Offering', 'Work', 'Product']},
          {'indices': [[41, 43],
                       [568, 570],
                       [787, 789],
                       [892, 894],
                       [1086, 1088],
                       [1427, 1429]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Offering', 'Work', 'Product', 'Organisation']},
          {'indices': [[149, 167]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 1.0,
           'text': 'speciality chemical',
           'types': ['Company', 'Products']},
          {'indices': [[1286, 1289], [1588, 1591]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_powers'},
           'score': 0.9974735379219055,
           'text': 'Axis',
           'types': ['EthnicGroup',
                     'Place',
                     'Nations',
                     'PopulatedPlace',
                     'Country',
                     'Location']},
          {'indices': [[1739, 1747]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/HDFC_Bank'},
           'score': 0.9960517287254333,
           'text': 'HDFC Bank',
           'types': ['Bank', 'Company', 'Agent', 'Banking', 'Organisation']},
          {'indices': [[1721, 1725]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.998941957950592,
           'text': 'India',
           'types': ['MusicalArtist',
                     'Place',
                     'PopulatedPlace',
                     'Country',
                     'Location']},
          {'indices': [[128, 133], [1903, 1908]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mumbai'},
           'score': 0.9956206679344177,
           'text': 'Mumbai',
           'types': ['Settlement',
                     'Place',
                     'City',
                     'PopulatedPlace',
                     'Location']},
          {'indices': [[210, 222], [259, 271], [973, 985], [1369, 1381]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Common_stock'},
           'score': 1.0,
           'text': 'equity shares',
           'types': ['Form']},
          {'indices': [[1707, 1719]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Goldman_Sachs'},
           'score': 0.9999684691429138,
           'text': 'Goldman Sachs',
           'types': ['Bank', 'Company', 'Agent', 'Organisation']},
          {'indices': [[1845, 1850]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Diesel_engine'},
           'score': 0.6513924598693848,
           'text': 'diesel',
           'types': ['Engine', 'Product', 'Company', 'Software']},
          {'indices': [[1413, 1415]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bombay_Stock_Exchange'},
           'score': 0.4205005466938019,
           'text': 'BSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[859, 863], [943, 947], [1111, 1115]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[1538, 1567]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Abu_Dhabi_Investment_Authority'},
           'score': 1.0,
           'text': 'Abu Dhabi Investment Authority',
           'types': ['Fund', 'Company', 'Agent', 'Organisation']},
          {'indices': [[1303, 1307], [1606, 1610]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/ICICI_Bank'},
           'score': 1.0,
           'text': 'ICICI',
           'types': ['Bank', 'Company', 'Agent', 'Banking', 'Organisation']},
          {'indices': [[1405, 1407]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.7186870574951172,
           'text': 'NSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[0, 14], [812, 826]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech',
           'types': ['Person', 'Organisation']},
          {'indices': [[516, 518]],
           'links': None,
           'score': None,
           'text': 'QIB',
           'types': ['Organisation']},
          {'indices': [[728, 755]],
           'links': None,
           'score': None,
           'text': 'SBI Cards & Payment Services',
           'types': ['Organisation']},
          {'indices': [[852, 853], [937, 938], [1104, 1105]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Organisation']},
          {'indices': [[937, 941]],
           'links': None,
           'score': None,
           'text': 'Rs 50',
           'types': ['Organisation']},
          {'indices': [[1034, 1036]],
           'links': None,
           'score': None,
           'text': 'OFS',
           'types': ['Organisation']},
          {'indices': [[1286, 1297]],
           'links': None,
           'score': None,
           'text': 'Axis Capital',
           'types': ['Organisation']},
          {'indices': [[1303, 1318]],
           'links': None,
           'score': None,
           'text': 'ICICI Securities',
           'types': ['Organisation']},
          {'indices': [[1570, 1585]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1588, 1603]],
           'links': None,
           'score': None,
           'text': 'Axis Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1606, 1633]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1636, 1650]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1653, 1672]],
           'links': None,
           'score': None,
           'text': 'Sundaram Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1675, 1701]],
           'links': None,
           'score': None,
           'text': 'HDFC Life Insurance Company',
           'types': ['Organisation']},
          {'indices': [[1707, 1725]],
           'links': None,
           'score': None,
           'text': 'Goldman Sachs India',
           'types': ['Organisation']}],
 'title': [{'indices': [[16, 18]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
            'score': 1.0,
            'text': 'IPO',
            'types': ['Work', 'Product', 'Offering']},
           {'indices': [[0, 14]],
            'links': None,
            'score': None,
            'text': 'Rossari Biotech',
            'types': ['Person']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.4099999964237213,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.17000000178813934,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04008023',
 'label': 'financial markets',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04008023',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04008000'},
 'score': 0.029999999329447746,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.921624},
 'title': {'polarity': 'neutral', 'score': 0.422259}}"
2020-07-13  11:56;Analysts find Rossari IPO asking valuation not so rosy: Should you subscribe?;NEW DELHI: The Rs 496 crore Rossari Biotech IPO hit the primary market this morning. At the higher end of the Rs 423-425 price band, the specialty chemicals manufacturer is seeking a valuation of 19.9 times FY20’s EV/Ebitda and 33.1 times earnings per share on a FY20 basis. The asking valuations are a bit higher than peers, but analysts largely have ‘subscribe’ ratings on the issue. “Rossari may command a premium over most of its chemical peers, as it is net debt free and has better asset turnover, working capital days return on equity,” said Angel Broking. This brokerage has a ‘subscribe’ rating on the issue. On Friday, the company raised Rs 148.87 crore from anchor investors, who included top three fund houses – SBI Mutual Fund, HDFC Mutual Fund and ICICI Prudential Mutual Fund. The company deals in three segments. The home care segment accounted for 46.81 per cent of FY20 revenues (against just 18.63 per cent in FY18), textile specialty 43.71 per cent (from 71.54 per cent in FY18) and animal healthcare 9.48 per cent (9.83 per cent in FY18). A few brokerages raised concerns over near-term demand from the textile industry. Among them is SMC Global, which said the company has heavy reliance on the demand from the textile industry and a significant portion of such revenues come from a few major institutional customers. “Moreover, Rossari’s manufacturing facility situated at Silvassa is critical to its business and any disturbance may have an adverse impact on its business, SMC Global said. Other brokerages, however, are not overly worried about it and noted that demand from home and personal care segments has been on the rise. In a Covid-19 update, the company said its revenues during the last 10 days of March were hit on account of the lockdown. But since April, plant utilisation level has picked up to 50-55 per cent and is expected to touch 75-80 per cent in July. Despite the lockdown and the pandemic, the company did not suffer any major losses in revenue in last four months. The company has added over 20 private label customers during the lockdown. The soaps & detergent and pulp & paper products segments have gained a lot of traction during this period, said Ventura Securities. The company has two R facilities – one within the Silvassa manufacturing facility and the second in Mumbai. Rossari said its Silvasa plant was operating at 94 per cent installed capacity of 120,000 MTPA, which pushed it to go for an expansion at Dahej. The new 132,500 MTPA plant, it said, is nearing completion and should be operational soon. After the capacity increase, the company will have to incur just maintenance capital expenditure for next 3-4 years, said Angel Broking. Among the company's listed peers, Galaxy Surfactants (24.3 times) and Atul (20.7 times) trade at a discount to Rossai's asking valuations. Others such as Fine Organics (36.3 times), Aarti Industries (30 times) and Vinati Organics (31 times) trade in line with Rossari's asking valuations. The asking multiple is within the range of the sectoral average. High return ratios coupled with the historic growth rates provide further comfort, said Anand Rathi Financial Services. Rossari's total revenues grew at a compounded annual growth rate of 41.65 per cent over FY18-20, Ebitda during the same period was up 56.58 per cent annually and profit after tax expanded 60.27 per cent over the same period. The company reported a return on net worth of 31.79 per cent for FY20, 43.32 per cent for FY19 and 34.08 per cent FY18. Return on capital employed (RoCE) stood at 24.79 per cent for FY20, 50.93 per cent for FY19 and 34.68 per cent for FY18. Nirali Shah, Senior Research Analyst at Samco Securities, said a robust management and sound corporate governance policy will drive growth for the company going ahead. “Since the asking P/E is slightly high at 31 times compared with the industry average P/E of 27 times, short-term investors can subscribe only for listing gains. For long-term investors, it still is a fair deal because of the handsome growth and strong book with a mere 0.3 debt-equity ratio and sufficient cash, which justifies valuations, Shah said. The IPO would be a mix of fresh issue and offer for sale (OFS). The promoters would sell up to 10,500,000 equity shares, comprising an OFS of up to 5,250,000 shares by Edward Menezes and up to 5,250,000 shares by Sunil Chari. It will close for subscription on July 15.;"{'body': [{'indices': [[364, 370]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nielsen_ratings'},
           'score': 0.9142705202102661,
           'text': 'ratings',
           'types': ['Systems', 'Place']},
          {'indices': [[4380, 4384]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Chari_River'},
           'score': 1.0,
           'text': 'Chari',
           'types': ['River']},
          {'indices': [[1010, 1019]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Health_care'},
           'score': 0.9986824989318848,
           'text': 'healthcare',
           'types': ['Maintenance', 'Company']},
          {'indices': [[2100, 2108]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Detergent'},
           'score': 0.9964843392372131,
           'text': 'detergent',
           'types': ['ChemicalCompound', 'Surfactant']},
          {'indices': [[3433, 3441]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Net_worth'},
           'score': 0.9885572791099548,
           'text': 'net worth',
           'types': ['Organisation', 'Assets']},
          {'indices': [[44, 46], [4165, 4167]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Offering', 'Work', 'Product', 'Organisation']},
          {'indices': [[3149, 3153]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Zebu'},
           'score': 0.4246990978717804,
           'text': 'Rathi',
           'types': ['Eukaryote', 'Species']},
          {'indices': [[2742, 2752]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Surfactant'},
           'score': 1.0,
           'text': 'Surfactants',
           'types': ['ChemicalCompound', 'Compounds']},
          {'indices': [[137, 155]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 0.9912170171737671,
           'text': 'specialty chemicals',
           'types': ['Products', 'Company']},
          {'indices': [[4010, 4018]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fair_Deal'},
           'score': 1.0,
           'text': 'fair deal',
           'types': ['Set']},
          {'indices': [[535, 540], [4088, 4093], [4267, 4272]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.585740327835083,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[3827, 3829], [3895, 3897]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Price–earnings_ratio'},
           'score': 1.0,
           'text': 'P/E',
           'types': ['Ratio']},
          {'indices': [[2043, 2055]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Private_label'},
           'score': 1.0,
           'text': 'private label',
           'types': ['Company']},
          {'indices': [[1396, 1403], [2270, 2277]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Silvassa'},
           'score': 1.0,
           'text': 'Silvassa',
           'types': ['Settlement',
                     'Place',
                     'PopulatedPlace',
                     'Location',
                     'Capital',
                     'City']},
          {'indices': [[2641, 2659]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Capital_expenditure'},
           'score': 1.0,
           'text': 'capital expenditure',
           'types': ['Expense']},
          {'indices': [[2320, 2325]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mumbai'},
           'score': 0.9957529306411743,
           'text': 'Mumbai',
           'types': ['Settlement',
                     'Place',
                     'PopulatedPlace',
                     'Location',
                     'City']},
          {'indices': [[4267, 4279]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Common_stock'},
           'score': 1.0,
           'text': 'equity shares',
           'types': ['Form']},
          {'indices': [[1124, 1139], [1233, 1248]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile_industry'},
           'score': 0.7709734439849854,
           'text': 'textile industry',
           'types': ['PersonFunction']},
          {'indices': [[22, 26], [658, 662]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[56, 69]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Primary_market'},
           'score': 1.0,
           'text': 'primary market',
           'types': ['Part']},
          {'indices': [[2466, 2470]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Gujarat'},
           'score': 1.0,
           'text': 'Dahej',
           'types': ['Settlement',
                     'State',
                     'Place',
                     'PopulatedPlace',
                     'Location',
                     'Person']},
          {'indices': [[1609, 1621]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Personal_care'},
           'score': 0.9800259470939636,
           'text': 'personal care',
           'types': ['Industry', 'Company']},
          {'indices': [[1766, 1773], [1910, 1917], [2078, 2085]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lockdown'},
           'score': 0.9409542679786682,
           'text': 'lockdown',
           'types': ['Book', 'Product', 'Definitions']},
          {'indices': [[214, 222]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Earnings_before_interest,_taxes,_depreciation,_and_amortization'},
           'score': 1.0,
           'text': 'EV/Ebitda',
           'types': ['Software', 'Product', 'Measure', 'Organisation']},
          {'indices': [[217, 222], [3272, 3277]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Earnings_before_interest,_taxes,_depreciation,_and_amortization'},
           'score': 1.0,
           'text': 'Ebitda',
           'types': ['Software', 'Product', 'Measure', 'Organisation']},
          {'indices': [[1927, 1934]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pandemic'},
           'score': 0.9951421618461609,
           'text': 'pandemic',
           'types': ['Arachnid', 'Epidemic']},
          {'indices': [[936, 942], [1124, 1130], [1233, 1239]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile'},
           'score': 0.994179368019104,
           'text': 'textile',
           'types': ['Material', 'ChemicalCompound', 'MusicGenre']},
          {'indices': [[2200, 2206]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ventura,_California'},
           'score': 0.8157802224159241,
           'text': 'Ventura',
           'types': ['Settlement',
                     'Place',
                     'PopulatedPlace',
                     'Location',
                     'Seat',
                     'City']},
          {'indices': [[549, 553], [2686, 2690]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Angel_(Buffy_the_Vampire_Slayer)'},
           'score': 0.5936272144317627,
           'text': 'Angel',
           'types': ['FictionalCharacter', 'Character']},
          {'indices': [[0, 8]],
           'links': None,
           'score': None,
           'text': 'NEW DELHI',
           'types': ['Place']},
          {'indices': [[110, 115]],
           'links': None,
           'score': None,
           'text': 'Rs 423',
           'types': ['Place']},
          {'indices': [[648, 656]],
           'links': None,
           'score': None,
           'text': 'Rs 148.87',
           'types': ['Place']},
          {'indices': [[28, 42]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech',
           'types': ['Person']},
          {'indices': [[549, 561], [2686, 2698]],
           'links': None,
           'score': None,
           'text': 'Angel Broking',
           'types': ['Person']},
          {'indices': [[2771, 2774]],
           'links': None,
           'score': None,
           'text': 'Atul',
           'types': ['Person']},
          {'indices': [[3641, 3651]],
           'links': None,
           'score': None,
           'text': 'Nirali Shah',
           'types': ['Person']},
          {'indices': [[3648, 3651], [4150, 4153]],
           'links': None,
           'score': None,
           'text': 'Shah',
           'types': ['Person']},
          {'indices': [[4329, 4342]],
           'links': None,
           'score': None,
           'text': 'Edward Menezes',
           'types': ['Person']},
          {'indices': [[4374, 4384]],
           'links': None,
           'score': None,
           'text': 'Sunil Chari',
           'types': ['Person']},
          {'indices': [[3263, 3269]],
           'links': None,
           'score': None,
           'text': 'FY18-20',
           'types': ['Product']},
          {'indices': [[207, 210],
                       [263, 266],
                       [883, 886],
                       [3465, 3468],
                       [3582, 3585]],
           'links': None,
           'score': None,
           'text': 'FY20',
           'types': ['Organisation']},
          {'indices': [[28, 34],
                       [387, 393],
                       [1351, 1357],
                       [2328, 2334],
                       [2961, 2967],
                       [3175, 3181]],
           'links': None,
           'score': None,
           'text': 'Rossari',
           'types': ['Organisation']},
          {'indices': [[724, 738]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[741, 756]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[762, 789]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2200, 2217]],
           'links': None,
           'score': None,
           'text': 'Ventura Securities',
           'types': ['Organisation']},
          {'indices': [[2345, 2351]],
           'links': None,
           'score': None,
           'text': 'Silvasa',
           'types': ['Organisation']},
          {'indices': [[2418, 2421], [2489, 2492]],
           'links': None,
           'score': None,
           'text': 'MTPA',
           'types': ['Organisation']},
          {'indices': [[2735, 2752]],
           'links': None,
           'score': None,
           'text': 'Galaxy Surfactants',
           'types': ['Organisation']},
          {'indices': [[2812, 2817]],
           'links': None,
           'score': None,
           'text': 'Rossai',
           'types': ['Organisation']},
          {'indices': [[2855, 2867]],
           'links': None,
           'score': None,
           'text': 'Fine Organics',
           'types': ['Organisation']},
          {'indices': [[2883, 2898]],
           'links': None,
           'score': None,
           'text': 'Aarti Industries',
           'types': ['Organisation']},
          {'indices': [[2915, 2929]],
           'links': None,
           'score': None,
           'text': 'Vinati Organics',
           'types': ['Organisation']},
          {'indices': [[3143, 3172]],
           'links': None,
           'score': None,
           'text': 'Anand Rathi Financial Services',
           'types': ['Organisation']},
          {'indices': [[3681, 3696]],
           'links': None,
           'score': None,
           'text': 'Samco Securities',
           'types': ['Organisation']},
          {'indices': [[4219, 4221], [4296, 4298]],
           'links': None,
           'score': None,
           'text': 'OFS',
           'types': ['Organisation']}],
 'title': [{'indices': [[22, 24]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
            'score': 1.0,
            'text': 'IPO',
            'types': ['Offering', 'Work', 'Product']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.4300000071525574,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-11',
 'label': 'Stocks',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-11',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.1599999964237213,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.03999999910593033,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'neutral', 'score': 0.668128},
 'title': {'polarity': 'neutral', 'score': 0.792059}}"
2020-07-13  08:52;Rossari Biotech raises Rs1,48.87cr from anchor investors IPO opens today;"Speciality chemicals manufacturer, Rossari Biotech Limited, announced its Initial Public Offering on July 8, 2020. India’s first IPO to launch amidst the pandemic has raised Rs148.87cr in anchor allotment and has finalized allocation of 35,02,940 shares to 15 institutional investors at Rs425 per share, which is the upper limit of the price band for the IPO.


The issue will open today and close on July 15, 2020, with a price band of Rs423– Rs425 per Equity Share of the face value of Rs2 each.


The Company proposed to raise Rs496.24cr via the fresh issue of Rs50cr and OFS of Rs446.25cr. The net proceeds from the fresh issue to prepay or repay certain indebtedness, including accrued interest, fund working capital requirements and for general corporate purposes.


A total of 8 mutual funds through 20 schemes bid for the anchor portion.


While Kotak has come out with a not rated note and Anand Rathi and Ventura Securities have come out with the subscribe report on the IPO keeping in mind its inorganic and organic growth opportunities. Collectively, they state that the strong RD capabilities, high return ratios are coupled with the proof of concept and its consistent performance, post IPO debt free status and strong demand for existing product line provides comfort.


Axis Capital Limited and ICICI Securities Limited have been appointed as the book running lead managers to the Offer and Axcelus Finserv Private Limited was appointed as advisor to the Offer.

 


	
		
			
				Sr No
			
				Anchor Investor Name (in alphabetical order)
			
				Amount (in crores)
		

		
			
				1
			
				ABU DHABI INVESTMENT AUTHORITY
			
				8.30
		

		
			
				2
			
				ASHOKA INDIA OPPORTUNITIES FUND
			
				14.00
		

		
			
				3
			
				AXIS MUTUAL FUND
			
				8.30
		

		
			
				4
			
				GOLDMAN SACHS INDIA LIMITED
			
				8.30
		

		
			
				5
			
				HDFC MUTUAL FUND (under various schemes)
			
				14.00
		

		
			
				6
			
				HDFC LIFE INSURANCE COMPANY LTD
			
				8.30
		

		
			
				7
			
				HSBC GLOBAL INVESTMENT FUNDS - INDIAN EQUITY
			
				8.30
		

		
			
				8
			
				ICICI PRUDENTIAL MUTUAL FUND (under various schemes)
			
				14.00
		

		
			
				9
			
				IIFL SPECIAL OPPORTUNITIES FUND - SERIES 4
			
				5.03
		

		
			
				10
			
				KOTAK MAHINDRA (INTERNATIONAL) LIMITED
			
				8.30
		

		
			
				11
			
				MALABAR INDIA FUND LIMITED
			
				14.00
		

		
			
				12
			
				MIRAE MUTUAL FUND (under various schemes)
			
				5.02
		

		
			
				13
			
				RELIANCE CAPITAL TRUSTEE CO LTD-A/C NIPPON INDIA SMALL CAP FUND
			
				14.00
		

		
			
				14
			
				SBI MUTUAL FUND (under various schemes)
			
				14.00
		

		
			
				15
			
				SUNDARAM MUTUAL FUND (under various schemes)
			
				5.02
		

		
			
			
			
				Total
			
				148.87
		

	

											

											 
											
											
											
												 Related Tags:";"{'body': [{'indices': [[2018, 2021]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/HSBC'},
           'score': 0.9949167370796204,
           'text': 'HSBC',
           'types': ['Company', 'Agent', 'Bank', 'Organisation', 'Banking']},
          {'indices': [[74, 96]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'Initial Public Offering',
           'types': ['Offering', 'Work', 'Product', 'Organisation']},
          {'indices': [[129, 131], [355, 357], [981, 983], [1201, 1203]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Offering', 'Work', 'Product']},
          {'indices': [[260, 282]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Institutional_investor'},
           'score': 1.0,
           'text': 'institutional investors',
           'types': ['Term']},
          {'indices': [[683, 698]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Accrued_interest'},
           'score': 1.0,
           'text': 'accrued interest',
           'types': ['Magazine', 'Product', 'Interest']},
          {'indices': [[0, 19]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 1.0,
           'text': 'Speciality chemicals',
           'types': ['Products', 'Company']},
          {'indices': [[1747, 1750]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AXIS_(comics)'},
           'score': 0.9783279895782471,
           'text': 'AXIS',
           'types': ['Storyline', 'Comic', 'Product']},
          {'indices': [[786, 797]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 0.9888682961463928,
           'text': 'mutual funds',
           'types': ['PersonFunction']},
          {'indices': [[1286, 1289]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_powers'},
           'score': 0.9962083697319031,
           'text': 'Axis',
           'types': ['PopulatedPlace',
                     'Nations',
                     'EthnicGroup',
                     'Location',
                     'Country',
                     'Place']},
          {'indices': [[115, 119]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.998401939868927,
           'text': 'India',
           'types': ['PopulatedPlace',
                     'MusicalArtist',
                     'Location',
                     'Country',
                     'Place']},
          {'indices': [[2353, 2359]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Malabar_region'},
           'score': 0.7269905805587769,
           'text': 'MALABAR',
           'types': ['AdministrativeRegion',
                     'PopulatedPlace',
                     'Area',
                     'Place',
                     'Region',
                     'Settlement',
                     'Location']},
          {'indices': [[1802, 1814]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Goldman_Sachs'},
           'score': 0.9999615550041199,
           'text': 'GOLDMAN SACHS',
           'types': ['Company', 'Agent', 'Bank', 'Organisation']},
          {'indices': [[594, 600]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/The_Net_(1995_film)'},
           'score': 0.9565790295600891,
           'text': 'The net',
           'types': ['Work', 'Product', 'Film', 'Wikidata:Q11424']},
          {'indices': [[905, 909]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Rati'},
           'score': 0.34485724568367004,
           'text': 'Rathi',
           'types': ['Goddess', 'MythologicalFigure']},
          {'indices': [[2281, 2288]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mahindra_&_Mahindra'},
           'score': 0.8507264256477356,
           'text': 'MAHINDRA',
           'types': ['Company', 'Agent', 'Organisation', 'Corporation']},
          {'indices': [[1607, 1636]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Abu_Dhabi_Investment_Authority'},
           'score': 1.0,
           'text': 'ABU DHABI INVESTMENT AUTHORITY',
           'types': ['Company', 'Agent', 'Fund', 'Organisation']},
          {'indices': [[154, 161]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pandemic'},
           'score': 0.9950003027915955,
           'text': 'pandemic',
           'types': ['Arachnid', 'Epidemic']},
          {'indices': [[915, 921]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ventura,_California'},
           'score': 0.8297020196914673,
           'text': 'Ventura',
           'types': ['Seat',
                     'PopulatedPlace',
                     'Settlement',
                     'Location',
                     'Place',
                     'City']},
          {'indices': [[1311, 1315], [2101, 2105]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/ICICI_Bank'},
           'score': 1.0,
           'text': 'ICICI',
           'types': ['Company', 'Agent', 'Bank', 'Organisation', 'Banking']},
          {'indices': [[1005, 1013]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Inorganic_compound'},
           'score': 0.9197594523429871,
           'text': 'inorganic',
           'types': ['ChemicalCompound', 'Compound']},
          {'indices': [[1090, 1091]],
           'links': None,
           'score': None,
           'text': 'RD',
           'types': ['Place']},
          {'indices': [[1397, 1401], [1471, 1475]],
           'links': None,
           'score': None,
           'text': 'Offer',
           'types': ['Place']},
          {'indices': [[174, 183]],
           'links': None,
           'score': None,
           'text': 'Rs148.87cr',
           'types': ['Person']},
          {'indices': [[899, 909]],
           'links': None,
           'score': None,
           'text': 'Anand Rathi',
           'types': ['Person']},
          {'indices': [[1496, 1500]],
           'links': None,
           'score': None,
           'text': 'Sr No',
           'types': ['Person']},
          {'indices': [[35, 57]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech Limited',
           'types': ['Organisation']},
          {'indices': [[362, 364], [500, 502], [594, 596]],
           'links': None,
           'score': None,
           'text': 'The',
           'types': ['Organisation']},
          {'indices': [[437, 465]],
           'links': None,
           'score': None,
           'text': 'Rs423– Rs425 per Equity Share',
           'types': ['Organisation']},
          {'indices': [[500, 510]],
           'links': None,
           'score': None,
           'text': 'The Company',
           'types': ['Organisation']},
          {'indices': [[575, 591]],
           'links': None,
           'score': None,
           'text': 'OFS of Rs446.25cr',
           'types': ['Organisation']},
          {'indices': [[0, -1],
                       [10, 9],
                       [11, 10],
                       [20, 19],
                       [21, 20],
                       [33, 32],
                       [35, 34],
                       [42, 41],
                       [43, 42],
                       [50, 49],
                       [51, 50],
                       [58, 57],
                       [60, 59],
                       [69, 68],
                       [70, 69],
                       [73, 72],
                       [74, 73],
                       [81, 80],
                       [82, 81],
                       [88, 87],
                       [89, 88],
                       [97, 96],
                       [98, 97],
                       [100, 99],
                       [101, 100],
                       [105, 104],
                       [106, 105],
                       [107, 106],
                       [109, 108],
                       [113, 112],
                       [115, 114],
                       [120, 119],
                       [121, 120],
                       [122, 121],
                       [123, 122],
                       [128, 127],
                       [129, 128],
                       [132, 131],
                       [133, 132],
                       [135, 134],
                       [136, 135],
                       [142, 141],
                       [143, 142],
                       [149, 148],
                       [150, 149],
                       [153, 152],
                       [154, 153],
                       [162, 161],
                       [163, 162],
                       [166, 165],
                       [167, 166],
                       [173, 172],
                       [174, 173],
                       [179, 178],
                       [180, 179],
                       [184, 183],
                       [185, 184],
                       [187, 186],
                       [188, 187],
                       [194, 193],
                       [195, 194],
                       [204, 203],
                       [205, 204],
                       [208, 207],
                       [209, 208],
                       [212, 211],
                       [213, 212],
                       [222, 221],
                       [223, 222],
                       [233, 232],
                       [234, 233],
                       [236, 235],
                       [237, 236],
                       [239, 238],
                       [240, 239],
                       [242, 241],
                       [243, 242],
                       [246, 245],
                       [247, 246],
                       [253, 252],
                       [254, 253],
                       [256, 255],
                       [257, 256],
                       [259, 258],
                       [260, 259],
                       [273, 272],
                       [274, 273],
                       [283, 282],
                       [284, 283],
                       [286, 285],
                       [287, 286],
                       [292, 291],
                       [293, 292],
                       [296, 295],
                       [297, 296],
                       [302, 301],
                       [304, 303],
                       [309, 308],
                       [310, 309],
                       [312, 311],
                       [313, 312],
                       [316, 315],
                       [317, 316],
                       [322, 321],
                       [323, 322],
                       [328, 327],
                       [329, 328],
                       [331, 330],
                       [332, 331],
                       [335, 334],
                       [336, 335],
                       [341, 340],
                       [342, 341],
                       [346, 345],
                       [347, 346],
                       [350, 349],
                       [351, 350],
                       [354, 353],
                       [355, 354],
                       [358, 357],
                       [362, 361],
                       [365, 364],
                       [366, 365],
                       [371, 370],
                       [372, 371],
                       [376, 375],
                       [377, 376],
                       [381, 380],
                       [382, 381],
                       [387, 386],
                       [388, 387],
                       [391, 390],
                       [392, 391],
                       [397, 396],
                       [398, 397],
                       [400, 399],
                       [401, 400],
                       [405, 404],
                       [406, 405],
                       [408, 407],
                       [410, 409],
                       [414, 413],
                       [416, 415],
                       [420, 419],
                       [421, 420],
                       [422, 421],
                       [423, 422],
                       [428, 427],
                       [429, 428],
                       [433, 432],
                       [434, 433],
                       [436, 435],
                       [437, 436],
                       [442, 441],
                       [444, 443],
                       [449, 448],
                       [450, 449],
                       [453, 452],
                       [454, 453],
                       [460, 459],
                       [461, 460],
                       [466, 465],
                       [467, 466],
                       [469, 468],
                       [470, 469],
                       [473, 472],
                       [474, 473],
                       [478, 477],
                       [479, 478],
                       [484, 483],
                       [485, 484],
                       [487, 486],
                       [488, 487],
                       [491, 490],
                       [492, 491],
                       [496, 495],
                       [500, 499],
                       [503, 502],
                       [504, 503],
                       [511, 510],
                       [512, 511],
                       [520, 519],
                       [521, 520],
                       [523, 522],
                       [524, 523],
                       [529, 528],
                       [530, 529],
                       [535, 534],
                       [536, 535],
                       [540, 539],
                       [541, 540],
                       [544, 543],
                       [545, 544],
                       [548, 547],
                       [549, 548],
                       [554, 553],
                       [555, 554],
                       [560, 559],
                       [561, 560],
                       [563, 562],
                       [564, 563],
                       [570, 569],
                       [571, 570],
                       [574, 573],
                       [575, 574],
                       [578, 577],
                       [579, 578],
                       [581, 580],
                       [582, 581],
                       [587, 586],
                       [588, 587],
                       [592, 591],
                       [594, 593],
                       [597, 596],
                       [598, 597],
                       [601, 600],
                       [602, 601],
                       [610, 609],
                       [611, 610],
                       [615, 614],
                       [616, 615],
                       [619, 618],
                       [620, 619],
                       [625, 624],
                       [626, 625],
                       [631, 630],
                       [632, 631],
                       [634, 633],
                       [635, 634],
                       [641, 640],
                       [642, 641],
                       [644, 643],
                       [645, 644],
                       [650, 649],
                       [651, 650],
                       [658, 657],
                       [659, 658],
                       [671, 670],
                       [673, 672],
                       [682, 681],
                       [683, 682],
                       [690, 689],
                       [691, 690],
                       [699, 698],
                       [701, 700],
                       [705, 704],
                       [706, 705],
                       [713, 712],
                       [714, 713],
                       [721, 720],
                       [722, 721],
                       [734, 733],
                       [735, 734],
                       [738, 737],
                       [739, 738],
                       [742, 741],
                       [743, 742],
                       [750, 749],
                       [751, 750],
                       [760, 759],
                       [761, 760],
                       [769, 768],
                       [773, 772],
                       [774, 773],
                       [775, 774],
                       [780, 779],
                       [781, 780],
                       [783, 782],
                       [784, 783],
                       [785, 784],
                       [786, 785],
                       [792, 791],
                       [793, 792],
                       [798, 797],
                       [799, 798],
                       [806, 805],
                       [807, 806],
                       [809, 808],
                       [810, 809],
                       [817, 816],
                       [818, 817],
                       [821, 820],
                       [822, 821],
                       [825, 824],
                       [826, 825],
                       [829, 828],
                       [830, 829],
                       [836, 835],
                       [837, 836],
                       [844, 843],
                       [848, 847],
                       [853, 852],
                       [854, 853],
                       [859, 858],
                       [860, 859],
                       [863, 862],
                       [864, 863],
                       [868, 867],
                       [869, 868],
                       [872, 871],
                       [873, 872],
                       [877, 876],
                       [878, 877],
                       [879, 878],
                       [880, 879],
                       [883, 882],
                       [884, 883],
                       [889, 888],
                       [890, 889],
                       [894, 893],
                       [895, 894],
                       [898, 897],
                       [899, 898],
                       [904, 903],
                       [905, 904],
                       [910, 909],
                       [911, 910],
                       [914, 913],
                       [915, 914],
                       [922, 921],
                       [923, 922],
                       [933, 932],
                       [934, 933],
                       [938, 937],
                       [939, 938],
                       [943, 942],
                       [944, 943],
                       [947, 946],
                       [948, 947],
                       [952, 951],
                       [953, 952],
                       [956, 955],
                       [957, 956],
                       [966, 965],
                       [967, 966],
                       [973, 972],
                       [974, 973],
                       [976, 975],
                       [977, 976],
                       [980, 979],
                       [981, 980],
                       [984, 983],
                       [985, 984],
                       [992, 991],
                       [993, 992],
                       [995, 994],
                       [996, 995],
                       [1000, 999],
                       [1001, 1000],
                       [1004, 1003],
                       [1005, 1004],
                       [1014, 1013],
                       [1015, 1014],
                       [1018, 1017],
                       [1019, 1018],
                       [1026, 1025],
                       [1027, 1026],
                       [1033, 1032],
                       [1034, 1033],
                       [1047, 1046],
                       [1049, 1048],
                       [1061, 1060],
                       [1063, 1062],
                       [1067, 1066],
                       [1068, 1067],
                       [1073, 1072],
                       [1074, 1073],
                       [1078, 1077],
                       [1079, 1078],
                       [1082, 1081],
                       [1083, 1082],
                       [1089, 1088],
                       [1090, 1089],
                       [1092, 1091],
                       [1093, 1092],
                       [1105, 1104],
                       [1107, 1106],
                       [1111, 1110],
                       [1112, 1111],
                       [1118, 1117],
                       [1119, 1118],
                       [1125, 1124],
                       [1126, 1125],
                       [1129, 1128],
                       [1130, 1129],
                       [1137, 1136],
                       [1138, 1137],
                       [1142, 1141],
                       [1143, 1142],
                       [1146, 1145],
                       [1147, 1146],
                       [1152, 1151],
                       [1153, 1152],
                       [1155, 1154],
                       [1156, 1155],
                       [1163, 1162],
                       [1164, 1163],
                       [1167, 1166],
                       [1168, 1167],
                       [1171, 1170],
                       [1172, 1171],
                       [1182, 1181],
                       [1183, 1182],
                       [1194, 1193],
                       [1196, 1195],
                       [1200, 1199],
                       [1201, 1200],
                       [1204, 1203],
                       [1205, 1204],
                       [1209, 1208],
                       [1210, 1209],
                       [1214, 1213],
                       [1215, 1214],
                       [1221, 1220],
                       [1222, 1221],
                       [1225, 1224],
                       [1226, 1225],
                       [1232, 1231],
                       [1233, 1232],
                       [1239, 1238],
                       [1240, 1239],
                       [1243, 1242],
                       [1244, 1243],
                       [1252, 1251],
                       [1253, 1252],
                       [1260, 1259],
                       [1261, 1260],
                       [1265, 1264],
                       [1266, 1265],
                       [1274, 1273],
                       [1275, 1274],
                       [1282, 1281],
                       [1286, 1285],
                       [1290, 1289],
                       [1291, 1290],
                       [1298, 1297],
                       [1299, 1298],
                       [1306, 1305],
                       [1307, 1306],
                       [1310, 1309],
                       [1311, 1310],
                       [1316, 1315],
                       [1317, 1316],
                       [1327, 1326],
                       [1328, 1327],
                       [1335, 1334],
                       [1336, 1335],
                       [1340, 1339],
                       [1341, 1340],
                       [1345, 1344],
                       [1346, 1345],
                       [1355, 1354],
                       [1356, 1355],
                       [1358, 1357],
                       [1359, 1358],
                       [1362, 1361],
                       [1363, 1362],
                       [1367, 1366],
                       [1368, 1367],
                       [1375, 1374],
                       [1376, 1375],
                       [1380, 1379],
                       [1381, 1380],
                       [1389, 1388],
                       [1390, 1389],
                       [1392, 1391],
                       [1393, 1392],
                       [1396, 1395],
                       [1397, 1396],
                       [1402, 1401],
                       [1403, 1402],
                       [1406, 1405],
                       [1407, 1406],
                       [1414, 1413],
                       [1415, 1414],
                       [1422, 1421],
                       [1423, 1422],
                       [1430, 1429],
                       [1431, 1430],
                       [1438, 1437],
                       [1439, 1438],
                       [1442, 1441],
                       [1443, 1442],
                       [1452, 1451],
                       [1453, 1452],
                       [1455, 1454],
                       [1456, 1455],
                       [1463, 1462],
                       [1464, 1463],
                       [1466, 1465],
                       [1467, 1466],
                       [1470, 1469],
                       [1471, 1470],
                       [1476, 1475],
                       [1496, 1495],
                       [1498, 1497],
                       [1499, 1498],
                       [1501, 1500],
                       [1510, 1509],
                       [1516, 1515],
                       [1517, 1516],
                       [1525, 1524],
                       [1526, 1525],
                       [1530, 1529],
                       [1532, 1531],
                       [1534, 1533],
                       [1535, 1534],
                       [1547, 1546],
                       [1548, 1547],
                       [1553, 1552],
                       [1563, 1562],
                       [1569, 1568],
                       [1571, 1570],
                       [1573, 1572],
                       [1574, 1573],
                       [1580, 1579],
                       [1597, 1596],
                       [1598, 1597],
                       [1607, 1606],
                       [1610, 1609],
                       [1611, 1610],
                       [1616, 1615],
                       [1617, 1616],
                       [1627, 1626],
                       [1628, 1627],
                       [1637, 1636],
                       [1646, 1645],
                       [1647, 1646],
                       [1648, 1647],
                       [1650, 1649],
                       [1666, 1665],
                       [1667, 1666],
                       [1676, 1675],
                       [1682, 1681],
                       [1683, 1682],
                       [1688, 1687],
                       [1689, 1688],
                       [1702, 1701],
                       [1703, 1702],
                       [1707, 1706],
                       [1716, 1715],
                       [1718, 1717],
                       [1719, 1718],
                       [1721, 1720],
                       [1737, 1736],
                       [1738, 1737],
                       [1747, 1746],
                       [1751, 1750],
                       [1752, 1751],
                       [1758, 1757],
                       [1759, 1758],
                       [1763, 1762],
                       [1772, 1771],
                       [1773, 1772],
                       [1774, 1773],
                       [1776, 1775],
                       [1792, 1791],
                       [1793, 1792],
                       [1802, 1801],
                       [1809, 1808],
                       [1810, 1809],
                       [1815, 1814],
                       [1816, 1815],
                       [1821, 1820],
                       [1822, 1821],
                       [1829, 1828],
                       [1838, 1837],
                       [1839, 1838],
                       [1840, 1839],
                       [1842, 1841],
                       [1858, 1857],
                       [1859, 1858],
                       [1868, 1867],
                       [1872, 1871],
                       [1873, 1872],
                       [1879, 1878],
                       [1880, 1879],
                       [1884, 1883],
                       [1886, 1885],
                       [1891, 1890],
                       [1892, 1891],
                       [1899, 1898],
                       [1900, 1899],
                       [1907, 1906],
                       [1917, 1916],
                       [1919, 1918],
                       [1920, 1919],
                       [1922, 1921],
                       [1938, 1937],
                       [1939, 1938],
                       [1948, 1947],
                       [1952, 1951],
                       [1953, 1952],
                       [1957, 1956],
                       [1958, 1957],
                       [1967, 1966],
                       [1968, 1967],
                       [1975, 1974],
                       [1976, 1975],
                       [1979, 1978],
                       [1988, 1987],
                       [1989, 1988],
                       [1990, 1989],
                       [1992, 1991],
                       [2008, 2007],
                       [2009, 2008],
                       [2018, 2017],
                       [2022, 2021],
                       [2023, 2022],
                       [2029, 2028],
                       [2030, 2029],
                       [2040, 2039],
                       [2041, 2040],
                       [2046, 2045],
                       [2049, 2048],
                       [2055, 2054],
                       [2056, 2055],
                       [2062, 2061],
                       [2071, 2070],
                       [2072, 2071],
                       [2073, 2072],
                       [2075, 2074],
                       [2091, 2090],
                       [2092, 2091],
                       [2101, 2100],
                       [2106, 2105],
                       [2107, 2106],
                       [2117, 2116],
                       [2118, 2117],
                       [2124, 2123],
                       [2125, 2124],
                       [2129, 2128],
                       [2131, 2130],
                       [2136, 2135],
                       [2137, 2136],
                       [2144, 2143],
                       [2145, 2144],
                       [2152, 2151],
                       [2162, 2161],
                       [2164, 2163],
                       [2165, 2164],
                       [2167, 2166],
                       [2183, 2182],
                       [2184, 2183],
                       [2193, 2192],
                       [2197, 2196],
                       [2198, 2197],
                       [2205, 2204],
                       [2206, 2205],
                       [2219, 2218],
                       [2220, 2219],
                       [2224, 2223],
                       [2227, 2226],
                       [2233, 2232],
                       [2234, 2233],
                       [2235, 2234],
                       [2244, 2243],
                       [2245, 2244],
                       [2246, 2245],
                       [2248, 2247],
                       [2264, 2263],
                       [2266, 2265],
                       [2275, 2274],
                       [2280, 2279],
                       [2281, 2280],
                       [2289, 2288],
                       [2291, 2290],
                       [2304, 2303],
                       [2306, 2305],
                       [2313, 2312],
                       [2322, 2321],
                       [2323, 2322],
                       [2324, 2323],
                       [2326, 2325],
                       [2342, 2341],
                       [2344, 2343],
                       [2353, 2352],
                       [2360, 2359],
                       [2361, 2360],
                       [2366, 2365],
                       [2367, 2366],
                       [2371, 2370],
                       [2372, 2371],
                       [2379, 2378],
                       [2388, 2387],
                       [2390, 2389],
                       [2391, 2390],
                       [2393, 2392],
                       [2409, 2408],
                       [2411, 2410],
                       [2420, 2419],
                       [2425, 2424],
                       [2426, 2425],
                       [2432, 2431],
                       [2433, 2432],
                       [2437, 2436],
                       [2439, 2438],
                       [2444, 2443],
                       [2445, 2444],
                       [2452, 2451],
                       [2453, 2452],
                       [2460, 2459],
                       [2470, 2469],
                       [2471, 2470],
                       [2472, 2471],
                       [2474, 2473],
                       [2490, 2489],
                       [2492, 2491],
                       [2501, 2500],
                       [2509, 2508],
                       [2510, 2509],
                       [2517, 2516],
                       [2518, 2517],
                       [2525, 2524],
                       [2526, 2525],
                       [2528, 2527],
                       [2529, 2528],
                       [2532, 2531],
                       [2533, 2532],
                       [2534, 2533],
                       [2535, 2534],
                       [2536, 2535],
                       [2537, 2536],
                       [2543, 2542],
                       [2544, 2543],
                       [2549, 2548],
                       [2550, 2549],
                       [2555, 2554],
                       [2556, 2555],
                       [2559, 2558],
                       [2560, 2559],
                       [2564, 2563],
                       [2573, 2572],
                       [2575, 2574],
                       [2576, 2575],
                       [2578, 2577],
                       [2594, 2593],
                       [2596, 2595],
                       [2605, 2604],
                       [2608, 2607],
                       [2609, 2608],
                       [2615, 2614],
                       [2616, 2615],
                       [2620, 2619],
                       [2622, 2621],
                       [2627, 2626],
                       [2628, 2627],
                       [2635, 2634],
                       [2636, 2635],
                       [2643, 2642],
                       [2653, 2652],
                       [2655, 2654],
                       [2656, 2655],
                       [2658, 2657],
                       [2674, 2673],
                       [2676, 2675],
                       [2685, 2684],
                       [2693, 2692],
                       [2694, 2693],
                       [2700, 2699],
                       [2701, 2700],
                       [2705, 2704],
                       [2707, 2706],
                       [2712, 2711],
                       [2713, 2712],
                       [2720, 2719],
                       [2721, 2720],
                       [2728, 2727],
                       [2738, 2737],
                       [2739, 2738],
                       [2740, 2739],
                       [2742, 2741],
                       [2766, 2765],
                       [2771, 2770],
                       [2780, 2779],
                       [2783, 2782],
                       [2784, 2783],
                       [2786, 2785],
                       [2869, 2868],
                       [2876, 2875],
                       [2877, 2876],
                       [2881, 2880]],
           'links': None,
           'score': None,
           'text': '',
           'types': ['Organisation']},
          {'indices': [[848, 858]],
           'links': None,
           'score': None,
           'text': 'While Kotak',
           'types': ['Organisation']},
          {'indices': [[915, 932]],
           'links': None,
           'score': None,
           'text': 'Ventura Securities',
           'types': ['Organisation']},
          {'indices': [[1286, 1305]],
           'links': None,
           'score': None,
           'text': 'Axis Capital Limited',
           'types': ['Organisation']},
          {'indices': [[1311, 1334]],
           'links': None,
           'score': None,
           'text': 'ICICI Securities Limited',
           'types': ['Organisation']},
          {'indices': [[1676, 1706]],
           'links': None,
           'score': None,
           'text': 'ASHOKA INDIA OPPORTUNITIES FUND',
           'types': ['Organisation']},
          {'indices': [[1747, 1762]],
           'links': None,
           'score': None,
           'text': 'AXIS MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[1802, 1828]],
           'links': None,
           'score': None,
           'text': 'GOLDMAN SACHS INDIA LIMITED',
           'types': ['Organisation']},
          {'indices': [[1868, 1883]],
           'links': None,
           'score': None,
           'text': 'HDFC MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[1948, 1978]],
           'links': None,
           'score': None,
           'text': 'HDFC LIFE INSURANCE COMPANY LTD',
           'types': ['Organisation']},
          {'indices': [[2101, 2128]],
           'links': None,
           'score': None,
           'text': 'ICICI PRUDENTIAL MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[2193, 2223]],
           'links': None,
           'score': None,
           'text': 'IIFL SPECIAL OPPORTUNITIES FUND',
           'types': ['Organisation']},
          {'indices': [[2275, 2279]],
           'links': None,
           'score': None,
           'text': 'KOTAK',
           'types': ['Organisation']},
          {'indices': [[2291, 2312]],
           'links': None,
           'score': None,
           'text': 'INTERNATIONAL) LIMITED',
           'types': ['Organisation']},
          {'indices': [[2353, 2378]],
           'links': None,
           'score': None,
           'text': 'MALABAR INDIA FUND LIMITED',
           'types': ['Organisation']},
          {'indices': [[2420, 2436]],
           'links': None,
           'score': None,
           'text': 'MIRAE MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[2501, 2531]],
           'links': None,
           'score': None,
           'text': 'RELIANCE CAPITAL TRUSTEE CO LTD',
           'types': ['Organisation']},
          {'indices': [[2533, 2563]],
           'links': None,
           'score': None,
           'text': 'A/C NIPPON INDIA SMALL CAP FUND',
           'types': ['Organisation']},
          {'indices': [[2605, 2619]],
           'links': None,
           'score': None,
           'text': 'SBI MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[2685, 2704]],
           'links': None,
           'score': None,
           'text': 'SUNDARAM MUTUAL FUND',
           'types': ['Organisation']}],
 'title': [{'indices': [[58, 60]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
            'score': 1.0,
            'text': 'IPO',
            'types': ['Offering', 'Work', 'Product']},
           {'indices': [[0, 14]],
            'links': None,
            'score': None,
            'text': 'Rossari Biotech',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.4099999964237213,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.25999999046325684,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.07000000029802322,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'neutral', 'score': 0.855071},
 'title': {'polarity': 'neutral', 'score': 0.918709}}"
2020-07-11  10:13;Rossari Biotech's Rs 500 crore IPO: Here are 10 key things to know;"Mumbai-based speciality chemicals firm Rossari Biotech will launch its initial public offer on July 13 ending the nearly four-month dry streak for IPOs in the domestic markets. SBI Cards & Payment Services was the last company that got listed in the market in mid-March.

Here are 10 things you need to know about the issue:

-- Issue date: The issue will open on July 13 and close on July 15.

-- Price band: The price band is of Rs 423-Rs 425/share. Each share will have a face value of Rs 2 with bid lots available in 35 shares and in multiples thereof.

-- Issue size: The issue size is pegged around Rs 494-Rs 496 crore. The IPO will consist of a fresh issue of equity shares aggregating up to Rs 50 crore and an offer for sale component of up to 10,500,000 equity shares.

-- Purpose: The proceeds from the IPO will be used to primarily repay debt and fund working capital requirements, along with general corporate purposes.

-- Listing date: Based on the indicative timeline, trading is likely to commence on July 23.

-- Merchant bankers: Axis Capital and ICICI Securities are the book running lead managers for the IPO and Axcelus Finserv Private Limited is the adviser to the offer.

-- About the company: Rossari Biotech’s business is organised in three main product categories –

As on May 31, 2020, it had a range of 2,030 different products sold across these categories. The products are used in the manufacture of soaps and detergents, paints, inks, tiles, papers, natural and man-made textiles.

HUL, IFB Industries & Arvind Ltd are some of its key customers and the firm counts Aarti Industries, Galaxy Surfactants, Atul Ltd, Vinati Organics & Fine Organics Industries as some of its listed peers.

Apart from India, it has operations in 17 countries, including Vietnam, Bangladesh and Mauritius.

-- Financials: In fiscal 2020, Rossari Biotech registered total revenue of Rs 603.82 crore, EBITDA of Rs 104.53 crore and net profit after tax of Rs 65.25 crore.

The revenue from sale of HPPC constituted 46.81 percent of the total revenue in fiscal 2020, textile specialty chemicals constituted 43.71 percent and the rest came from the animal health and nutrition products category.

The firm has been able to increase the total revenue from fiscal 2018 to fiscal 2020 at a CAGR of 41.65 percent, EBITDA at a CAGR rate of 56.58 percent and the profit after tax has increased at a CAGR of 60.27 percent over the same period.

-- Promoter holding: Edward Menezes and Sunil Chari are the promoters of the company. They hold 42.10 percent and 42.05 percent stake as, respectively, while the public shareholding stands at 4.9 percent.

-- Pre-IPO placements: Rossari Biotech on Friday said it has raised Rs 149 crore from anchor investors. The anchor investors include Abu Dhabi Investment Authority, HDFC Mutual Fund, Axis Mutual Fund, ICICI Prudential Mutual Fund, SBI Mutual Fund, Sundaram Mutual Fund, HDFC Life Insurance Company and Goldman Sachs India.

In a statement, the company said it has raised Rs 148.87 crore in anchor allotment and has finalised allocation of 35,02,940 shares to 15 institutional investors at Rs 425 per share, which is the upper limit of the price band for the IPO.

As per company's red herring prospectus (RHP), the company had previously raised Rs 100 crore in a pre-IPO placement in March with Malabar India Fund, White Oak, Kotak Infina, Axis AMC, Mirae Asset, Sundaram Mutual Fund, IIFL and ICICI Lombard General Insurance.";"{'body': [{'indices': [[2171, 2179]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nutrition'},
           'score': 0.9946185350418091,
           'text': 'nutrition',
           'types': ['MusicGenre', 'Science', 'Work', 'Product']},
          {'indices': [[3363, 3367]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Race_and_ethnicity_in_the_United_States_Census'},
           'score': 0.9985753893852234,
           'text': 'White',
           'types': ['Disease', 'Items']},
          {'indices': [[2488, 2492]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Chari_River'},
           'score': 1.0,
           'text': 'Chari',
           'types': ['River']},
          {'indices': [[1938, 1947]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Net_profit'},
           'score': 0.9606010913848877,
           'text': 'net profit',
           'types': ['Software', 'Product', 'Measure']},
          {'indices': [[71, 90]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'initial public offer',
           'types': ['Work', 'Product', 'Offering']},
          {'indices': [[630, 632],
                       [813, 815],
                       [1125, 1127],
                       [2655, 2657],
                       [3206, 3208],
                       [3315, 3317]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Work', 'Product', 'Offering', 'Organisation']},
          {'indices': [[3110, 3132]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Institutional_investor'},
           'score': 1.0,
           'text': 'institutional investors',
           'types': ['Term']},
          {'indices': [[591, 596]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fixed_exchange-rate_system'},
           'score': 0.994091808795929,
           'text': 'pegged',
           'types': ['Country', 'Regime']},
          {'indices': [[1621, 1631]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Surfactant'},
           'score': 1.0,
           'text': 'Surfactants',
           'types': ['Compounds', 'ChemicalCompound']},
          {'indices': [[13, 32]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 1.0,
           'text': 'speciality chemicals',
           'types': ['Products', 'Company']},
          {'indices': [[2080, 2098]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 0.9915829300880432,
           'text': 'specialty chemicals',
           'types': ['Products', 'Company']},
          {'indices': [[963, 972]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Realis_mood'},
           'score': 0.9567005634307861,
           'text': 'indicative',
           'types': ['Software', 'Product', 'Mood']},
          {'indices': [[1048, 1051], [2831, 2834], [3388, 3391]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_powers'},
           'score': 0.9970167875289917,
           'text': 'Axis',
           'types': ['Nations',
                     'Country',
                     'PopulatedPlace',
                     'Location',
                     'Place',
                     'EthnicGroup']},
          {'indices': [[2201, 2208]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/The_Firm_(1993_film)'},
           'score': 0.3081560432910919,
           'text': 'The firm',
           'types': ['Film', 'Product', 'Wikidata:Q11424', 'Work']},
          {'indices': [[1728, 1732], [2964, 2968], [3351, 3355]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9988319873809814,
           'text': 'India',
           'types': ['Country',
                     'PopulatedPlace',
                     'MusicalArtist',
                     'Location',
                     'Place']},
          {'indices': [[1780, 1786]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Vietnam'},
           'score': 0.9721004962921143,
           'text': 'Vietnam',
           'types': ['Country',
                     'PopulatedPlace',
                     'MusicalArtist',
                     'Location',
                     'Place']},
          {'indices': [[3343, 3349]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Malabar_region'},
           'score': 0.7337419986724854,
           'text': 'Malabar',
           'types': ['Area',
                     'PopulatedPlace',
                     'AdministrativeRegion',
                     'Settlement',
                     'Location',
                     'Place',
                     'Region']},
          {'indices': [[667, 679], [763, 775]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Common_stock'},
           'score': 1.0,
           'text': 'equity shares',
           'types': ['Form']},
          {'indices': [[2950, 2962]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Goldman_Sachs'},
           'score': 0.9999630451202393,
           'text': 'Goldman Sachs',
           'types': ['Agent', 'Bank', 'Company', 'Organisation']},
          {'indices': [[619, 623],
                       [705, 709],
                       [1901, 1905],
                       [1928, 1932],
                       [1971, 1975],
                       [2723, 2727],
                       [3029, 3033],
                       [3300, 3304]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[1908, 1913], [2314, 2319]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Earnings_before_interest,_taxes,_depreciation,_and_amortization'},
           'score': 1.0,
           'text': 'EBITDA',
           'types': ['Software', 'Product', 'Measure', 'Organisation']},
          {'indices': [[2781, 2810]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Abu_Dhabi_Investment_Authority'},
           'score': 1.0,
           'text': 'Abu Dhabi Investment Authority',
           'types': ['Fund', 'Agent', 'Company', 'Organisation']},
          {'indices': [[2072, 2078]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile'},
           'score': 0.9939629435539246,
           'text': 'textile',
           'types': ['MusicGenre', 'Material', 'ChemicalCompound']},
          {'indices': [[2570, 2574]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Stake_(Latter_Day_Saints)'},
           'score': 0.6728987693786621,
           'text': 'stake',
           'types': ['Organisation', 'Unit']},
          {'indices': [[1065, 1069], [2849, 2853], [3442, 3446]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/ICICI_Bank'},
           'score': 1.0,
           'text': 'ICICI',
           'types': ['Agent', 'Bank', 'Company', 'Banking', 'Organisation']},
          {'indices': [[2291, 2294], [2326, 2329], [2397, 2400]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Compound_annual_growth_rate'},
           'score': 1.0,
           'text': 'CAGR',
           'types': ['Business', 'Company', 'Person', 'Organisation']},
          {'indices': [[1804, 1812]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mauritius'},
           'score': 0.9988653063774109,
           'text': 'Mauritius',
           'types': ['Country',
                     'PopulatedPlace',
                     'Location',
                     'Place',
                     'Nation',
                     'Person']},
          {'indices': [[1789, 1798]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bangladesh'},
           'score': 0.9967702031135559,
           'text': 'Bangladesh',
           'types': ['Country', 'PopulatedPlace', 'Location', 'Place']},
          {'indices': [[3393, 3395]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
           'score': 0.6691171526908875,
           'text': 'AMC',
           'types': ['Agent',
                     'Broadcaster',
                     'TelevisionStation',
                     'Organisation',
                     'Cable']},
          {'indices': [[0, 5]],
           'links': None,
           'score': None,
           'text': 'Mumbai',
           'types': ['Place']},
          {'indices': [[329, 338]],
           'links': None,
           'score': None,
           'text': 'Issue date',
           'types': ['Place']},
          {'indices': [[431, 432],
                       [438, 439],
                       [489, 490],
                       [605, 606],
                       [612, 613],
                       [699, 700],
                       [1891, 1892],
                       [1918, 1919],
                       [1962, 1963],
                       [2716, 2717],
                       [3019, 3020],
                       [3137, 3138],
                       [3293, 3294]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place', 'Organisation']},
          {'indices': [[1962, 1969]],
           'links': None,
           'score': None,
           'text': 'Rs 65.25',
           'types': ['Place']},
          {'indices': [[2445, 2452]],
           'links': None,
           'score': None,
           'text': 'Promoter',
           'types': ['Place']},
          {'indices': [[3019, 3027]],
           'links': None,
           'score': None,
           'text': 'Rs 148.87',
           'types': ['Place']},
          {'indices': [[398, 402]],
           'links': None,
           'score': None,
           'text': 'Price',
           'types': ['Person']},
          {'indices': [[782, 788]],
           'links': None,
           'score': None,
           'text': 'Purpose',
           'types': ['Person']},
          {'indices': [[950, 954]],
           'links': None,
           'score': None,
           'text': 'Based',
           'types': ['Person']},
          {'indices': [[39, 53], [1217, 1231], [1847, 1861], [2671, 2685]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech',
           'types': ['Person', 'Organisation']},
          {'indices': [[1717, 1721]],
           'links': None,
           'score': None,
           'text': 'Apart',
           'types': ['Person']},
          {'indices': [[2463, 2476]],
           'links': None,
           'score': None,
           'text': 'Edward Menezes',
           'types': ['Person']},
          {'indices': [[2651, 2657]],
           'links': None,
           'score': None,
           'text': 'Pre-IPO',
           'types': ['Person']},
          {'indices': [[3388, 3395]],
           'links': None,
           'score': None,
           'text': 'Axis AMC',
           'types': ['Person']},
          {'indices': [[3398, 3408]],
           'links': None,
           'score': None,
           'text': 'Mirae Asset',
           'types': ['Person']},
          {'indices': [[177, 204]],
           'links': None,
           'score': None,
           'text': 'SBI Cards & Payment Services',
           'types': ['Organisation']},
          {'indices': [[489, 492]],
           'links': None,
           'score': None,
           'text': 'Rs 2',
           'types': ['Organisation']},
          {'indices': [[329, 333], [561, 565]],
           'links': None,
           'score': None,
           'text': 'Issue',
           'types': ['Organisation']},
          {'indices': [[936, 947]],
           'links': None,
           'score': None,
           'text': 'Listing date',
           'types': ['Organisation']},
          {'indices': [[1048, 1059]],
           'links': None,
           'score': None,
           'text': 'Axis Capital',
           'types': ['Organisation']},
          {'indices': [[1065, 1080]],
           'links': None,
           'score': None,
           'text': 'ICICI Securities',
           'types': ['Organisation']},
          {'indices': [[1513, 1515]],
           'links': None,
           'score': None,
           'text': 'HUL',
           'types': ['Organisation']},
          {'indices': [[1518, 1544]],
           'links': None,
           'score': None,
           'text': 'IFB Industries & Arvind Ltd',
           'types': ['Organisation']},
          {'indices': [[1596, 1611]],
           'links': None,
           'score': None,
           'text': 'Aarti Industries',
           'types': ['Organisation']},
          {'indices': [[1614, 1631]],
           'links': None,
           'score': None,
           'text': 'Galaxy Surfactants',
           'types': ['Organisation']},
          {'indices': [[1634, 1641]],
           'links': None,
           'score': None,
           'text': 'Atul Ltd',
           'types': ['Organisation']},
          {'indices': [[1644, 1685]],
           'links': None,
           'score': None,
           'text': 'Vinati Organics & Fine Organics Industries',
           'types': ['Organisation']},
          {'indices': [[1819, 1828]],
           'links': None,
           'score': None,
           'text': 'Financials',
           'types': ['Organisation']},
          {'indices': [[2004, 2007]],
           'links': None,
           'score': None,
           'text': 'HPPC',
           'types': ['Organisation']},
          {'indices': [[2813, 2828]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2831, 2846]],
           'links': None,
           'score': None,
           'text': 'Axis Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2849, 2876]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2879, 2893]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2896, 2915], [3411, 3430]],
           'links': None,
           'score': None,
           'text': 'Sundaram Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2918, 2944]],
           'links': None,
           'score': None,
           'text': 'HDFC Life Insurance Company',
           'types': ['Organisation']},
          {'indices': [[2950, 2968]],
           'links': None,
           'score': None,
           'text': 'Goldman Sachs India',
           'types': ['Organisation']},
          {'indices': [[3343, 3360]],
           'links': None,
           'score': None,
           'text': 'Malabar India Fund',
           'types': ['Organisation']},
          {'indices': [[3433, 3436]],
           'links': None,
           'score': None,
           'text': 'IIFL',
           'types': ['Organisation']},
          {'indices': [[3442, 3472]],
           'links': None,
           'score': None,
           'text': 'ICICI Lombard General Insurance',
           'types': ['Organisation']}],
 'title': [{'indices': [[31, 33]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
            'score': 1.0,
            'text': 'IPO',
            'types': ['Offering', 'Work', 'Product']},
           {'indices': [[0, 14]],
            'links': None,
            'score': None,
            'text': 'Rossari Biotech',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.44999998807907104,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.20999999344348907,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.07999999821186066,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.815905},
 'title': {'polarity': 'neutral', 'score': 0.646079}}"
2020-07-10  23:10;Rossari Biotech garners Rs 149 crore from anchor investors ahead of IPO;"Specialty chemicals manufacturer Rossari Biotech on Friday said it has raised Rs 149 crore from anchor investors ahead of its initial share-sale that opens on Monday. The anchor investors include Abu Dhabi Investment Authority, HDFC Mutual Fund, Axis Mutual Fund, ICICI Prudential Mutual Fund, SBI Mutual Fund, Sundaram Mutual Fund, HDFC Life Insurance Company and Goldman Sachs India.

In a statement, the company said it has raised Rs 148.87 crore in anchor allotment and has finalised allocation of 35,02,940 shares to 15 institutional investors at Rs 425 per share, which is the upper limit of the price band for the IPO.

The company has fixed a price band of Rs 423-425 per equity share for its initial public offer (IPO) which will be open for public subscription from July 13-15.

Rossari Biotech's initial share-sale will end four months of inactivity in the IPO markets. SBI Cards & Payment Services was the last company to float IPO in March.

Rossari Biotech's IPO comprises fresh issuance of shares worth Rs 50 crore and sale of 1,05,00,000 equity shares by company's promoters through offer-for-sale route.

At the upper end of price band, the IPO size is about Rs 496 crore.

The company has already raised Rs 100 crore in pre-IPO placement.

Net proceeds from the issue will be utilised for funding working capital requirements, repaying certain debt availed by the company and for general corporate purposes.

Axis Capital and ICICI Securities are the merchant bankers for the share-sale. The equity shares will be listed on the NSE and BSE.

The company, which filed its draft papers with Sebi in December 2019, received clearance from the regulator in February to launch the IPO.

Rossari Biotech is a specialty chemicals manufacturing firm with focus on home and personal care, performance chemicals, textile specialty chemicals and animal health and nutrition products.

Apart from India, it has operations in 17 countries, including Vietnam, Bangladesh and Mauritius.";"{'body': [{'indices': [[1871, 1879]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nutrition'},
           'score': 0.9949631094932556,
           'text': 'nutrition',
           'types': ['MusicGenre', 'Science', 'Work', 'Product']},
          {'indices': [[621, 623],
                       [723, 725],
                       [868, 870],
                       [940, 942],
                       [973, 975],
                       [1158, 1160],
                       [1242, 1244],
                       [1694, 1696]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Offering', 'Work', 'Product', 'Organisation']},
          {'indices': [[701, 720]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'initial public offer',
           'types': ['Offering', 'Work', 'Product']},
          {'indices': [[525, 547]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Institutional_investor'},
           'score': 1.0,
           'text': 'institutional investors',
           'types': ['Term']},
          {'indices': [[0, 18]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 1.0,
           'text': 'Specialty chemicals',
           'types': ['Company', 'Products']},
          {'indices': [[1721, 1739], [1829, 1847]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 0.9929224848747253,
           'text': 'specialty chemicals',
           'types': ['Company', 'Products']},
          {'indices': [[1798, 1818]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 1.0,
           'text': 'performance chemicals',
           'types': ['Company', 'Products']},
          {'indices': [[680, 685], [1054, 1059], [1510, 1515]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.6092248558998108,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[246, 249], [1427, 1430]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_powers'},
           'score': 0.997078537940979,
           'text': 'Axis',
           'types': ['Nations',
                     'Location',
                     'Place',
                     'Country',
                     'PopulatedPlace',
                     'EthnicGroup']},
          {'indices': [[379, 383], [1903, 1907]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9989765286445618,
           'text': 'India',
           'types': ['Location',
                     'Place',
                     'Country',
                     'MusicalArtist',
                     'PopulatedPlace']},
          {'indices': [[1955, 1961]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Vietnam'},
           'score': 0.9719151854515076,
           'text': 'Vietnam',
           'types': ['Location',
                     'Place',
                     'Country',
                     'MusicalArtist',
                     'PopulatedPlace']},
          {'indices': [[1054, 1066], [1510, 1522]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Common_stock'},
           'score': 1.0,
           'text': 'equity shares',
           'types': ['Form']},
          {'indices': [[365, 377]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Goldman_Sachs'},
           'score': 0.999963104724884,
           'text': 'Goldman Sachs',
           'types': ['Bank', 'Agent', 'Organisation', 'Company']},
          {'indices': [[1554, 1556]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bombay_Stock_Exchange'},
           'score': 0.38871797919273376,
           'text': 'BSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[85, 89],
                       [444, 448],
                       [1024, 1028],
                       [1183, 1187],
                       [1229, 1233]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[1783, 1795]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Personal_care'},
           'score': 0.9789260625839233,
           'text': 'personal care',
           'types': ['Company', 'Industry']},
          {'indices': [[196, 225]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Abu_Dhabi_Investment_Authority'},
           'score': 1.0,
           'text': 'Abu Dhabi Investment Authority',
           'types': ['Agent', 'Organisation', 'Fund', 'Company']},
          {'indices': [[1821, 1827]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile'},
           'score': 0.9944132566452026,
           'text': 'textile',
           'types': ['ChemicalCompound', 'MusicGenre', 'Material']},
          {'indices': [[264, 268], [1444, 1448]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/ICICI_Bank'},
           'score': 1.0,
           'text': 'ICICI',
           'types': ['Bank', 'Agent', 'Banking', 'Organisation', 'Company']},
          {'indices': [[1546, 1548]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.742631196975708,
           'text': 'NSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[1979, 1987]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mauritius'},
           'score': 0.9990590214729309,
           'text': 'Mauritius',
           'types': ['Location',
                     'Place',
                     'Country',
                     'PopulatedPlace',
                     'Nation',
                     'Person']},
          {'indices': [[1964, 1973]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bangladesh'},
           'score': 0.9971117377281189,
           'text': 'Bangladesh',
           'types': ['Location', 'Place', 'Country', 'PopulatedPlace']},
          {'indices': [[434, 442]],
           'links': None,
           'score': None,
           'text': 'Rs 148.87',
           'types': ['Place']},
          {'indices': [[33, 47], [789, 803], [955, 969], [1700, 1714]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech',
           'types': ['Person']},
          {'indices': [[1892, 1896]],
           'links': None,
           'score': None,
           'text': 'Apart',
           'types': ['Person']},
          {'indices': [[0, 8]],
           'links': None,
           'score': None,
           'text': 'Specialty',
           'types': ['Organisation']},
          {'indices': [[228, 243]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[246, 261]],
           'links': None,
           'score': None,
           'text': 'Axis Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[264, 291]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[294, 308]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[311, 330]],
           'links': None,
           'score': None,
           'text': 'Sundaram Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[333, 359]],
           'links': None,
           'score': None,
           'text': 'HDFC Life Insurance Company',
           'types': ['Organisation']},
          {'indices': [[365, 383]],
           'links': None,
           'score': None,
           'text': 'Goldman Sachs India',
           'types': ['Organisation']},
          {'indices': [[78, 79],
                       [434, 435],
                       [552, 553],
                       [665, 666],
                       [1018, 1019],
                       [1176, 1177],
                       [1222, 1223]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Organisation']},
          {'indices': [[881, 908]],
           'links': None,
           'score': None,
           'text': 'SBI Cards & Payment Services',
           'types': ['Organisation']},
          {'indices': [[1018, 1022]],
           'links': None,
           'score': None,
           'text': 'Rs 50',
           'types': ['Organisation']},
          {'indices': [[1427, 1438]],
           'links': None,
           'score': None,
           'text': 'Axis Capital',
           'types': ['Organisation']},
          {'indices': [[1444, 1459]],
           'links': None,
           'score': None,
           'text': 'ICICI Securities',
           'types': ['Organisation']}],
 'title': [{'indices': [[68, 70]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
            'score': 1.0,
            'text': 'IPO',
            'types': ['Offering', 'Work', 'Product']},
           {'indices': [[24, 29]],
            'links': None,
            'score': None,
            'text': 'Rs 149',
            'types': ['Place']},
           {'indices': [[0, 14]],
            'links': None,
            'score': None,
            'text': 'Rossari Biotech',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.4000000059604645,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.18000000715255737,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.03999999910593033,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.823978},
 'title': {'polarity': 'neutral', 'score': 0.7897}}"
2020-07-10  21:53;Rossari Biotech raises Rs 148.87 cr from anchor investors top 3 MFs key investors;Mumbai: Specialty chemicals maker Rossari Biotech said on Friday it has raised Rs 148.87 crore from anchor investors, and the top three fund houses of the country – SBI Mutual Fund, HDFC Mutual Fund and ICICI Mutual Fund – were among the top investors. The three fund houses – SBI Mutual Fund, HDFC Mutual Fund and ICICI Mutual Fund, invested Rs 14 crore each in their various schemes. Apart from these, Ashoka India Opportunities Fund and Nippon India Small Cap Fund also invested Rs 14 crore each in the company. Other investors included Abu Dhabi Investment Authority, Axis Mutual Fund, Goldman Sachs India, HDFC Life Insurance Co, HSBC Global Investment Funds, IIFL Special Opportunities Fund - Series 4, Kotak Mahindra (International) , Malabar India Fund, Mirae Mutual Fund and Sundaram Mutual Fund. 76896603 Rossari Biotech intends to raise Rs 496.24 crore via the fresh issue of Rs 50 crore and offer for sale (OFS) of Rs 446.25 crore. The price band for the IPO has been set at Rs 423-425 a piece. The issue will open on July 13. The net proceeds from the fresh issue to prepay or repay certain indebtedness, including accrued interest, fund working capital requirements and for general corporate purposes, the company said. Axis Capital and ICICI Securities are the book running lead managers to the offer and Axcelus Finserv Private is the advisor to the offer.;"{'body': [{'indices': [[635, 638]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/HSBC'},
           'score': 0.9950991868972778,
           'text': 'HSBC',
           'types': ['Agent', 'Company', 'Organisation', 'Bank', 'Banking']},
          {'indices': [[967, 969]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Work', 'Product', 'Offering', 'Organisation']},
          {'indices': [[1128, 1143]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Accrued_interest'},
           'score': 1.0,
           'text': 'accrued interest',
           'types': ['Interest', 'Magazine', 'Product']},
          {'indices': [[8, 26]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 1.0,
           'text': 'Specialty chemicals',
           'types': ['Company', 'Products']},
          {'indices': [[572, 575], [1234, 1237]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_powers'},
           'score': 0.9965508580207825,
           'text': 'Axis',
           'types': ['PopulatedPlace',
                     'EthnicGroup',
                     'Location',
                     'Country',
                     'Place',
                     'Nations']},
          {'indices': [[709, 722]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Kotak_Mahindra_Bank'},
           'score': 1.0,
           'text': 'Kotak Mahindra',
           'types': ['Agent', 'Company', 'Organisation', 'Bank', 'Banking']},
          {'indices': [[411, 415], [447, 451], [604, 608], [750, 754]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9986361861228943,
           'text': 'India',
           'types': ['PopulatedPlace',
                     'Country',
                     'MusicalArtist',
                     'Place',
                     'Location']},
          {'indices': [[0, 5]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mumbai'},
           'score': 0.9951327443122864,
           'text': 'Mumbai',
           'types': ['PopulatedPlace',
                     'City',
                     'Settlement',
                     'Location',
                     'Place']},
          {'indices': [[742, 748]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Malabar_region'},
           'score': 0.7367748022079468,
           'text': 'Malabar',
           'types': ['Area',
                     'PopulatedPlace',
                     'Settlement',
                     'Region',
                     'AdministrativeRegion',
                     'Location',
                     'Place']},
          {'indices': [[590, 602]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Goldman_Sachs'},
           'score': 0.9999667406082153,
           'text': 'Goldman Sachs',
           'types': ['Agent', 'Company', 'Bank', 'Organisation']},
          {'indices': [[1039, 1045]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/The_Net_(1995_film)'},
           'score': 0.765802264213562,
           'text': 'The net',
           'types': ['Film', 'Product', 'Wikidata:Q11424', 'Work']},
          {'indices': [[89, 93],
                       [349, 353],
                       [488, 492],
                       [858, 862],
                       [893, 897],
                       [937, 941]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[540, 569]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Abu_Dhabi_Investment_Authority'},
           'score': 1.0,
           'text': 'Abu Dhabi Investment Authority',
           'types': ['Agent', 'Company', 'Fund', 'Organisation']},
          {'indices': [[203, 207], [315, 319], [1251, 1255]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/ICICI_Bank'},
           'score': 1.0,
           'text': 'ICICI',
           'types': ['Agent', 'Company', 'Organisation', 'Bank', 'Banking']},
          {'indices': [[404, 409]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ashoka'},
           'score': 0.9984495043754578,
           'text': 'Ashoka',
           'types': ['Agent', 'Royalty', 'Person', 'Emperor']},
          {'indices': [[79, 87]],
           'links': None,
           'score': None,
           'text': 'Rs 148.87',
           'types': ['Place']},
          {'indices': [[34, 48], [815, 829]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech',
           'types': ['Person', 'Organisation']},
          {'indices': [[1320, 1342]],
           'links': None,
           'score': None,
           'text': 'Axcelus Finserv Private',
           'types': ['Person']},
          {'indices': [[8, 16]],
           'links': None,
           'score': None,
           'text': 'Specialty',
           'types': ['Organisation']},
          {'indices': [[165, 179], [277, 291]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[182, 197], [294, 309]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[203, 219], [315, 331]],
           'links': None,
           'score': None,
           'text': 'ICICI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[343, 347], [482, 486]],
           'links': None,
           'score': None,
           'text': 'Rs 14',
           'types': ['Organisation']},
          {'indices': [[404, 434]],
           'links': None,
           'score': None,
           'text': 'Ashoka India Opportunities Fund',
           'types': ['Organisation']},
          {'indices': [[440, 466]],
           'links': None,
           'score': None,
           'text': 'Nippon India Small Cap Fund',
           'types': ['Organisation']},
          {'indices': [[79, 80],
                       [343, 344],
                       [482, 483],
                       [848, 849],
                       [887, 888],
                       [927, 928],
                       [987, 988]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Organisation']},
          {'indices': [[572, 587]],
           'links': None,
           'score': None,
           'text': 'Axis Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[590, 608]],
           'links': None,
           'score': None,
           'text': 'Goldman Sachs India',
           'types': ['Organisation']},
          {'indices': [[611, 632]],
           'links': None,
           'score': None,
           'text': 'HDFC Life Insurance Co',
           'types': ['Organisation']},
          {'indices': [[665, 695]],
           'links': None,
           'score': None,
           'text': 'IIFL Special Opportunities Fund',
           'types': ['Organisation']},
          {'indices': [[709, 737]],
           'links': None,
           'score': None,
           'text': 'Kotak Mahindra (International',
           'types': ['Organisation']},
          {'indices': [[742, 759]],
           'links': None,
           'score': None,
           'text': 'Malabar India Fund',
           'types': ['Organisation']},
          {'indices': [[762, 778]],
           'links': None,
           'score': None,
           'text': 'Mirae Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[784, 803]],
           'links': None,
           'score': None,
           'text': 'Sundaram Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[919, 921]],
           'links': None,
           'score': None,
           'text': 'OFS',
           'types': ['Organisation']},
          {'indices': [[1234, 1245]],
           'links': None,
           'score': None,
           'text': 'Axis Capital',
           'types': ['Organisation']},
          {'indices': [[1251, 1266]],
           'links': None,
           'score': None,
           'text': 'ICICI Securities',
           'types': ['Organisation']}],
 'title': [{'indices': [[23, 31]],
            'links': None,
            'score': None,
            'text': 'Rs 148.87',
            'types': ['Place']},
           {'indices': [[0, 14]],
            'links': None,
            'score': None,
            'text': 'Rossari Biotech',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.4699999988079071,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.3799999952316284,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.07999999821186066,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'neutral', 'score': 0.485285},
 'title': {'polarity': 'neutral', 'score': 0.795638}}"
2020-07-10  19:50;ADIA, Sumeet Nagar’s hedge fund among anchor investors in Rossari Biotech’s IPO;"Speciality chemicals maker Rossari Biotech Ltd has raised Rs 148.87 crore ($19.8 million) from a bunch of anchor investors including Abu Dhabi’s sovereign wealth fund and existing investor Malabar Investments.

Rossari allotted a little over 3.5 million shares at the upper end of the Rs 423-425 apiece price band to 15 investors, India’s largest manufacturer of textile specialty chemicals informed stock exchanges on Friday.

Abu Dhabi Investment Authority (ADIA) and Kotak Mahindra (International) Ltd each bought Rossari shares worth Rs 8.3 crore. Malabar India Fund bought shares worth Rs 14 crore.

Indian asset managers that subscribed to Rossari shares are HDFC Mutual Fund, SBI Mutual Fund, ICICI Prudential Fund, Mirae Asset Mutual Fund and Sundaram Mutual Fund.

HDFC Life Insurance Company was the sole insurer in the list of investors.

Anchor investors, also known as cornerstone investors, are institutions that accept a one-month lock-in for a sizeable allocation of shares. Their participation highlights investors’ confidence in an IPO and sets a benchmark for the investor community at large.

A little more than four months ago, Rossari had raised Rs 100 crore in a pre-IPO round by allotting shares to eight institutional investors including PE and hedge funds.

With the pre-IPO transaction, Rossari had managed to raise two-thirds of the fresh money it was otherwise aiming to mop up via the IPO when it filed its draft prospectus in December 2019.

At the time of filing, the IPO’s size was estimated at Rs 700 crore. Now, the IPO size stands at Rs 496.25 – excluding the pre-IPO round – at the upper end of the price band announced.

The company is now seeking a valuation of Rs 2,206 at the upper end of the price band as compared with an estimated Rs 2,681 crore it had sought at the time of its IPO filing seven months ago.

Rossari Biotech denied it had cut its valuation. “We… have not trimmed our valuations. In February 2020 we did our pre-IPO placement… at Rs 425 per share and even now our IPO is priced at Rs 425 per share,” the company said.

However, the company didn't clarify on its December 2019 estimated valuation.

The IPO comprises a sale of 5.25 million shares each by promoters Edward Menezes and Sunil Chari worth Rs 446 crore. The company also aims to raise Rs 50 crore in fresh capital. Rossari will use the fresh capital and the pre-IPO money to repay debt, fund working capital requirements and meet general corporate expenses.

A successful IPO will see Rossari join listed peers such as Aarti Industries Ltd, Vinati Organics Ltd, Atul Ltd as well as Galaxy Surfactants Ltd and Fine Organics Industries Ltd, both of which went public in 2018.

Axis Capital and ICICI Securities are merchant bankers arranging the share sale. Axcelus Finserv Pvt. Ltd is the adviser to the overall offer.

Rossari was originally incorporated as a partnership firm, Rossari Labtech, in March 2003. It makes specialty chemicals used as raw material in the FMCG, apparel, poultry and animal feed industries.

The company reported consolidated net profit of Rs 65.25 crore for the year ended March 2020 on operating revenue of Rs 603.81 crore. Its 2018-19 consolidated net profit was Rs 45.68 crore on revenue of Rs 517.12 crore.";"{'body': [{'indices': [[145, 165]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Sovereign_wealth_fund'},
           'score': 0.9977667331695557,
           'text': 'sovereign wealth fund',
           'types': ['Company', 'Fund']},
          {'indices': [[1443, 1452]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Prospectus_(finance)'},
           'score': 0.9938062429428101,
           'text': 'prospectus',
           'types': ['Document', 'Book', 'Product']},
          {'indices': [[2249, 2253]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Chari_River'},
           'score': 1.0,
           'text': 'Chari',
           'types': ['River']},
          {'indices': [[3074, 3083], [3199, 3208]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Net_profit'},
           'score': 0.9580627679824829,
           'text': 'net profit',
           'types': ['Measure', 'Software', 'Product']},
          {'indices': [[1050, 1052],
                       [1190, 1192],
                       [1297, 1299],
                       [1415, 1417],
                       [1500, 1502],
                       [1551, 1553],
                       [1600, 1602],
                       [1823, 1825],
                       [1972, 1974],
                       [2024, 2026],
                       [2162, 2164],
                       [2383, 2385],
                       [2493, 2495]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
           'score': 1.0,
           'text': 'IPO',
           'types': ['Work', 'Product', 'Offering', 'Organisation']},
          {'indices': [[1229, 1251]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Institutional_investor'},
           'score': 1.0,
           'text': 'institutional investors',
           'types': ['Term']},
          {'indices': [[2610, 2620]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Surfactant'},
           'score': 1.0,
           'text': 'Surfactants',
           'types': ['ChemicalCompound', 'Compounds']},
          {'indices': [[0, 19]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 1.0,
           'text': 'Speciality chemicals',
           'types': ['Company', 'Products']},
          {'indices': [[371, 389], [2940, 2958]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Speciality_chemicals'},
           'score': 0.9910469055175781,
           'text': 'specialty chemicals',
           'types': ['Company', 'Products']},
          {'indices': [[2696, 2699]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_powers'},
           'score': 0.9965142607688904,
           'text': 'Axis',
           'types': ['Country',
                     'Location',
                     'Place',
                     'Nations',
                     'EthnicGroup',
                     'PopulatedPlace']},
          {'indices': [[3003, 3009]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Poultry'},
           'score': 0.9926052689552307,
           'text': 'poultry',
           'types': ['Birds', 'Bird', 'PersonFunction']},
          {'indices': [[470, 483]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Kotak_Mahindra_Bank'},
           'score': 1.0,
           'text': 'Kotak Mahindra',
           'types': ['Bank',
                     'Agent',
                     'Banking',
                     'Organisation',
                     'Company',
                     'Person']},
          {'indices': [[331, 335], [560, 564]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9988735318183899,
           'text': 'India',
           'types': ['Country',
                     'Location',
                     'Place',
                     'PopulatedPlace',
                     'MusicalArtist']},
          {'indices': [[2988, 2991]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fast-moving_consumer_goods'},
           'score': 0.9664218425750732,
           'text': 'FMCG',
           'types': ['Company', 'Products', 'Organisation']},
          {'indices': [[706, 715]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Prudential_Financial'},
           'score': 0.6017587780952454,
           'text': 'Prudential',
           'types': ['Agent', 'Organisation', 'Company', 'Bank']},
          {'indices': [[189, 195], [552, 558]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Malabar_region'},
           'score': 0.7433087825775146,
           'text': 'Malabar',
           'types': ['Place',
                     'Settlement',
                     'AdministrativeRegion',
                     'Area',
                     'PopulatedPlace',
                     'Region',
                     'Location']},
          {'indices': [[612, 625]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asset_management'},
           'score': 0.9082177877426147,
           'text': 'asset managers',
           'types': ['MusicGenre']},
          {'indices': [[68, 72],
                       [545, 549],
                       [597, 601],
                       [1175, 1179],
                       [1535, 1539],
                       [1784, 1788],
                       [2268, 2272],
                       [2312, 2316],
                       [3097, 3101],
                       [3167, 3171],
                       [3223, 3227],
                       [3253, 3257]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Organisation', 'Unit']},
          {'indices': [[133, 141], [428, 436]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Abu_Dhabi'},
           'score': 0.9965289235115051,
           'text': 'Abu Dhabi',
           'types': ['City',
                     'Settlement',
                     'Place',
                     'PopulatedPlace',
                     'Capital',
                     'Location',
                     'Organisation']},
          {'indices': [[3015, 3025]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Animal_feed'},
           'score': 0.8736950159072876,
           'text': 'animal feed',
           'types': ['Food', 'Product']},
          {'indices': [[1270, 1280]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Hedge_fund'},
           'score': 0.9984038472175598,
           'text': 'hedge funds',
           'types': ['PersonFunction', 'Company', 'Fund']},
          {'indices': [],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Abu_Dhabi_Investment_Authority'},
           'score': 1.0,
           'text': 'Abu Dhabi Investment Authority (ADIA)',
           'types': ['Fund', 'Agent', 'Organisation', 'Company']},
          {'indices': [[363, 369]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Textile'},
           'score': 0.9943497776985168,
           'text': 'textile',
           'types': ['MusicGenre', 'ChemicalCompound', 'Material']},
          {'indices': [[700, 704], [2713, 2717]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/ICICI_Bank'},
           'score': 1.0,
           'text': 'ICICI',
           'types': ['Bank', 'Agent', 'Banking', 'Organisation', 'Company']},
          {'indices': [[58, 66]],
           'links': None,
           'score': None,
           'text': 'Rs 148.87',
           'types': ['Place']},
          {'indices': [[591, 595]],
           'links': None,
           'score': None,
           'text': 'Rs 14',
           'types': ['Place']},
          {'indices': [[58, 59],
                       [285, 286],
                       [538, 539],
                       [591, 592],
                       [1168, 1169],
                       [1528, 1529],
                       [1570, 1571],
                       [1701, 1702],
                       [1775, 1776],
                       [1990, 1991],
                       [2041, 2042],
                       [2261, 2262],
                       [2306, 2307],
                       [3088, 3089],
                       [3157, 3158],
                       [3214, 3215],
                       [3243, 3244]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place', 'Organisation']},
          {'indices': [[3157, 3165]],
           'links': None,
           'score': None,
           'text': 'Rs 603.81',
           'types': ['Place']},
          {'indices': [[3214, 3221]],
           'links': None,
           'score': None,
           'text': 'Rs 45.68',
           'types': ['Place']},
          {'indices': [[189, 207]],
           'links': None,
           'score': None,
           'text': 'Malabar Investments',
           'types': ['Person']},
          {'indices': [[27, 33],
                       [211, 217],
                       [517, 523],
                       [646, 652],
                       [1149, 1155],
                       [1314, 1320],
                       [1853, 1859],
                       [2336, 2342],
                       [2506, 2512],
                       [2840, 2846],
                       [2899, 2905]],
           'links': None,
           'score': None,
           'text': 'Rossari',
           'types': ['Person', 'Organisation']},
          {'indices': [[27, 41], [1853, 1867]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech',
           'types': ['Person']},
          {'indices': [[2785, 2795]],
           'links': None,
           'score': None,
           'text': 'Finserv Pvt',
           'types': ['Person']},
          {'indices': [[2899, 2913]],
           'links': None,
           'score': None,
           'text': 'Rossari Labtech',
           'types': ['Person']},
          {'indices': [[27, 45]],
           'links': None,
           'score': None,
           'text': 'Rossari Biotech Ltd',
           'types': ['Organisation']},
          {'indices': [[428, 457]],
           'links': None,
           'score': None,
           'text': 'Abu Dhabi Investment Authority',
           'types': ['Organisation']},
          {'indices': [[460, 463]],
           'links': None,
           'score': None,
           'text': 'ADIA',
           'types': ['Organisation']},
          {'indices': [[486, 503]],
           'links': None,
           'score': None,
           'text': 'International) Ltd',
           'types': ['Organisation']},
          {'indices': [[552, 569]],
           'links': None,
           'score': None,
           'text': 'Malabar India Fund',
           'types': ['Organisation']},
          {'indices': [[665, 680]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[683, 697]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[700, 720]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Fund',
           'types': ['Organisation']},
          {'indices': [[723, 745]],
           'links': None,
           'score': None,
           'text': 'Mirae Asset Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[751, 770]],
           'links': None,
           'score': None,
           'text': 'Sundaram Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[774, 800]],
           'links': None,
           'score': None,
           'text': 'HDFC Life Insurance Company',
           'types': ['Organisation']},
          {'indices': [[850, 855]],
           'links': None,
           'score': None,
           'text': 'Anchor',
           'types': ['Organisation']},
          {'indices': [[1263, 1264]],
           'links': None,
           'score': None,
           'text': 'PE',
           'types': ['Organisation']},
          {'indices': [[2224, 2253]],
           'links': None,
           'score': None,
           'text': 'Edward Menezes and Sunil Chari',
           'types': ['Organisation']},
          {'indices': [[2540, 2559]],
           'links': None,
           'score': None,
           'text': 'Aarti Industries Ltd',
           'types': ['Organisation']},
          {'indices': [[2562, 2580]],
           'links': None,
           'score': None,
           'text': 'Vinati Organics Ltd',
           'types': ['Organisation']},
          {'indices': [[2583, 2590]],
           'links': None,
           'score': None,
           'text': 'Atul Ltd',
           'types': ['Organisation']},
          {'indices': [[2603, 2624]],
           'links': None,
           'score': None,
           'text': 'Galaxy Surfactants Ltd',
           'types': ['Organisation']},
          {'indices': [[2630, 2657]],
           'links': None,
           'score': None,
           'text': 'Fine Organics Industries Ltd',
           'types': ['Organisation']},
          {'indices': [[2696, 2707]],
           'links': None,
           'score': None,
           'text': 'Axis Capital',
           'types': ['Organisation']},
          {'indices': [[2713, 2728]],
           'links': None,
           'score': None,
           'text': 'ICICI Securities',
           'types': ['Organisation']}],
 'title': [{'indices': [[76, 78]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Initial_public_offering'},
            'score': 1.0,
            'text': 'IPO',
            'types': ['Work', 'Product', 'Offering']},
           {'indices': [[21, 30]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Hedge_fund'},
            'score': 1.0,
            'text': 'hedge fund',
            'types': ['PersonFunction', 'Company', 'Fund']},
           {'indices': [[0, 3]],
            'links': None,
            'score': None,
            'text': 'ADIA',
            'types': ['Organisation']},
           {'indices': [[58, 72]],
            'links': None,
            'score': None,
            'text': 'Rossari Biotech',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.4300000071525574,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.20999999344348907,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04019000',
 'label': 'finance (general)',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04019000',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04000000'},
 'score': 0.03999999910593033,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.807199},
 'title': {'polarity': 'neutral', 'score': 0.794207}}"
2020-07-09  21:27;Schroder Asian Growth Fund offloads Arvind Fashions RE shares, HDFC MF sells stake in Tejas Networks;"HDFC Mutual Fund through its HDFC Growth Fund on July 9 has offloaded 1.32 percent equity stake in Tejas Networks through open market transactions.

HDFC Growth Fund sold 12,19,691 equity shares in Tejas at Rs 51.8 per share, bulk deals data on the National Stock Exchange showed.

Tejas Networks was locked in a 5 percent upper circuit at Rs 51.80 on July 9, especially after Kedia Securities acquired 0.81 percent stake in Tejas in the previous session.

Schroder Asian Growth Fund sold 3,21,371 Rights Entitlement shares of Arvind Fashions at Rs 55.89 per share.

Tejas Tradefin bought 15 lakh shares in Reliance Capital at Rs 10.7 per share.

Among other deals, Marfatia Nishil Surendra sold 18,24,283 shares in Bil Energy Systems at Rs 1.1 per share.

Paramount Trading bought 96,000 shares in Globe Textiles at Rs 47.5 per share.

UMW India Ventures sold 3,52,283 shares in Oil Country Tubular at Rs 4.85 per share.

Dilipkumar Vishindas Lakhi acquired 60,719 shares in Premier Explosives at Rs 132.7 per share.

Adesh Ventures offloaded 1,11,389 shares in Trejhara Solutions at Rs 1,1.65 per share and Vishwakarma Trading House bought 90,000 shares in United Polyfab Gujarat at Rs 9.25 per share.";"{'body': [{'indices': [[466, 470]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Race_and_ethnicity_in_the_United_States_Census'},
           'score': 0.997893214225769,
           'text': 'Asian',
           'types': ['Disease', 'Items']},
          {'indices': [[1109, 1119]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Vishvakarman'},
           'score': 0.9955974221229553,
           'text': 'Vishwakarma',
           'types': ['Personification', 'MythologicalFigure']},
          {'indices': [[83, 88], [181, 186]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.4908944070339203,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[1121, 1133]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Joint-stock_company'},
           'score': 1.0,
           'text': 'Trading House',
           'types': ['Company', 'Organisation', 'Entity']},
          {'indices': [[841, 845]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9990367293357849,
           'text': 'India',
           'types': ['Location',
                     'PopulatedPlace',
                     'Place',
                     'MusicalArtist',
                     'Country']},
          {'indices': [[181, 193]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Common_stock'},
           'score': 1.0,
           'text': 'equity shares',
           'types': ['Form']},
          {'indices': [[592, 595]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Unit', 'Organisation']},
          {'indices': [[1174, 1180]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Gujarat'},
           'score': 0.9995927214622498,
           'text': 'Gujarat',
           'types': ['Location',
                     'State',
                     'PopulatedPlace',
                     'Settlement',
                     'Place']},
          {'indices': [[757, 765]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Paramount_Pictures'},
           'score': 0.9843621253967285,
           'text': 'Paramount',
           'types': ['Studio', 'Agent', 'Company', 'Organisation']},
          {'indices': [[457, 464]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Dennis_Schröder'},
           'score': 1.0,
           'text': 'Schroder',
           'types': ['BasketballPlayer',
                     'Agent',
                     'Player',
                     'Athlete',
                     'Person']},
          {'indices': [[99, 103],
                       [198, 202],
                       [282, 286],
                       [425, 429],
                       [567, 571]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Texas'},
           'score': 0.950516939163208,
           'text': 'Tejas',
           'types': ['Location',
                     'Region',
                     'State',
                     'PopulatedPlace',
                     'AdministrativeRegion',
                     'Place']},
          {'indices': [[90, 94], [416, 420]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Stake_(Latter_Day_Saints)'},
           'score': 0.6154926419258118,
           'text': 'stake',
           'types': ['Unit', 'Organisation']},
          {'indices': [[249, 271]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.9982823133468628,
           'text': 'National Stock Exchange',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[682, 689]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Indra'},
           'score': 0.9908931851387024,
           'text': 'Surendra',
           'types': ['Person', 'Leader']},
          {'indices': [[207, 208],
                       [340, 341],
                       [546, 547],
                       [627, 628],
                       [738, 739],
                       [817, 818],
                       [903, 904],
                       [998, 999],
                       [1085, 1086],
                       [1185, 1186]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place']},
          {'indices': [[567, 580]],
           'links': None,
           'score': None,
           'text': 'Tejas Tradefin',
           'types': ['Place']},
          {'indices': [[880, 898]],
           'links': None,
           'score': None,
           'text': 'Oil Country Tubular',
           'types': ['Place']},
          {'indices': [[666, 689]],
           'links': None,
           'score': None,
           'text': 'Marfatia Nishil Surendra',
           'types': ['Person']},
          {'indices': [[934, 948]],
           'links': None,
           'score': None,
           'text': 'Vishindas Lakhi',
           'types': ['Person']},
          {'indices': [[0, 15]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[29, 44], [149, 164]],
           'links': None,
           'score': None,
           'text': 'HDFC Growth Fund',
           'types': ['Organisation']},
          {'indices': [[340, 347]],
           'links': None,
           'score': None,
           'text': 'Rs 51.80',
           'types': ['Organisation']},
          {'indices': [[377, 392]],
           'links': None,
           'score': None,
           'text': 'Kedia Securities',
           'types': ['Organisation']},
          {'indices': [[498, 515]],
           'links': None,
           'score': None,
           'text': 'Rights Entitlement',
           'types': ['Organisation']},
          {'indices': [[527, 553]],
           'links': None,
           'score': None,
           'text': 'Arvind Fashions at Rs 55.89',
           'types': ['Organisation']},
          {'indices': [[607, 622]],
           'links': None,
           'score': None,
           'text': 'Reliance Capital',
           'types': ['Organisation']},
          {'indices': [[716, 733]],
           'links': None,
           'score': None,
           'text': 'Bil Energy Systems',
           'types': ['Organisation']},
          {'indices': [[799, 812]],
           'links': None,
           'score': None,
           'text': 'Globe Textiles',
           'types': ['Organisation']},
          {'indices': [[837, 854]],
           'links': None,
           'score': None,
           'text': 'UMW India Ventures',
           'types': ['Organisation']},
          {'indices': [[1063, 1080]],
           'links': None,
           'score': None,
           'text': 'Trejhara Solutions',
           'types': ['Organisation']},
          {'indices': [[1109, 1133]],
           'links': None,
           'score': None,
           'text': 'Vishwakarma Trading House',
           'types': ['Organisation']},
          {'indices': [[1159, 1180]],
           'links': None,
           'score': None,
           'text': 'United Polyfab Gujarat',
           'types': ['Organisation']}],
 'title': [{'indices': [[9, 13]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Race_and_ethnicity_in_the_United_States_Census'},
            'score': 0.9969136118888855,
            'text': 'Asian',
            'types': ['Disease', 'Items']},
           {'indices': [[86, 90]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Texas'},
            'score': 0.9999998807907104,
            'text': 'Tejas',
            'types': ['Location',
                      'Region',
                      'State',
                      'PopulatedPlace',
                      'AdministrativeRegion',
                      'Place']},
           {'indices': [[68, 69]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Midfielder'},
            'score': 0.9963701963424683,
            'text': 'MF',
            'types': ['Person', 'Position', 'Product']},
           {'indices': [[0, 25]],
            'links': None,
            'score': None,
            'text': 'Schroder Asian Growth Fund',
            'types': ['Organisation']},
           {'indices': [[36, 53]],
            'links': None,
            'score': None,
            'text': 'Arvind Fashions RE',
            'types': ['Organisation']},
           {'indices': [[63, 66]],
            'links': None,
            'score': None,
            'text': 'HDFC',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.41999998688697815,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-11',
 'label': 'Stocks',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-11',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.18000000715255737,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': '04011002',
 'label': 'automotive equipment',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04011002',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04011000'},
 'score': 0.20999999344348907,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.434372},
 'title': {'polarity': 'neutral', 'score': 0.938385}}"
2020-07-09  13:32;HDFC AMC, Nippon Life AMC decline as equity fund inflows tumble in June;"Shares of asset management companies (AMCs) were trading weak for the second straight day on Thursday in an otherwise firm market as equity fund inflows fell sharply in June.

Nippon Life Asset Management slipped 4 per cent to Rs 291, while dropped 3 per cent lower to Rs 2,490 in the intra-day trade on the BSE. On Wednesday, these stocks ended lower between 2 per cent and 3 per cent. In comparison, the S&P BSE Sensex was up 0.80 per cent at 36,618 points at 12:02 pm.

Nippon Life India AMC is the asset manager of Nippon India Mutual Fund, while is the investment manager to the schemes of HDFC Mutual Fund.

Inflows into equity mutual funds in June declined sharply to a four-year low of Rs 241 crore compared to Rs 5,257 crore in May. This is the third consecutive monthly decline in inflow in equity mutual funds, data by the Association of Mutual Funds in India (Amfi) showed on Wednesday.

AMC’s almost 75 per cent of the total revenues are contributed by equity and the company maintained that equity will be the key focus area though they are cautiously optimistic regarding recovery in equity.

“Investors seem to be reducing their exposure to equity in the recent rally as retail sentiment remains weak. While SIP (Systematic Investment Plan) inflows also fell in June to Rs 7,927 crore from Rs 8,123 crore in the previous month, they remain largely stable,” ICICI Securities said in a note.

“A steep correction in equity has impacted both AUM and earnings momentum. The near-term outlook remains uncertain but structural changes, including an increase in financial savings, remain positive. It is expected to maintain its leadership through healthy AUM growth. Focus on strong operating efficiency and higher proportion of equity AUM is seen aiding profitability,” the brokerage firm said in March quarter results update.

MTM decline led to schemes falling in a low-value slab, enabling higher total expense ratio (TER) cushioning declining revenue. HDFC AMC’s business franchise is seen remaining strong with a substantial market share of 14-15 per cent and strong operational performance (39-40 bps). Hence, its strong positioning and superior earnings profile deserve, it said.

Analysts at Centrum Broking maintain HDFC AMC’s assets under management (AUM) growth estimates for FY21 and FY22 while accounting for lower employee cost and rebound in equity in FY22 (thus positively impacting yields). This might result in higher profit after tax by 4.5 per cent/11.5 per cent for FY21/FY22E vs previous estimates, the brokerage firm said in Q4 results update.";"{'body': [{'indices': [[176, 186], [473, 483]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nippon_Life'},
           'score': 1.0,
           'text': 'Nippon Life',
           'types': ['Agent', 'Organisation', 'Company', 'Bank']},
          {'indices': [[133, 138],
                       [627, 632],
                       [801, 806],
                       [966, 971],
                       [1005, 1010],
                       [1099, 1104],
                       [1157, 1162],
                       [1430, 1435],
                       [1739, 1744],
                       [2368, 2373]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.5797893404960632,
           'text': 'equity',
           'types': ['Disease', 'Difference']},
          {'indices': [[1224, 1226]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Session_Initiation_Protocol'},
           'score': 0.9851226806640625,
           'text': 'SIP',
           'types': ['Protocol', 'MusicGenre', 'Software', 'Product']},
          {'indices': [[634, 645], [808, 819]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 0.9900458455085754,
           'text': 'mutual funds',
           'types': ['PersonFunction']},
          {'indices': [[485, 489], [526, 530], [865, 869]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9988052248954773,
           'text': 'India',
           'types': ['Location',
                     'MusicalArtist',
                     'Country',
                     'PopulatedPlace',
                     'Place']},
          {'indices': [[2041, 2052]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Market_share'},
           'score': 0.9992260336875916,
           'text': 'market share',
           'types': ['Percentage']},
          {'indices': [[10, 25]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asset_management'},
           'score': 0.9650262594223022,
           'text': 'asset management',
           'types': ['MusicGenre']},
          {'indices': [[502, 514]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asset_management'},
           'score': 0.9431535601615906,
           'text': 'asset manager',
           'types': ['MusicGenre']},
          {'indices': [[558, 575]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asset_management'},
           'score': 0.5486297011375427,
           'text': 'investment manager',
           'types': ['MusicGenre']},
          {'indices': [[308, 310], [410, 412]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bombay_Stock_Exchange'},
           'score': 0.4768252372741699,
           'text': 'BSE',
           'types': ['Exchange', 'Company', 'Organisation']},
          {'indices': [[2318, 2327]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Accounting'},
           'score': 0.9994428753852844,
           'text': 'accounting',
           'types': ['MusicGenre', 'Measurement', 'Company']},
          {'indices': [[701, 705], [728, 732], [1295, 1299], [1315, 1319]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[1932, 1934]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Transport_express_régional'},
           'score': 0.9982340931892395,
           'text': 'TER',
           'types': ['Agent',
                     'RailwayLine',
                     'PublicTransitSystem',
                     'Organisation',
                     'Company',
                     'Name']},
          {'indices': [[410, 419]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/BSE_SENSEX'},
           'score': 1.0,
           'text': 'BSE Sensex',
           'types': ['Index', 'Work', 'Product']},
          {'indices': [[1373, 1377]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/ICICI_Bank'},
           'score': 1.0,
           'text': 'ICICI',
           'types': ['Banking', 'Agent', 'Organisation', 'Company', 'Bank']},
          {'indices': [[1785, 1798], [2536, 2549]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Brokerage_firm'},
           'score': 0.991925060749054,
           'text': 'brokerage firm',
           'types': ['Institution', 'University']},
          {'indices': [[491, 493], [900, 902], [1972, 1974], [2241, 2243]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
           'score': 0.6884567737579346,
           'text': 'AMC',
           'types': ['Agent',
                     'Organisation',
                     'Broadcaster',
                     'TelevisionStation',
                     'Cable',
                     'Product']},
          {'indices': [[872, 875]],
           'links': None,
           'score': None,
           'text': 'Amfi',
           'types': ['Place']},
          {'indices': [[1306, 1313]],
           'links': None,
           'score': None,
           'text': 'Rs 8,123',
           'types': ['Place']},
          {'indices': [[2307, 2310], [2378, 2381]],
           'links': None,
           'score': None,
           'text': 'FY22',
           'types': ['Product']},
          {'indices': [[176, 203]],
           'links': None,
           'score': None,
           'text': 'Nippon Life Asset Management',
           'types': ['Organisation']},
          {'indices': [[406, 419]],
           'links': None,
           'score': None,
           'text': 'S&P BSE Sensex',
           'types': ['Organisation']},
          {'indices': [[473, 493]],
           'links': None,
           'score': None,
           'text': 'Nippon Life India AMC',
           'types': ['Organisation']},
          {'indices': [[519, 542]],
           'links': None,
           'score': None,
           'text': 'Nippon India Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[595, 610]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[227, 228],
                       [269, 270],
                       [694, 695],
                       [719, 720],
                       [1286, 1287],
                       [1306, 1307]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Organisation']},
          {'indices': [[834, 860]],
           'links': None,
           'score': None,
           'text': 'Association of Mutual Funds',
           'types': ['Organisation']},
          {'indices': [[1224, 1254]],
           'links': None,
           'score': None,
           'text': 'SIP (Systematic Investment Plan',
           'types': ['Organisation']},
          {'indices': [],
           'links': None,
           'score': None,
           'text': '” ICICI Securities',
           'types': ['Organisation']},
          {'indices': [[1455, 1457], [1665, 1667], [1746, 1748], [2272, 2274]],
           'links': None,
           'score': None,
           'text': 'AUM',
           'types': ['Organisation']},
          {'indices': [[1839, 1841]],
           'links': None,
           'score': None,
           'text': 'MTM',
           'types': ['Organisation']},
          {'indices': [[595, 598], [1967, 1970], [2236, 2239]],
           'links': None,
           'score': None,
           'text': 'HDFC',
           'types': ['Organisation']},
          {'indices': [[2211, 2225]],
           'links': None,
           'score': None,
           'text': 'Centrum Broking',
           'types': ['Organisation']},
          {'indices': [[2298, 2301], [2498, 2501]],
           'links': None,
           'score': None,
           'text': 'FY21',
           'types': ['Organisation']}],
 'title': [{'indices': [[10, 20]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Nippon_Life'},
            'score': 1.0,
            'text': 'Nippon Life',
            'types': ['Company', 'Organisation', 'Agent', 'Bank']},
           {'indices': [[5, 7], [22, 24]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
            'score': 0.8749300837516785,
            'text': 'AMC',
            'types': ['TelevisionStation',
                      'Organisation',
                      'Agent',
                      'Broadcaster',
                      'Cable',
                      'Product']},
           {'indices': [[10, 24]],
            'links': None,
            'score': None,
            'text': 'Nippon Life AMC',
            'types': ['Product']},
           {'indices': [[0, 3]],
            'links': None,
            'score': None,
            'text': 'HDFC',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.47999998927116394,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.2800000011920929,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016018',
 'label': 'earnings',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016018',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.09000000357627869,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'neutral', 'score': 0.855205},
 'title': {'polarity': 'neutral', 'score': 0.824039}}"
2020-07-04  14:26;Explained: What are Social Stock Exchanges and how do they work;"With business impacted due to the COVID-19 induced lockdown, Securities and Exchange Board of India constituted panel on social stock exchanges on June 1 had recommended direct listing of non-profit organisations (NPOs) through the issuance of bonds and a range of funding mechanisms in a report submitted to the market regulator.

For submitting public comments on proposal of Social Stock Exchange, SEBI has further extended the date to July 15, which was earlier June 30.

Here is a look at what are SSEs and how they would help the fight against COVID-19.

What is an SSE?

An SSE allows the listing of non-profit or non-government organisations on stock exchanges, providing them with an alternative fund-raising structure. It may be listed on BSE or NSE. Countries like the UK, Canada and Brazil have SSEs.

“The fund-raising is proposed through several instruments such as zero-coupon-zero-principal bonds, social venture funds and mutual funds. The duration of listing of an entity would depend on its objectives and future plans,” Moin Ladha, Partner, Khaitan & Co, said.

What is the size of the market?

India has over 31 lakh NPOs – more than double the number of schools and  250 times the number of government hospitals, which amount to one NPO for 400 Indians.

What are the objectives of SSEs?

According to the draft SEBI report, a Social Stock Exchange may be helpful in rebuilding the livelihoods of people who are affected during pandemics like COVID-19.

“The SSEs will aim at unlocking large pools of social capital, and  encourage blended finance structures, so that conventional capital can partner with social capital to address the urgent challenges of COVID-19.”

How will it work and what are the eligibility criteria?

The SSE shall be a separate segment under the existing stock exchanges. It is a set of processes as much as a place. This means that the SSE will not be only a place where securities or other funding structures are “listed” but also a set of procedures that act as a filter, selecting only those entities that are creating measurable positive social impact and reporting such impact.

What instruments will NPOs offer on SSEs?

The Sebi working group report lays out several funding instruments such as zero-coupon-zero-principal bonds, social venture funds, and mutual funds, “providing a wide gamut of options to “donor” investors looking to invest with an objective to create a social impact. This initiative may also enable companies to be able to deploy CSR funding by connecting directly with social organisations,” Ladha said.

Can you give an example?

The Cancer Fund by HDFC Mutual Fund is one example. It operates as a standard mutual fund, with the exception that the returns generated are channelled towards the financing of NPOs. Its investors get their money back from HDFC MF, but any interest or gains that are made are donated to the NPO.

What are the tax benefits?

Investors will get Section 80G benefits which allow all investments in securities/instruments of NPOs listed on SSE to be tax deductible, and corporates to deduct CSR expenditure from their taxable income, among other things. Investment by companies will be considered as part of their Corporate Social Responsibility (CSR) initiatives.

What about transparency and reporting standards?

Information Repositories will provide credible, standardised information about the NPOs. IRs are expected to create an appropriate financial reporting standards, so that NPOs can then adhere to them. The new standards are expected to be in place before the end of 2020. Similarly, social auditors will perform an independent verification of impact reporting. While in the immediate term, NPOs need only self-reporting, from the intermediate term onwards, social auditors can take over this function.";"{'body': [{'indices': [[1523, 1536], [1628, 1641]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Social_capital'},
           'score': 1.0,
           'text': 'social capital',
           'types': ['Form']},
          {'indices': [[1920, 1929], [3005, 3014]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Security_(finance)'},
           'score': 0.9975745677947998,
           'text': 'securities',
           'types': ['Agent', 'Asset']},
          {'indices': [[795, 800]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Brazil'},
           'score': 0.995263397693634,
           'text': 'Brazil',
           'types': ['State',
                     'Country',
                     'PopulatedPlace',
                     'Location',
                     'Place']},
          {'indices': [[3060, 3069]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Deductible'},
           'score': 0.8682502508163452,
           'text': 'deductible',
           'types': ['Amount', 'Disease']},
          {'indices': [[401, 404], [1334, 1337]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Securities_and_Exchange_Board_of_India'},
           'score': 1.0,
           'text': 'SEBI',
           'types': ['Company',
                     'Regulator',
                     'Organisation',
                     'GovernmentAgency',
                     'Agent']},
          {'indices': [[939, 950], [2311, 2322]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 0.9899054765701294,
           'text': 'mutual funds',
           'types': ['PersonFunction']},
          {'indices': [[2687, 2697]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 1.0,
           'text': 'mutual fund',
           'types': ['PersonFunction']},
          {'indices': [[3453, 3471]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Financial_statement'},
           'score': 1.0,
           'text': 'financial reporting',
           'types': ['Album', 'Product', 'Record']},
          {'indices': [[784, 789]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Canada'},
           'score': 0.9996744394302368,
           'text': 'Canada',
           'types': ['MusicalArtist',
                     'Country',
                     'PopulatedPlace',
                     'Location',
                     'Place']},
          {'indices': [[94, 98], [1115, 1119]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9990087747573853,
           'text': 'India',
           'types': ['Country',
                     'MusicalArtist',
                     'PopulatedPlace',
                     'Location',
                     'Place']},
          {'indices': [[2837, 2838]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Midfielder'},
           'score': 0.986981213092804,
           'text': 'MF',
           'types': ['Position', 'Person', 'Product']},
          {'indices': [[1133, 1136]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Unit', 'Organisation']},
          {'indices': [[572, 574],
                       [581, 583],
                       [1752, 1754],
                       [1885, 1887],
                       [3046, 3048]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Streaming_SIMD_Extensions'},
           'score': 0.9737558960914612,
           'text': 'SSE',
           'types': ['ProgrammingLanguage',
                     'Product',
                     'Instruction',
                     'Organisation']},
          {'indices': [[214, 217],
                       [1138, 1141],
                       [2155, 2158],
                       [2786, 2789],
                       [3031, 3034],
                       [3405, 3408],
                       [3492, 3495],
                       [3710, 3713]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nonprofit_organization'},
           'score': 1.0,
           'text': 'NPOs',
           'types': ['Organization', 'MusicGenre', 'Organisation']},
          {'indices': [[1255, 1257], [2900, 2902]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nonprofit_organization'},
           'score': 0.872167706489563,
           'text': 'NPO',
           'types': ['Organization', 'MusicGenre', 'Organisation']},
          {'indices': [[749, 751]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bombay_Stock_Exchange'},
           'score': 0.48941755294799805,
           'text': 'BSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[51, 58]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lockdown'},
           'score': 0.962048351764679,
           'text': 'lockdown',
           'types': ['Book', 'Product', 'Definitions']},
          {'indices': [[2507, 2509], [3097, 3099], [3253, 3255]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Corporate_social_responsibility'},
           'score': 0.8432280421257019,
           'text': 'CSR',
           'types': ['Form', 'Organisation']},
          {'indices': [],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Corporate_social_responsibility'},
           'score': 1.0,
           'text': 'Corporate Social Responsibility (CSR)',
           'types': ['Form']},
          {'indices': [[2343, 2347]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Gamut'},
           'score': 0.9374687671661377,
           'text': 'gamut',
           'types': ['Subset', 'ProgrammingLanguage', 'Product']},
          {'indices': [[1450, 1458]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pandemic'},
           'score': 0.9991253614425659,
           'text': 'pandemics',
           'types': ['Epidemic', 'Arachnid']},
          {'indices': [[621, 648]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Non-governmental_organization'},
           'score': 1.0,
           'text': 'non-government organisations',
           'types': ['PersonFunction', 'Organization', 'Organisation']},
          {'indices': [[34, 41], [550, 557], [1465, 1472], [1679, 1686]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Coronavirus_disease_2019'},
           'score': 1.0,
           'text': 'COVID-19',
           'types': ['Organisation']},
          {'indices': [[756, 758]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.7741513252258301,
           'text': 'NSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[780, 781]],
           'links': None,
           'score': None,
           'text': 'UK',
           'types': ['Place']},
          {'indices': [[1045, 1049], [2570, 2574]],
           'links': None,
           'score': None,
           'text': 'Ladha',
           'types': ['Person']},
          {'indices': [[2934, 2942]],
           'links': None,
           'score': None,
           'text': 'Investors',
           'types': ['Person']},
          {'indices': [[3592, 3600]],
           'links': None,
           'score': None,
           'text': 'Similarly',
           'types': ['Person']},
          {'indices': [[2953, 2963]],
           'links': None,
           'score': None,
           'text': 'Section 80G',
           'types': ['Product']},
          {'indices': [[61, 89]],
           'links': None,
           'score': None,
           'text': 'Securities and Exchange Board',
           'types': ['Organisation']},
          {'indices': [[378, 398], [1349, 1369]],
           'links': None,
           'score': None,
           'text': 'Social Stock Exchange',
           'types': ['Organisation']},
          {'indices': [[1061, 1072]],
           'links': None,
           'score': None,
           'text': 'Khaitan & Co',
           'types': ['Organisation']},
          {'indices': [[1347, 1369]],
           'links': None,
           'score': None,
           'text': 'a Social Stock Exchange',
           'types': ['Organisation']},
          {'indices': [[2609, 2623]],
           'links': None,
           'score': None,
           'text': 'The Cancer Fund',
           'types': ['Organisation']},
          {'indices': [[2628, 2643]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2628, 2631], [2832, 2835]],
           'links': None,
           'score': None,
           'text': 'HDFC',
           'types': ['Organisation']},
          {'indices': [],
           'links': None,
           'score': None,
           'text': 'ir Corporate Social Responsibility',
           'types': ['Organisation']},
          {'indices': [[3322, 3345]],
           'links': None,
           'score': None,
           'text': 'Information Repositories',
           'types': ['Organisation']}],
 'title': [{'indices': [[20, 41]],
            'links': None,
            'score': None,
            'text': 'Social Stock Exchanges',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.38999998569488525,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.17000000178813934,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': '04019000',
 'label': 'finance (general)',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04019000',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04000000'},
 'score': 0.12999999523162842,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'neutral', 'score': 0.967512},
 'title': {'polarity': 'neutral', 'score': 0.669403}}"
2020-07-03  16:19;Best Mutual Funds Investment App by Imperial Finsol Pvt.Ltd. | PressReleasePoint;"Imperial Finsol Pvt.Ltd. Luanched the Mutual Fund Investment App Called Imperial Money - offers the Simple, Free and most convenient way of Investing in Mutual Funds.



Nagpur, Maharashtra, India., July 3, 2020 - /PressReleasePoint/ - Imperial Money offers the Simple, Free and most convenient way of Investing in Mutual Funds on Online Platform.



Imperial Finsol Pvt.Ltd. Launching the Mutual Fund Investment App. It’s all just on fingertips, No paperwork, No hassles, Invest in the best mutual funds using Imperial Money. All Indian mutual funds are available in one single app.



 In Imperial money start SIP, lump-sum investment for free. Switching of the funds from one fund to other fund and Systematic withdrawal plan or funds from liquid to equity or equity to liquid while re-balancing of the portfolio can be done here anytime anywhere.

 

Investing becomes easy with fingertips - Get Sign up in minutes, One time KYC process within the app, Buy, Sell, Shift mutual funds within fund family. Buying Systematic investment plan or doing the STP or SWP is just simple and easy.

 

Invest in all mutual funds online for free - Do not require paying any additional cost for buying funds from Imperial money, Most researched Mutual funds baskets are available. Sell anytime - Money comes to bank account directly, Learn to invest in mutual funds with as low as Amount of Rs.500/- with respect to the objective and planning of life the portfolio are builder for giving one of the state of art experience

 

Mutual Fund Investing:-

· Simple design, Easy to understand

· Made for beginners and experts both

· Financial planning can be done here itself Invest in the researched and ready-made basket of mutual funds recommended by experts with years together experience.

· Latest finance news and insights, notifications

· Most important is the teams of experts are available here to help in any type of Issues.



For Mutual Funds Details & Investments Download the App

https://play.google.com/store/apps/details?id=com.iw.imperialmoney

 

Steps After Imperial Money App Install:

· Verify KYC

· If the KYC is not available then use following process

· PAN/KYC

· Profile set up

· Make an investment of sip or lumpsum

 

Need of KYC for mutual funds as per process of the Government of India for making a Tax saving funds (ELSS mutual funds):

 

Invest in tax saving mutual funds to get tax exemption under section 80c. The total exempt limit is 1.5 Lakhs. Invest in equity mutual funds - small cap, large cap, mid cap, multi-cap - for the long term and higher returns. Check out SIP Calculator to know how much returns can be made.

 

Safe & Secure: Imperial Money uses the latest security standards to keep data safe and encrypted.

 

IMPERIAL MONEY is secure and does not store any information on the device or SIM card. Download and stay connected to the Mutual Fund investments always. Imperial Money uses NSE (National Stock Exchange) for transactions. Imperial Money support all RTAs - CAMS, Karvy and Franklin.

 

Following AMC’s are supported on IMPERIAL MONEY Mutual Fund App:

 

SBI Mutual Fund,NIPPON Mutual Fund,ICICI Prudential Mutual Fund,HDFC Mutual Fund,Aditya Birla Sun Life Mutual Fund,Franklin Templeton Mutual Fund DSP Mutual Fund,Kotak Mutual Fund, Mirae Asset Mutual Fund, Axis Mutual Fund Motilal Oswal Mutual Fund, L&T Mutual Fund,IDFC Mutual Fund,INVESCO Mutual Fund UTI Mutual Fund,Sundaram Mutual Fund,Tata Mutual Fund,ITI MUTUAL FUND,BNP PARIBAS MUTUAL FUNDS,EDELWEISSS MUTUAL FUND,HSBC MUTUAL FUND MAHINDRA MUTUALA FUND,PGIM MUTUAL FUND,PRINCIPLE MUTUAL FUND UNION MUTUAL FUND



For More Details Visit at - https://www.imperialfin.com/mutual-fund-investment-app/

 

IMPERIAL MONEY - KEY FEATURES

Access your investments across multiple Mutual Funds through a Single Gateway No more managing multiple PINs, Folios numbers, login ids

· Mobile PIN & Pattern login– Simplified Imperial Money App login process now. Just pick the preferred login methods – Mobile PIN, Pattern or Password right away

· Paperless Investing: Quick & paperless account creation and instant Activation. Within a couple of minutes, All set to ride the new wave of investing.

· Instant SIP: Once registered. It takes less than a minute to start a SIP.

· SIP Calculators: With the help of SIP calculators plan investment needs to achieve Financial Goals. Happy investing with Imperial money!!!



About Us: Meet Imperial Finsol Pvt.Ltd., a Firm committed for providing a personalized solution for Wealth Management needs. Imperial Finsol Pvt.Ltd. helps to make smart investment choices with the money to get maximize returns. Knowledge of the financial markets and dedicated Client service team, are the pillars of Imperial Finsol Pvt.Ltd. success. Imperial Finsol Pvt.Ltd. now catering to 2000 plus clients. Imperial Finsol Pvt.Ltd. is a preferred choice of Clients when it comes to Wealth Management.

 

Investment Sahi…Future Sahi";"{'body': [{'indices': [[2770, 2772]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Subscriber_identity_module'},
           'score': 0.9989826083183289,
           'text': 'SIM',
           'types': ['Chip']},
          {'indices': [[2104, 2106]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Action_Party_(Mexico)'},
           'score': 0.9112026691436768,
           'text': 'PAN',
           'types': ['PoliticalParty', 'Agent', 'Organisation']},
          {'indices': [[2443, 2451]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Market_capitalization'},
           'score': 1.0,
           'text': 'small cap',
           'types': ['Value', 'Company']},
          {'indices': [[2454, 2462]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Market_capitalization'},
           'score': 1.0,
           'text': 'large cap',
           'types': ['Value', 'Company']},
          {'indices': [[3469, 3472]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/HSBC'},
           'score': 0.99558025598526,
           'text': 'HSBC',
           'types': ['Agent', 'Banking', 'Company', 'Organisation', 'Bank']},
          {'indices': [[3933, 3940]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Password'},
           'score': 0.7028904557228088,
           'text': 'Password',
           'types': ['Food', 'Product', 'Word', 'Person']},
          {'indices': [[3421, 3431]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/BNP_Paribas'},
           'score': 0.9997409582138062,
           'text': 'BNP PARIBAS',
           'types': ['Agent', 'Company', 'Organisation', 'Bank']},
          {'indices': [[1620, 1637]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Financial_plan'},
           'score': 1.0,
           'text': 'Financial planning',
           'types': ['Evaluation', 'Aircraft', 'Product']},
          {'indices': [[3793, 3798], [3910, 3915]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mobile,_Alabama'},
           'score': 0.949927568435669,
           'text': 'Mobile',
           'types': ['Seat',
                     'Location',
                     'Place',
                     'Settlement',
                     'City',
                     'PopulatedPlace']},
          {'indices': [[753, 758], [763, 768], [2421, 2426]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.5812020897865295,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[612, 614],
                       [2534, 2536],
                       [4118, 4120],
                       [4179, 4181],
                       [4187, 4189],
                       [4221, 4223]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Session_Initiation_Protocol'},
           'score': 0.9908138513565063,
           'text': 'SIP',
           'types': ['Software',
                     'Product',
                     'Protocol',
                     'MusicGenre',
                     'Organisation']},
          {'indices': [[2155, 2157]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Session_Initiation_Protocol'},
           'score': 0.9908138513565063,
           'text': 'sip',
           'types': ['Software', 'Product', 'Protocol', 'MusicGenre']},
          {'indices': [[492, 503],
                       [538, 549],
                       [974, 985],
                       [1108, 1119],
                       [1343, 1354],
                       [1713, 1724],
                       [2190, 2201],
                       [2281, 2292],
                       [2321, 2332],
                       [2428, 2439]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 0.9904342889785767,
           'text': 'mutual funds',
           'types': ['PersonFunction']},
          {'indices': [[3254, 3257]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_powers'},
           'score': 0.9961141347885132,
           'text': 'Axis',
           'types': ['Location',
                     'EthnicGroup',
                     'Place',
                     'Country',
                     'Nations',
                     'PopulatedPlace']},
          {'indices': [[2341, 2353]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Tax_exemption'},
           'score': 1.0,
           'text': 'tax exemption',
           'types': ['PersonFunction']},
          {'indices': [[929, 931],
                       [2039, 2041],
                       [2053, 2055],
                       [2108, 2110],
                       [2182, 2184]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Know_your_customer'},
           'score': 1.0,
           'text': 'KYC',
           'types': ['Election', 'Process', 'Organisation']},
          {'indices': [[2949, 2952]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Confederation_of_Australian_Motor_Sport'},
           'score': 0.9900524020195007,
           'text': 'CAMS',
           'types': ['Official']},
          {'indices': [[2449, 2451], [2460, 2462], [2469, 2471], [2480, 2482]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Cap_(sport)'},
           'score': 0.714723527431488,
           'text': 'cap',
           'types': ['Term']},
          {'indices': [[191, 195], [2239, 2243]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9987887144088745,
           'text': 'India',
           'types': ['Location',
                     'Place',
                     'Country',
                     'MusicalArtist',
                     'PopulatedPlace']},
          {'indices': [[1054, 1056]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Standard_conditions_for_temperature_and_pressure'},
           'score': 0.658422589302063,
           'text': 'STP',
           'types': ['Sets', 'Train', 'Organisation']},
          {'indices': [[3194, 3196]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Digital_signal_processor'},
           'score': 0.6121925711631775,
           'text': 'DSP',
           'types': ['Microprocessor']},
          {'indices': [[178, 188]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Maharashtra'},
           'score': 0.9992673397064209,
           'text': 'Maharashtra',
           'types': ['Location',
                     'Place',
                     'Settlement',
                     'State',
                     'PopulatedPlace',
                     'Organisation']},
          {'indices': [[1301, 1304]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bank'},
           'score': 0.9990646243095398,
           'text': 'bank',
           'types': ['University', 'Institution', 'PersonFunction']},
          {'indices': [[3800, 3802], [3917, 3919]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Personal_identification_number'},
           'score': 0.9771061539649963,
           'text': 'PIN',
           'types': ['Software', 'Product', 'Password', 'Organisation']},
          {'indices': [[170, 175]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nagpur'},
           'score': 0.9909562468528748,
           'text': 'Nagpur',
           'types': ['Location',
                     'Place',
                     'Settlement',
                     'Capital',
                     'City',
                     'PopulatedPlace',
                     'Person']},
          {'indices': [[3486, 3493]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mahindra_&_Mahindra'},
           'score': 0.81194007396698,
           'text': 'MAHINDRA',
           'types': ['Agent', 'Company', 'Organisation', 'Corporation']},
          {'indices': [[3129, 3140]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Aditya_Vikram_Birla'},
           'score': 0.6816630959510803,
           'text': 'Aditya Birla',
           'types': ['Person', 'Industrialist', 'Agent']},
          {'indices': [[1989, 1993]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Steps_(pop_group)'},
           'score': 0.9987645745277405,
           'text': 'Steps',
           'types': ['Band', 'Agent', 'Organisation', 'Group']},
          {'indices': [[2867, 2869]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.7845900654792786,
           'text': 'NSE',
           'types': ['Exchange', 'Company']},
          {'indices': [[2872, 2894]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.9957119822502136,
           'text': 'National Stock Exchange',
           'types': ['Exchange', 'Company']},
          {'indices': [[3163, 3180]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Franklin_Templeton_Investments'},
           'score': 1.0,
           'text': 'Franklin Templeton',
           'types': ['Agent', 'Company', 'Organisation', 'Bank']},
          {'indices': [[2989, 2991]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
           'score': 0.6830765604972839,
           'text': 'AMC',
           'types': ['Cable',
                     'Agent',
                     'Organisation',
                     'TelevisionStation',
                     'Broadcaster']},
          {'indices': [[473, 478],
                       [1094, 1099],
                       [1663, 1668],
                       [2300, 2305],
                       [2411, 2416]],
           'links': None,
           'score': None,
           'text': 'Invest',
           'types': ['Place']},
          {'indices': [[1784, 1789]],
           'links': None,
           'score': None,
           'text': 'Latest',
           'types': ['Place']},
          {'indices': [[2955, 2959]],
           'links': None,
           'score': None,
           'text': 'Karvy',
           'types': ['Place']},
          {'indices': [[4335, 4336]],
           'links': None,
           'score': None,
           'text': 'Us',
           'types': ['Place']},
          {'indices': [[9, 18], [360, 369]],
           'links': None,
           'score': None,
           'text': 'Finsol Pvt',
           'types': ['Person']},
          {'indices': [[376, 384]],
           'links': None,
           'score': None,
           'text': 'Launching',
           'types': ['Person']},
          {'indices': [[957, 959]],
           'links': None,
           'score': None,
           'text': 'Buy',
           'types': ['Person']},
          {'indices': [[1324, 1328]],
           'links': None,
           'score': None,
           'text': 'Learn',
           'types': ['Person']},
          {'indices': [[1559, 1562]],
           'links': None,
           'score': None,
           'text': 'Easy',
           'types': ['Person']},
          {'indices': [[2032, 2041]],
           'links': None,
           'score': None,
           'text': 'Verify KYC',
           'types': ['Person']},
          {'indices': [[2115, 2121]],
           'links': None,
           'score': None,
           'text': 'Profile',
           'types': ['Person']},
          {'indices': [[2404, 2408]],
           'links': None,
           'score': None,
           'text': 'Lakhs',
           'types': ['Person']},
          {'indices': [[2465, 2467]],
           'links': None,
           'score': None,
           'text': 'mid',
           'types': ['Person']},
          {'indices': [[72, 85],
                       [236, 249],
                       [511, 524],
                       [2001, 2014],
                       [2606, 2619],
                       [2847, 2860],
                       [2915, 2928],
                       [3832, 3845]],
           'links': None,
           'score': None,
           'text': 'Imperial Money',
           'types': ['Person', 'Organisation']},
          {'indices': [[3956, 3974]],
           'links': None,
           'score': None,
           'text': 'Paperless Investing',
           'types': ['Person']},
          {'indices': [[4024, 4033]],
           'links': None,
           'score': None,
           'text': 'Activation',
           'types': ['Person']},
          {'indices': [[16, 18],
                       [367, 369],
                       [4360, 4362],
                       [4470, 4472],
                       [4663, 4665],
                       [4697, 4699],
                       [4757, 4759]],
           'links': None,
           'score': None,
           'text': 'Pvt',
           'types': ['Person']},
          {'indices': [[4839, 4853]],
           'links': None,
           'score': None,
           'text': 'Investment Sahi',
           'types': ['Person']},
          {'indices': [[0, 7],
                       [72, 79],
                       [236, 243],
                       [351, 358],
                       [511, 518],
                       [591, 598],
                       [1203, 1210],
                       [2001, 2008],
                       [2606, 2613],
                       [2847, 2854],
                       [2915, 2922],
                       [3832, 3839],
                       [4308, 4315],
                       [4344, 4351],
                       [4454, 4461],
                       [4647, 4654],
                       [4681, 4688],
                       [4741, 4748]],
           'links': None,
           'score': None,
           'text': 'Imperial',
           'types': ['Organisation']},
          {'indices': [[25, 94]],
           'links': None,
           'score': None,
           'text': 'Luanched the Mutual Fund Investment App Called Imperial '
                   'Money - offers',
           'types': ['Organisation']},
          {'indices': [[100, 111], [262, 273]],
           'links': None,
           'score': None,
           'text': 'Simple, Free',
           'types': ['Organisation']},
          {'indices': [[140, 164], [302, 326]],
           'links': None,
           'score': None,
           'text': 'Investing in Mutual Funds',
           'types': ['Organisation']},
          {'indices': [[331, 345]],
           'links': None,
           'score': None,
           'text': 'Online Platform',
           'types': ['Organisation']},
          {'indices': [[38, 63], [390, 415]],
           'links': None,
           'score': None,
           'text': 'Mutual Fund Investment App',
           'types': ['Organisation']},
          {'indices': [[702, 711], [1014, 1023]],
           'links': None,
           'score': None,
           'text': 'Systematic',
           'types': ['Organisation']},
          {'indices': [[140, 148],
                       [302, 310],
                       [855, 863],
                       [1529, 1537],
                       [3966, 3974]],
           'links': None,
           'score': None,
           'text': 'Investing',
           'types': ['Organisation']},
          {'indices': [[962, 965], [1271, 1274]],
           'links': None,
           'score': None,
           'text': 'Sell',
           'types': ['Organisation']},
          {'indices': [[968, 972]],
           'links': None,
           'score': None,
           'text': 'Shift',
           'types': ['Organisation']},
          {'indices': [[1061, 1063]],
           'links': None,
           'score': None,
           'text': 'SWP',
           'types': ['Organisation']},
          {'indices': [[1371, 1376]],
           'links': None,
           'score': None,
           'text': 'Amount',
           'types': ['Organisation']},
          {'indices': [[1517, 1537]],
           'links': None,
           'score': None,
           'text': 'Mutual Fund Investing',
           'types': ['Organisation']},
          {'indices': [[1931, 1973]],
           'links': None,
           'score': None,
           'text': 'Mutual Funds Details & Investments Download',
           'types': ['Organisation']},
          {'indices': [[61, 63],
                       [413, 415],
                       [1979, 1981],
                       [2016, 2018],
                       [3039, 3041],
                       [3847, 3849]],
           'links': None,
           'score': None,
           'text': 'App',
           'types': ['Organisation']},
          {'indices': [[2001, 2026]],
           'links': None,
           'score': None,
           'text': 'Imperial Money App Install',
           'types': ['Organisation']},
          {'indices': [[2104, 2110]],
           'links': None,
           'score': None,
           'text': 'PAN/KYC',
           'types': ['Organisation']},
          {'indices': [[2174, 2180]],
           'links': None,
           'score': None,
           'text': 'Need of',
           'types': ['Organisation']},
          {'indices': [[2534, 2547]],
           'links': None,
           'score': None,
           'text': 'SIP Calculator',
           'types': ['Organisation']},
          {'indices': [[2591, 2603]],
           'links': None,
           'score': None,
           'text': 'Safe & Secure',
           'types': ['Organisation']},
          {'indices': [[2693, 2700], [3012, 3019], [3621, 3628]],
           'links': None,
           'score': None,
           'text': 'IMPERIAL',
           'types': ['Organisation']},
          {'indices': [[1966, 1973], [2780, 2787]],
           'links': None,
           'score': None,
           'text': 'Download',
           'types': ['Organisation']},
          {'indices': [[38, 48],
                       [390, 400],
                       [1517, 1527],
                       [2815, 2825],
                       [3027, 3037],
                       [3052, 3062],
                       [3071, 3081],
                       [3100, 3110],
                       [3117, 3127],
                       [3151, 3161],
                       [3182, 3192],
                       [3198, 3208],
                       [3216, 3226],
                       [3241, 3251],
                       [3259, 3269],
                       [3285, 3295],
                       [3302, 3312],
                       [3319, 3329],
                       [3339, 3349],
                       [3355, 3365],
                       [3376, 3386],
                       [3393, 3403]],
           'links': None,
           'score': None,
           'text': 'Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2867, 2894]],
           'links': None,
           'score': None,
           'text': 'NSE (National Stock Exchange',
           'types': ['Organisation']},
          {'indices': [[2965, 2972], [3163, 3170]],
           'links': None,
           'score': None,
           'text': 'Franklin',
           'types': ['Organisation']},
          {'indices': [[3012, 3037]],
           'links': None,
           'score': None,
           'text': 'IMPERIAL MONEY Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3048, 3062]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3064, 3081]],
           'links': None,
           'score': None,
           'text': 'NIPPON Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3083, 3110]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3112, 3127]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3129, 3161]],
           'links': None,
           'score': None,
           'text': 'Aditya Birla Sun Life Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3163, 3208]],
           'links': None,
           'score': None,
           'text': 'Franklin Templeton Mutual Fund DSP Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3210, 3226]],
           'links': None,
           'score': None,
           'text': 'Kotak Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3229, 3251]],
           'links': None,
           'score': None,
           'text': 'Mirae Asset Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3254, 3295]],
           'links': None,
           'score': None,
           'text': 'Axis Mutual Fund Motilal Oswal Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3298, 3312]],
           'links': None,
           'score': None,
           'text': 'L&T Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3314, 3329]],
           'links': None,
           'score': None,
           'text': 'IDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3331, 3365]],
           'links': None,
           'score': None,
           'text': 'INVESCO Mutual Fund UTI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3367, 3386]],
           'links': None,
           'score': None,
           'text': 'Sundaram Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3388, 3403]],
           'links': None,
           'score': None,
           'text': 'Tata Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3405, 3419]],
           'links': None,
           'score': None,
           'text': 'ITI MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[3446, 3467]],
           'links': None,
           'score': None,
           'text': 'EDELWEISSS MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[3469, 3484]],
           'links': None,
           'score': None,
           'text': 'HSBC MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[3495, 3506]],
           'links': None,
           'score': None,
           'text': 'MUTUALA FUND',
           'types': ['Organisation']},
          {'indices': [[3508, 3523]],
           'links': None,
           'score': None,
           'text': 'PGIM MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[3525, 3563]],
           'links': None,
           'score': None,
           'text': 'PRINCIPLE MUTUAL FUND UNION MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[3621, 3657]],
           'links': None,
           'score': None,
           'text': 'IMPERIAL MONEY - KEY FEATURES\n\nAccess',
           'types': ['Organisation']},
          {'indices': [[3713, 3728]],
           'links': None,
           'score': None,
           'text': 'a Single Gateway',
           'types': ['Organisation']},
          {'indices': [[3793, 3812]],
           'links': None,
           'score': None,
           'text': 'Mobile PIN & Pattern',
           'types': ['Organisation']},
          {'indices': [[3806, 3812], [3922, 3928]],
           'links': None,
           'score': None,
           'text': 'Pattern',
           'types': ['Organisation']},
          {'indices': [[3977, 3981]],
           'links': None,
           'score': None,
           'text': 'Quick',
           'types': ['Organisation']},
          {'indices': [[4187, 4201]],
           'links': None,
           'score': None,
           'text': 'SIP Calculators',
           'types': ['Organisation']},
          {'indices': [[4270, 4284]],
           'links': None,
           'score': None,
           'text': 'Financial Goals',
           'types': ['Organisation']},
          {'indices': [[4429, 4445], [4816, 4832]],
           'links': None,
           'score': None,
           'text': 'Wealth Management',
           'types': ['Organisation']}],
 'title': [{'indices': [[45, 54]],
            'links': None,
            'score': None,
            'text': 'Finsol Pvt',
            'types': ['Person']},
           {'indices': [[36, 43]],
            'links': None,
            'score': None,
            'text': 'Imperial',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.49000000953674316,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.4399999976158142,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': '04019000',
 'label': 'finance (general)',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04019000',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04000000'},
 'score': 0.27000001072883606,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.909053},
 'title': {'polarity': 'positive', 'score': 0.627815}}"
2020-07-02  20:16;Mutual Funds Investment App By Imperial Money;"Mutual Funds Investment App By Imperial Money


        


        Imperial Money - Mutual Funds Investment App






It’s all just on fingertips, No paperwork, No hassles, Invest in the best mutual funds using Imperial Money. All Indian mutual funds are available in one single app. In Imperial money you can start SIP, lump-sum investment for free. Switching of the funds from one fund to other fund and Systematic withdrawal plan or funds from liquid to equity or equity to liquid while re-balancing of the portfolio you can just do it here anytime anywhere you are.
For Mutual Funds Details  Investments Download the App






https://play.google.com/store/apps/details?id=com.iw.imperialmoney
 
Investing becomes easy with your fingertips

· Get Sign up in minutes,
· One time KYC process within the app
· Buy, Sell, Shift mutual funds within fund family.
· Buying Systematic investment plan or doing the STP or SWP is just simple and easy.
Invest in all mutual funds online for free

· You do not require paying any additional cost for buying funds from Imperial money!!
· Most researched Mutual funds baskets are available.
· Sell anytime - Money comes to your bank account directly
· Learn to invest in mutual funds with as low as Amount of Rs.500/- with respect to your objective and planning of life the portfolio are builder for giving one of the state of art experience
Mutual Fund Investing for You:-

· Simple design, Easy to understand
· Made for beginners and experts both
· Financial planning you can do it here itself Invest in the researched and ready-made basket of mutual funds recommended by experts with years together experience bringing for you.
· Latest finance news and insights, notifications
· Most important is the teams of experts are available here to help you out in any type of Issues.
Steps After Imperial Money App Install:

· Verify your KYC
· If the KYC is not available then use following process
· PAN/KYC
· Profile set up
· Make an investment of sip or lumpsum
Need of KYC for mutual funds as per process of the Government of India for making a Tax saving funds (ELSS mutual funds):
Invest in tax saving mutual funds to get tax exemption under section 80c. The total exempt limit is 1.5 Lakhs. Invest in equity mutual funds - small cap, large cap, mid cap, multi-cap - for the long term and higher returns. Check out SIP Calculator to know how much returns you can make.
Safe  Secure: We use the latest security standards to keep your data safe and encrypted.
IMPERIAL MONEY is secure and does not store any information on your device or SIM card. Download and stay connected to your Mutual Fund investments always. Imperial Money uses NSE (National Stock Exchange) for transactions. We support all RTAs - CAMS, Karvy and Franklin.
Following AMC’s are supported on IMPERIAL MONEY Mutual Fund App:
SBI Mutual Fund,NIPPON Mutual Fund,ICICI Prudential Mutual Fund,HDFC Mutual Fund,Aditya Birla Sun Life Mutual Fund,Franklin Templeton Mutual Fund DSP Mutual Fund,Kotak Mutual Fund, Mirae Asset Mutual Fund, Axis Mutual Fund Motilal Oswal Mutual Fund, LT Mutual Fund,IDFC Mutual Fund,INVESCO Mutual Fund UTI Mutual Fund,Sundaram Mutual Fund,Tata Mutual Fund,ITI MUTUAL FUND,BNP PARIBAS MUTUAL FUNDS,EDELWEISSS MUTUAL FUND,HSBC MUTUAL FUND MAHINDRA MUTUALA FUND,PGIM MUTUAL FUND,PRINCIPLE MUTUAL FUND UNION MUTUAL FUND
IMPERIAL MONEY - KEY FEATURES

Access your investments across multiple Mutual Funds through a Single Gateway No more managing multiple PINs, Folios numbers, login ids
· Mobile PIN  Pattern login– Simplified your Imperial Money App login process now. Just pick your preferred login methods – Mobile PIN, Pattern or Password right away
· Paperless Investing: Quick  paperless account creation and instant Activation. Within a couple of minutes, you are all set to ride the new wave of investing.
· Instant SIP: Once you are registered. It takes less than a minute to start a SIP.
· SIP Calculators: With the help of our calculators plan your investment needs to achieve your Financial Goals. Happy investing with Imperial money!!!
Investment Sahi…Future Sahi
IMPERIAL FINSOL PVT. LTD. 

302, Royal Vista Building. Opp.Dhantoli Garden, Dhantoli 

Nagpur. 440012
Contact Us : 8793187860 / 9595889988 / 7887800057
Email Us : wecare@imperialfin.com
Follow Us: 
https://www.facebook.com/imperialfinsolFollow Us: 
https://www.linkedin.com/company/imperialfinsol/Visit Us    : 
www.imperialfin.comImperial Finsol, a Firm committed for providing a personalized solution for your Wealth Management needs. We help you to make smart investment choices with your money to get maximize returns. Knowledge of the financial markets and dedicated Client service team, are the pillars of our success. We now catering to 2000 plus clients. We are a preferred choice of Clients when it comes to Wealth Management.
This release was published on openPR.";"{'body': [{'indices': [[2513, 2515]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Subscriber_identity_module'},
           'score': 0.9988534450531006,
           'text': 'SIM',
           'types': ['Chip']},
          {'indices': [[1872, 1874]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Action_Party_(Mexico)'},
           'score': 0.9028045535087585,
           'text': 'PAN',
           'types': ['Agent', 'Organisation', 'PoliticalParty']},
          {'indices': [[2201, 2209]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Market_capitalization'},
           'score': 1.0,
           'text': 'small cap',
           'types': ['Company', 'Value']},
          {'indices': [[2212, 2220]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Market_capitalization'},
           'score': 1.0,
           'text': 'large cap',
           'types': ['Company', 'Value']},
          {'indices': [[3192, 3195]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/HSBC'},
           'score': 0.9955176711082458,
           'text': 'HSBC',
           'types': ['Bank', 'Agent', 'Company', 'Organisation', 'Banking']},
          {'indices': [[3604, 3611]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Password'},
           'score': 0.700995922088623,
           'text': 'Password',
           'types': ['Word', 'Food', 'Product', 'Person']},
          {'indices': [[3144, 3154]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/BNP_Paribas'},
           'score': 0.9997409582138062,
           'text': 'BNP PARIBAS',
           'types': ['Bank', 'Agent', 'Company', 'Organisation']},
          {'indices': [[1425, 1442]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Financial_plan'},
           'score': 1.0,
           'text': 'Financial planning',
           'types': ['Aircraft', 'Product', 'Evaluation']},
          {'indices': [[3459, 3464], [3581, 3586]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mobile,_Alabama'},
           'score': 0.9510769248008728,
           'text': 'Mobile',
           'types': ['PopulatedPlace',
                     'Place',
                     'City',
                     'Location',
                     'Seat',
                     'Settlement']},
          {'indices': [[457, 462], [467, 472], [2179, 2184]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.5812904834747314,
           'text': 'equity',
           'types': ['Disease', 'Difference']},
          {'indices': [[316, 318],
                       [2292, 2294],
                       [3794, 3796],
                       [3863, 3865],
                       [3870, 3872]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Session_Initiation_Protocol'},
           'score': 0.9898495078086853,
           'text': 'SIP',
           'types': ['Software',
                     'Product',
                     'Protocol',
                     'MusicGenre',
                     'Organisation']},
          {'indices': [[1921, 1923]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Session_Initiation_Protocol'},
           'score': 0.9898495078086853,
           'text': 'sip',
           'types': ['Software', 'Product', 'Protocol', 'MusicGenre']},
          {'indices': [[192, 203],
                       [238, 249],
                       [762, 773],
                       [894, 905],
                       [1145, 1156],
                       [1520, 1531],
                       [1952, 1963],
                       [2043, 2054],
                       [2079, 2090],
                       [2186, 2197]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mutual_fund'},
           'score': 0.9904342889785767,
           'text': 'mutual funds',
           'types': ['PersonFunction']},
          {'indices': [[2978, 2981]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Axis_powers'},
           'score': 0.9957481622695923,
           'text': 'Axis',
           'types': ['PopulatedPlace',
                     'Country',
                     'Place',
                     'Nations',
                     'EthnicGroup',
                     'Location']},
          {'indices': [[2099, 2111]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Tax_exemption'},
           'score': 1.0,
           'text': 'tax exemption',
           'types': ['PersonFunction']},
          {'indices': [[716, 718],
                       [1809, 1811],
                       [1822, 1824],
                       [1876, 1878],
                       [1944, 1946]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Know_your_customer'},
           'score': 1.0,
           'text': 'KYC',
           'types': ['Process', 'Election', 'Organisation']},
          {'indices': [[2681, 2684]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Confederation_of_Australian_Motor_Sport'},
           'score': 0.9900058507919312,
           'text': 'CAMS',
           'types': ['Official']},
          {'indices': [[2207, 2209], [2218, 2220], [2227, 2229], [2238, 2240]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Cap_(sport)'},
           'score': 0.7128609418869019,
           'text': 'cap',
           'types': ['Term']},
          {'indices': [[2001, 2005]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9987794160842896,
           'text': 'India',
           'types': ['PopulatedPlace',
                     'Country',
                     'Place',
                     'MusicalArtist',
                     'Location']},
          {'indices': [[844, 846]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Standard_conditions_for_temperature_and_pressure'},
           'score': 0.6508508324623108,
           'text': 'STP',
           'types': ['Train', 'Sets', 'Organisation']},
          {'indices': [[2918, 2920]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Digital_signal_processor'},
           'score': 0.6129060387611389,
           'text': 'DSP',
           'types': ['Microprocessor']},
          {'indices': [[1102, 1105]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bank'},
           'score': 0.9990931153297424,
           'text': 'bank',
           'types': ['Institution', 'University', 'PersonFunction']},
          {'indices': [[3466, 3468], [3588, 3590]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Personal_identification_number'},
           'score': 0.9767093062400818,
           'text': 'PIN',
           'types': ['Software', 'Product', 'Password', 'Organisation']},
          {'indices': [[4134, 4139]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nagpur'},
           'score': 0.9915165901184082,
           'text': 'Nagpur',
           'types': ['PopulatedPlace',
                     'Place',
                     'City',
                     'Location',
                     'Capital',
                     'Settlement']},
          {'indices': [[3209, 3216]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mahindra_&_Mahindra'},
           'score': 0.8108404278755188,
           'text': 'MAHINDRA',
           'types': ['Corporation', 'Agent', 'Company', 'Organisation']},
          {'indices': [[2853, 2864]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Aditya_Vikram_Birla'},
           'score': 0.6777475476264954,
           'text': 'Aditya Birla',
           'types': ['Person', 'Agent', 'Industrialist']},
          {'indices': [[1754, 1758]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Steps_(pop_group)'},
           'score': 0.9988303184509277,
           'text': 'Steps',
           'types': ['Band', 'Agent', 'Organisation', 'Group']},
          {'indices': [[2611, 2613]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.7858027815818787,
           'text': 'NSE',
           'types': ['Company', 'Exchange']},
          {'indices': [[2616, 2638]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.985880970954895,
           'text': 'National Stock Exchange',
           'types': ['Company', 'Exchange']},
          {'indices': [[2887, 2904]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Franklin_Templeton_Investments'},
           'score': 1.0,
           'text': 'Franklin Templeton',
           'types': ['Bank', 'Agent', 'Company', 'Organisation']},
          {'indices': [[2717, 2719]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
           'score': 0.672776997089386,
           'text': 'AMC',
           'types': ['Cable',
                     'Agent',
                     'Organisation',
                     'Broadcaster',
                     'TelevisionStation']},
          {'indices': [[173, 178],
                       [880, 885],
                       [1470, 1475],
                       [2058, 2063],
                       [2169, 2174]],
           'links': None,
           'score': None,
           'text': 'Invest',
           'types': ['Place']},
          {'indices': [[1607, 1612]],
           'links': None,
           'score': None,
           'text': 'Latest',
           'types': ['Place']},
          {'indices': [[2687, 2691]],
           'links': None,
           'score': None,
           'text': 'Karvy',
           'types': ['Place']},
          {'indices': [[4102, 4104]],
           'links': None,
           'score': None,
           'text': 'Opp',
           'types': ['Place']},
          {'indices': [[4106, 4120]],
           'links': None,
           'score': None,
           'text': 'Dhantoli Garden',
           'types': ['Place']},
          {'indices': [[745, 747]],
           'links': None,
           'score': None,
           'text': 'Buy',
           'types': ['Person']},
          {'indices': [[750, 753], [1067, 1070]],
           'links': None,
           'score': None,
           'text': 'Sell',
           'types': ['Person', 'Organisation']},
          {'indices': [[1126, 1130]],
           'links': None,
           'score': None,
           'text': 'Learn',
           'types': ['Person']},
          {'indices': [[1366, 1369]],
           'links': None,
           'score': None,
           'text': 'Easy',
           'types': ['Person']},
          {'indices': [[2162, 2166]],
           'links': None,
           'score': None,
           'text': 'Lakhs',
           'types': ['Person']},
          {'indices': [[2223, 2225]],
           'links': None,
           'score': None,
           'text': 'mid',
           'types': ['Person']},
          {'indices': [[3626, 3644]],
           'links': None,
           'score': None,
           'text': 'Paperless Investing',
           'types': ['Person']},
          {'indices': [[3693, 3702]],
           'links': None,
           'score': None,
           'text': 'Activation',
           'types': ['Person']},
          {'indices': [[4715, 4720]],
           'links': None,
           'score': None,
           'text': 'openPR',
           'types': ['Person']},
          {'indices': [[4123, 4139]],
           'links': None,
           'score': None,
           'text': 'Dhantoli \n\nNagpur',
           'types': ['Product']},
          {'indices': [[31, 44],
                       [67, 80],
                       [211, 224],
                       [1766, 1779],
                       [2591, 2604],
                       [3502, 3515]],
           'links': None,
           'score': None,
           'text': 'Imperial Money',
           'types': ['Organisation']},
          {'indices': [[67, 106]],
           'links': None,
           'score': None,
           'text': 'Imperial Money - Mutual Funds Investment',
           'types': ['Organisation']},
          {'indices': [[31, 38],
                       [67, 74],
                       [211, 218],
                       [287, 294],
                       [994, 1001],
                       [1766, 1773],
                       [2591, 2598],
                       [3502, 3509],
                       [4001, 4008]],
           'links': None,
           'score': None,
           'text': 'Imperial',
           'types': ['Organisation']},
          {'indices': [[406, 415], [804, 813]],
           'links': None,
           'score': None,
           'text': 'Systematic',
           'types': ['Organisation']},
          {'indices': [[570, 593]],
           'links': None,
           'score': None,
           'text': 'For Mutual Funds Details',
           'types': ['Organisation']},
          {'indices': [[621, 642]],
           'links': None,
           'score': None,
           'text': 'App\n\n\n\n\n\n\n\n \nInvesting',
           'types': ['Organisation']},
          {'indices': [[756, 760]],
           'links': None,
           'score': None,
           'text': 'Shift',
           'types': ['Organisation']},
          {'indices': [[797, 813]],
           'links': None,
           'score': None,
           'text': 'Buying Systematic',
           'types': ['Organisation']},
          {'indices': [[851, 853]],
           'links': None,
           'score': None,
           'text': 'SWP',
           'types': ['Organisation']},
          {'indices': [[1173, 1188]],
           'links': None,
           'score': None,
           'text': 'Amount of Rs.500',
           'types': ['Organisation']},
          {'indices': [[1316, 1336]],
           'links': None,
           'score': None,
           'text': 'Mutual Fund Investing',
           'types': ['Organisation']},
          {'indices': [[1766, 1791]],
           'links': None,
           'score': None,
           'text': 'Imperial Money App Install',
           'types': ['Organisation']},
          {'indices': [[1872, 1878]],
           'links': None,
           'score': None,
           'text': 'PAN/KYC',
           'types': ['Organisation']},
          {'indices': [[1936, 1946]],
           'links': None,
           'score': None,
           'text': 'Need of KYC',
           'types': ['Organisation']},
          {'indices': [[2292, 2305]],
           'links': None,
           'score': None,
           'text': 'SIP Calculator',
           'types': ['Organisation']},
          {'indices': [[2346, 2357]],
           'links': None,
           'score': None,
           'text': 'Safe  Secure',
           'types': ['Organisation']},
          {'indices': [[2435, 2442], [2740, 2747], [3288, 3295], [4047, 4054]],
           'links': None,
           'score': None,
           'text': 'IMPERIAL',
           'types': ['Organisation']},
          {'indices': [[1316, 1326],
                       [2559, 2569],
                       [2755, 2765],
                       [2776, 2786],
                       [2795, 2805],
                       [2824, 2834],
                       [2841, 2851],
                       [2875, 2885],
                       [2906, 2916],
                       [2922, 2932],
                       [2940, 2950],
                       [2965, 2975],
                       [2983, 2993],
                       [3009, 3019],
                       [3025, 3035],
                       [3042, 3052],
                       [3062, 3072],
                       [3078, 3088],
                       [3099, 3109],
                       [3116, 3126]],
           'links': None,
           'score': None,
           'text': 'Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2611, 2638]],
           'links': None,
           'score': None,
           'text': 'NSE (National Stock Exchange',
           'types': ['Organisation']},
          {'indices': [[2697, 2704], [2887, 2894]],
           'links': None,
           'score': None,
           'text': 'Franklin',
           'types': ['Organisation']},
          {'indices': [[2740, 2765]],
           'links': None,
           'score': None,
           'text': 'IMPERIAL MONEY Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2772, 2786]],
           'links': None,
           'score': None,
           'text': 'SBI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2788, 2805]],
           'links': None,
           'score': None,
           'text': 'NIPPON Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2807, 2834]],
           'links': None,
           'score': None,
           'text': 'ICICI Prudential Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2836, 2851]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2853, 2885]],
           'links': None,
           'score': None,
           'text': 'Aditya Birla Sun Life Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2887, 2932]],
           'links': None,
           'score': None,
           'text': 'Franklin Templeton Mutual Fund DSP Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2934, 2950]],
           'links': None,
           'score': None,
           'text': 'Kotak Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2953, 2975]],
           'links': None,
           'score': None,
           'text': 'Mirae Asset Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[2978, 3019]],
           'links': None,
           'score': None,
           'text': 'Axis Mutual Fund Motilal Oswal Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3022, 3035]],
           'links': None,
           'score': None,
           'text': 'LT Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3037, 3052]],
           'links': None,
           'score': None,
           'text': 'IDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3054, 3088]],
           'links': None,
           'score': None,
           'text': 'INVESCO Mutual Fund UTI Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3090, 3109]],
           'links': None,
           'score': None,
           'text': 'Sundaram Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3111, 3126]],
           'links': None,
           'score': None,
           'text': 'Tata Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[3128, 3142]],
           'links': None,
           'score': None,
           'text': 'ITI MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[3169, 3190]],
           'links': None,
           'score': None,
           'text': 'EDELWEISSS MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[3192, 3207]],
           'links': None,
           'score': None,
           'text': 'HSBC MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[3218, 3229]],
           'links': None,
           'score': None,
           'text': 'MUTUALA FUND',
           'types': ['Organisation']},
          {'indices': [[3231, 3246]],
           'links': None,
           'score': None,
           'text': 'PGIM MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[3248, 3286]],
           'links': None,
           'score': None,
           'text': 'PRINCIPLE MUTUAL FUND UNION MUTUAL FUND',
           'types': ['Organisation']},
          {'indices': [[3288, 3316]],
           'links': None,
           'score': None,
           'text': 'IMPERIAL MONEY - KEY FEATURES',
           'types': ['Organisation']},
          {'indices': [[3380, 3395]],
           'links': None,
           'score': None,
           'text': 'a Single Gateway',
           'types': ['Organisation']},
          {'indices': [[1766, 1783], [3502, 3519]],
           'links': None,
           'score': None,
           'text': 'Imperial Money App',
           'types': ['Organisation']},
          {'indices': [[3471, 3477], [3593, 3599]],
           'links': None,
           'score': None,
           'text': 'Pattern',
           'types': ['Organisation']},
          {'indices': [[3647, 3651]],
           'links': None,
           'score': None,
           'text': 'Quick',
           'types': ['Organisation']},
          {'indices': [[3870, 3884]],
           'links': None,
           'score': None,
           'text': 'SIP Calculators',
           'types': ['Organisation']},
          {'indices': [[4068, 4070]],
           'links': None,
           'score': None,
           'text': 'LTD',
           'types': ['Organisation']},
          {'indices': [[4361, 4377], [4666, 4682]],
           'links': None,
           'score': None,
           'text': 'Wealth Management',
           'types': ['Organisation']}],
 'title': [{'indices': [[31, 44]],
            'links': None,
            'score': None,
            'text': 'Imperial Money',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.5199999809265137,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.5099999904632568,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': '04019000',
 'label': 'finance (general)',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04019000',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04000000'},
 'score': 0.2800000011920929,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.963308},
 'title': {'polarity': 'neutral', 'score': 0.663634}}"
2020-07-01  23:38;Morningstar downgrades two HDFC Mutual Fund's equity schemes to 'silver';"HDFC AMC’s star Prashant Jain has seen two of his schemes downgraded by recently. HDFC Top 100 and HDFC Equity have been downgraded from ‘gold’ to ‘silver’ by the (MF) research house.

“Prashant Jain’s long-term investment approach to investing, which entails taking high-risk conviction bets and sticking to them if they underperform over the short term, has often yielded satisfactory results,” said Himanshu Srivastava, senior analyst at

“The execution has been noteworthy. Yet, there have been occasions when the strategy has resulted in significant underperformance for the fund, such as in 2013 and 2015,” he added.

While the fund’s ability to make a comeback after hitting a trough was taken into account, the grading note also observed that the risk in strategy had also risen steadily.

According to data from Value Research, HDFC Top 100 fund is down 21 per cent in one-year period, as against 11.45 per cent dip in BSE 100 total return index. HDFC Equity Fund is down more than 23 per cent in the same period, as against 10.9 per cent dip in BSE 500 total return index.

Both the schemes have been popular among and are among the larger schemes in their respective categories.

As of June 30, 2020, HDFC Top 100 had assets under management of Rs 15,481 crore. HDFC Equity fund had asset base of Rs 18,495 crore.

note pointed out that Jain’s investment strategy has not been able to fully to adapt to changing market dynamics. “Consequently, while the risk in the strategy has gone up sharply, there are times when the fund has been found wanting in terms of generating commensurate returns for investors,” Srivastava said.

The note maintained conviction in Jain's skilled fund management and fund's ability to deliver outperformance over a market cycle, albeit with relatively higher volatility/risk.";"{'body': [{'indices': [[25, 28], [195, 198], [1348, 1351], [1672, 1675]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Jainism'},
           'score': 0.9997768998146057,
           'text': 'Jain',
           'types': ['EthnicGroup', 'Religion', 'Country', 'Person']},
          {'indices': [[11, 14]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Star'},
           'score': 0.9981689453125,
           'text': 'star',
           'types': ['Sphere', 'ArtificialSatellite', 'Product']},
          {'indices': [[928, 930], [1055, 1057]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bovine_spongiform_encephalopathy'},
           'score': 0.461469441652298,
           'text': 'BSE',
           'types': ['Disease', 'Organisation']},
          {'indices': [[1294, 1298]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asset'},
           'score': 0.9972822666168213,
           'text': 'asset',
           'types': ['Work', 'Product', 'Resource']},
          {'indices': [[138, 141]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Gold'},
           'score': 0.9569670557975769,
           'text': 'gold',
           'types': ['Currency', 'Element', 'MilitaryUnit']},
          {'indices': [[164, 165]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Midfielder'},
           'score': 0.988832950592041,
           'text': 'MF',
           'types': ['Position', 'Person', 'Organisation']},
          {'indices': [[1687, 1701]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asset_management'},
           'score': 0.7408838868141174,
           'text': 'fund management',
           'types': ['MusicGenre']},
          {'indices': [[1266, 1270], [1318, 1322]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[1638, 1645]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/List_of_Dynasty_episodes'},
           'score': 0.9684581756591797,
           'text': 'The note',
           'types': ['List']},
          {'indices': [[684, 689]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Trough_(meteorology)'},
           'score': 0.9898504614830017,
           'text': 'trough',
           'types': ['Region', 'Settlement']},
          {'indices': [[1799, 1808]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Volatility_(finance)'},
           'score': 0.9730975031852722,
           'text': 'volatility',
           'types': ['Degree', 'University']},
          {'indices': [[1355, 1373]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Investment_strategy'},
           'score': 1.0,
           'text': 'investment strategy',
           'types': ['Set', 'PersonFunction']},
          {'indices': [[5, 7]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/AMC_(TV_channel)'},
           'score': 0.7674976587295532,
           'text': 'AMC',
           'types': ['TelevisionStation',
                     'Agent',
                     'Cable',
                     'Broadcaster',
                     'Organisation',
                     'Product']},
          {'indices': [[1256, 1264]],
           'links': None,
           'score': None,
           'text': 'Rs 15,481',
           'types': ['Place']},
          {'indices': [[1308, 1316]],
           'links': None,
           'score': None,
           'text': 'Rs 18,495',
           'types': ['Place']},
          {'indices': [[16, 28], [186, 198]],
           'links': None,
           'score': None,
           'text': 'Prashant Jain',
           'types': ['Person']},
          {'indices': [[402, 420]],
           'links': None,
           'score': None,
           'text': 'Himanshu Srivastava',
           'types': ['Person']},
          {'indices': [[0, 3],
                       [82, 85],
                       [99, 102],
                       [837, 840],
                       [956, 959],
                       [1212, 1215],
                       [1273, 1276]],
           'links': None,
           'score': None,
           'text': 'HDFC',
           'types': ['Organisation']},
          {'indices': [[99, 109], [956, 966], [1273, 1283]],
           'links': None,
           'score': None,
           'text': 'HDFC Equity',
           'types': ['Organisation']},
          {'indices': [[821, 834]],
           'links': None,
           'score': None,
           'text': 'Value Research',
           'types': ['Organisation']},
          {'indices': [[837, 853]],
           'links': None,
           'score': None,
           'text': 'HDFC Top 100 fund',
           'types': ['Organisation']},
          {'indices': [[928, 934]],
           'links': None,
           'score': None,
           'text': 'BSE 100',
           'types': ['Organisation']},
          {'indices': [[956, 971]],
           'links': None,
           'score': None,
           'text': 'HDFC Equity Fund',
           'types': ['Organisation']},
          {'indices': [[82, 93], [837, 848], [1212, 1223]],
           'links': None,
           'score': None,
           'text': 'HDFC Top 100',
           'types': ['Organisation']},
          {'indices': [[411, 420], [1620, 1629]],
           'links': None,
           'score': None,
           'text': 'Srivastava',
           'types': ['Organisation']}],
 'title': [{'indices': [[46, 51]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
            'score': 0.6815910339355469,
            'text': 'equity',
            'types': ['Disease', 'Difference']},
           {'indices': [[0, 10]],
            'links': None,
            'score': None,
            'text': 'Morningstar',
            'types': ['Organisation']},
           {'indices': [[27, 42]],
            'links': None,
            'score': None,
            'text': 'HDFC Mutual Fund',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.30000001192092896,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.20999999344348907,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.03999999910593033,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'neutral', 'score': 0.592766},
 'title': {'polarity': 'neutral', 'score': 0.842487}}"
2020-07-01  20:56;HDFC MF acquires shares in Anup Engineering, Birla Sun Life Insurance offloads stake in Somany Ceramics;"HDFC Mutual Fund has acquired 0.81 percent equity stake in Anup Engineering via open market transactions on July 1.

The fund house through its HDFC Retirement Savings Fund-Equity Plan has bought 83,513 equity shares at Rs 380.1 per share, as per bulk deals data on the National Stock Exchange (NSE).

Among other deals, Birla Sun Life Insurance Company sold 2,27,000 shares in Somany Ceramics (representing 0.53 percent of its total paid-up equity capital) at Rs 117.8 per share.

Sanghvi Associates bought 3.5 lakh equity shares in BC Power Controls at Rs 5.15 per share, while Bessemer India Capital OGPL sold another 1,31,69,304 shares in Orient Green Power Company (representing 1.75 percent of its total paid-up equity capital) at Rs 2.8 per share.

On June 30, Bessemer India Capital OGPL had sold 44,38,085 shares (0.59 percent stake) in Orient Green Power at Rs 2.62 per share. It had held 13.16 percent, or 9,87,95,691 shares, in Orient Green Power as of March 31.

Pratik Bankda sold 20 lakh shares in Syncom Healthcare at Rs 3.15 per share on the NSE, whereas Saumil Arvind Bhavnagari and Nupur Anil Shah acquired 3,07,933 and 5 lakh shares, respectively, at Rs 3.15 per share.";"{'body': [{'indices': [[580, 587], [768, 775]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bessemer,_Alabama'},
           'score': 0.674635112285614,
           'text': 'Bessemer',
           'types': ['City',
                     'Location',
                     'Settlement',
                     'Place',
                     'PopulatedPlace']},
          {'indices': [[43, 48],
                       [203, 208],
                       [442, 447],
                       [517, 522],
                       [718, 723]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.5394750833511353,
           'text': 'equity',
           'types': ['Difference', 'Disease']},
          {'indices': [[442, 455], [718, 731]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 1.0,
           'text': 'equity capital',
           'types': ['Difference', 'Disease']},
          {'indices': [[1101, 1105]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Rati_Pandey'},
           'score': 1.0,
           'text': 'Nupur',
           'types': ['Person', 'Agent', 'Actress']},
          {'indices': [[558, 561]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/5:15'},
           'score': 1.0,
           'text': '5.15',
           'types': ['Single', 'Work', 'Product', 'MusicalWork']},
          {'indices': [[589, 593], [777, 781]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9988606572151184,
           'text': 'India',
           'types': ['Location',
                     'Place',
                     'PopulatedPlace',
                     'MusicalArtist',
                     'Country']},
          {'indices': [[203, 215], [517, 529]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Common_stock'},
           'score': 1.0,
           'text': 'equity shares',
           'types': ['Form']},
          {'indices': [[512, 515], [998, 1001], [1141, 1144]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Organisation', 'Unit']},
          {'indices': [[327, 352]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Sun_Life_Financial'},
           'score': 1.0,
           'text': 'Sun Life Insurance Company',
           'types': ['Organisation', 'Bank', 'Company', 'Agent']},
          {'indices': [[50, 54], [836, 840]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Stake_(Latter_Day_Saints)'},
           'score': 0.6365368366241455,
           'text': 'stake',
           'types': ['Organisation', 'Unit']},
          {'indices': [],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 1.0,
           'text': 'National Stock Exchange (NSE)',
           'types': ['Company', 'Exchange']},
          {'indices': [[295, 297], [1059, 1061]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.8222297430038452,
           'text': 'NSE',
           'types': ['Company', 'Exchange', 'Organisation']},
          {'indices': [[976, 988]],
           'links': None,
           'score': None,
           'text': 'Pratik Bankda',
           'types': ['Person']},
          {'indices': [[1072, 1095]],
           'links': None,
           'score': None,
           'text': 'Saumil Arvind Bhavnagari',
           'types': ['Person']},
          {'indices': [[1101, 1115]],
           'links': None,
           'score': None,
           'text': 'Nupur Anil Shah',
           'types': ['Person']},
          {'indices': [[0, 15]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[59, 74]],
           'links': None,
           'score': None,
           'text': 'Anup Engineering',
           'types': ['Organisation']},
          {'indices': [[144, 183]],
           'links': None,
           'score': None,
           'text': 'HDFC Retirement Savings Fund-Equity Plan',
           'types': ['Organisation']},
          {'indices': [[220, 221],
                       [461, 462],
                       [555, 556],
                       [737, 738],
                       [868, 869],
                       [1034, 1035],
                       [1171, 1172]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Organisation']},
          {'indices': [[270, 292]],
           'links': None,
           'score': None,
           'text': 'National Stock Exchange',
           'types': ['Organisation']},
          {'indices': [[321, 352]],
           'links': None,
           'score': None,
           'text': 'Birla Sun Life Insurance Company',
           'types': ['Organisation']},
          {'indices': [[378, 392]],
           'links': None,
           'score': None,
           'text': 'Somany Ceramics',
           'types': ['Organisation']},
          {'indices': [[482, 499]],
           'links': None,
           'score': None,
           'text': 'Sanghvi Associates',
           'types': ['Organisation']},
          {'indices': [[534, 550]],
           'links': None,
           'score': None,
           'text': 'BC Power Controls',
           'types': ['Organisation']},
          {'indices': [[580, 606], [768, 794]],
           'links': None,
           'score': None,
           'text': 'Bessemer India Capital OGPL',
           'types': ['Organisation']},
          {'indices': [[643, 668]],
           'links': None,
           'score': None,
           'text': 'Orient Green Power Company',
           'types': ['Organisation']},
          {'indices': [[643, 660], [846, 863], [940, 957]],
           'links': None,
           'score': None,
           'text': 'Orient Green Power',
           'types': ['Organisation']},
          {'indices': [[1013, 1029]],
           'links': None,
           'score': None,
           'text': 'Syncom Healthcare',
           'types': ['Organisation']}],
 'title': [{'indices': [[5, 6]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Midfielder'},
            'score': 0.9920845031738281,
            'text': 'MF',
            'types': ['Person', 'Position', 'Product']},
           {'indices': [[79, 83]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Stake_(Latter_Day_Saints)'},
            'score': 0.41401511430740356,
            'text': 'stake',
            'types': ['Organisation', 'Unit']},
           {'indices': [[0, 3]],
            'links': None,
            'score': None,
            'text': 'HDFC',
            'types': ['Organisation']},
           {'indices': [[27, 42]],
            'links': None,
            'score': None,
            'text': 'Anup Engineering',
            'types': ['Organisation']},
           {'indices': [[45, 68]],
            'links': None,
            'score': None,
            'text': 'Birla Sun Life Insurance',
            'types': ['Organisation']},
           {'indices': [[88, 102]],
            'links': None,
            'score': None,
            'text': 'Somany Ceramics',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.4699999988079071,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-11',
 'label': 'Stocks',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-11',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.15000000596046448,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': '04011002',
 'label': 'automotive equipment',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04011002',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04011000'},
 'score': 0.14000000059604645,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.725884},
 'title': {'polarity': 'neutral', 'score': 0.815133}}"
2020-06-30  02:27;Glenmark Pharmaceuticals ADR (GLKQY) CEO Glenn Saldanha on Q4 2020 Results - Earnings Call Transcript;"Ladies and gentlemen, good day, and welcome to Q4 FY20 Earnings Conference Call of Glenmark Pharmaceuticals Limited [Operator Instructions]. Please note that this conference is being recorded.

I would now like to hand the conference over to Mr. Jason D'souza. Thank you, and over to you, sir.

Thank you moderator. Welcome to Glenmark's Q4 earnings call. Before I start the call, I would like to introduce the members at Glenmark. We have Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals V. S. Mani, Executive Director and CFO, Glenmark Pharmaceuticals and Robert Matsuk, President, North America.

First, the review of operations for the quarter ended March 31, 2020. For the fourth quarter, Glenmark's consolidated revenue was at INR27,674 million, recording an increase of INR796 million. For the year ended Glenmark's consolidated revenue was INR106,406.69 million recording an increase of 7.86%.

Business update on account of the COVID situation. The COVID-19 pandemic and the subsequent lockdown across India affected Glenmark's production facilities in the month of March and April. However, by the end of April, Glenmark's manufacturing units managed to stabilize production and logistics were also in place in order to ensure uninterrupted supply to all our markets. As of now, all of Glenmark's manufacturing facilities are operational and the supply of raw material has also improved significantly. Further, internal logistics within India was stabilized by end April and exposed to all markets resumed to a significant extent by the first week of May.

Since the start of the outbreak, Glenmark's employees across operations around the world have worked round the clock to formulate and adopt best practices that adhere to the highest standards of safety. Glenmark's employees have also facilitated the uninterrupted supply of medicines to every market it services. The company has made significant efforts to reduce the volume on the community on account of COVID-19 across its operational countries and manufacturing locations. The details are available on the company's website.

In a landmark development for COVID-19 patients in India, Glenmark announced the launch of anti drug antiviral drug, Favipiravir, brand name FabiFlu for the treatment of mild to moderate COVID-19 patients. Glenmark received manufacturing and marketing approval from India's regulator as part of the accelerated approval process, considering the emergency situation of the COVID-19 outbreak in India.

The approvals restricted use entails responsible medication use where every patient must have signed an informed consent before treatment indication. Glenmark approvals from India’s regulators makes FabiFlu the first oral Favipiravir approved medication in India for the treatment of COVID-19. Glenmark would be conducting a post marketing study as recommended by the Indian regulator on Favipiravir on thousand patients of mild to moderate COVID-19 for further evaluation of safety and efficacy.

Further, Glenmark also recently announced a new randomized open label study to test the combined efficacy of two antiviral drugs, Favipiravir and c, as a potential COVID-19 treatment strategy. The two antiviral drugs have a different mechanism of action, and their combination may demonstrate improved treatment efficacy by effectively tackling high viral loads in patients during early stage of the disease.

Early administration of a combination of antiviral medications acted by different mechanism is desirable for the treatment of COVID-19, since the viral load of SARS-CoV-2 peaks around the time of symptom onset. The new combination trial will be called FAITH. 158 hospitalized patients of moderate COVID-19 infections will be enrolled in the combination study and randomized in two groups one group receiving Favipiravir and Umifenovir with standard supportive care and one group receiving Favipiravir along with standard supportive care.

The business, first the India business. Sales for the formulation business in India for the fourth quarter was INR7607.53 million, recording a growth of 14.52%. The India business continued to outperform the industry growth as per IQVIA. Glenmark‘s India business recorded growth of 15.90% as compared to IPM growth of 9.68%. As for IQVIA MAT, March 20, Glenmark's India business recorded growth of 14.22% as compared to IPM growth of 10.55%. In terms of market share, Glenmark's India business for the segment in the support therapy areas, such as cardiac, diabetes and respiratory.

In April 2019, Glenmark announced the launch of this novel patent protected globally research SGLT-2 inhibitor Remogliflozin etabonate in India. Glenmark is the first company in the world to launch Remogliflozin and the response from KOLs has been extremely positive. As per IQVIA March 20 data, the sales for the Remogliflozin franchise is tracking at INR53 million per month. Glenmark has attained 7.34% market share in March '20 in terms of value in the overall SGLT-2 market in India.

Glenmark has also launched the combination of Remogliflozin etabonate and Metformin hydrochloride for adults with Type 2 diabetes. The combination of the product has also received a good response from the market with sales crossing INR10 million in the month of March '20 itself. During the fourth quarter, Glenmark announced the partnership of its gynaecology division with Integrace Limited, a True North company. Thus, under this arrangement, the gynaecology business of India and Nepal was transferred to Integrace along with the employees of that division. The gynaecology division revenue is insignificant to the overall India business and is part of Glenmark's non-core business. The transaction was signed and closed in the fourth quarter of the financial year.

Glenmark's consumer care business in India continue to maintain a strong growth momentum of 31% in the fourth quarter, setting a new milestone of sales of INR2,038 million, INR203 crores in this financial year. The strong growth in the fourth quarter was led by candid dusting powder with the highest ever growth of 38%. Modern trade channel led to the growth agenda for consumer care portfolio with 34% growth during the year.

During the quarter, the company announced that it entered into an agreement with Hindustan Unilever Limited for the divestment of its VWash brand and other extension. Under this agreement, the brand and other trademark copyrights knowhow associated with Glenmark’s VWash business will be transferred to HUL. Glenmark will receive an upfront payment and a certain percentage of sales for three years. No employees will be transferred as part of this agreement. The transaction was completed on June 25, 2020.

USA, Glenmark pharmaceuticals recorded revenue of finished dosage of INR7,619 million, USD105.11 million, recording fee growth of minus 1%. In the fiscal year '19-'20, Glenmark was given 14 ANDAs comprising of 12 final and two tentative approvals. Additionally, Glenmark was also granted approvals on a pass to make an over the counter version of Adapalene Gel 0.1% available. Notable approvals during the year include Fulvestrant Injection, Pimecrolimus Cream, Deferasirox tablets for oral suspension. The company filed a total of ANDA applications with the USFDA throughout the fiscal year.

The genetic industry continues to be subdued with the overall generic topical dermatology market continuing to witness price erosion on a Q-on-Q basis. On a YTD basis, the overall genetic topical dermatology market is estimated to witness price erosion of around 20% for the entire financial year. During the financial year, the U.S. business was significantly impacted in terms of accounts of three products, Mupirocin Cream, Atomoxetine and Calcipotriene Cream. Further, the sales was also impacted in the year due to ranitidine.

Glenmark completed the successful launch of 16 products during the financial year. Africa, Asia and CIS region. For the fourth quarter, the revenue from this region was INR3,365 million, recording de-growth of 12.65%. In the fourth quarters of financial year, secondary sales Russian subsidiary showed 3.8% growth in value. The Russia business continued to be subdued in the fourth quarter and currency devaluation further impacted the business. The Asia region’s performance in the fourth quarter was averaged and secondary sales of only 1% reported for the region. Sales continued to remain subdued across all major Asian markets for Glenmark. The African region recorded secondary sales growth in the fourth quarter, the secondary sales growth was on account of the performance of the Kenya subsidiary.

Europe. Glenmark‘s Europe operation revenue was for the fourth quarter was INR4,115 million, recording growth of 29.26%. Glenmark’s Europe operations performed well in the fourth quarter recording growth in excess of 20% in constant currency. The Western European business recorded growth of 23% in the quarter on account of good growth recorded by the German subsidiary. The Central Eastern European business grew well in the fourth quarter. During the quarter, Glenmark Poland announced the partnership of its CNS portfolio to Neuraxpharm, a leading European pharma company.

Following the transaction the Glenmark CNS commercial team in Poland will join Neuraxpharm’s Polska existing sales and marketing organization to create a strong player in the Polish CNS market with excellent access to psychiatrists, neurologists and pharmacies. Latin America. Glenmark’s revenue from its Latin America and Caribbean operations was at INR1,768 million, recording an increase of 46.9%. The strong growth recorded with a subsidiary was in account of the Brazil subsidiary, which continues to benefit from the launch of three respiratory products licensed from Novartis. During the quarter, the Brazilian subsidiary announced the partnership of a set of dermatology brands with a leading Brazilian pharmaceutical company, Hypera. The transaction was signed in the fourth quarter of the financial year.

GPL, speciality and innovative pipeline, Ryaltris. Ryaltris nasal spray is the company's respiratory pipeline and is currently under review with the US FDA as a treatment of seasonal allergic rhinitis in the USA. During the fourth quarter, Glenmark and Hikma entered into an exclusive licensing arrangement for the commercialization of Ryaltris seasonal allergic rhinitis nasal spray in the U.S. Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltris by the US FDA, while Hikma will be responsible for the commercialization of Ryaltris in the U.S. Glenmark will receive an upfront payment and on regulatory approval also. Glenmark will also receive commercial milestone payments, as well as royalties from Hikma called Ryaltris.

Besides the U.S. deal, Glenmark has also already signed licensing deals for commercializing Ryaltris in China, Australia, New Zealand and Korea. Glenmark is working close to close a partnership for Ryaltris in various other markets, including the EU. The company has already filed an application for Ryaltris approval in the European Union. During the first quarter FY19, ‘20, the US FDA has issued a CRL pertaining to the new drug application for Ryaltris. We continue to work with the agency to resolve the issue in the CRL. The CRL’s response is currently on track for submission shortly. We are in communication with the FDA and all deficiencies except facility clearances are minor in nature and have already been addressed.

During the third quarter of the financial year, Glenmark announced that its partner Seqirus Australia has received marketing approval for Ryaltris from TGA Australia. We have already dispatched large quantities to Seqirus in this month and they are planning for the launch of Ryaltris in Australia in Q2 FY21. Recently, the company's approval -- company’s partner in South Korea, Yuhan Corporation, also received regulatory approval, which paves the way for the launch of Ryaltris in South Korea. Further, in the last few months, Ryaltris has been approved in Cambodia, Uzbekistan, Namibia and South Africa. Also, Ryaltris clinical trials in Russia have been completed and the subsidiary will shortly seek regulatory approval from the regulator.

GBR-310, during FY19, Glenmark announced phase one results, suggest similarity in pharmacokinetics, pharmacodynamic, safety and immunogenicity profiles between GBR-310 and the reference product, omalizumab. The company is in discussions with potential partners and is targeting to conclude a deal before initiating phase three studies. GRC 39815, this compound is currently in preclinical development and the company plans to initiate a phase one study shortly. Glenmark Life Sciences. For the fourth quarter, external sales of Glenmark Life Sciences was at INR2,613 million as against $2,487 million, recording growth of 5.07%. For the entire year, external sales of Glenmark Life Sciences recorded revenue of INR10,239 million as against INR9,493 million recording growth of 7.86%.

Ichnos Sciences. For the nine months ended December 31, 2020, Glenmark invested INR5,943 million, INR85.03 million and in the fourth quarter of the financial year, the company invested approximately INR2,250 million. Thus, for the entire financial year, Glenmark invested INR8,193 million, equivalent of USD115.73 million in Ichnos Sciences. Ichnos Sciences initiated the process to raise capital in the U.S. in the current month to fund the development of its pipeline and for future growth plans. For further updates on the pipeline and the organization, please log on to ichnossciences.com. The pipeline update for the fourth quarter is published.

Update on the Chief Commercial Officer for Glenmark Pharmaceuticals Limited. Glenmark recently announced the appointment of Mr. Robert Crockart as Chief Commercial Officer Glenmark Pharmaceuticals Limited. Mr. Crockart will be based at Glenmark's head office in Mumbai and will report directly to the Chairman and Managing Director. Mr. Crokart comes with 26 years of end to end experience across various industries, including pharmaceutical industries, consumer, health, retail, pharmaceutical, wholesale and outsourcing. He has successfully completed and transformed businesses for growth across multiple geographies in Europe, Asia, Latin America, Middle East and Africa.

Prior to Glenmark, Mr. Crokart was divisional Vice President Asia-Pacific for Abbott. He was instrumental in expanding the MEAP region for Abbott year on year for over five years as EVP. He also established the EPD sales and strategy globally across all emerging markets, and contribute consistently to the overall achievements of the business. All the business heads at Glenmark will report into Mr. Crokart. He will be responsible for the entire formulation business of Glenmark Pharmaceuticals.

Before we open the floor for question and answers a few notes. The R&D expenditure for the quarter was INR350 crores, which was around 12.6% of sales. R&D expenditure for the year was INR1,352 crores, which was 12.7% of sales. Innovation expenditure was at INR819 crores, which constitute 60% of the overall R&D expenditure. Generic R&D expenditure was INR533 crores, which contributes around 40% of the total R&D expenditure. ForEx gain and other income was INR35 crores in Q4 and was INR115 crores in the full year. This is recorded in other income.

Inventory was INR2,136 crores at 73 days in FY20 as compared to INR2,252 crores at 83 days in FY '19. Receivables was INR2,409 crores at 83 days in FY20 as compared to INR2,195 crores at 81 days in FY19. Payables was INR2,126 crores at 73 days in FY'20 as compared to INR2,221 crores at 82 days in FY19. Net working capital was at INR2,419 crores at 83 days in FY20 as compared to INR2,226 crores at 82 days in FY19. Gross debt was INR4,868 crores as on March 31, 2020.

Net debt was at INR3,758 crores as on March 31, 2020. Net debt at constant currency has come down by USD14 million as compared to the quarter ended December 31, 2020, where it stood at 513 million as compared to presently where it is at 499 million. Impact on currency on gross debt was over 375 crores for the year. Total asset addition during the year was 931 crores, down from 1,237 crores in FY19.

With this, moderator, we would like to open the floor for question and answers. Over to you.

[Operator Instructions] We take the first question from the line of Prakash Agarwal from Axis Capital.

Glenn, first question for you in terms of understanding the revenue that we have clogged in in India and Europe. Are there any COVID related one-offs stocking, or how could we think about fiscal '21 across your major revenue items U.S., India, Europe, et cetera?

Prakash, if I look at India, in Q4 itself right, because there was some patients talking we saw. We got some positive benefit coming on account and particularly in the last two, three weeks of the quarter. As far as Europe goes, I think because of the Italian situation, one of our competitors was not able to supply and we were able to get some good business out of that in the last month of the quarter. I mean the run rate for both India and Europe, obviously, we cannot sustain this run rate in this current year, given the COVID situation and Q1 being a challenging quarter on account of COVID.

Any guidance you're giving on overall top line…

We're not giving any guidance this year, Prakash.

And any color on US, I mean in terms of like you said India and Europe. U.S., since we had a softer base given the dermal pressure, rising pressure now. How does it look fiscal '21 in terms of launches and in terms of growing on that base?

So, the U.S. continues to be a challenging environment. But our view is we have some good launches coming up, so there could be some benefits we see out of the U.S.

And my second question on the cost front, so we have seen significant improvement on the cost side. So, are we like 50% done on the cost side or there is more to go in the fiscal '21?

Yes, Prakash. So, Mani here. So, as it is on the cost front on the other expenses, you can actually see that all the efforts we put over the last one, two years has really borne fruit. So going forward, we also look at reducing or keeping some of our cost under check, both on the manpower cost front, as well as on the R&D front, okay. So both of this will subsequently also tie in, you know bring down the cost position.

So there is more room you are saying?

Yes, definitely, there is some more room.

And my last question on Favipiravir, so congrats on that. Just trying to understand how has been the initial pick up since it's the only oral for mild to moderate, and what are the expectation in terms of patient penetration and has health ministry or ICMR approved the drug?

So, look, Favi is a good launch for the company. However, obviously, this is a drug which is approved under emergency authorization and as to be prescribed by the doctor. So, there are quite a lot of restrictions in terms of usage of the drug but it's a good launch. It'll help patients in these COVID times where there is hardly any therapy out there. We think it can really benefit patients and it'll help in the longer-term as far as the company goes.

And last one if I may squeeze in on, follow up on Favipiravir. The combination looks more promising, and what are the timelines for that?

So combination we have initiated the trials, I can't give a definitive time line but it will take two, three months from this.

For the launch, or you completing the trial?

Thank you [Operator Instructions]. We will take next question from the line of Nitin Agarwal from IDFC Securities. Please go ahead.

Glenn, couple of things on the CapEx at 900 crores, it still stays reasonably high versus most of our industry peers who’s pretty much seemed to be consolidating more for the last two, three years now. I mean for us now how are you looking at this you know this whole CapEx spend situation going forward?

So, Nitin. This is Mani here. So, I think it will come down even more here. So we expect it to be around 700 or little higher than that. So, I mean, as we are guided even the last time, because we had some expenses in Monroe, et cetera, et cetera that is why it was a little bit higher. But going forward, we will see it lower, okay, both on the regulatory whatever we do, the routine CapEx as well as any growth or on that all put together, it should all be well below, I mean much lower than INR800 million.

So, still where how would you split it roughly between tangibles and intangibles, the INR700 million to INR800 million going forward roughly?

It should be about max about INR200 million for the in-licensing or whatever we do, and the rest will all be towards actually largely growth CapEx and routine CapEx. So, we will definitely try to bring it down, yes.

So this INR500 million, INR600 million on the tangible CapEx, do you think that's going to stay at these levels, it's not going to come down below that?

It will come down little below that as well, yes. We’ll see how much we can push it. We'll definitely try to bring in below that.

Secondly, Glenn, I want on the Favi, I mean how do you look at export opportunity for -- how should one look at export part opportunity for this product?

Well, Nitin, there are opportunities. Favi is already approved for emergency authorization in a host of countries, right, Russia, China, Japan, Italy, Saudi Arabia, Bangladesh, so many countries. So, there is an export opportunity going forward. But our first goal is to try and make it available to Indian patients. So, Indian patients get the maximum benefit.

And in terms of capacity, is there a constraint to capacity that we have for the product assuming there is a pick-up of the drug as per the trials and all go through?

No, we don't have any constraints, we have adequate capacities.

And lastly on R&D, I mean the breakup that you’ve provided us, I mean at [500] odd crores of generic spends. R&D spends are little, are fairly muted versus what’s the size of the business, right? So are we in the risk of under investing in certain businesses over the last couple of years and it’s probably reflecting the way our U.S. has grown. I mean how should one look at that number, and in terms of how it’s been in the recent past and how it will be going forward?

I think R&D as a percent to sales will come down substantially on account of just reducing overall R&D costs, even Ichnos spend Y-o-Y coming down this year compared to last year. Additionally, I think it's important to keep in mind that Ichnos will capital raise this year, so that will further take out that, improve our cash flows there. So, I think R&D, there is substantial scope for improvement overall as a percentage of sales.

And in what timelines it will for the Ichnos fund raise?

So, we've initiated the process, we'll see when it gets done.

[Operator Instructions] Next is from the line of Shyam Srinivasan from Goldman Sachs.

My first one is on the efficacy for Favipiravir as a COVID-19 treatment. There's lots of literature around the world, including from Japan. So, just want to understand how effective is this drug and has it completed our trials that we initiated, or we’re just in the process of completing the trials just for Favipiravir? I am not looking about the combination. So that’s my first question.

So, I think Favipiravir has several, keep in mind that COVID is only a four to six month event. So all trials, I mean, there are tons and tons of trials going on globally on Favipiravir. And over 5,000 patients have been treated with Favipiravir. So, there's a sufficient safety database there. As far as efficacy, there are several trials globally, which have shown the drug is actually working, namely in mild and moderate. I mean, there are studies coming out of multiple geographies, because it's been so -- it's only been four to six months, many of these trials are now beginning to report. As far as Glenmark goes, we have -- now we've completed the randomization and we are still -- some of the patients are still completing the trial. So we are hoping that the trial should complete shortly and then we will unlock the database and get the data. So, that's kind of where we stand.

So Glenn, you will make the data public, right? What was the trial data at some point…

My second question is on Ryaltris. I think the MD&A talks about the next steps. But I think critical in that is the plant resolution. So, if you can update us on the plant resolution or [Favi]?

So we're still working on that, on resolving the open items for [Favi].

So any timelines, because we've seen a host of Indian plant getting cleared. Is there something that, does it require an inspection, just can it be done through virtual audit, if you can help us just understand some timing?

I can't comment on that. I can't give any more visibility other than to say that we are working on it and it should happen soon.

And the last follow up on that is, so it will be contingent I think the Ryaltris approval for the U.S. is contingent on that clearance, right?

We have an alternate site also under qualification, so hopefully that should further help.

And the last question is on the Latin American business. You talked about Europe and India being not sustainable. But do you think the run rate that you're seeing in the Latin American business, is that something, or does it also have some one-offs for the fourth quarter?

So Latin America by enlarge had no one-offs in the fourth quarter. But keep in mind because of COVID, right, I think Q1 is going to be challenging for most geographies around the world, particularly countries in Latin America.

Thank you. We take the next question from the line of Saion Mukherjee from Nomura. Please go ahead.

My first question is on the cost related to the Monroe site. How much has already come in? Can you quantify the number below, above EBITDA and also on the depreciation, because of commissioning of the site?

So Saion, in this quarter, I mean it just got property commercialized only at the end of the quarter. So obviously, there’s not too much on that. On the depreciation, also it does not a very, very significant amount, okay. So I think you'll see the full impact of that in the next quarter.

So can you just quantify the numbers that you see on expense and on depreciation?

It's not much as of now. But going forward, you will definitely see at least INR10 million add to the expenses, which should be absorbed with the products we manufacture there.

So, this is annualized number you are saying?

Exactly, on the OSD side, yes.

So, basically it seems to be a mixed bag. So how do you lead on commercial liability at this stage, given that the secondary endpoint was not met and how to think about the results and any comments there?

Your question was on ISB830, right?

So I was, my question is on ISB830, your comments on that, given the pace to be reverses which came out, it seems to be a mixed bag with the higher benchmark secondary endpoint, not met and you're looking for a higher dose there. So in this backdrop, how do you see this product and commercial liability and potential outlicensing deal there?

So I think from this study, right, we can just conclude that the drug worked right at the top dose. And we're waiting for the part two data and hopefully, the part two, we will need primary and secondary endpoints, so that should help the drug. But you're right, I mean, it is what it is at this point.

[Operator Instructions] We take the next question from the line of Vishal Manchanda from Nirmal Bang.

On ISB830, whether the secondary endpoints were not met even for the highest dose or the secondary endpoint was not met for the composite effect of all the doses?

No, for the highest does, the secondary endpoints, there was a numerical change in the secondary endpoints, even at the highest dose. However, it was not statistically significant.

And next one on your R&D strength in FY21. Would there be an absolute reduction since there are no large phase two trials that are ongoing, the last year you had a couple of phase twos running?

Yes. So on an absolute number it will be lower there.

And some sense on how much lower maybe like 5%, 10% is it?

I wouldn't like to throw a number, but definitely I mean current year also it is kind of lower than the last year and next year also it should be lower than the current year, yes.

And just on the debt, what part of your long-term debt is calling due in FY21?

So we have around 400 odd crores that is falling due in the next year, and we have tied up all this. So there is no issues on those.

But would this be refinanced is what you mean?

Yes, I’m saying refinance, yes. But some of those could also be repaired based on how the thing goes along. So we definitely see some reduction in the debt, because of reduction in CapEx, reduction in expenses, reduction in R&D, all this should go down to reduce our debt. And also some of the noncore assets that we were diverse at, so all this should go around to reduce it, wouldn't like to give a number but definitely it go down.

And with Q1 as we now over, could you give a sense on what kind of a decline should we anticipate over last year?

No, I wouldn't like to give away, when I’d break it out, yes.

Thank you [Operator Instructions]. Next question is from the line of Vikas Sharda from NTAsset Management.

Could you spell out the increase in the intangibles for the year, I mean what are the key items there?

So, basically these are in licensing what we do across these geographies. It's a little in excess of INR300 crores.

And so primarily in Europe, is it?

In Europe and maybe little bit in North America I think.

Thank you [Operator Instructions]. Next question is from the line of Chirag Dagli from HDFC Mutual Fund. Please go ahead.

So beyond GBR 830, what are the key data readouts for the rest of FY21?

So, we have a lot of data coming out on, Ichnos, right. We have 1342, which is clearly the most exciting asset in the portfolio, right, for multiple myeloma. We have some of the 1302 also. I mean, there is a host of data readouts and inflection points in FY21. And I think from hereon, you see every year multiple inflection points in terms of Ichnos and some of the data coming out.

Do you think 830 sets you back in terms of capital raising at Ichnos?

Not at all. See, Ichnos is, main value proposition is it's oncology franchise bispecific, the technology, that's the main value proposition for Ichnos. And the focus for the company is more oncology than immunology going forward. We have number of assets in preclinical, which we believe is the next generation in oncology, in multiple myeloma and various other indications.

And can you split the capital work-in-progress, what are the key elements? You’ve been running a very high [CV] for the last two, three years. What are the key points here if you split it?

So as you see, this year itself would just come down. So now its about 1.000 crores. So of it most of it, a large portion of that is basically Monroe. So right now we could only capitalize the OSD side. We still have the injectables and nebulizers, and a couple of other projects work-in-progress in India. So broadly, it's more of Monroe and a few small parts in India.

And this you see capitalizing in FY21, all of it?

Not all of it, at least a good portion. I mean, the injectables would get capitalized in. So, you would see corresponding like the current year, there will be reduction again in the next year, it will come down.

And again going back to an earlier question, CapEx for your size of business, we are seeing much larger companies cut CapEx. What is it that your are spending, going to spend the INR700 crores on?

So as I said, already we have reduced in the current year. We expect to reduce it further in the coming year also. So as we said, we have guided to a number of little excess of INR700 crores. So of this about INR200 crores would be put in licensing, whatever we do as everybody does that also. So the balance would be towards routine CapEx, any growth CapEx that we would need. But the endeavor would always be to reduce it further as well.

So the INR500 crores that you will do on tangible assets does have not any large ticket item, it’s basically run of the mill time?

Most of them, yes. And as we progress further on, Monroe we require a few additions here and then and those also would come in, yes.

So how are we thinking about encashing on or getting the return of the Monroe pipeline, because there’s a large capital expenditure?

So I think, I mean, Chirag, this year we've got Fulvestrant, which is commercialized. We've got close Chlorzoxazone commercialize, two products, one oral solid, one injectable. We anticipate a few more injectable approvals this year. We have couple of good nebulizer launches coming up early next year. So, I think overall the viability of the site and the quality of the launches, which come out of Monroe will continue to stay pretty exciting.

And the last question if I can on working capital. What are your thoughts, we’ve seen from linkage. Is it sustainable, can we improve?

We’ll keep it tight here, Chirag to, I mean, number of days will be as much as it is. So, the growth in business, obviously, there could be some little growth but broadly we'll try and keep it very tight.

[Operator Instructions] Next question is from the line of Alankar Garude from Macquarie.

Glenn, when you say statistically significant improvement from the baseline for ISB 830, what was the [ESI] score achieved at week [60]? Was it and say more than 50 or less than 50, any color on that?

So Alankar, we can’t give any more data. This is only part of the, we will put the full data out once we get the part two, so both part one and part two.

So that will be in first half of FY21 then?

So on that, Glenn, is it now safer to assume that we'll look to do any outlicensing deal for ISB 830 only after the part two data comes out, till then basically there’s, the focus would be just on the fundraiser of Ichnos?

Not really. So, partnerships is a big priority for Ichnos. And in the current year, we will target to try and close at least one partnership deal in FY21.

And that would be 830 as well?

Not necessary, Alankar there are, we have multiple levers, right? I mean, we've publicly stated that on the pain side, we are looking at partnering up pain asset, so 17536 remains very exciting.. Immunology is another area where we will do partnerships, and even oncology. There's a possibility that we may partner or co-commercialize co-partnerships with some, on some oncology assets. So, there are multiple levers and Ichnos, which we will use in FY21.

And my second question, Glenn, is if you could elaborate on the on ground situation in the domestic business, broadly how has been the impact on prescriptions over the last three months, MR interactions, anything on that would be very helpful?

I mean April and May were tough months in the domestic market for obvious reasons, right? Sales reps not being able to call on doctors. I think most lockdowns in many places. So, these are difficult months for the domestic market. I think June, we may see some recovery but I think overall, the quarter as a whole Q1 will be a tough quarter for the domestic market.

Thank you. Next question is from the line of Neha Manpuria from JPMorgan [Operator Instructions]. Over to you ma'am.

My first question is on the U.S. business. Glenn, you mentioned that you have a good number of launches coming up. Is it fair to assume that most of these good launches would be from Monroe, basically the injectable launches that you indicated to the previous question?

I think the bulk of it will be for Monroe but there will be some from India also.

And how many launches are you expecting based on your submissions to the FDA? How many should we expect this year?

Typically, we would expect maybe about 10 odd lunches this year.

And the second question is on the personnel, on the manpower costs, when you say you should see a reduction. Is this as a percentage of sales the number should decline, or that number also should see an absolute reduction?

Well, you'll see it as a decline in the percentage of sales.

And do we want to quantify that number?

No, I wouldn't, Neha. As you can see when in another expenses given \some decent work, we brought it down by a percentage or two. So similarly, we will try our best to bring it down but we don't like to state a number.

And my third question is on the net debt. Now that we'll have proceeds coming in from the pool and divestment and also the consumer business. Is it fair to assume that some net debt reduction would be seen in the first half itself?

Yes, Neha, you will see some reduction in debt in the first half. So basically, one is obviously some of these non-core asset divestments plus as we already stated, our R&D will prune down or expenses will keep under control. We'll also take care of our CapEx as well. So, all this should contribute to some reduction in the net debt on constant currency.

And besides Ichnos, as you know stake sales or fund raising whenever that was, that is supposed to happen. Is there any other non-core assets that we have in our portfolio for divestment or a large part of it is done with 304 deal that we've announced?

So, there is one more asset, which we may do during the course of this year. I can't talk about it. But there is one more which is possible.

Thank you [Operator Instructions]. Next question is from the line of Tushar Manudhane from Motilal Oswal. Please go ahead.

Just from the API business side, if you could just highlight U.S., Europe forming what percent of the API sales?

I would say, it's almost 70% 80% of the total sales. But I'd say U.S. are include of course generic players based in India who are shipping product to the U.S., if you know what I mean.

And in terms of number of products, or let's say top 10 or top five products contributing to your API sales?

It's very diversified. The whole portfolio is very diversified.

So even at least again would not be more than 5%, 6%?

[Operator Instructions] Next question is from the line of Vikas Sharda from NTAsset Management.

Mani, just to follow-up on the previous question. So your guidance of CapEx which includes in licensing for this year to be of INR700 crore to INR800 crore. What would be the comfortable number for FY20?

FY20 was about INR900 million right, that's what we have shown.

So that is for tangible assets or including intangibles?

Both, all put together.

And on the cost side to clarify your guidance, so R&D will be lower in absolute numbers and the start should be lower as a percentage of sales, right?

[Operator Instructions] Next question is from the line of Damayanti Kerai from HSBC Securities.

My question is on the U.S. business. So, in your opening comment you mentioned operating environment remains challenging there. So can you please elaborate what will be key factor, which would help you in going from current level? And if you can talk a bit about your non [oral] solid initiative, say injectables or nebulizers for the U.S market, how do you see pickup there? And how many products for such opportunities have been filed so far, or something on that front?

So I think the key driver for the U.S. will be the new product approvals, going forward. The pricing environment seems to be stabilizing but the new product approvals are going to be the key driver. And for Glenmark, I think injectables, nebulizers, some of the other dosage forms, should start contributing in the current year, which will help the business.

And on the derma portfolio, are we still seeing price pressure or is stabilizing there also?

On the derm side as you know, mupirocin and we have one more competitor. So there is some pricing pressure, which is still there. For the most of the portfolio, we've already gone through all our price erosions last year, the bulk of it.

And for this year, you're hoping for 10 new launches for the U.S. market, right?

And on the European side, if you can talk about some progress on the inhalers portfolio, like the product which we have launched in the market so far. How these products are scaling up there?

So European respiratory portfolio continues to do exceedingly well. So we have beclomethasone, Salmex now. We've settled the litigation with GSK. We have a couple of other products, which are in the works. So, I think it's a nice franchise in terms of European respiratory.

Any guidance you would like to provide, like how do you want to scale up that business from current levels, say two years from now?

We can't give any visibility beyond this.

And my last question on the supply side, I think you mentioned like we have seen now since normalizing on all geography. So if you can talk more about supply from API perspective. I understand most of the players have spoken about China supply as being now normal. So, how do you see that front? And any perspective for bringing in more in-house capability to rely, to reduce the dependence on the Chinese supplies?

I think we have already done that over the last last one year. We had a lot of, some of the intermediates and some of the manufacturing, we already bought back to India and we continue to do that.

Thank you [Operator Instructions]. Next question is from the line of Aditya Khemka from DSP Mutual Fund. Please go ahead.

Glenn, on the U.S. business. What part of your current revenue comes from derma portfolio?

Aditya, now on the revenue side it has come down substantially. It's probably about, I don't know, 25%, 30%, I'm guessing.

And what was the comparable number at the beginning of last year?

And if you could speak about the price erosion on your mupirocin portfolio. I know it's better, I mean lesser than the derma portfolio, but how much lesser at minus 2%, minus 5% in the derma, or flat…

Now, its pretty much stabilized at about 5%, 6%, I'm guessing.

And on Monroe facility, Glenn, so the general notion is at the cost of manufacturing in U.S. is you know definitely higher than what we do in India. So, you spoke about injectables being launched from both locations, India and U.S., we have Monroe and the plants here…

No, we don't have injectables in India. We only have in the U.S.

You only have it in the U.S. Okay. Got it. So, just about the other sort of block in Monroe and the other sort of blocks you have in India. What would be the different profitability from the full plants and the asset between the two locations?

The cost will be a little higher, Aditya, in Monro compared to India. But then see the broader opportunity like in injectables and nebulizers as we go ahead and we have some good approvals there. So, as you would also know, strategically, its a big advantage to have a plant in the U.S. considering whatever it is. So, it's much helpful to have a plant there. And so we put one there. And purely we are not a OSD plant and looking at the profitability there, it’s also there along with that there is a line for that. You can use and make whatever we want.

What I was trying to understand is in India generally you know the gross asset turn for a plant and the total solid let's say is 2 times, right. So, if it’s under INR100 crore worth plant, you can expect INR200 crores of revenue. If I were to look at a similar level for a plant in U.S., if the plant cost $100 million, what would be the asset around plant?

Yes, in India also it take you two, three years. Three year or four years before you reach the twice that turnover. So, I believe that in the long run, we should be somewhere there, yes, leaving the cost aside in terms of turnover, you should be much better off as we go along. Can't put a number to that but definitely it will be much, much higher, yes.

Thank you [Operator Instructions]. We take the next question from the line of Chirag Dagli from HDFC Mutual Funds. Please go ahead.

Thank you for the follow up. In your opening remarks, you mentioned dermatology pricing at about 20% year on year. Is this for your portfolio or for the market?

This is for the market.

Okay, this is for the market. Okay. And has the Ranitidine sort of completely came in the base for Q1?

Yes, in Q4 it has come in the base.

So from hereon, we should think about the business as growing on this base of INR105 million?

So Chirag, I think in theory, yes. Unfortunately, because of COVID, obviously, there could be some ups and downs in terms of the base also. But I think on a full year basis, this is the base.

Thank you [Operator Instructions]. Next question is from the line of Tarang Agrawal from Old Bridge Capital. Please go ahead.

I have the following three questions. One, what proportion of your R&D would be in implied costs?

Employee cost also as part of the R&D, we’ll try and get back to you but it should be around 40% to 45%…

Yes, it should be about 40% to 45%.

In case of Favi, is Glenmark manufacturing the entire value chain, that is intermediary, API and the formulation…

And exactly how difficult is it to manufacture this molecule in terms of chemistry?

So it's an eight step process, I don't know all the details but we have all the capabilities in house.

And the last question, what is your blended cost of debt including currency exposure?

So roughly you can say it will be around 5% to 6%, depending on how the currency moves there. We have to take it over a two three year period, you can't take it like one-off like current year.

Thank you. We take the next question from the line of Prakash Agarwal from Axis Capital. Please go ahead.

Just wanted to understand for Ichnos, what is the total balance sheet size in terms of investment done so far? And what is the kind of fund raise we are planning for the year?

So, over the year we've been investing as you can see like current year also at INR100 million. So last two three years we have invested some descent amount of money there.

The capital raise, Prakash, we can't give any visibility at this point, the amount, the quantum.

But any color on balance sheet side please?

Yes, broadly around last one two years, whatever are the number. So those could broadly be figuring out in.

So we watch it something, which we will book in Q1, since that you will put a press release. And Ichnos is the second one. What are the other levers in terms of debt deduction going forward?

I told you there are three more, one is reduction in CapEx, pruning down R&D spends, reduction in MPC cost as a percentage to turnover, plus also the divestment of non-core. So, all this should go to reduce…

Yes, I mean my question more from the non-core side. I mean, are we seeing more

There is one more, which we can't, we're not seeing right now but should happen sometime during this year.

But it's not API that we had planned earlier?

That's off those, yes?

Yes, that's off.

Thank you. We take the last question from the line of Neha Manpuria from JPMorgan. Please go ahead.

On the gross margins, obviously, the derma pricing pressures reflected in the gross margin erosion that we've seen year on year. But if I were to look at the fourth quarter level of 64.5%, 65%. Should we be able to maintain this level of gross margin next year, particularly since we have good lunches coming from Monroe. How should we look at the gross margin?

We should see it very close to what it is. I mean fourth quarter may not be the most ideal one. And the year is a better indicator always. So, if you look at our overall, it'll be around 64.5%, 65%, somewhere close to that.

Thank you. Well, ladies and gentlemen, that was the last question. I would now like to hand the conference over to Mr. Jason D'souza for closing comments. Over to you.

Thank you, moderator. Before we close the call, just like to leave the disclaimer. The information statement analysis made during this call describing company's objectives, projections and estimates are forward-looking statements, and progressive within the meaning of applicable security laws and regulations. The analysis contained herein is based on numerous assumptions. Actual results may vary from those expressed or implied, depending upon economic conditions, government policies and other incidental factors. No representation or warranties are expressed or implied is provided in relation to this presentation. This presentation should not be regarded by recipients as a substitute for the exercise of their own judgment.

With this, we end Glenmark's Q4 earnings call. Thank you, everyone.

Thank you. On behalf of Glenmark Pharmaceuticals Limited, this conclude today’s conference. Thank you all for joining. You may now disconnect your lines.";"{'body': [{'indices': [[8501, 8505]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Race_and_ethnicity_in_the_United_States_Census'},
           'score': 0.997516930103302,
           'text': 'Asian',
           'types': ['Items', 'Disease']},
          {'indices': [[9251, 9256]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pharmaceutical_industry'},
           'score': 1.0,
           'text': 'pharma',
           'types': ['PersonFunction']},
          {'indices': [[9979, 10000]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pharmaceutical_industry'},
           'score': 0.9995675086975098,
           'text': 'pharmaceutical company',
           'types': ['PersonFunction']},
          {'indices': [[12743, 12765]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pre-clinical_development'},
           'score': 1.0,
           'text': 'preclinical development',
           'types': ['Person', 'Stage']},
          {'indices': [[7230, 7236]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Tablet_computer'},
           'score': 0.8571804761886597,
           'text': 'tablets',
           'types': ['Computer', 'InformationAppliance', 'Product']},
          {'indices': [[5396, 5406], [5497, 5507], [5613, 5623]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Gynaecology'},
           'score': 1.0,
           'text': 'gynaecology',
           'types': ['PersonFunction',
                     'Company',
                     'Practice',
                     'MedicalSpecialty']},
          {'indices': [[4203, 4207], [4305, 4309], [4832, 4836]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/IQVIA'},
           'score': 1.0,
           'text': 'IQVIA',
           'types': ['Person']},
          {'indices': [[12448, 12463]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pharmacokinetics'},
           'score': 1.0,
           'text': 'pharmacokinetics',
           'types': ['Organisation', 'Branch']},
          {'indices': [[9736, 9741]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Brazil'},
           'score': 0.9958844780921936,
           'text': 'Brazil',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'State']},
          {'indices': [[9518, 9527]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pharmacy'},
           'score': 0.998602032661438,
           'text': 'pharmacies',
           'types': ['Work', 'Product', 'PersonFunction', 'Science']},
          {'indices': [[610, 622], [29952, 29964]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/North_America'},
           'score': 0.9957175850868225,
           'text': 'North America',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'Continent']},
          {'indices': [[5121, 5129]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Metformin'},
           'score': 1.0,
           'text': 'Metformin',
           'types': ['Drug',
                     'Product',
                     'ChemicalSubstance',
                     'Medication',
                     'Person']},
          {'indices': [[8671, 8675]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Kenya'},
           'score': 0.9987301230430603,
           'text': 'Kenya',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'MusicalArtist']},
          {'indices': [[7870, 7879]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Ranitidine'},
           'score': 1.0,
           'text': 'ranitidine',
           'types': ['Drug', 'Product', 'ChemicalSubstance', 'Medication']},
          {'indices': [[5178, 5192], [19462, 19476]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/The_Combination'},
           'score': 1.0,
           'text': 'The combination',
           'types': ['SoccerLeague',
                     'Agent',
                     'SportsLeague',
                     'Organisation',
                     'League']},
          {'indices': [[5443, 5452]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/True_north'},
           'score': 0.5331783294677734,
           'text': 'True North',
           'types': ['Direction', 'Company', 'Organisation']},
          {'indices': [[7983, 7985]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Commonwealth_of_Independent_States'},
           'score': 0.8690861463546753,
           'text': 'CIS',
           'types': ['Location',
                     'Organisation',
                     'Country',
                     'PopulatedPlace',
                     'Place']},
          {'indices': [[7428, 7438],
                       [7546, 7556],
                       [9935, 9945],
                       [44407, 44417]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Dermatology'},
           'score': 1.0,
           'text': 'dermatology',
           'types': ['PersonFunction',
                     'Organisation',
                     'MedicalSpecialty',
                     'Branch']},
          {'indices': [[9842, 9849]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Novartis'},
           'score': 1.0,
           'text': 'Novartis',
           'types': ['Agent', 'Organisation', 'Company', 'Place']},
          {'indices': [[10999, 11007],
                       [11711, 11719],
                       [11775, 11783],
                       [11907, 11915]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Australia'},
           'score': 0.9932729005813599,
           'text': 'Australia',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'MusicalArtist']},
          {'indices': [[8159, 8165]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Russian_language'},
           'score': 0.6338623762130737,
           'text': 'Russian',
           'types': ['Language']},
          {'indices': [],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Kodashim'},
           'score': 1.0,
           'text': 'HUL.',
           'types': ['Order', 'Eukaryote']},
          {'indices': [[7966, 7971], [12219, 12224], [14470, 14475]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Africa'},
           'score': 0.9990716576576233,
           'text': 'Africa',
           'types': ['World',
                     'Agent',
                     'Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'Continent']},
          {'indices': [[549, 551]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Chief_financial_officer'},
           'score': 1.0,
           'text': 'CFO',
           'types': ['Person', 'Officer', 'Organisation']},
          {'indices': [[1215, 1223], [1456, 1464]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Logistics'},
           'score': 0.980404794216156,
           'text': 'logistics',
           'types': ['MusicGenre']},
          {'indices': [[4616, 4621]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Patent'},
           'score': 0.9982509016990662,
           'text': 'patent',
           'types': ['PersonFunction', 'Set']},
          {'indices': [[12242, 12256]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Clinical_trial'},
           'score': 0.9983939528465271,
           'text': 'clinical trials',
           'types': ['Organisation', 'Experiments']},
          {'indices': [[8690, 8695],
                       [8709, 8714],
                       [8822, 8827],
                       [14425, 14430],
                       [16708, 16713],
                       [16847, 16852],
                       [17083, 17088],
                       [17312, 17317],
                       [17632, 17637],
                       [25478, 25483],
                       [29902, 29907],
                       [29921, 29926],
                       [38010, 38015]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Europe'},
           'score': 0.9985402226448059,
           'text': 'Europe',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'Continent']},
          {'indices': [[12179, 12186]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Cambodia'},
           'score': 0.9996380805969238,
           'text': 'Cambodia',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'MusicalArtist']},
          {'indices': [[9530, 9542],
                       [9573, 9585],
                       [14439, 14451],
                       [25681, 25693],
                       [25890, 25902]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Latin_America'},
           'score': 0.9999121427536011,
           'text': 'Latin America',
           'types': ['Location',
                     'Country',
                     'Group',
                     'PopulatedPlace',
                     'Place',
                     'Continent',
                     'Band']},
          {'indices': [[9591, 9599]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Caribbean'},
           'score': 0.9923628568649292,
           'text': 'Caribbean',
           'types': ['Settlement', 'Country', 'Region', 'Place']},
          {'indices': [[3578, 3587]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Viral_load'},
           'score': 1.0,
           'text': 'viral load',
           'types': ['Expression', 'Organisation']},
          {'indices': [[10084, 10086]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/GNU_General_Public_License'},
           'score': 1.0,
           'text': 'GPL',
           'types': ['Person']},
          {'indices': [[11771, 11773]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Therapeutic_Goods_Administration'},
           'score': 0.8819012641906738,
           'text': 'TGA',
           'types': ['Body', 'Organisation']},
          {'indices': [[5408, 5415], [5599, 5606], [5625, 5632]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Division_(military)'},
           'score': 0.9935106039047241,
           'text': 'division',
           'types': ['Unit', 'Organisation', 'MilitaryUnit']},
          {'indices': [[1037, 1041],
                       [1473, 1477],
                       [2174, 2178],
                       [2389, 2393],
                       [2516, 2520],
                       [2698, 2702],
                       [2781, 2785],
                       [3996, 4000],
                       [4050, 4054],
                       [4137, 4141],
                       [4221, 4225],
                       [4337, 4341],
                       [4452, 4456],
                       [4695, 4699],
                       [5039, 5043],
                       [5521, 5525],
                       [5674, 5678],
                       [5855, 5859],
                       [16698, 16702],
                       [16840, 16844],
                       [16889, 16893],
                       [17302, 17306],
                       [17622, 17626],
                       [25489, 25493],
                       [31494, 31498],
                       [31558, 31562],
                       [36091, 36095],
                       [38174, 38178],
                       [41646, 41650],
                       [42495, 42499],
                       [42570, 42574],
                       [42656, 42660],
                       [42822, 42826],
                       [42997, 43001],
                       [43529, 43533],
                       [43858, 43862]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.99883633852005,
           'text': 'India',
           'types': ['Country',
                     'Location',
                     'PopulatedPlace',
                     'Place',
                     'MusicalArtist']},
          {'indices': [[3882, 3896], [3954, 3968]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Therapy'},
           'score': 1.0,
           'text': 'supportive care',
           'types': ['MusicGenre', 'Remediation']},
          {'indices': [[14065, 14070]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mumbai'},
           'score': 0.9960054159164429,
           'text': 'Mumbai',
           'types': ['Settlement',
                     'Location',
                     'PopulatedPlace',
                     'Place',
                     'City']},
          {'indices': [[8277, 8296]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Devaluation'},
           'score': 1.0,
           'text': 'currency devaluation',
           'types': ['Reduction', 'Organisation']},
          {'indices': [[7974, 7977],
                       [8333, 8336],
                       [14433, 14436],
                       [14540, 14543]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Asia'},
           'score': 0.9980325102806091,
           'text': 'Asia',
           'types': ['Location',
                     'Country',
                     'Earth',
                     'PopulatedPlace',
                     'Place',
                     'Continent']},
          {'indices': [[7175, 7185], [32918, 32928]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fulvestrant'},
           'score': 1.0,
           'text': 'Fulvestrant',
           'types': ['Drug',
                     'Product',
                     'ChemicalSubstance',
                     'Treatment',
                     'Organisation']},
          {'indices': [[12189, 12198]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Uzbekistan'},
           'score': 0.9976251721382141,
           'text': 'Uzbekistan',
           'types': ['Location', 'Country', 'PopulatedPlace', 'Place']},
          {'indices': [[8211, 8216], [12261, 12266], [21584, 21589]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Russia'},
           'score': 0.992032527923584,
           'text': 'Russia',
           'types': ['Location', 'Country', 'PopulatedPlace', 'Place']},
          {'indices': [[4427, 4438], [4963, 4974]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Market_share'},
           'score': 0.9993112087249756,
           'text': 'market share',
           'types': ['Percentage']},
          {'indices': [[10258, 10283], [10429, 10454]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Rhinitis'},
           'score': 1.0,
           'text': 'seasonal allergic rhinitis',
           'types': ['Irritation', 'Disease']},
          {'indices': [[12201, 12207]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Namibia'},
           'score': 0.9986144304275513,
           'text': 'Namibia',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'MusicalArtist']},
          {'indices': [[9162, 9167], [9330, 9335]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Poland'},
           'score': 0.9958329200744629,
           'text': 'Poland',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'MusicalArtist']},
          {'indices': [[9443, 9448]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Poland'},
           'score': 0.8850383758544922,
           'text': 'Polish',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'MusicalArtist']},
          {'indices': [[4658, 4666]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Enzyme_inhibitor'},
           'score': 0.983218252658844,
           'text': 'inhibitor',
           'types': ['ChemicalCompound', 'Molecule']},
          {'indices': [[10849, 10857]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Royalty_payment'},
           'score': 0.9894008636474609,
           'text': 'royalties',
           'types': ['Payment', 'Software', 'Product']},
          {'indices': [[11986, 11996], [12103, 12113]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/South_Korea'},
           'score': 0.9989084005355835,
           'text': 'South Korea',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'State']},
          {'indices': [[8080, 8088]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Degrowth'},
           'score': 1.0,
           'text': 'de-growth',
           'types': ['Movement', 'Organisation']},
          {'indices': [[6363, 6372],
                       [36932, 36941],
                       [37599, 37608],
                       [46961, 46970]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Divestment'},
           'score': 0.9844775199890137,
           'text': 'divestment',
           'types': ['Reduction', 'Organisation']},
          {'indices': [[12494, 12507]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Immunogenicity'},
           'score': 1.0,
           'text': 'immunogenicity',
           'types': ['Ability', 'Disease']},
          {'indices': [[5131, 5143]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Hydrochloride'},
           'score': 0.9783219695091248,
           'text': 'hydrochloride',
           'types': ['ChemicalCompound', 'Salt']},
          {'indices': [[5531, 5535]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Nepal'},
           'score': 0.9989550113677979,
           'text': 'Nepal',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'MusicalArtist']},
          {'indices': [[6456, 6464]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Trademark'},
           'score': 0.9995692372322083,
           'text': 'trademark',
           'types': ['Broadcaster', 'PersonFunction', 'Sign']},
          {'indices': [[7475, 7481],
                       [7595, 7601],
                       [42126, 42132],
                       [47490, 47496]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Erosion'},
           'score': 0.9974589943885803,
           'text': 'erosion',
           'types': ['MilitaryConflict', 'Action']},
          {'indices': [[7211, 7215], [7770, 7774], [7807, 7811]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Cream_(band)'},
           'score': 0.9123181104660034,
           'text': 'Cream',
           'types': ['Agent', 'Organisation', 'Group', 'Band']},
          {'indices': [[4651, 4656], [5022, 5027]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/SGLT2'},
           'score': 1.0,
           'text': 'SGLT-2',
           'types': ['Protein']},
          {'indices': [[11026, 11030], [11992, 11996], [12109, 12113]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Korea'},
           'score': 0.9189104437828064,
           'text': 'Korea',
           'types': ['Territory',
                     'Agent',
                     'Country',
                     'Organisation',
                     'PopulatedPlace',
                     'Place']},
          {'indices': [[5161, 5175]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Diabetes_mellitus_type_2'},
           'score': 1.0,
           'text': 'Type 2 diabetes',
           'types': ['Disorder', 'Disease']},
          {'indices': [[3628, 3634]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Symptom'},
           'score': 1.0,
           'text': 'symptom',
           'types': ['Departure', 'Single']},
          {'indices': [[10992, 10996], [21592, 21596], [41297, 41301]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/China'},
           'score': 0.9981744289398193,
           'text': 'China',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'State']},
          {'indices': [[10115, 10122],
                       [10185, 10192],
                       [13612, 13619],
                       [13677, 13684],
                       [13749, 13756],
                       [32814, 32821]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pipeline_transport'},
           'score': 0.9862622618675232,
           'text': 'pipeline',
           'types': ['Company', 'Transportation']},
          {'indices': [[3592, 3599]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/SARS_coronavirus'},
           'score': 1.0,
           'text': 'SARS-CoV',
           'types': ['Species', 'Virus']},
          {'indices': [[4530, 4537], [5168, 5175]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Diabetes_mellitus'},
           'score': 0.9974285364151001,
           'text': 'diabetes',
           'types': ['Group', 'Band', 'Disease']},
          {'indices': [[14313, 14323]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Outsourcing'},
           'score': 0.9998156428337097,
           'text': 'outsourcing',
           'types': ['PersonFunction']},
          {'indices': [[599, 607], [14530, 14538]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/President_of_the_United_States'},
           'score': 0.7868102788925171,
           'text': 'President',
           'types': ['Person', 'PersonFunction', 'Head']},
          {'indices': [[1021, 1028]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lockdown'},
           'score': 0.9482803344726562,
           'text': 'lockdown',
           'types': ['Definitions', 'Book', 'Product']},
          {'indices': [[7354, 7360], [7530, 7536]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Genetics'},
           'score': 0.975424587726593,
           'text': 'genetic',
           'types': ['PersonFunction', 'Study', 'Book', 'Product']},
          {'indices': [[3372, 3376], [3578, 3582]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Virus'},
           'score': 0.8737707734107971,
           'text': 'viral',
           'types': ['Agent', 'Species', 'Animal']},
          {'indices': [[12561, 12570]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Omalizumab'},
           'score': 1.0,
           'text': 'omalizumab',
           'types': ['Antibody', 'Drug', 'Product', 'ChemicalSubstance']},
          {'indices': [[6903, 6913], [7336, 7346]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Fiscal_year'},
           'score': 1.0,
           'text': 'fiscal year',
           'types': ['Period', 'Country']},
          {'indices': [[7420, 7426], [7538, 7544]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Topical_medication'},
           'score': 0.9906163811683655,
           'text': 'topical',
           'types': ['Drug', 'Product', 'Medication']},
          {'indices': [[993, 1000]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pandemic'},
           'score': 0.9952638745307922,
           'text': 'pandemic',
           'types': ['Arachnid', 'Epidemic']},
          {'indices': [[7777, 7787]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Atomoxetine'},
           'score': 1.0,
           'text': 'Atomoxetine',
           'types': ['Inhibitor', 'Drug', 'Product', 'ChemicalSubstance']},
          {'indices': [[520, 523],
                       [18178, 18181],
                       [20170, 20173],
                       [38571, 38574]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Mani_Peninsula'},
           'score': 0.5975437164306641,
           'text': 'Mani',
           'types': ['Settlement', 'Country', 'Region', 'Person']},
          {'indices': [[8277, 8284],
                       [8923, 8930],
                       [16077, 16084],
                       [16262, 16269],
                       [37412, 37419],
                       [45695, 45702],
                       [45787, 45794]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Currency'},
           'score': 0.998273491859436,
           'text': 'currency',
           'types': ['PersonFunction']},
          {'indices': [[963, 967],
                       [984, 988],
                       [1999, 2003],
                       [2153, 2157],
                       [2310, 2314],
                       [2495, 2499],
                       [2808, 2812],
                       [2965, 2969],
                       [3186, 3190],
                       [3558, 3562],
                       [3729, 3733],
                       [16730, 16734],
                       [17395, 17399],
                       [17460, 17464],
                       [19239, 19243],
                       [23227, 23231],
                       [23621, 23625],
                       [25773, 25777],
                       [44823, 44827]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Coronavirus_disease_2019'},
           'score': 1.0,
           'text': 'COVID',
           'types': ['Product']},
          {'indices': [[984, 991],
                       [1999, 2006],
                       [2153, 2160],
                       [2310, 2317],
                       [2495, 2502],
                       [2808, 2815],
                       [2965, 2972],
                       [3186, 3193],
                       [3558, 3565],
                       [3729, 3736],
                       [23227, 23234]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Coronavirus_disease_2019'},
           'score': 1.0,
           'text': 'COVID-19',
           'types': ['Person', 'Organisation']},
          {'indices': [[12213, 12224]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/South_Africa'},
           'score': 0.9940606951713562,
           'text': 'South Africa',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'State']},
          {'indices': [[778, 786],
                       [896, 904],
                       [4103, 4111],
                       [6862, 6870],
                       [8070, 8078],
                       [8783, 8791],
                       [8877, 8885],
                       [9637, 9645],
                       [12968, 12976],
                       [13123, 13131]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Sound_recording_and_reproduction'},
           'score': 0.8718945980072021,
           'text': 'recording',
           'types': ['PersonFunction', 'Inscription', 'Book', 'Product']},
          {'indices': [[7315, 7319]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Food_and_Drug_Administration'},
           'score': 1.0,
           'text': 'USFDA',
           'types': ['GovernmentAgency', 'Agent', 'Organisation', 'Agency']},
          {'indices': [[10233, 10238], [10616, 10621], [11269, 11274]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Food_and_Drug_Administration'},
           'score': 1.0,
           'text': 'US FDA',
           'types': ['GovernmentAgency', 'Agent', 'Organisation', 'Agency']},
          {'indices': [[10236, 10238],
                       [10619, 10621],
                       [11272, 11274],
                       [11513, 11515],
                       [36177, 36179]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Food_and_Drug_Administration'},
           'score': 1.0,
           'text': 'FDA',
           'types': ['GovernmentAgency', 'Agent', 'Organisation', 'Agency']},
          {'indices': [[11010, 11020]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/New_Zealand'},
           'score': 0.991263747215271,
           'text': 'New Zealand',
           'types': ['Location',
                     'Country',
                     'PopulatedPlace',
                     'Place',
                     'MusicalArtist']},
          {'indices': [[14454, 14464]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Middle_East'},
           'score': 0.9995709657669067,
           'text': 'Middle East',
           'types': ['Settlement', 'Country', 'Region', 'Place']},
          {'indices': [[2224, 2237]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Antiviral_drug'},
           'score': 1.0,
           'text': 'antiviral drug',
           'types': ['Drug', 'Product', 'Medication']},
          {'indices': [[3135, 3149], [3223, 3237]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Antiviral_drug'},
           'score': 1.0,
           'text': 'antiviral drugs',
           'types': ['Drug', 'Product', 'Medication']},
          {'indices': [[2224, 2232], [3135, 3143], [3223, 3231], [3473, 3481]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Antiviral_drug'},
           'score': 0.9977399706840515,
           'text': 'antiviral',
           'types': ['Drug', 'Product', 'Medication']},
          {'indices': [[2628, 2643]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Informed_consent'},
           'score': 0.9996436834335327,
           'text': 'informed consent',
           'types': ['Election', 'Process']},
          {'indices': [[11135, 11136]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/European_Union'},
           'score': 0.9880654811859131,
           'text': 'EU',
           'types': ['Location',
                     'Organisation',
                     'Country',
                     'Union',
                     'PopulatedPlace',
                     'Place']},
          {'indices': [[11213, 11226]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/European_Union'},
           'score': 0.9999270439147949,
           'text': 'European Union',
           'types': ['Location',
                     'Organisation',
                     'Country',
                     'Union',
                     'PopulatedPlace',
                     'Place']},
          {'indices': [[6328, 6353]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Hindustan_Unilever'},
           'score': 1.0,
           'text': 'Hindustan Unilever Limited',
           'types': ['Agent', 'Organisation', 'Company']},
          {'indices': [[83, 90],
                       [327, 334],
                       [422, 429],
                       [488, 495],
                       [554, 561],
                       [720, 727],
                       [838, 845],
                       [1052, 1059],
                       [1148, 1155],
                       [1322, 1329],
                       [1626, 1633],
                       [1796, 1803],
                       [2181, 2188],
                       [2329, 2336],
                       [2674, 2681],
                       [2818, 2825],
                       [3031, 3038],
                       [4210, 4217],
                       [4326, 4333],
                       [4441, 4448],
                       [4572, 4579],
                       [4702, 4709],
                       [4935, 4942],
                       [5047, 5054],
                       [5354, 5361],
                       [5704, 5711],
                       [5818, 5825],
                       [6501, 6508],
                       [6555, 6562],
                       [6761, 6768],
                       [6924, 6931],
                       [7018, 7025],
                       [7883, 7890],
                       [8519, 8526],
                       [8698, 8705],
                       [8811, 8818],
                       [9153, 9160],
                       [9298, 9305],
                       [9545, 9552],
                       [10324, 10331],
                       [10514, 10521],
                       [10706, 10713],
                       [10780, 10787],
                       [10911, 10918],
                       [11033, 11040],
                       [11667, 11674],
                       [12388, 12395],
                       [12828, 12835],
                       [12894, 12901],
                       [13034, 13041],
                       [13213, 13220],
                       [13405, 13412],
                       [13846, 13853],
                       [13880, 13887],
                       [13975, 13982],
                       [14039, 14046],
                       [14488, 14495],
                       [14850, 14857],
                       [14951, 14958],
                       [24173, 24180],
                       [39854, 39861],
                       [45344, 45351],
                       [48907, 48914],
                       [48982, 48989]],
           'links': None,
           'score': None,
           'text': 'Glenmark',
           'types': ['Place', 'Person', 'Organisation']},
          {'indices': [[2240, 2250],
                       [2746, 2756],
                       [2912, 2922],
                       [3152, 3162],
                       [3841, 3851],
                       [3922, 3932],
                       [18690, 18700],
                       [19449, 19459],
                       [23210, 23220],
                       [23483, 23493],
                       [23578, 23588],
                       [23740, 23750],
                       [23800, 23810]],
           'links': None,
           'score': None,
           'text': 'Favipiravir',
           'types': ['Place', 'Product']},
          {'indices': [[4668, 4680], [4755, 4767], [4871, 4883], [5093, 5105]],
           'links': None,
           'score': None,
           'text': 'Remogliflozin',
           'types': ['Place']},
          {'indices': [[5279, 5283], [13077, 13081], [26666, 26670]],
           'links': None,
           'score': None,
           'text': 'INR10',
           'types': ['Place']},
          {'indices': [[6381, 6385], [6512, 6516]],
           'links': None,
           'score': None,
           'text': 'VWash',
           'types': ['Place']},
          {'indices': [[7679, 7681],
                       [10475, 10477],
                       [10701, 10703],
                       [10900, 10902],
                       [13555, 13557],
                       [16834, 16836],
                       [17640, 17642],
                       [17817, 17819],
                       [17969, 17971],
                       [22388, 22390],
                       [25266, 25268],
                       [35778, 35780],
                       [38004, 38006],
                       [38122, 38124],
                       [38212, 38214],
                       [39195, 39197],
                       [39508, 39510],
                       [39681, 39683],
                       [40401, 40403],
                       [41818, 41820],
                       [42441, 42443],
                       [42580, 42582],
                       [42683, 42685],
                       [42713, 42715],
                       [43216, 43218],
                       [43773, 43775]],
           'links': None,
           'score': None,
           'text': 'U.S',
           'types': ['Place']},
          {'indices': [[10125, 10132],
                       [10135, 10142],
                       [10420, 10427],
                       [10600, 10607],
                       [10685, 10692],
                       [10877, 10884],
                       [10980, 10987],
                       [11086, 11093],
                       [11188, 11195],
                       [11336, 11343],
                       [11757, 11764],
                       [11895, 11902],
                       [12091, 12098],
                       [12149, 12156],
                       [12233, 12240],
                       [24570, 24577],
                       [25240, 25247]],
           'links': None,
           'score': None,
           'text': 'Ryaltris',
           'types': ['Place', 'Person']},
          {'indices': [[12366, 12372], [12526, 12532]],
           'links': None,
           'score': None,
           'text': 'GBR-310',
           'types': ['Place']},
          {'indices': [[14557, 14562], [14618, 14623]],
           'links': None,
           'score': None,
           'text': 'Abbott',
           'types': ['Place']},
          {'indices': [[15235, 15240]],
           'links': None,
           'score': None,
           'text': 'INR819',
           'types': ['Place']},
          {'indices': [[15963, 15970]],
           'links': None,
           'score': None,
           'text': 'INR4,868',
           'types': ['Place']},
          {'indices': [[10233, 10234],
                       [10616, 10617],
                       [11269, 11270],
                       [17585, 17586]],
           'links': None,
           'score': None,
           'text': 'US',
           'types': ['Place']},
          {'indices': [[20369, 20374],
                       [26055, 26060],
                       [31337, 31342],
                       [31526, 31531],
                       [32652, 32657],
                       [32807, 32812],
                       [33270, 33275],
                       [35933, 35938],
                       [36056, 36061],
                       [42360, 42365],
                       [42594, 42599],
                       [42774, 42779],
                       [47713, 47718]],
           'links': None,
           'score': None,
           'text': 'Monroe',
           'types': ['Place']},
          {'indices': [[21599, 21603], [23307, 23311]],
           'links': None,
           'score': None,
           'text': 'Japan',
           'types': ['Place']},
          {'indices': [[21606, 21610]],
           'links': None,
           'score': None,
           'text': 'Italy',
           'types': ['Place']},
          {'indices': [[21613, 21624]],
           'links': None,
           'score': None,
           'text': 'Saudi Arabia',
           'types': ['Place']},
          {'indices': [[21627, 21636]],
           'links': None,
           'score': None,
           'text': 'Bangladesh',
           'types': ['Place']},
          {'indices': [[27073, 27078], [27117, 27122], [27843, 27848]],
           'links': None,
           'score': None,
           'text': 'ISB830',
           'types': ['Place']},
          {'indices': [[11923, 11926],
                       [28223, 28226],
                       [28750, 28753],
                       [30165, 30168],
                       [30427, 30430],
                       [31599, 31602],
                       [34139, 34142],
                       [34524, 34527],
                       [35013, 35016]],
           'links': None,
           'score': None,
           'text': 'FY21',
           'types': ['Place', 'Product', 'Organisation']},
          {'indices': [[19876, 19880],
                       [20113, 20117],
                       [20536, 20540],
                       [20946, 20950],
                       [20964, 20968],
                       [21077, 21081],
                       [29120, 29124],
                       [31875, 31879],
                       [31948, 31952],
                       [32362, 32366],
                       [32380, 32384],
                       [37320, 37324],
                       [38641, 38645],
                       [46864, 46868]],
           'links': None,
           'score': None,
           'text': 'CapEx',
           'types': ['Place', 'Organisation']},
          {'indices': [[30045, 30050],
                       [32890, 32895],
                       [33479, 33484],
                       [44284, 44289],
                       [44765, 44770]],
           'links': None,
           'score': None,
           'text': 'Chirag',
           'types': ['Place']},
          {'indices': [[33717, 33723], [33954, 33960], [34578, 34584]],
           'links': None,
           'score': None,
           'text': 'Alankar',
           'types': ['Place']},
          {'indices': [[42979, 42983]],
           'links': None,
           'score': None,
           'text': 'Monro',
           'types': ['Place']},
          {'indices': [[43654, 43659], [46273, 46278]],
           'links': None,
           'score': None,
           'text': 'INR100',
           'types': ['Place']},
          {'indices': [[246, 258], [48106, 48118]],
           'links': None,
           'score': None,
           'text': ""Jason D'souza"",
           'types': ['Person']},
          {'indices': [[440, 453]],
           'links': None,
           'score': None,
           'text': 'Glenn Saldanha',
           'types': ['Person']},
          {'indices': [[514, 523]],
           'links': None,
           'score': None,
           'text': 'V. S. Mani',
           'types': ['Person']},
          {'indices': [[584, 596]],
           'links': None,
           'score': None,
           'text': 'Robert Matsuk',
           'types': ['Person']},
          {'indices': [[626, 630]],
           'links': None,
           'score': None,
           'text': 'First',
           'types': ['Person']},
          {'indices': [[1438, 1444],
                       [3022, 3028],
                       [7814, 7820],
                       [12116, 12122]],
           'links': None,
           'score': None,
           'text': 'Further',
           'types': ['Person']},
          {'indices': [[4305, 4313]],
           'links': None,
           'score': None,
           'text': 'IQVIA MAT',
           'types': ['Person']},
          {'indices': [[5422, 5438]],
           'links': None,
           'score': None,
           'text': 'Integrace Limited',
           'types': ['Person']},
          {'indices': [[5422, 5430], [5556, 5564]],
           'links': None,
           'score': None,
           'text': 'Integrace',
           'types': ['Person']},
          {'indices': [[7103, 7119]],
           'links': None,
           'score': None,
           'text': 'Adapalene Gel 0.1',
           'types': ['Person']},
          {'indices': [[9153, 9167]],
           'links': None,
           'score': None,
           'text': 'Glenmark Poland',
           'types': ['Person']},
          {'indices': [[9219, 9229], [9347, 9357]],
           'links': None,
           'score': None,
           'text': 'Neuraxpharm',
           'types': ['Person', 'Organisation']},
          {'indices': [[13931, 13945]],
           'links': None,
           'score': None,
           'text': 'Robert Crockart',
           'types': ['Person']},
          {'indices': [[13938, 13945], [14013, 14020]],
           'links': None,
           'score': None,
           'text': 'Crockart',
           'types': ['Person']},
          {'indices': [[14140, 14146], [14502, 14508], [14880, 14886]],
           'links': None,
           'score': None,
           'text': 'Crokart',
           'types': ['Person']},
          {'indices': [[14540, 14551]],
           'links': None,
           'score': None,
           'text': 'Asia-Pacific',
           'types': ['Person']},
          {'indices': [[15531, 15539]],
           'links': None,
           'score': None,
           'text': 'Inventory',
           'types': ['Person']},
          {'indices': [[16567, 16581], [45963, 45977]],
           'links': None,
           'score': None,
           'text': 'Prakash Agarwal',
           'types': ['Person']},
          {'indices': [[440, 444],
                       [16603, 16607],
                       [19845, 19849],
                       [21317, 21321],
                       [24460, 24464],
                       [33749, 33753],
                       [34163, 34167],
                       [35044, 35048],
                       [35793, 35797],
                       [41804, 41808],
                       [42377, 42381]],
           'links': None,
           'score': None,
           'text': 'Glenn',
           'types': ['Person']},
          {'indices': [[16567, 16573],
                       [16867, 16873],
                       [17558, 17564],
                       [18165, 18171],
                       [45963, 45969],
                       [46386, 46392]],
           'links': None,
           'score': None,
           'text': 'Prakash',
           'types': ['Person']},
          {'indices': [[17809, 17810],
                       [18075, 18076],
                       [18174, 18175],
                       [18189, 18190],
                       [18345, 18346],
                       [18497, 18498],
                       [18584, 18585],
                       [18943, 18944],
                       [19114, 19115],
                       [19538, 19539],
                       [20151, 20152],
                       [20181, 20182],
                       [20227, 20228],
                       [20288, 20289],
                       [20662, 20663],
                       [20971, 20972],
                       [21022, 21023],
                       [21658, 21659],
                       [21779, 21780],
                       [22254, 22255],
                       [22871, 22872],
                       [23024, 23025],
                       [23314, 23315],
                       [23536, 23537],
                       [23566, 23567],
                       [23662, 23663],
                       [23813, 23814],
                       [24310, 24311],
                       [24421, 24422],
                       [24457, 24458],
                       [24679, 24680],
                       [24740, 24741],
                       [24813, 24814],
                       [25678, 25679],
                       [26215, 26216],
                       [26317, 26318],
                       [26438, 26439],
                       [26506, 26507],
                       [26767, 26768],
                       [26846, 26847],
                       [26888, 26889],
                       [27089, 27090],
                       [27319, 27320],
                       [27433, 27434],
                       [28386, 28387],
                       [28757, 28758],
                       [28858, 28859],
                       [29047, 29048],
                       [29765, 29766],
                       [30099, 30100],
                       [30172, 30173],
                       [31194, 31195],
                       [31248, 31249],
                       [31279, 31280],
                       [31345, 31346],
                       [31501, 31502],
                       [31707, 31708],
                       [32028, 32029],
                       [32143, 32144],
                       [32220, 32221],
                       [32322, 32323],
                       [32470, 32471],
                       [32736, 32737],
                       [32870, 32871],
                       [33173, 33174],
                       [33539, 33540],
                       [33951, 33952],
                       [34106, 34107],
                       [34151, 34152],
                       [34387, 34388],
                       [34950, 34951],
                       [35440, 35441],
                       [36743, 36744],
                       [37132, 37133],
                       [37335, 37336],
                       [37677, 37678],
                       [38419, 38420],
                       [38621, 38622],
                       [38841, 38842],
                       [39210, 39211],
                       [39301, 39302],
                       [39647, 39648],
                       [40174, 40175],
                       [40615, 40616],
                       [40683, 40684],
                       [40821, 40822],
                       [41187, 41188],
                       [41331, 41332],
                       [42502, 42503],
                       [42732, 42733],
                       [43130, 43131],
                       [43249, 43250],
                       [43636, 43637],
                       [43966, 43967],
                       [44667, 44668],
                       [44762, 44763],
                       [45524, 45525],
                       [45715, 45716],
                       [46193, 46194],
                       [46289, 46290],
                       [46575, 46576],
                       [46619, 46620],
                       [46985, 46986],
                       [47901, 47902]],
           'links': None,
           'score': None,
           'text': 'So',
           'types': ['Person']},
          {'indices': [[19791, 19803]],
           'links': None,
           'score': None,
           'text': 'Nitin Agarwal',
           'types': ['Person']},
          {'indices': [[19791, 19795], [20155, 20159], [21468, 21472]],
           'links': None,
           'score': None,
           'text': 'Nitin',
           'types': ['Person']},
          {'indices': [[13151, 13156],
                       [13476, 13481],
                       [13493, 13498],
                       [22646, 22651],
                       [22768, 22773],
                       [23004, 23009],
                       [30213, 30218],
                       [30516, 30521],
                       [30619, 30624],
                       [30645, 30650],
                       [30772, 30777],
                       [34366, 34371],
                       [34426, 34431],
                       [34984, 34989],
                       [37435, 37440],
                       [46046, 46051],
                       [46716, 46721]],
           'links': None,
           'score': None,
           'text': 'Ichnos',
           'types': ['Person', 'Organisation']},
          {'indices': [[23136, 23151]],
           'links': None,
           'score': None,
           'text': 'Shyam Srinivasan',
           'types': ['Person']},
          {'indices': [[24457, 24464]],
           'links': None,
           'score': None,
           'text': 'So Glenn',
           'types': ['Person']},
          {'indices': [[27804, 27819]],
           'links': None,
           'score': None,
           'text': 'Vishal Manchanda',
           'types': ['Person']},
          {'indices': [[27826, 27836]],
           'links': None,
           'score': None,
           'text': 'Nirmal Bang',
           'types': ['Person']},
          {'indices': [[29622, 29633], [38532, 38543]],
           'links': None,
           'score': None,
           'text': 'Vikas Sharda',
           'types': ['Person']},
          {'indices': [[33717, 33730]],
           'links': None,
           'score': None,
           'text': 'Alankar Garude',
           'types': ['Person']},
          {'indices': [[33737, 33745]],
           'links': None,
           'score': None,
           'text': 'Macquarie',
           'types': ['Person']},
          {'indices': [[35677, 35689], [47352, 47364]],
           'links': None,
           'score': None,
           'text': 'Neha Manpuria',
           'types': ['Person']},
          {'indices': [[36220, 36228]],
           'links': None,
           'score': None,
           'text': 'Typically',
           'types': ['Person']},
          {'indices': [[35677, 35680],
                       [36629, 36632],
                       [37071, 37074],
                       [47352, 47355]],
           'links': None,
           'score': None,
           'text': 'Neha',
           'types': ['Person']},
          {'indices': [[37888, 37903]],
           'links': None,
           'score': None,
           'text': 'Tushar Manudhane',
           'types': ['Person']},
          {'indices': [[41750, 41762]],
           'links': None,
           'score': None,
           'text': 'Aditya Khemka',
           'types': ['Person']},
          {'indices': [[41750, 41755], [41896, 41901], [42968, 42973]],
           'links': None,
           'score': None,
           'text': 'Aditya',
           'types': ['Person']},
          {'indices': [[36875, 36877], [42289, 42291]],
           'links': None,
           'score': None,
           'text': 'Now',
           'types': ['Person']},
          {'indices': [[42718, 42721], [44526, 44529], [44556, 44559]],
           'links': None,
           'score': None,
           'text': 'Okay',
           'types': ['Person']},
          {'indices': [[44574, 44583]],
           'links': None,
           'score': None,
           'text': 'Ranitidine',
           'types': ['Person']},
          {'indices': [[45181, 45188]],
           'links': None,
           'score': None,
           'text': 'Employee',
           'types': ['Person']},
          {'indices': [[17415, 17416],
                       [25795, 25796],
                       [29384, 29385],
                       [35579, 35580],
                       [44625, 44626],
                       [46667, 46668]],
           'links': None,
           'score': None,
           'text': 'Q1',
           'types': ['Product']},
          {'indices': [[21030, 21035], [32477, 32482]],
           'links': None,
           'score': None,
           'text': 'INR500',
           'types': ['Product']},
          {'indices': [[117, 137],
                       [16500, 16520],
                       [19723, 19743],
                       [23088, 23108],
                       [27738, 27758],
                       [29564, 29584],
                       [29987, 30007],
                       [33660, 33680],
                       [35706, 35726],
                       [37830, 37850],
                       [38475, 38495],
                       [39077, 39097],
                       [41692, 41712],
                       [44217, 44237],
                       [44966, 44986]],
           'links': None,
           'score': None,
           'text': 'Operator Instructions',
           'types': ['Organisation']},
          {'indices': [[83, 106],
                       [488, 511],
                       [554, 577],
                       [13846, 13869],
                       [13975, 13998],
                       [14951, 14974],
                       [48982, 49005]],
           'links': None,
           'score': None,
           'text': 'Glenmark Pharmaceuticals',
           'types': ['Organisation']},
          {'indices': [[929, 936]],
           'links': None,
           'score': None,
           'text': 'Business',
           'types': ['Organisation']},
          {'indices': [[2264, 2270], [2723, 2729]],
           'links': None,
           'score': None,
           'text': 'FabiFlu',
           'types': ['Organisation']},
          {'indices': [[3684, 3688]],
           'links': None,
           'score': None,
           'text': 'FAITH',
           'types': ['Organisation']},
          {'indices': [[3857, 3866]],
           'links': None,
           'score': None,
           'text': 'Umifenovir',
           'types': ['Organisation']},
          {'indices': [[4277, 4279], [4393, 4395]],
           'links': None,
           'score': None,
           'text': 'IPM',
           'types': ['Organisation']},
          {'indices': [[6550, 6552]],
           'links': None,
           'score': None,
           'text': 'HUL',
           'types': ['Organisation']},
          {'indices': [[6756, 6758], [10292, 10294]],
           'links': None,
           'score': None,
           'text': 'USA',
           'types': ['Organisation']},
          {'indices': [[7175, 7215]],
           'links': None,
           'score': None,
           'text': 'Fulvestrant Injection, Pimecrolimus Cream',
           'types': ['Organisation']},
          {'indices': [[7218, 7228]],
           'links': None,
           'score': None,
           'text': 'Deferasirox',
           'types': ['Organisation']},
          {'indices': [[7288, 7291]],
           'links': None,
           'score': None,
           'text': 'ANDA',
           'types': ['Organisation']},
          {'indices': [[7507, 7509]],
           'links': None,
           'score': None,
           'text': 'YTD',
           'types': ['Organisation']},
          {'indices': [[7760, 7774]],
           'links': None,
           'score': None,
           'text': 'Mupirocin Cream',
           'types': ['Organisation']},
          {'indices': [[7777, 7811]],
           'links': None,
           'score': None,
           'text': 'Atomoxetine and Calcipotriene Cream',
           'types': ['Organisation']},
          {'indices': [[8811, 8827]],
           'links': None,
           'score': None,
           'text': 'Glenmark’s Europe',
           'types': ['Organisation']},
          {'indices': [[9062, 9089]],
           'links': None,
           'score': None,
           'text': 'The Central Eastern European',
           'types': ['Organisation']},
          {'indices': [[9202, 9204], [9307, 9309], [9450, 9452]],
           'links': None,
           'score': None,
           'text': 'CNS',
           'types': ['Organisation']},
          {'indices': [[9361, 9366]],
           'links': None,
           'score': None,
           'text': 'Polska',
           'types': ['Organisation']},
          {'indices': [[10003, 10008]],
           'links': None,
           'score': None,
           'text': 'Hypera',
           'types': ['Organisation']},
          {'indices': [[10337, 10341], [10630, 10634], [10864, 10868]],
           'links': None,
           'score': None,
           'text': 'Hikma',
           'types': ['Organisation']},
          {'indices': [[11703, 11719]],
           'links': None,
           'score': None,
           'text': 'Seqirus Australia',
           'types': ['Organisation']},
          {'indices': [[11771, 11783]],
           'links': None,
           'score': None,
           'text': 'TGA Australia',
           'types': ['Organisation']},
          {'indices': [[11703, 11709], [11833, 11839]],
           'links': None,
           'score': None,
           'text': 'Seqirus',
           'types': ['Organisation']},
          {'indices': [[11999, 12015]],
           'links': None,
           'score': None,
           'text': 'Yuhan Corporation',
           'types': ['Organisation']},
          {'indices': [[12828, 12849], [12894, 12915], [13034, 13055]],
           'links': None,
           'score': None,
           'text': 'Glenmark Life Sciences',
           'types': ['Organisation']},
          {'indices': [[13151, 13165], [13476, 13490], [13493, 13507]],
           'links': None,
           'score': None,
           'text': 'Ichnos Sciences',
           'types': ['Organisation']},
          {'indices': [[83, 114],
                       [13846, 13877],
                       [13975, 14006],
                       [48982, 49013]],
           'links': None,
           'score': None,
           'text': 'Glenmark Pharmaceuticals Limited',
           'types': ['Organisation']},
          {'indices': [[14661, 14663]],
           'links': None,
           'score': None,
           'text': 'EVP',
           'types': ['Organisation']},
          {'indices': [[14690, 14692]],
           'links': None,
           'score': None,
           'text': 'EPD',
           'types': ['Organisation']},
          {'indices': [[15081, 15086]],
           'links': None,
           'score': None,
           'text': 'INR350',
           'types': ['Organisation']},
          {'indices': [[15437, 15441]],
           'links': None,
           'score': None,
           'text': 'INR35',
           'types': ['Organisation']},
          {'indices': [[15545, 15552]],
           'links': None,
           'score': None,
           'text': 'INR2,136',
           'types': ['Organisation']},
          {'indices': [[50, 53],
                       [15575, 15578],
                       [15679, 15682],
                       [15892, 15895],
                       [38769, 38772],
                       [38776, 38779]],
           'links': None,
           'score': None,
           'text': 'FY20',
           'types': ['Organisation']},
          {'indices': [[15912, 15919]],
           'links': None,
           'score': None,
           'text': 'INR2,226',
           'types': ['Organisation']},
          {'indices': [[16588, 16599], [45984, 45995]],
           'links': None,
           'score': None,
           'text': 'Axis Capital',
           'types': ['Organisation']},
          {'indices': [[18918, 18921]],
           'links': None,
           'score': None,
           'text': 'ICMR',
           'types': ['Organisation']},
          {'indices': [[18953, 18956],
                       [21338, 21341],
                       [21500, 21503],
                       [24732, 24735],
                       [24805, 24808],
                       [45335, 45338]],
           'links': None,
           'score': None,
           'text': 'Favi',
           'types': ['Organisation']},
          {'indices': [[19810, 19824]],
           'links': None,
           'score': None,
           'text': 'IDFC Securities',
           'types': ['Organisation']},
          {'indices': [[23158, 23170]],
           'links': None,
           'score': None,
           'text': 'Goldman Sachs',
           'types': ['Organisation']},
          {'indices': [[24592, 24595]],
           'links': None,
           'score': None,
           'text': 'MD&A',
           'types': ['Organisation']},
          {'indices': [[25960, 25974]],
           'links': None,
           'score': None,
           'text': 'Saion Mukherjee',
           'types': ['Organisation']},
          {'indices': [[25981, 25986]],
           'links': None,
           'score': None,
           'text': 'Nomura',
           'types': ['Organisation']},
          {'indices': [[26139, 26144]],
           'links': None,
           'score': None,
           'text': 'EBITDA',
           'types': ['Organisation']},
          {'indices': [[26215, 26222]],
           'links': None,
           'score': None,
           'text': 'So Saion',
           'types': ['Organisation']},
          {'indices': [[26830, 26832], [31387, 31389], [43343, 43345]],
           'links': None,
           'score': None,
           'text': 'OSD',
           'types': ['Organisation']},
          {'indices': [[29640, 29657], [38550, 38567]],
           'links': None,
           'score': None,
           'text': 'NTAsset Management',
           'types': ['Organisation']},
          {'indices': [[29866, 29871]],
           'links': None,
           'score': None,
           'text': 'INR300',
           'types': ['Organisation']},
          {'indices': [[30045, 30056], [44284, 44295]],
           'links': None,
           'score': None,
           'text': 'Chirag Dagli',
           'types': ['Organisation']},
          {'indices': [[30063, 30078]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[31112, 31113]],
           'links': None,
           'score': None,
           'text': 'CV',
           'types': ['Organisation']},
          {'indices': [[32972, 32984]],
           'links': None,
           'score': None,
           'text': 'Chlorzoxazone',
           'types': ['Organisation']},
          {'indices': [[33829, 33835], [34244, 34250]],
           'links': None,
           'score': None,
           'text': 'ISB 830',
           'types': ['Organisation']},
          {'indices': [[33852, 33854]],
           'links': None,
           'score': None,
           'text': 'ESI',
           'types': ['Organisation']},
          {'indices': [[35696, 35703], [47371, 47378]],
           'links': None,
           'score': None,
           'text': 'JPMorgan',
           'types': ['Organisation']},
          {'indices': [[37910, 37922]],
           'links': None,
           'score': None,
           'text': 'Motilal Oswal',
           'types': ['Organisation']},
          {'indices': [[37957, 37959],
                       [38045, 38047],
                       [38342, 38344],
                       [41229, 41231],
                       [45413, 45415],
                       [47222, 47224]],
           'links': None,
           'score': None,
           'text': 'API',
           'types': ['Organisation']},
          {'indices': [[39134, 39148]],
           'links': None,
           'score': None,
           'text': 'Damayanti Kerai',
           'types': ['Organisation']},
          {'indices': [[39155, 39169]],
           'links': None,
           'score': None,
           'text': 'HSBC Securities',
           'types': ['Organisation']},
          {'indices': [[40710, 40715]],
           'links': None,
           'score': None,
           'text': 'Salmex',
           'types': ['Organisation']},
          {'indices': [[40756, 40758]],
           'links': None,
           'score': None,
           'text': 'GSK',
           'types': ['Organisation']},
          {'indices': [[41769, 41783]],
           'links': None,
           'score': None,
           'text': 'DSP Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[30063, 30066], [44302, 44305]],
           'links': None,
           'score': None,
           'text': 'HDFC',
           'types': ['Organisation']},
          {'indices': [[44762, 44770]],
           'links': None,
           'score': None,
           'text': 'So Chirag',
           'types': ['Organisation']},
          {'indices': [[45024, 45037]],
           'links': None,
           'score': None,
           'text': 'Tarang Agrawal',
           'types': ['Organisation']},
          {'indices': [[45044, 45061]],
           'links': None,
           'score': None,
           'text': 'Old Bridge Capital',
           'types': ['Organisation']},
          {'indices': [[46909, 46911]],
           'links': None,
           'score': None,
           'text': 'MPC',
           'types': ['Organisation']}],
 'title': [{'indices': [[25, 27]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Dubbing_(filmmaking)'},
            'score': 1.0,
            'text': 'ADR',
            'types': ['Election', 'Process', 'PersonFunction']},
           {'indices': [[37, 39]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Chief_executive_officer'},
            'score': 0.9999976754188538,
            'text': 'CEO',
            'types': ['PersonFunction']},
           {'indices': [[41, 54]],
            'links': None,
            'score': None,
            'text': 'Glenn Saldanha',
            'types': ['Person']},
           {'indices': [[0, 23]],
            'links': None,
            'score': None,
            'text': 'Glenmark Pharmaceuticals',
            'types': ['Organisation']},
           {'indices': [[30, 34]],
            'links': None,
            'score': None,
            'text': 'GLKQY',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB3',
 'label': 'Business',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB3',
           'parent': None},
 'score': 0.25999999046325684,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB3-11',
 'label': 'Marketing',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB3-11',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB3'},
 'score': 0.2199999988079071,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.2199999988079071,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': 'IAB13-11',
 'label': 'Stocks',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-11',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.1899999976158142,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': '04016029',
 'label': 'marketing',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016029',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04016000'},
 'score': 0.14000000059604645,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.790187},
 'title': {'polarity': 'neutral', 'score': 0.898476}}"
2020-06-29  22:28;Bluewater Investment offloads Rs 632 crore stake in Laurus Labs, Titan Europe sells shares worth Rs 146.74 crore in Wheels India;"Investor Bluewater Investment has offloaded 11.68 percent equity stake in Laurus Labs via open market transaction on June 29.

Bluewater Investment sold 1,24,89,596 equity shares (representing 11.68 percent of its total paid-up equity capital) in Laurus Labs at Rs 506.07 per share, bulk deals data on BSE showed.

The above stake sale was worth Rs 632 crore.

Bluewater Investment had also sold 85 lakh equity shares in Laurus Labs at Rs 441.26 on May 28, which indicated that it offloaded its entire 19.63 percent stake (2,09,89,596 shares) in the pharma company during the June quarter.

BNP Paribas Arbitrage acquired 15 lakh shares in Laurus Labs at Rs 504.25 per share, Government Pension Fund Global bought 9,41,732 shares at Rs 504 per share, and MK Ventures acquired 7,58,000 shares at Rs 504.89 per share.

Among other deals, foreign promoter Titan Europe sold 34,31,845 equity shares (representing 14.26 percent of the total paid-up equity) in Wheels India at Rs 427.60 per share on the BSE. The deal was worth Rs 146.74 crore.

So far in the June quarter, Titan Europe sold 48,08,919 equity shares in Wheels India (the supplier of wheels) against its shareholding of 48,12,912 shares (representing 20 percent of its total paid-up equity capital) on March 31.

On the other side, its Indian promoter and its group companies - Sundaram Finance Holdings acquired 11,31,200 shares in Wheels India at Rs 427.60 per share. Both India Motor Parts and Accessories bought 5,14,000 shares and Royal Sundaram Alliance Insurance Company purchased 5,61,270 shares at the same price.

IDFC Mutual Fund and HDFC Mutual Fund bought 2,33,864 and  9,91,511 shares, respectively, in Wheels India at Rs 427.60 per share.

Beacon Trusteeship sold 31,84,498 shares in Tourism Finance Corporation of India at Rs 36.52 per share on the NSE and 9,44,757 shares at Rs 36.61 per share on the BSE. ICM Finance Pvt offloaded 7,20,088 shares in company at Rs 36.19 per share on the NSE.

Last week, Beacon Trusteeship had sold total 23,15,792 equity shares in Tourism Finance Corp via three transactions worth Rs 8.23 crore.

Sawarnbhumi Vanijya Pvt acquired 1,56,571 shares in Oriental Trimex at Rs 14.93 per share and Bunkim Finance and Investments sold 25 lakh shares in Ruchi Infrastructure at Rs 22.4 per share on the NSE.";"{'body': [{'indices': [[550, 555]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Pharmaceutical_industry'},
           'score': 1.0,
           'text': 'pharma',
           'types': ['PersonFunction']},
          {'indices': [[591, 601]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/BNP_Paribas'},
           'score': 0.999785304069519,
           'text': 'BNP Paribas',
           'types': ['Company', 'Agent', 'Bank', 'Organisation']},
          {'indices': [[9, 17], [127, 135], [361, 369]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bluewater_(shopping_centre)'},
           'score': 0.9833359718322754,
           'text': 'Bluewater',
           'types': ['ShoppingMall',
                     'Building',
                     'Location',
                     'ArchitecturalStructure',
                     'Place']},
          {'indices': [[58, 63],
                       [165, 170],
                       [228, 233],
                       [404, 409],
                       [881, 886],
                       [944, 949],
                       [1096, 1101],
                       [1242, 1247],
                       [2025, 2030]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 0.6293148994445801,
           'text': 'equity',
           'types': ['Disease', 'Difference']},
          {'indices': [[228, 241], [1242, 1255]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
           'score': 1.0,
           'text': 'equity capital',
           'types': ['Disease', 'Difference']},
          {'indices': [[859, 864], [1074, 1079]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Europe'},
           'score': 0.998126208782196,
           'text': 'Europe',
           'types': ['Country',
                     'PopulatedPlace',
                     'Continent',
                     'Location',
                     'Place']},
          {'indices': [[962, 966],
                       [1120, 1124],
                       [1399, 1403],
                       [1434, 1438],
                       [1683, 1687],
                       [1789, 1793]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
           'score': 0.9988570809364319,
           'text': 'India',
           'types': ['Country',
                     'PopulatedPlace',
                     'MusicalArtist',
                     'Location',
                     'Place']},
          {'indices': [[74, 79], [247, 252], [421, 426], [640, 645]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Laurus'},
           'score': 1.0,
           'text': 'Laurus',
           'types': ['Trees', 'Species', 'Plant', 'Eukaryote']},
          {'indices': [[165, 177],
                       [404, 416],
                       [881, 893],
                       [1096, 1108],
                       [2025, 2037]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Common_stock'},
           'score': 1.0,
           'text': 'equity shares',
           'types': ['Form']},
          {'indices': [[399, 402], [625, 628], [2241, 2244]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Lakh'},
           'score': 1.0,
           'text': 'lakh',
           'types': ['Unit', 'Organisation']},
          {'indices': [[302, 304], [998, 1000], [1877, 1879]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Bombay_Stock_Exchange'},
           'score': 0.5202836990356445,
           'text': 'BSE',
           'types': ['Exchange', 'Company', 'Organisation']},
          {'indices': [[353, 357], [1032, 1036], [2100, 2104]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
           'score': 1.0,
           'text': 'crore',
           'types': ['Unit', 'Organisation']},
          {'indices': [[687, 705]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Government_Pension_Fund_of_Norway'},
           'score': 1.0,
           'text': 'Pension Fund Global',
           'types': ['Company']},
          {'indices': [[603, 611]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Arbitrage'},
           'score': 1.0,
           'text': 'Arbitrage',
           'types': ['Practice', 'Company']},
          {'indices': [[1003, 1010]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/The_Deal_(2003_film)'},
           'score': 0.9999265074729919,
           'text': 'The deal',
           'types': ['Work', 'Product', 'TelevisionShow', 'Film']},
          {'indices': [[65, 69], [325, 329], [516, 520]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Stake_(Latter_Day_Saints)'},
           'score': 0.549546480178833,
           'text': 'stake',
           'types': ['Unit', 'Organisation']},
          {'indices': [[1824, 1826], [1964, 1966], [2305, 2307]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/National_Stock_Exchange_of_India'},
           'score': 0.7641948461532593,
           'text': 'NSE',
           'types': ['Exchange', 'Company', 'Organisation']},
          {'indices': [[1882, 1884]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/International_Congress_of_Mathematicians'},
           'score': 0.9666646122932434,
           'text': 'ICM',
           'types': ['SocietalEvent',
                     'Conference',
                     'Convention',
                     'Event',
                     'Organisation']},
          {'indices': [[853, 857], [1068, 1072]],
           'links': {'dbpedia': 'http://dbpedia.org/resource/Titan_(moon)'},
           'score': 0.8765548467636108,
           'text': 'Titan',
           'types': ['Planet', 'Moon', 'CelestialBody', 'Location', 'Place']},
          {'indices': [[436, 444]],
           'links': None,
           'score': None,
           'text': 'Rs 441.26',
           'types': ['Place']},
          {'indices': [[655, 663]],
           'links': None,
           'score': None,
           'text': 'Rs 504.25',
           'types': ['Place']},
          {'indices': [[853, 864], [1068, 1079]],
           'links': None,
           'score': None,
           'text': 'Titan Europe',
           'types': ['Place']},
          {'indices': [[955, 966], [1113, 1124], [1392, 1403], [1676, 1687]],
           'links': None,
           'score': None,
           'text': 'Wheels India',
           'types': ['Place']},
          {'indices': [[971, 979], [1408, 1416], [1692, 1700]],
           'links': None,
           'score': None,
           'text': 'Rs 427.60',
           'types': ['Place']},
          {'indices': [[1022, 1030]],
           'links': None,
           'score': None,
           'text': 'Rs 146.74',
           'types': ['Place']},
          {'indices': [[955, 960], [1113, 1118], [1392, 1397], [1676, 1681]],
           'links': None,
           'score': None,
           'text': 'Wheels',
           'types': ['Place']},
          {'indices': [[1714, 1731], [1981, 1998]],
           'links': None,
           'score': None,
           'text': 'Beacon Trusteeship',
           'types': ['Place', 'Organisation']},
          {'indices': [[262, 263],
                       [346, 347],
                       [436, 437],
                       [655, 656],
                       [733, 734],
                       [795, 796],
                       [971, 972],
                       [1022, 1023],
                       [1408, 1409],
                       [1692, 1693],
                       [1798, 1799],
                       [1851, 1852],
                       [1938, 1939],
                       [2092, 2093],
                       [2179, 2180],
                       [2280, 2281]],
           'links': None,
           'score': None,
           'text': 'Rs',
           'types': ['Place']},
          {'indices': [[1938, 1945]],
           'links': None,
           'score': None,
           'text': 'Rs 36.19',
           'types': ['Place']},
          {'indices': [[2280, 2286]],
           'links': None,
           'score': None,
           'text': 'Rs 22.4',
           'types': ['Place']},
          {'indices': [[9, 28], [127, 146], [361, 380]],
           'links': None,
           'score': None,
           'text': 'Bluewater Investment',
           'types': ['Person']},
          {'indices': [[591, 611]],
           'links': None,
           'score': None,
           'text': 'BNP Paribas Arbitrage',
           'types': ['Person']},
          {'indices': [[1894, 1896], [2128, 2130]],
           'links': None,
           'score': None,
           'text': 'Pvt',
           'types': ['Person']},
          {'indices': [[2108, 2130]],
           'links': None,
           'score': None,
           'text': 'Sawarnbhumi Vanijya Pvt',
           'types': ['Person']},
          {'indices': [[2202, 2215]],
           'links': None,
           'score': None,
           'text': 'Bunkim Finance',
           'types': ['Person']},
          {'indices': [[0, 28]],
           'links': None,
           'score': None,
           'text': 'Investor Bluewater Investment',
           'types': ['Organisation']},
          {'indices': [[74, 84], [247, 257], [421, 431], [640, 650]],
           'links': None,
           'score': None,
           'text': 'Laurus Labs',
           'types': ['Organisation']},
          {'indices': [[676, 705]],
           'links': None,
           'score': None,
           'text': 'Government Pension Fund Global',
           'types': ['Organisation']},
          {'indices': [[755, 765]],
           'links': None,
           'score': None,
           'text': 'MK Ventures',
           'types': ['Organisation']},
          {'indices': [[795, 803]],
           'links': None,
           'score': None,
           'text': 'Rs 504.89',
           'types': ['Organisation']},
          {'indices': [[1337, 1361]],
           'links': None,
           'score': None,
           'text': 'Sundaram Finance Holdings',
           'types': ['Organisation']},
          {'indices': [[1434, 1450]],
           'links': None,
           'score': None,
           'text': 'India Motor Parts',
           'types': ['Organisation']},
          {'indices': [[1456, 1466]],
           'links': None,
           'score': None,
           'text': 'Accessories',
           'types': ['Organisation']},
          {'indices': [[1495, 1535]],
           'links': None,
           'score': None,
           'text': 'Royal Sundaram Alliance Insurance Company',
           'types': ['Organisation']},
          {'indices': [[1583, 1598]],
           'links': None,
           'score': None,
           'text': 'IDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1604, 1619]],
           'links': None,
           'score': None,
           'text': 'HDFC Mutual Fund',
           'types': ['Organisation']},
          {'indices': [[1758, 1784]],
           'links': None,
           'score': None,
           'text': 'Tourism Finance Corporation',
           'types': ['Organisation']},
          {'indices': [[2042, 2061]],
           'links': None,
           'score': None,
           'text': 'Tourism Finance Corp',
           'types': ['Organisation']},
          {'indices': [[2221, 2231]],
           'links': None,
           'score': None,
           'text': 'Investments',
           'types': ['Organisation']},
          {'indices': [[2256, 2275]],
           'links': None,
           'score': None,
           'text': 'Ruchi Infrastructure',
           'types': ['Organisation']}],
 'title': [{'indices': [[65, 69]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Titan_(mythology)'},
            'score': 0.9394182562828064,
            'text': 'Titan',
            'types': ['Members']},
           {'indices': [[0, 8]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Bluewater_(shopping_centre)'},
            'score': 1.0,
            'text': 'Bluewater',
            'types': ['Place',
                      'ShoppingMall',
                      'Building',
                      'ArchitecturalStructure',
                      'Location']},
           {'indices': [[43, 47]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Equity_(finance)'},
            'score': 0.699138879776001,
            'text': 'stake',
            'types': ['Disease', 'Difference']},
           {'indices': [[71, 76]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Europe'},
            'score': 0.9988340735435486,
            'text': 'Europe',
            'types': ['Place',
                      'Country',
                      'Location',
                      'PopulatedPlace',
                      'Continent']},
           {'indices': [[123, 127]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/India'},
            'score': 0.9995120763778687,
            'text': 'India',
            'types': ['Place',
                      'Country',
                      'Location',
                      'PopulatedPlace',
                      'MusicalArtist']},
           {'indices': [[52, 57]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Laurus'},
            'score': 1.0,
            'text': 'Laurus',
            'types': ['Species', 'Plant', 'Eukaryote', 'Trees']},
           {'indices': [[37, 41], [107, 111]],
            'links': {'dbpedia': 'http://dbpedia.org/resource/Crore'},
            'score': 1.0,
            'text': 'crore',
            'types': ['Organisation', 'Unit']},
           {'indices': [[65, 76]],
            'links': None,
            'score': None,
            'text': 'Titan Europe',
            'types': ['Place']},
           {'indices': [[97, 105]],
            'links': None,
            'score': None,
            'text': 'Rs 146.74',
            'types': ['Place']},
           {'indices': [[116, 127]],
            'links': None,
            'score': None,
            'text': 'Wheels India',
            'types': ['Place']},
           {'indices': [[0, 19]],
            'links': None,
            'score': None,
            'text': 'Bluewater Investment',
            'types': ['Organisation']},
           {'indices': [[52, 62]],
            'links': None,
            'score': None,
            'text': 'Laurus Labs',
            'types': ['Organisation']}]}";"[{'confident': True,
 'id': 'IAB13',
 'label': 'Personal Finance',
 'level': 1,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13',
           'parent': None},
 'score': 0.5099999904632568,
 'taxonomy': 'iab-qag'}, {'confident': False,
 'id': 'IAB13-8',
 'label': 'Mutual Funds',
 'level': 2,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13-8',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iab-qag/IAB13'},
 'score': 0.1599999964237213,
 'taxonomy': 'iab-qag'}, {'confident': True,
 'id': '04011002',
 'label': 'automotive equipment',
 'level': 3,
 'links': {'_self': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04011002',
           'parent': 'https://api.aylien.com/api/v1/classify/taxonomy/iptc-subjectcode/04011000'},
 'score': 0.11999999731779099,
 'taxonomy': 'iptc-subjectcode'}]";"{'body': {'polarity': 'positive', 'score': 0.730025},
 'title': {'polarity': 'neutral', 'score': 0.758074}}"
